<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:googleplay="http://www.google.com/schemas/play-podcasts/1.0" xmlns:itunes="http://www.itunes.com/dtds/podcast-1.0.dtd" xmlns:media="http://search.yahoo.com/mrss/" xmlns:podcast="https://podcastindex.org/namespace/1.0">
  <channel>
    <atom:link href="https://feeds.simplecast.com/3xFUWysr" rel="self" title="MP3 Audio" type="application/atom+xml"/>
    <atom:link href="https://simplecast.superfeedr.com" rel="hub" xmlns="http://www.w3.org/2005/Atom"/>
    <generator>https://simplecast.com</generator>
    <title>TheBrief.Health</title>
    <description>Medical News and Information in 2 Minutes or Less.</description>
    <copyright>2025-2026 TheBrief.Health</copyright>
    <language>en</language>
    <pubDate>Thu, 21 May 2026 20:00:00 +0000</pubDate>
    <lastBuildDate>Thu, 21 May 2026 20:00:12 +0000</lastBuildDate>
    <image>
      <link>https://thebrief-health.simplecast.com</link>
      <title>TheBrief.Health</title>
      <url>https://image.simplecastcdn.com/images/90af2279-f7d9-426f-bdb6-cb4a4a221358/e73b2da8-efa4-49ef-98e2-a9f59a227a12/3000x3000/thebriefhealth-square-logo-white-background.jpg?aid=rss_feed</url>
    </image>
    <link>https://thebrief-health.simplecast.com</link>
    <itunes:type>episodic</itunes:type>
    <itunes:summary>Medical News and Information in 2 Minutes or Less.</itunes:summary>
    <itunes:author>TheBrief.Health</itunes:author>
    <itunes:explicit>false</itunes:explicit>
    <itunes:image href="https://image.simplecastcdn.com/images/90af2279-f7d9-426f-bdb6-cb4a4a221358/e73b2da8-efa4-49ef-98e2-a9f59a227a12/3000x3000/thebriefhealth-square-logo-white-background.jpg?aid=rss_feed"/>
    <itunes:new-feed-url>https://feeds.simplecast.com/3xFUWysr</itunes:new-feed-url>
    <itunes:keywords>healthcare professionals, pharma, pharma media, pharma news</itunes:keywords>
    <itunes:owner>
      <itunes:name>TheBrief.Health</itunes:name>
      <itunes:email>info@thebrief.health</itunes:email>
    </itunes:owner>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Medicine"/>
    </itunes:category>
    <itunes:category text="Health &amp; Fitness">
      <itunes:category text="Nutrition"/>
    </itunes:category>
    <item>
      <guid isPermaLink="false">a18cc2d1-361f-48ef-bdca-a404d46e7018</guid>
      <title>5% of Americans May Carry Genetic Variants Increasing Cancer Risk</title>
      <description><![CDATA[A recent study found 5% of Americans carry inherited cancer-risk variants, highlighting genetic testing’s growing role in personalized prevention, surveillance, and precision oncology care. 
]]></description>
      <pubDate>Thu, 21 May 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/5-of-americans-may-carry-genetic-variants-increasing-cancer-risk-3ydaC8Z3</link>
      <enclosure length="927494" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/dfe34429-6e87-446c-bcb1-d41be137b21d/group-item/a1ab3efa-5308-4be4-b6fd-4f5023f1f642/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>5% of Americans May Carry Genetic Variants Increasing Cancer Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:57</itunes:duration>
      <itunes:summary>A recent study found 5% of Americans carry inherited cancer-risk variants, highlighting genetic testing’s growing role in personalized prevention, surveillance, and precision oncology care.</itunes:summary>
      <itunes:subtitle>A recent study found 5% of Americans carry inherited cancer-risk variants, highlighting genetic testing’s growing role in personalized prevention, surveillance, and precision oncology care.</itunes:subtitle>
      <itunes:keywords>a recent study found 5% of americans carry inherited cancer-risk variants, highlighting genetic testing’s growing role in personalized prevention, and precision oncology care., surveillance</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>464</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">401d9f48-584b-4018-a74a-64116ff644fa</guid>
      <title>Advanced Molecular Diagnostics Enhance Classification of Primary Myelofibrosis</title>
      <description><![CDATA[Advances in molecular diagnostics are improving primary myelofibrosis classification, enabling more precise diagnoses, personalized treatments, and targeted therapies based on patients’ genetic profiles. 
]]></description>
      <pubDate>Thu, 21 May 2026 19:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advanced-molecular-diagnostics-enhance-classification-of-primary-myelofibrosis-gl71IVk6</link>
      <enclosure length="1554015" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/63ad1511-610e-4a25-beb5-6ab5f9ab6ded/group-item/e73d09f4-f5fd-497d-b9ef-1c0a54b8d076/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advanced Molecular Diagnostics Enhance Classification of Primary Myelofibrosis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>Advances in molecular diagnostics are improving primary myelofibrosis classification, enabling more precise diagnoses, personalized treatments, and targeted therapies based on patients’ genetic profiles.</itunes:summary>
      <itunes:subtitle>Advances in molecular diagnostics are improving primary myelofibrosis classification, enabling more precise diagnoses, personalized treatments, and targeted therapies based on patients’ genetic profiles.</itunes:subtitle>
      <itunes:keywords>enabling more precise diagnoses, and targeted therapies based on patients’ genetic profiles., advances in molecular diagnostics are improving primary myelofibrosis classification, personalized treatments</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>463</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5d3b0f8a-a0f2-4ba8-9386-9d6b2189f17f</guid>
      <title>Exploring Key Health Policy Challenges in Women’s Health</title>
      <description><![CDATA[Policy changes and healthcare inequities are limiting women’s access to reproductive and maternal care, disproportionately affecting low-income, marginalized, and gender-diverse populations nationwide. 
]]></description>
      <pubDate>Thu, 21 May 2026 18:10:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/exploring-key-health-policy-challenges-in-womens-health-WZ1SeYTL</link>
      <enclosure length="835125" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5dd54f5f-7263-4dc2-8268-04dc1cfec66c/group-item/348ffc01-fdb9-4c40-ae18-6f4d5afbc457/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Exploring Key Health Policy Challenges in Women’s Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:52</itunes:duration>
      <itunes:summary>Policy changes and healthcare inequities are limiting women’s access to reproductive and maternal care, disproportionately affecting low-income, marginalized, and gender-diverse populations nationwide.</itunes:summary>
      <itunes:subtitle>Policy changes and healthcare inequities are limiting women’s access to reproductive and maternal care, disproportionately affecting low-income, marginalized, and gender-diverse populations nationwide.</itunes:subtitle>
      <itunes:keywords>marginalized, and gender-diverse populations nationwide., policy changes and healthcare inequities are limiting women’s access to reproductive and maternal care, disproportionately affecting low-income</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>462</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9416e0f1-84ec-4a91-924f-5e6d334e8121</guid>
      <title>Rising Health Care Costs May Impact Patient Affordability</title>
      <description><![CDATA[Rising U.S. healthcare costs continue exceeding inflation, creating affordability challenges, delayed medical care, growing debt, and unequal access despite widespread insurance coverage nationwide. 
]]></description>
      <pubDate>Thu, 21 May 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rising-health-care-costs-may-impact-patient-affordability-j4a4F7kV</link>
      <enclosure length="1559866" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d583e39a-2a43-4118-a377-3e497c6dbfc0/group-item/94dfc044-1509-4cf4-831b-44bee9efab2f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rising Health Care Costs May Impact Patient Affordability</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>Rising U.S. healthcare costs continue exceeding inflation, creating affordability challenges, delayed medical care, growing debt, and unequal access despite widespread insurance coverage nationwide.</itunes:summary>
      <itunes:subtitle>Rising U.S. healthcare costs continue exceeding inflation, creating affordability challenges, delayed medical care, growing debt, and unequal access despite widespread insurance coverage nationwide.</itunes:subtitle>
      <itunes:keywords>and unequal access despite widespread insurance coverage nationwide., creating affordability challenges, growing debt, delayed medical care, rising u.s. healthcare costs continue exceeding inflation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>461</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8e8e2ac5-ce88-4ce1-9299-fbf30093e90b</guid>
      <title>Uninsured Populations: Exploring Health Coverage Gaps</title>
      <description><![CDATA[U.S. health coverage challenges persist as policy changes threaten to increase uninsured rates, disproportionately affecting low-income and underserved communities’ access to healthcare services. 
]]></description>
      <pubDate>Thu, 21 May 2026 16:15:51 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/uninsured-populations-exploring-health-coverage-gaps-sGiNRQjL</link>
      <enclosure length="1549835" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/33c11561-370a-42c8-9a02-460f9582e41f/group-item/98b730ab-c1dd-41d0-92ab-241421a1f7ea/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Uninsured Populations: Exploring Health Coverage Gaps</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>U.S. health coverage challenges persist as policy changes threaten to increase uninsured rates, disproportionately affecting low-income and underserved communities’ access to healthcare services.</itunes:summary>
      <itunes:subtitle>U.S. health coverage challenges persist as policy changes threaten to increase uninsured rates, disproportionately affecting low-income and underserved communities’ access to healthcare services.</itunes:subtitle>
      <itunes:keywords>disproportionately affecting low-income and underserved communities’ access to healthcare services., u.s. health coverage challenges persist as policy changes threaten to increase uninsured rates</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>460</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">07b0c1db-466e-4cf8-8333-a1aee01276a8</guid>
      <title>Penpulimab Regimens May Improve Outcomes in Resectable NSCLC</title>
      <description><![CDATA[Emerging combination therapy using penpulimab, anlotinib, and chemotherapy shows promise for improving pathological response and survival outcomes in resectable non-small cell lung cancer. 
]]></description>
      <pubDate>Wed, 20 May 2026 19:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/penpulimab-regimens-may-improve-outcomes-in-resectable-nsclc-ervnOzpb</link>
      <enclosure length="1366351" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a943bacb-5c18-4d5d-b5b3-ea707b3d7e9e/group-item/b912461b-ded9-4c77-bfd5-5d57c1a32997/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Penpulimab Regimens May Improve Outcomes in Resectable NSCLC</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Emerging combination therapy using penpulimab, anlotinib, and chemotherapy shows promise for improving pathological response and survival outcomes in resectable non-small cell lung cancer.</itunes:summary>
      <itunes:subtitle>Emerging combination therapy using penpulimab, anlotinib, and chemotherapy shows promise for improving pathological response and survival outcomes in resectable non-small cell lung cancer.</itunes:subtitle>
      <itunes:keywords>anlotinib, emerging combination therapy using penpulimab, and chemotherapy shows promise for improving pathological response and survival outcomes in resectable non-small cell lung cancer.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>459</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e4be10c9-748a-4ac3-aa30-521b3f563c77</guid>
      <title>Exploring Future Directions for the National Prostate Cancer Audit (NCPA)</title>
      <description><![CDATA[The National Prostate Cancer Audit aims to improve prostate cancer care through enhanced outcome tracking, updated clinical guidelines, and better patient support services nationwide. 
]]></description>
      <pubDate>Wed, 20 May 2026 18:10:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/exploring-future-directions-for-the-national-prostate-cancer-audit-ncpa-57F3MJiu</link>
      <enclosure length="1666028" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/c0a9e4bb-91e9-42d9-b480-c1dad3782a2b/group-item/25c145a1-993f-40c4-b374-2b43cef3fdc3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Exploring Future Directions for the National Prostate Cancer Audit (NCPA)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>The National Prostate Cancer Audit aims to improve prostate cancer care through enhanced outcome tracking, updated clinical guidelines, and better patient support services nationwide.</itunes:summary>
      <itunes:subtitle>The National Prostate Cancer Audit aims to improve prostate cancer care through enhanced outcome tracking, updated clinical guidelines, and better patient support services nationwide.</itunes:subtitle>
      <itunes:keywords>updated clinical guidelines, the national prostate cancer audit aims to improve prostate cancer care through enhanced outcome tracking, and better patient support services nationwide.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>458</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9225d2ef-322b-4967-9067-449989d6425b</guid>
      <title>Experts Optimistic About SERD Development in HR-Positive Breast Cancer</title>
      <description><![CDATA[Emerging selective estrogen receptor degraders (SERDs) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life. 
]]></description>
      <pubDate>Wed, 20 May 2026 17:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/experts-optimistic-about-serd-development-in-hr-positive-breast-cancer-77Xnrel7</link>
      <enclosure length="1694867" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/ce2df3f7-86e0-42c2-b271-82259ad44d15/group-item/90585910-3930-4026-9b0b-dff25a7b9d25/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Experts Optimistic About SERD Development in HR-Positive Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Emerging selective estrogen receptor degraders (SERDs) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life.</itunes:summary>
      <itunes:subtitle>Emerging selective estrogen receptor degraders (SERDs) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life.</itunes:subtitle>
      <itunes:keywords>emerging selective estrogen receptor degraders (serds) offer promising targeted treatment options for early-stage hormone receptor-positive breast cancer, potentially improving survival rates and patient quality of life.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>457</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7f267a22-8e72-41fb-91a1-482f2608de4c</guid>
      <title>Order of Advanced Airway Devices in Out-of-Hospital Cardiac Arrest</title>
      <description><![CDATA[A nationwide EMS study found supraglottic airways achieved higher success rates than endotracheal intubation during out-of-hospital cardiac arrest, supporting faster, more reliable airway management. 
]]></description>
      <pubDate>Wed, 20 May 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/order-of-advanced-airway-devices-in-out-of-hospital-cardiac-arrest-U0TkX4vh</link>
      <enclosure length="1643040" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3f7df2cd-69ac-4890-908d-9af0b88b1420/group-item/5345cb30-c9d5-49c9-ad16-50d4817d546f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Order of Advanced Airway Devices in Out-of-Hospital Cardiac Arrest</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>A nationwide EMS study found supraglottic airways achieved higher success rates than endotracheal intubation during out-of-hospital cardiac arrest, supporting faster, more reliable airway management.</itunes:summary>
      <itunes:subtitle>A nationwide EMS study found supraglottic airways achieved higher success rates than endotracheal intubation during out-of-hospital cardiac arrest, supporting faster, more reliable airway management.</itunes:subtitle>
      <itunes:keywords>supporting faster, more reliable airway management., a nationwide ems study found supraglottic airways achieved higher success rates than endotracheal intubation during out-of-hospital cardiac arrest</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>456</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">97bf0388-e5eb-4dfa-bef2-bed9747b4d16</guid>
      <title>FDA Device Authorizations Over the Past Decade: AI/ML, Pathway, and Specialty</title>
      <description><![CDATA[Over the past decade, the U.S. Food and Drug Administration (FDA) device authorizations have shifted from incremental hardware approvals toward a flood of software-driven and artificial intelligence/machine learning (AI/ML) products that behave more like continuous services than one-time tools. 
]]></description>
      <pubDate>Wed, 20 May 2026 13:34:05 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-device-authorizations-over-the-past-decade-ai-ml-pathway-and-specialty-AhgjOqXZ</link>
      <enclosure length="1741261" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/af97a3dc-91cb-46bb-b193-74f620ae2e34/group-item/130e6486-55ab-4ec3-b3df-9707d4d9cbc2/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Device Authorizations Over the Past Decade: AI/ML, Pathway, and Specialty</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Over the past decade, the U.S. Food and Drug Administration (FDA) device authorizations have shifted from incremental hardware approvals toward a flood of software-driven and artificial intelligence/machine learning (AI/ML) products that behave more like continuous services than one-time tools.</itunes:summary>
      <itunes:subtitle>Over the past decade, the U.S. Food and Drug Administration (FDA) device authorizations have shifted from incremental hardware approvals toward a flood of software-driven and artificial intelligence/machine learning (AI/ML) products that behave more like continuous services than one-time tools.</itunes:subtitle>
      <itunes:keywords>safety oversight, fda device approvals increasingly favor ai-driven technologies cleared through the 510(k) pathway, raising concerns about limited clinical evidence, and healthcare accountability.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>455</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">418265e6-dcd3-4a35-89c9-7204c83bd416</guid>
      <title>Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation</title>
      <description><![CDATA[Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly. 
]]></description>
      <pubDate>Mon, 18 May 2026 18:35:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bridging-the-chasm-in-ventricular-tachycardia-medtronics-sphere-9-fda-breakthrough-designation-_2uXF4tp</link>
      <enclosure length="1689852" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/09cea466-0d64-4327-acce-1350c9385183/group-item/151ee779-3ad9-4a01-9ae9-8c0ce628cb2d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bridging the Chasm in Ventricular Tachycardia: Medtronic’s Sphere-9 FDA Breakthrough Designation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.</itunes:summary>
      <itunes:subtitle>Medtronic’s Sphere-9 catheter earned FDA Breakthrough status for ventricular tachycardia, combining RF and pulsed-field ablation to improve lesion durability, procedural safety, and recurrence outcomes significantly.</itunes:subtitle>
      <itunes:keywords>medtronic’s sphere-9 catheter earned fda breakthrough status for ventricular tachycardia, procedural safety, and recurrence outcomes significantly., combining rf and pulsed-field ablation to improve lesion durability</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>454</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e77f79b3-e41d-48cb-9327-a6d8f224d23d</guid>
      <title>Women’s Health Primary Care Practitioners and VHA Care Attrition:Why Provider Stability Matters for Women Veterans</title>
      <description><![CDATA[Specialized women’s health primary care practitioners improve retention, continuity, trauma-informed care, and preventive services for women Veterans while supporting expanding VA healthcare access nationwide equitably. 
]]></description>
      <pubDate>Mon, 18 May 2026 18:05:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/womens-health-primary-care-practitioners-and-vha-care-attrition-why-provider-stability-matters-for-women-veterans-DjZSfjYD</link>
      <enclosure length="1616291" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d8097b1b-3a3b-4c81-a05a-f0b2cc4f1a36/group-item/cd5b3622-6b40-470e-94a2-5fec38185556/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Women’s Health Primary Care Practitioners and VHA Care Attrition:Why Provider Stability Matters for Women Veterans</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Specialized women’s health primary care practitioners improve retention, continuity, trauma-informed care, and preventive services for women Veterans while supporting expanding VA healthcare access nationwide equitably.</itunes:summary>
      <itunes:subtitle>Specialized women’s health primary care practitioners improve retention, continuity, trauma-informed care, and preventive services for women Veterans while supporting expanding VA healthcare access nationwide equitably.</itunes:subtitle>
      <itunes:keywords>continuity, specialized women’s health primary care practitioners improve retention, and preventive services for women veterans while supporting expanding va healthcare access nationwide equitably., trauma-informed care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>453</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fc0896fc-7bb7-4e40-8bcd-f86ab11f1ac5</guid>
      <title>Pharmacy-Based Methadone Treatment for Opioid Use Disorder: Expanding Access Through Community Pharmacies</title>
      <description><![CDATA[Pharmacy-based methadone treatment expands opioid addiction care by letting patients receive daily methadone at local pharmacies, improving access, convenience, treatment retention, and overdose prevention outcomes. 
]]></description>
      <pubDate>Mon, 18 May 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pharmacy-based-methadone-treatment-for-opioid-use-disorder-expanding-access-through-community-pharmacies-jPOq4CZD</link>
      <enclosure length="1887546" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e1edf4f0-74f1-404e-8430-dca138eb50bb/group-item/4671723b-295c-4706-ac45-4f4b6750be9c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pharmacy-Based Methadone Treatment for Opioid Use Disorder: Expanding Access Through Community Pharmacies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Pharmacy-based methadone treatment expands opioid addiction care by letting patients receive daily methadone at local pharmacies, improving access, convenience, treatment retention, and overdose prevention outcomes.</itunes:summary>
      <itunes:subtitle>Pharmacy-based methadone treatment expands opioid addiction care by letting patients receive daily methadone at local pharmacies, improving access, convenience, treatment retention, and overdose prevention outcomes.</itunes:subtitle>
      <itunes:keywords>improving access, convenience, pharmacy-based methadone treatment expands opioid addiction care by letting patients receive daily methadone at local pharmacies, treatment retention, and overdose prevention outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>452</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f2f713a6-c81f-4adc-9108-eae51157e38a</guid>
      <title>Pulse Biosciences Highlights Promising PFA Results for AFib Treatment at HRS 2026</title>
      <description><![CDATA[Early pulsed-field ablation data show durable atrial fibrillation control, faster procedures, and fewer complications, signaling potential transformation of catheter-based cardiac rhythm treatment for many patients. 
]]></description>
      <pubDate>Mon, 18 May 2026 15:45:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pulse-biosciences-highlights-promising-pfa-results-for-afib-treatment-at-hrs-2026-MUSp9kdD</link>
      <enclosure length="1968212" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/bbde78a3-74d7-4fab-ac47-37a009831aea/group-item/af170583-3da6-4f4d-9b65-2122cbd14d5d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pulse Biosciences Highlights Promising PFA Results for AFib Treatment at HRS 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Early pulsed-field ablation data show durable atrial fibrillation control, faster procedures, and fewer complications, signaling potential transformation of catheter-based cardiac rhythm treatment for many patients.</itunes:summary>
      <itunes:subtitle>Early pulsed-field ablation data show durable atrial fibrillation control, faster procedures, and fewer complications, signaling potential transformation of catheter-based cardiac rhythm treatment for many patients.</itunes:subtitle>
      <itunes:keywords>faster procedures, and fewer complications, signaling potential transformation of catheter-based cardiac rhythm treatment for many patients., early pulsed-field ablation data show durable atrial fibrillation control</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>451</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">da63bf44-35d2-4d0f-a818-d0d232cdbf8d</guid>
      <title>Pharmacist-Led Hospital Discharge Care: Who Benefits Most</title>
      <description><![CDATA[Pharmacist-led discharge care improves medication safety through reconciliation, patient counseling, and follow-up, reducing preventable errors, hospital readmissions, and complications after hospitalization. 
]]></description>
      <pubDate>Mon, 18 May 2026 15:22:01 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pharmacist-led-hospital-discharge-care-who-benefits-most-3FgjWmps</link>
      <enclosure length="1823598" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e641e58c-ee3c-4acb-9a78-cf649c1e4198/group-item/6b4d4339-eaf4-4af8-838b-df3326edf921/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pharmacist-Led Hospital Discharge Care: Who Benefits Most</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:53</itunes:duration>
      <itunes:summary>Pharmacist-led discharge care improves medication safety through reconciliation, patient counseling, and follow-up, reducing preventable errors, hospital readmissions, and complications after hospitalization.</itunes:summary>
      <itunes:subtitle>Pharmacist-led discharge care improves medication safety through reconciliation, patient counseling, and follow-up, reducing preventable errors, hospital readmissions, and complications after hospitalization.</itunes:subtitle>
      <itunes:keywords>pharmacist-led discharge care improves medication safety through reconciliation, hospital readmissions, and follow-up, patient counseling, reducing preventable errors, and complications after hospitalization.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>450</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6eaa33c0-9b4d-4fdc-aec2-6a9d3ae9e26b</guid>
      <title>2026 AAN Neurology Updates: The Changing Face of Neuroinfectious Disease</title>
      <description><![CDATA[New neuroinfectious disease updates emphasize biomarker-driven diagnosis, genetic testing, earlier steroid use, and shorter fungal treatment regimens to improve outcomes in high-risk neurological infections. 
]]></description>
      <pubDate>Fri, 15 May 2026 18:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/2026-aan-neurology-updates-the-changing-face-of-neuroinfectious-disease-c1CFUKxU</link>
      <enclosure length="2081897" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5cd0198d-2209-428c-9cf9-fa926593890d/group-item/1f16cb07-9727-4f14-b556-ecff602956d8/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>2026 AAN Neurology Updates: The Changing Face of Neuroinfectious Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:10</itunes:duration>
      <itunes:summary>New neuroinfectious disease updates emphasize biomarker-driven diagnosis, genetic testing, earlier steroid use, and shorter fungal treatment regimens to improve outcomes in high-risk neurological infections.</itunes:summary>
      <itunes:subtitle>New neuroinfectious disease updates emphasize biomarker-driven diagnosis, genetic testing, earlier steroid use, and shorter fungal treatment regimens to improve outcomes in high-risk neurological infections.</itunes:subtitle>
      <itunes:keywords>and shorter fungal treatment regimens to improve outcomes in high-risk neurological infections., genetic testing, earlier steroid use, new neuroinfectious disease updates emphasize biomarker-driven diagnosis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>449</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">200663bb-863a-43f9-932a-39013b517718</guid>
      <title>A New Era for Huntington’s Disease Care: 2026 AAN Key Takeaways</title>
      <description><![CDATA[Modern Huntington’s disease care emphasizes multidisciplinary management of motor, cognitive, and psychiatric symptoms while integrating advanced staging systems and preparing patients for emerging therapies. 
]]></description>
      <pubDate>Fri, 15 May 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/a-new-era-for-huntingtons-disease-care-2026-aan-key-takeaways-9jsz2rnI</link>
      <enclosure length="2157548" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/c3668bec-78bc-401a-9b7e-83886982f0f3/group-item/da26fa5e-dc51-4f1b-a8a4-b0ac04bd095e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>A New Era for Huntington’s Disease Care: 2026 AAN Key Takeaways</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:14</itunes:duration>
      <itunes:summary>Modern Huntington’s disease care emphasizes multidisciplinary management of motor, cognitive, and psychiatric symptoms while integrating advanced staging systems and preparing patients for emerging therapies.</itunes:summary>
      <itunes:subtitle>Modern Huntington’s disease care emphasizes multidisciplinary management of motor, cognitive, and psychiatric symptoms while integrating advanced staging systems and preparing patients for emerging therapies.</itunes:subtitle>
      <itunes:keywords>and psychiatric symptoms while integrating advanced staging systems and preparing patients for emerging therapies., cognitive, modern huntington’s disease care emphasizes multidisciplinary management of motor</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>448</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8ac49078-9979-45ea-9b7e-70ad0eb2a490</guid>
      <title>Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study</title>
      <description><![CDATA[Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients. 
]]></description>
      <pubDate>Fri, 15 May 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/vdyne-granted-fda-ide-for-tricuspid-valve-replacement-study-NV37SPIR</link>
      <enclosure length="1597483" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a22d5ab0-2919-4b70-8498-3bae7c094978/group-item/40fab0b6-70bc-40c5-b78e-f6b292a08ed1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Vdyne Granted FDA IDE For Tricuspid Valve Replacement Study</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.</itunes:summary>
      <itunes:subtitle>Vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.</itunes:subtitle>
      <itunes:keywords>vdyne’s investigational transcatheter tricuspid valve replacement device advances less invasive treatment for severe tricuspid regurgitation, potentially improving heart failure outcomes in high-risk patients.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>447</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">145660dd-4efe-47ae-a82c-008ca86ef8d7</guid>
      <title>Insurance Churn And Diabetes Outcomes In Low-Income Patients</title>
      <description><![CDATA[Insurance churn disrupts diabetes care for low-income patients, worsening blood sugar control, increasing complications, and driving preventable emergency visits, hospitalizations, and long-term healthcare costs. 
]]></description>
      <pubDate>Fri, 15 May 2026 13:20:43 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/insurance-churn-and-diabetes-outcomes-in-low-income-patients-SkFwljfc</link>
      <enclosure length="1429463" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e5735f83-ea90-465d-8fec-f11784c7c540/group-item/1275805b-392a-4beb-b0ab-0d897e12ecd9/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Insurance Churn And Diabetes Outcomes In Low-Income Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Insurance churn disrupts diabetes care for low-income patients, worsening blood sugar control, increasing complications, and driving preventable emergency visits, hospitalizations, and long-term healthcare costs.</itunes:summary>
      <itunes:subtitle>Insurance churn disrupts diabetes care for low-income patients, worsening blood sugar control, increasing complications, and driving preventable emergency visits, hospitalizations, and long-term healthcare costs.</itunes:subtitle>
      <itunes:keywords>worsening blood sugar control, insurance churn disrupts diabetes care for low-income patients, increasing complications, and driving preventable emergency visits, and long-term healthcare costs., hospitalizations</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>446</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1afcf52b-65b6-46f0-9ffb-8d494b6f4866</guid>
      <title>FDA Approves Leucovorin Calcium For Cerebral Folate Deficiency</title>
      <description><![CDATA[FDA-approved leucovorin calcium standardizes treatment for cerebral folate deficiency, improving dosing clarity, insurance access, and earlier intervention for children facing progressive neurological damage and disability. 
]]></description>
      <pubDate>Wed, 13 May 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-leucovorin-calcium-for-cerebral-folate-deficiency-EhvxR3vB</link>
      <enclosure length="1469169" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4eb28f0f-b6e5-4835-bd2c-7873ab494044/group-item/6c06693c-c93b-40d5-b0d3-8dd0015b4951/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves Leucovorin Calcium For Cerebral Folate Deficiency</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>FDA-approved leucovorin calcium standardizes treatment for cerebral folate deficiency, improving dosing clarity, insurance access, and earlier intervention for children facing progressive neurological damage and disability.</itunes:summary>
      <itunes:subtitle>FDA-approved leucovorin calcium standardizes treatment for cerebral folate deficiency, improving dosing clarity, insurance access, and earlier intervention for children facing progressive neurological damage and disability.</itunes:subtitle>
      <itunes:keywords>insurance access, improving dosing clarity, and earlier intervention for children facing progressive neurological damage and disability., fda-approved leucovorin calcium standardizes treatment for cerebral folate deficiency</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>445</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9303a48e-4786-4653-98e8-034dc09afd05</guid>
      <title>Health Care Costs May Be More Commonly Burdensome Than Estimated</title>
      <description><![CDATA[New findings suggest healthcare financial burdens are more widespread than previously estimated, highlighting growing affordability challenges and the need for stronger patient support and policy reforms. 
]]></description>
      <pubDate>Wed, 13 May 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/health-care-costs-may-be-more-commonly-burdensome-than-estimated-vYduv0n2</link>
      <enclosure length="1585780" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7537de62-6b4b-48ae-ad85-415d6213a4ee/group-item/d567130f-9e15-4910-82da-52c9a5c719cd/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Health Care Costs May Be More Commonly Burdensome Than Estimated</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>New findings suggest healthcare financial burdens are more widespread than previously estimated, highlighting growing affordability challenges and the need for stronger patient support and policy reforms.</itunes:summary>
      <itunes:subtitle>New findings suggest healthcare financial burdens are more widespread than previously estimated, highlighting growing affordability challenges and the need for stronger patient support and policy reforms.</itunes:subtitle>
      <itunes:keywords>highlighting growing affordability challenges and the need for stronger patient support and policy reforms., new findings suggest healthcare financial burdens are more widespread than previously estimated</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>444</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ca765643-19aa-4258-8ee2-09c9b8da943f</guid>
      <title>In-Hospital Outcomes of Healthcare-Associated COVID-19 vs Influenza</title>
      <description><![CDATA[Recent evidence shows healthcare-associated COVID-19 and influenza now have similar hospital outcomes, supporting unified respiratory infection management, resource planning, and evidence-based triage strategies. 
]]></description>
      <pubDate>Wed, 13 May 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/in-hospital-outcomes-of-healthcare-associated-covid-19-vs-influenza-NUZPCLsx</link>
      <enclosure length="1742932" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1b763677-e8a6-4344-8a2b-874a02954612/group-item/b0453944-bccf-45e0-964c-3ca69e847118/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>In-Hospital Outcomes of Healthcare-Associated COVID-19 vs Influenza</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Recent evidence shows healthcare-associated COVID-19 and influenza now have similar hospital outcomes, supporting unified respiratory infection management, resource planning, and evidence-based triage strategies.</itunes:summary>
      <itunes:subtitle>Recent evidence shows healthcare-associated COVID-19 and influenza now have similar hospital outcomes, supporting unified respiratory infection management, resource planning, and evidence-based triage strategies.</itunes:subtitle>
      <itunes:keywords>supporting unified respiratory infection management, resource planning, recent evidence shows healthcare-associated covid-19 and influenza now have similar hospital outcomes, and evidence-based triage strategies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>443</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cf18622c-d796-46c6-91ce-1a17d2548dca</guid>
      <title>AI-Driven ECG Interpretation May Enable Early COPD Detection</title>
      <description><![CDATA[AI-enhanced ECG interpretation may enable earlier COPD detection, supporting faster intervention, reduced hospitalizations, improved preventive care strategies, and more efficient chronic disease management workflows. 
]]></description>
      <pubDate>Wed, 13 May 2026 13:42:10 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-driven-ecg-interpretation-may-enable-early-copd-detection-vd1StxXp</link>
      <enclosure length="1408983" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0c3b50a4-717d-416c-ba2a-1fdfce5d6ca8/group-item/056083be-6c2c-4ff3-b919-25d973e3613e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI-Driven ECG Interpretation May Enable Early COPD Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>AI-enhanced ECG interpretation may enable earlier COPD detection, supporting faster intervention, reduced hospitalizations, improved preventive care strategies, and more efficient chronic disease management workflows.</itunes:summary>
      <itunes:subtitle>AI-enhanced ECG interpretation may enable earlier COPD detection, supporting faster intervention, reduced hospitalizations, improved preventive care strategies, and more efficient chronic disease management workflows.</itunes:subtitle>
      <itunes:keywords>supporting faster intervention, ai-enhanced ecg interpretation may enable earlier copd detection, and more efficient chronic disease management workflows., reduced hospitalizations, improved preventive care strategies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>442</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7b846241-f880-4a06-832d-9f1fb4cc2c30</guid>
      <title>Smartphone Assessment of Daytime Insomnia Symptoms With Suvorexant</title>
      <description><![CDATA[Smartphone-based ecological momentary assessment captured real-time insomnia symptoms and daytime functioning, offering clinicians a sensitive tool to personalize treatment, monitor safety, and improve outcomes. 
]]></description>
      <pubDate>Tue, 12 May 2026 14:21:56 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/smartphone-assessment-of-daytime-insomnia-symptoms-with-suvorexant-M16vBz4Y</link>
      <enclosure length="1589541" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/268a10fd-326a-4727-996d-ce3aaa761b70/group-item/907defe6-e5ce-4cfc-b19c-63eedc35e3a0/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Smartphone Assessment of Daytime Insomnia Symptoms With Suvorexant</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Smartphone-based ecological momentary assessment captured real-time insomnia symptoms and daytime functioning, offering clinicians a sensitive tool to personalize treatment, monitor safety, and improve outcomes.</itunes:summary>
      <itunes:subtitle>Smartphone-based ecological momentary assessment captured real-time insomnia symptoms and daytime functioning, offering clinicians a sensitive tool to personalize treatment, monitor safety, and improve outcomes.</itunes:subtitle>
      <itunes:keywords>smartphone-based ecological momentary assessment captured real-time insomnia symptoms and daytime functioning, and improve outcomes., offering clinicians a sensitive tool to personalize treatment, monitor safety</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>441</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dc1ebacb-d715-435f-a998-4dbd6dd6e0bc</guid>
      <title>3D-Printed Tympanostomy Tube Design Optimized With Neural Networks</title>
      <description><![CDATA[A data-driven framework using neural networks and 3D validation optimized tympanostomy tube design, improving drainage efficiency and advancing machine learning applications in medical device engineering 
]]></description>
      <pubDate>Mon, 11 May 2026 18:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/3d-printed-tympanostomy-tube-design-optimized-with-neural-networks-Rw2sQFUF</link>
      <enclosure length="1645548" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/088c116c-9820-4fcd-8cb3-fe2ca2d07fc9/group-item/da73b409-8c95-4817-8b13-cf7176dce2d2/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>3D-Printed Tympanostomy Tube Design Optimized With Neural Networks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>A data-driven framework using neural networks and 3D validation optimized tympanostomy tube design, improving drainage efficiency and advancing machine learning applications in medical device engineering</itunes:summary>
      <itunes:subtitle>A data-driven framework using neural networks and 3D validation optimized tympanostomy tube design, improving drainage efficiency and advancing machine learning applications in medical device engineering</itunes:subtitle>
      <itunes:keywords>a data-driven framework using neural networks and 3d validation optimized tympanostomy tube design, improving drainage efficiency and advancing machine learning applications in medical device engineering</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>440</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4d19b936-33bf-4387-b9cd-293506d468fe</guid>
      <title>Adagio Ventricular Ablation Tech Performs Well In Clinical Trial</title>
      <description><![CDATA[New cryoablation technology for ventricular tachycardia may simplify treatment, reduce ICD shocks and medication dependence, and improve long term patient quality of life over time 
]]></description>
      <pubDate>Mon, 11 May 2026 17:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/adagio-ventricular-ablation-tech-performs-well-in-clinical-trial-lzLy0JN_</link>
      <enclosure length="1727468" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/dd65ecef-bc96-473f-a9a8-37018a3386e8/group-item/badb1909-407c-4f8d-b4e3-1def54afa9c6/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Adagio Ventricular Ablation Tech Performs Well In Clinical Trial</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>New cryoablation technology for ventricular tachycardia may simplify treatment, reduce ICD shocks and medication dependence, and improve long term patient quality of life over time</itunes:summary>
      <itunes:subtitle>New cryoablation technology for ventricular tachycardia may simplify treatment, reduce ICD shocks and medication dependence, and improve long term patient quality of life over time</itunes:subtitle>
      <itunes:keywords>and improve long term patient quality of life over time, reduce icd shocks and medication dependence, new cryoablation technology for ventricular tachycardia may simplify treatment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>439</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4c6cf5e4-a598-4f67-9942-02151a889a99</guid>
      <title>Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression</title>
      <description><![CDATA[Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression. 
]]></description>
      <pubDate>Mon, 11 May 2026 15:45:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/motif-neurotech-gets-fda-ide-to-study-brain-implant-in-depression-4JwyMV7F</link>
      <enclosure length="1658087" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3c3a0957-e68a-45e0-8858-126b612734ee/group-item/4689f368-85ca-4508-aec0-04ec78841265/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Motif Neurotech Gets FDA IDE To Study Brain Implant In Depression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.</itunes:summary>
      <itunes:subtitle>Motif Neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.</itunes:subtitle>
      <itunes:keywords>motif neurotech’s implantable depression device may expand treatment options through minimally invasive brain stimulation, offering personalized at-home therapy for patients with treatment-resistant depression.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>438</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1d012e91-25ad-4701-b4e1-157b5c2b7268</guid>
      <title>Chronic Kidney Disease Screening Via Mobile Health Units</title>
      <description><![CDATA[Mobile chronic kidney disease screening may improve early detection, expand access for underserved populations, and support prevention-focused care through timely follow-up, treatment, and community outreach. 
]]></description>
      <pubDate>Mon, 11 May 2026 14:55:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/chronic-kidney-disease-screening-via-mobile-health-units-X6vpw3Lb</link>
      <enclosure length="1875007" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/754bb22a-9903-41ce-a8bd-3dd4b314bf05/group-item/dddf62c5-55c8-4f62-9c0a-c3718f00dea3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Chronic Kidney Disease Screening Via Mobile Health Units</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Mobile chronic kidney disease screening may improve early detection, expand access for underserved populations, and support prevention-focused care through timely follow-up, treatment, and community outreach.</itunes:summary>
      <itunes:subtitle>Mobile chronic kidney disease screening may improve early detection, expand access for underserved populations, and support prevention-focused care through timely follow-up, treatment, and community outreach.</itunes:subtitle>
      <itunes:keywords>and support prevention-focused care through timely follow-up, and community outreach., treatment, expand access for underserved populations, mobile chronic kidney disease screening may improve early detection</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>437</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1cd5328c-3926-4643-a617-05e48a702bb6</guid>
      <title>Exploring Sexual Dysfunction in Women with Parkinson’s Disease</title>
      <description><![CDATA[Addressing sexual dysfunction in women with Parkinson’s disease may improve quality of life through better communication, tailored treatments, routine assessments, and more holistic multidisciplinary care. 
]]></description>
      <pubDate>Thu, 7 May 2026 18:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/exploring-sexual-dysfunction-in-women-with-parkinsons-disease-GG_4IDhj</link>
      <enclosure length="1603334" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6c405e6b-adef-4c38-9bcf-b2c8057660f1/group-item/819068b1-ed94-49d6-91ba-0b8331a7ac36/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Exploring Sexual Dysfunction in Women with Parkinson’s Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Addressing sexual dysfunction in women with Parkinson’s disease may improve quality of life through better communication, tailored treatments, routine assessments, and more holistic multidisciplinary care.</itunes:summary>
      <itunes:subtitle>Addressing sexual dysfunction in women with Parkinson’s disease may improve quality of life through better communication, tailored treatments, routine assessments, and more holistic multidisciplinary care.</itunes:subtitle>
      <itunes:keywords>and more holistic multidisciplinary care., addressing sexual dysfunction in women with parkinson’s disease may improve quality of life through better communication, routine assessments, tailored treatments</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>436</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">46c5f72d-7120-411c-9d75-4762a571c6a5</guid>
      <title>New Strategies Against Brain Tumors</title>
      <description><![CDATA[Emerging glioblastoma research is advancing immune-targeted therapies and innovative treatment strategies, offering hope for improved survival, stronger treatment responses, and better quality of life outcomes. 
]]></description>
      <pubDate>Thu, 7 May 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-strategies-against-brain-tumors-ey2X9X5N</link>
      <enclosure length="1514309" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6787b6fb-2001-4d44-a6e3-ab463ffba051/group-item/181d9431-a048-4a1c-8fc0-bfb4c45e6cb0/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Strategies Against Brain Tumors</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Emerging glioblastoma research is advancing immune-targeted therapies and innovative treatment strategies, offering hope for improved survival, stronger treatment responses, and better quality of life outcomes.</itunes:summary>
      <itunes:subtitle>Emerging glioblastoma research is advancing immune-targeted therapies and innovative treatment strategies, offering hope for improved survival, stronger treatment responses, and better quality of life outcomes.</itunes:subtitle>
      <itunes:keywords>stronger treatment responses, and better quality of life outcomes., offering hope for improved survival, emerging glioblastoma research is advancing immune-targeted therapies and innovative treatment strategies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>435</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2c7c118f-a287-4b25-b8d8-cdfea15e42c3</guid>
      <title>Post-Meal Blood Sugar Spikes May Raise Alzheimer’s Risk</title>
      <description><![CDATA[Emerging research links post-meal blood sugar spikes with higher Alzheimer’s risk, highlighting glucose control, insulin resistance management, and lifestyle interventions as important strategies for brain health. 
]]></description>
      <pubDate>Thu, 7 May 2026 15:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/post-meal-blood-sugar-spikes-may-raise-alzheimers-risk-GBJ_vOkF</link>
      <enclosure length="1638025" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8ff261c6-8079-4269-9e44-acc63b9fd324/group-item/86de207d-9206-4878-aa10-80e1bcafc252/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Post-Meal Blood Sugar Spikes May Raise Alzheimer’s Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Emerging research links post-meal blood sugar spikes with higher Alzheimer’s risk, highlighting glucose control, insulin resistance management, and lifestyle interventions as important strategies for brain health.</itunes:summary>
      <itunes:subtitle>Emerging research links post-meal blood sugar spikes with higher Alzheimer’s risk, highlighting glucose control, insulin resistance management, and lifestyle interventions as important strategies for brain health.</itunes:subtitle>
      <itunes:keywords>insulin resistance management, and lifestyle interventions as important strategies for brain health., emerging research links post-meal blood sugar spikes with higher alzheimer’s risk, highlighting glucose control</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>434</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8e2de11c-d672-471c-b318-2baf0c7fcebe</guid>
      <title>The End of the “Wait and See” Era: How Blood Tests Are Revolutionizing Neurology</title>
      <description><![CDATA[High-accuracy Alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, more accessible diagnosis, improving treatment access, precision staging, and personalized neurodegenerative care worldwide. 
]]></description>
      <pubDate>Thu, 7 May 2026 14:31:49 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-end-of-the-wait-and-see-era-how-blood-tests-are-revolutionizing-neurology-sAxJXuEu</link>
      <enclosure length="1852438" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a6e26c34-d134-402d-b4c7-d4bbe16c37ab/group-item/fb548e68-f460-41fb-adc4-cfdcda7b1cbd/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The End of the “Wait and See” Era: How Blood Tests Are Revolutionizing Neurology</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>High-accuracy Alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, more accessible diagnosis, improving treatment access, precision staging, and personalized neurodegenerative care worldwide.</itunes:summary>
      <itunes:subtitle>High-accuracy Alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, more accessible diagnosis, improving treatment access, precision staging, and personalized neurodegenerative care worldwide.</itunes:subtitle>
      <itunes:keywords>and personalized neurodegenerative care worldwide., more accessible diagnosis, precision staging, high-accuracy alzheimer’s blood tests using biomarkers like p-tau217 may enable earlier, improving treatment access</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>433</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8abff05c-e1b6-4181-aa04-89663cb99cfd</guid>
      <title>Estradiol Patch Matches Standard Hormone Therapy in Phase 3 Trial: A New First-Line Option for Menopause</title>
      <description><![CDATA[Estradiol patch shows comparable efficacy to oral hormone therapy for menopause symptoms, offering a convenient transdermal option that may improve safety, adherence, and personalized treatment choices. 
]]></description>
      <pubDate>Wed, 6 May 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/estradiol-patch-matches-standard-hormone-therapy-in-phase-3-trial-a-new-first-line-option-for-menopause-5zhqsNSk</link>
      <enclosure length="1548999" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e18ac6a8-e426-4231-8d10-2d5ed8beee4d/group-item/aae7a2e6-798f-41f6-99a6-cd76f1de7fc5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Estradiol Patch Matches Standard Hormone Therapy in Phase 3 Trial: A New First-Line Option for Menopause</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Estradiol patch shows comparable efficacy to oral hormone therapy for menopause symptoms, offering a convenient transdermal option that may improve safety, adherence, and personalized treatment choices.</itunes:summary>
      <itunes:subtitle>Estradiol patch shows comparable efficacy to oral hormone therapy for menopause symptoms, offering a convenient transdermal option that may improve safety, adherence, and personalized treatment choices.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>432</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4e7701a7-0787-4840-a67b-0e6d98dece4c</guid>
      <title>ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability</title>
      <description><![CDATA[Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven. 
]]></description>
      <pubDate>Wed, 6 May 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ctdna-in-early-breast-cancer-prognostic-power-vs-clinical-actionability-hyF5cwNW</link>
      <enclosure length="1979915" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3189adb2-1d86-4b90-b67e-ea5512dae387/group-item/847e1ca6-1522-4346-bc47-1dec317bfcbc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>ctDNA in Early Breast Cancer: Prognostic Power vs Clinical Actionability</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:03</itunes:duration>
      <itunes:summary>Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.</itunes:summary>
      <itunes:subtitle>Circulating tumor DNA helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.</itunes:subtitle>
      <itunes:keywords>circulating tumor dna helps detect minimal residual disease and predict recurrence risk in early breast cancer, but its role in guiding treatment decisions remains promising yet unproven.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>431</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f642f020-6848-465e-abba-f0822554be50</guid>
      <title>Cost-Effectiveness of Point-of-Care HCV RNA Testing in US</title>
      <description><![CDATA[Point-of-care HCV RNA testing enables same-visit diagnosis and treatment, improving cure rates, reducing transmission, and proving cost-effective by minimizing follow-up loss and long-term complications. 
]]></description>
      <pubDate>Wed, 6 May 2026 14:35:55 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cost-effectiveness-of-point-of-care-hcv-rna-testing-in-us-Wpq5Fdkk-zvH6EiDP</link>
      <enclosure length="1699047" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/be77e7ce-d588-404a-bca1-da229a027ea8/group-item/afe3f903-3079-4b76-902e-e680c96689db/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cost-Effectiveness of Point-of-Care HCV RNA Testing in US</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Point-of-care HCV RNA testing enables same-visit diagnosis and treatment, improving cure rates, reducing transmission, and proving cost-effective by minimizing follow-up loss and long-term complications.</itunes:summary>
      <itunes:subtitle>Point-of-care HCV RNA testing enables same-visit diagnosis and treatment, improving cure rates, reducing transmission, and proving cost-effective by minimizing follow-up loss and long-term complications.</itunes:subtitle>
      <itunes:keywords>reducing transmission, improving cure rates, point-of-care hcv rna testing enables same-visit diagnosis and treatment, and proving cost-effective by minimizing follow-up loss and long-term complications.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>430</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">64a8994e-5032-41af-9946-209b681abb28</guid>
      <title>Cost-Effectiveness of Point-of-Care HCV RNA Testing in US</title>
      <description><![CDATA[Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As direct-acting antiviral drugs make cure routine, the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments. 
]]></description>
      <pubDate>Tue, 5 May 2026 17:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cost-effectiveness-of-point-of-care-hcv-rna-testing-in-us-p1SDKTvy</link>
      <enclosure length="1785982" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e33a3dd8-af0c-4b93-abcd-0e9f16c3be24/group-item/b48d55b4-2c27-4790-bea6-7166c8083aac/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cost-Effectiveness of Point-of-Care HCV RNA Testing in US</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:51</itunes:duration>
      <itunes:summary>Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As direct-acting antiviral drugs make cure routine, the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments.</itunes:summary>
      <itunes:subtitle>Hepatitis C virus (HCV) RNA testing at the point of care is emerging as a practical way to identify and treat people living with HCV more quickly. As direct-acting antiviral drugs make cure routine, the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments.</itunes:subtitle>
      <itunes:keywords>the real bottleneck has shifted to identifying who is infected and getting them started on treatment without losing them between appointments., hepatitis c virus (hcv) rna testing at the point of care is emerging as a practical way to identify and treat people living with hcv more quickly. as direct-acting antiviral drugs make cure routine</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>429</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ba119827-921a-4cec-8efa-b7fca3766534</guid>
      <title>CYP2C19 Genetic Testing Guides Personalized Blood Thinner Therapy</title>
      <description><![CDATA[CYP2C19 genetic testing is emerging as a practical tool to tailor antiplatelet therapy for people who need blood thinners after a heart attack, stent placement, or other vascular events. Clinicians are starting to use simple genetic results to decide whether the standard drug will work or whether a different medicine is safer and more effective for an individual patient. 
]]></description>
      <pubDate>Tue, 5 May 2026 15:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cyp2c19-genetic-testing-guides-personalized-blood-thinner-therapy-a5ifsnPg</link>
      <enclosure length="1591213" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fac16ca8-32fa-42dd-a1e5-0ee0b2257acd/group-item/1e78a497-795a-4015-a3d4-20d4bd126236/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>CYP2C19 Genetic Testing Guides Personalized Blood Thinner Therapy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>CYP2C19 genetic testing is emerging as a practical tool to tailor antiplatelet therapy for people who need blood thinners after a heart attack, stent placement, or other vascular events. Clinicians are starting to use simple genetic results to decide whether the standard drug will work or whether a different medicine is safer and more effective for an individual patient.</itunes:summary>
      <itunes:subtitle>CYP2C19 genetic testing is emerging as a practical tool to tailor antiplatelet therapy for people who need blood thinners after a heart attack, stent placement, or other vascular events. Clinicians are starting to use simple genetic results to decide whether the standard drug will work or whether a different medicine is safer and more effective for an individual patient.</itunes:subtitle>
      <itunes:keywords>stent placement, or other vascular events. clinicians are starting to use simple genetic results to decide whether the standard drug will work or whether a different medicine is safer and more effective for an individual patient., cyp2c19 genetic testing is emerging as a practical tool to tailor antiplatelet therapy for people who need blood thinners after a heart attack</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>428</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e5e46379-bf0c-4f42-ae20-2b1ed6e0587f</guid>
      <title>Warfarin Self-Management in U.S. Health Care: Nonrandomized Trial</title>
      <description><![CDATA[Warfarin self-management empowers patients to monitor INR and adjust dosing, improving control and outcomes while reducing clinic burden, though requiring careful training, oversight, and equitable access. 
]]></description>
      <pubDate>Tue, 5 May 2026 14:39:55 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/warfarin-self-management-in-us-health-care-nonrandomized-trial-KrtSm1v7</link>
      <enclosure length="1628412" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1947c35f-41d5-4075-9235-fba6dd88eb74/group-item/a9bb2889-ff09-43f8-9fcb-5190ea115cf4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Warfarin Self-Management in U.S. Health Care: Nonrandomized Trial</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Warfarin self-management empowers patients to monitor INR and adjust dosing, improving control and outcomes while reducing clinic burden, though requiring careful training, oversight, and equitable access.</itunes:summary>
      <itunes:subtitle>Warfarin self-management empowers patients to monitor INR and adjust dosing, improving control and outcomes while reducing clinic burden, though requiring careful training, oversight, and equitable access.</itunes:subtitle>
      <itunes:keywords>though requiring careful training, oversight, and equitable access., improving control and outcomes while reducing clinic burden, warfarin self-management empowers patients to monitor inr and adjust dosing</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>427</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8bc1abb5-4c95-4557-910d-437adcebb406</guid>
      <title>Why Some Men May Struggle to Open Up Emotionally</title>
      <description><![CDATA[Men’s mental health is often overlooked due to stigma around emotional expression, delaying support and increasing risk of crisis, highlighting need for proactive, normalized, and accessible care strategies. 
]]></description>
      <pubDate>Mon, 4 May 2026 19:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/why-some-men-may-struggle-to-open-up-emotionally-ZaaswOl2</link>
      <enclosure length="1329153" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/75505828-5a0a-46bf-8c18-a9c59f99f780/group-item/bc7f8ff3-a71f-4dc6-90f1-671b9218625b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Why Some Men May Struggle to Open Up Emotionally</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Men’s mental health is often overlooked due to stigma around emotional expression, delaying support and increasing risk of crisis, highlighting need for proactive, normalized, and accessible care strategies.</itunes:summary>
      <itunes:subtitle>Men’s mental health is often overlooked due to stigma around emotional expression, delaying support and increasing risk of crisis, highlighting need for proactive, normalized, and accessible care strategies.</itunes:subtitle>
      <itunes:keywords>highlighting need for proactive, normalized, and accessible care strategies., delaying support and increasing risk of crisis, men’s mental health is often overlooked due to stigma around emotional expression</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>426</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b7b99aaf-8a4d-4983-8f38-b909f5300456</guid>
      <title>FDA recommends guidance Revision Over Dialysis System Tubing Concern</title>
      <description><![CDATA[The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings. 
]]></description>
      <pubDate>Mon, 4 May 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-recommends-guidance-revision-over-dialysis-system-tubing-concern-__5tqPsk</link>
      <enclosure length="1786400" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5b3bb845-a9d3-4d1d-89d8-5158b194720f/group-item/92a9a5a5-d5cd-4297-a5ac-9171307e3f07/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA recommends guidance Revision Over Dialysis System Tubing Concern</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:51</itunes:duration>
      <itunes:summary>The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.</itunes:summary>
      <itunes:subtitle>The Food and Drug Administration updated Prismaflex guidance highlights tubing-related risks, urging vigilance to prevent air-in-blood events and ensure safe, uninterrupted renal replacement therapy in critical care settings.</itunes:subtitle>
      <itunes:keywords>the food and drug administration updated prismaflex guidance highlights tubing-related risks, uninterrupted renal replacement therapy in critical care settings., urging vigilance to prevent air-in-blood events and ensure safe</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>425</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">16adb6f7-1dd3-40c5-a2b7-d181af0fa7dc</guid>
      <title>Surgeons Drive Momentum for Robotics in Acute Care Settings</title>
      <description><![CDATA[Robotic-assisted surgeries, led by da Vinci Surgical System, are expanding rapidly, improving efficiency, outcomes, and competition while driving adoption, innovation, and investment across modern healthcare systems. 
]]></description>
      <pubDate>Mon, 4 May 2026 16:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/surgeons-drive-momentum-for-robotics-in-acute-care-settings-DvrI1wNu</link>
      <enclosure length="1903429" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/c8c7a7f5-fc02-4339-a0a4-c7ca76b75a7e/group-item/c0f47e5d-6c6c-4d76-9560-44dace5a3b9f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Surgeons Drive Momentum for Robotics in Acute Care Settings</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>Robotic-assisted surgeries, led by da Vinci Surgical System, are expanding rapidly, improving efficiency, outcomes, and competition while driving adoption, innovation, and investment across modern healthcare systems.</itunes:summary>
      <itunes:subtitle>Robotic-assisted surgeries, led by da Vinci Surgical System, are expanding rapidly, improving efficiency, outcomes, and competition while driving adoption, innovation, and investment across modern healthcare systems.</itunes:subtitle>
      <itunes:keywords>and competition while driving adoption, outcomes, and investment across modern healthcare systems., innovation, robotic-assisted surgeries, improving efficiency, are expanding rapidly, led by da vinci surgical system</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>424</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">22632f1a-3828-492b-9283-719634f6bb8e</guid>
      <title>Cerebral Oximetry’s Impact on Oxygenation in Preterm Infants</title>
      <description><![CDATA[Monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, improve survival, guide NICU care, and support better long-term neurodevelopmental outcomes. 
]]></description>
      <pubDate>Mon, 4 May 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cerebral-oximetrys-impact-on-oxygenation-in-preterm-infants-s_sIQb6o</link>
      <enclosure length="1534789" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f78595a6-2543-4dd9-a3ed-74c2083ec321/group-item/3e9f646c-c74d-40d9-951c-7bc2cc226391/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cerebral Oximetry’s Impact on Oxygenation in Preterm Infants</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:35</itunes:duration>
      <itunes:summary>Monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, improve survival, guide NICU care, and support better long-term neurodevelopmental outcomes.</itunes:summary>
      <itunes:subtitle>Monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, improve survival, guide NICU care, and support better long-term neurodevelopmental outcomes.</itunes:subtitle>
      <itunes:keywords>and support better long-term neurodevelopmental outcomes., monitoring cerebral oxygenation in extremely preterm infants enables early intervention to prevent brain injury, guide nicu care, improve survival</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>423</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f2b7ad82-a060-4bdf-a0f3-a34c1059a1df</guid>
      <title>Extending Mental Health Interventions Beyond Therapy Settings</title>
      <description><![CDATA[Digital tools, wearables, and AI extend therapy beyond sessions, enabling real-time support, earlier intervention, and personalized care, while requiring updated reimbursement models, privacy safeguards, and clinician workflows. 
]]></description>
      <pubDate>Mon, 4 May 2026 14:22:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/extending-mental-health-interventions-beyond-therapy-settings-l0R3xQWo</link>
      <enclosure length="1358410" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8c3ed7f1-d2fa-4984-92cd-8ef8a66d29e8/group-item/55f5610e-5414-49be-ad6d-2aabf61a0f9b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Extending Mental Health Interventions Beyond Therapy Settings</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:24</itunes:duration>
      <itunes:summary>Digital tools, wearables, and AI extend therapy beyond sessions, enabling real-time support, earlier intervention, and personalized care, while requiring updated reimbursement models, privacy safeguards, and clinician workflows.</itunes:summary>
      <itunes:subtitle>Digital tools, wearables, and AI extend therapy beyond sessions, enabling real-time support, earlier intervention, and personalized care, while requiring updated reimbursement models, privacy safeguards, and clinician workflows.</itunes:subtitle>
      <itunes:keywords>earlier intervention, and clinician workflows., wearables, privacy safeguards, digital tools, and ai extend therapy beyond sessions, enabling real-time support, while requiring updated reimbursement models, and personalized care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>422</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">22782398-7840-4adc-823c-99ee133ec7b6</guid>
      <title>Fetal Alcohol Spectrum Disorder (FASD): Understanding Its Lifelong Mental Health Impact</title>
      <description><![CDATA[Fetal Alcohol Spectrum Disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, leading to cognitive, behavioral, and mental health challenges requiring early diagnosis, coordinated care, and support. 
]]></description>
      <pubDate>Fri, 1 May 2026 18:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fetal-alcohol-spectrum-disorder-fasd-understanding-its-lifelong-mental-health-impact-sPSOiU_q</link>
      <enclosure length="1588287" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/682d1183-071d-4118-9e15-4a8fe1f575ec/group-item/132ab13f-1253-4551-8297-22f019021bfc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Fetal Alcohol Spectrum Disorder (FASD): Understanding Its Lifelong Mental Health Impact</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Fetal Alcohol Spectrum Disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, leading to cognitive, behavioral, and mental health challenges requiring early diagnosis, coordinated care, and support.</itunes:summary>
      <itunes:subtitle>Fetal Alcohol Spectrum Disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, leading to cognitive, behavioral, and mental health challenges requiring early diagnosis, coordinated care, and support.</itunes:subtitle>
      <itunes:keywords>behavioral, leading to cognitive, and support., coordinated care, fetal alcohol spectrum disorder is a lifelong neurodevelopmental condition caused by prenatal alcohol exposure, and mental health challenges requiring early diagnosis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>421</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b5b0c058-9264-4da5-b989-c4efe35f4821</guid>
      <title>Narcolepsy Comorbidities and Their Symptom Profiles: What Clinicians and Patients Should Know</title>
      <description><![CDATA[Narcolepsy often coexists with psychiatric, respiratory, and metabolic conditions, complicating diagnosis and treatment, requiring comprehensive, multidisciplinary care to improve safety, functioning, and long-term patient outcomes. 
]]></description>
      <pubDate>Fri, 1 May 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/narcolepsy-comorbidities-and-their-symptom-profiles-what-clinicians-and-patients-should-know-G6HBVSZ1</link>
      <enclosure length="1438240" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/00c02508-9fbd-456b-8d9f-987305f1808e/group-item/505d23fd-0a13-465c-a7bd-6252dfed325c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Narcolepsy Comorbidities and Their Symptom Profiles: What Clinicians and Patients Should Know</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Narcolepsy often coexists with psychiatric, respiratory, and metabolic conditions, complicating diagnosis and treatment, requiring comprehensive, multidisciplinary care to improve safety, functioning, and long-term patient outcomes.</itunes:summary>
      <itunes:subtitle>Narcolepsy often coexists with psychiatric, respiratory, and metabolic conditions, complicating diagnosis and treatment, requiring comprehensive, multidisciplinary care to improve safety, functioning, and long-term patient outcomes.</itunes:subtitle>
      <itunes:keywords>multidisciplinary care to improve safety, functioning, requiring comprehensive, and metabolic conditions, narcolepsy often coexists with psychiatric, respiratory, complicating diagnosis and treatment, and long-term patient outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>420</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ce8a2773-84bd-48b0-9d28-967a4c7e3ea9</guid>
      <title>Big Ideas from the 2026 American Academy of Neurology Annual Meeting (AAN): What’s Changing in Brain Health and Why It Matters</title>
      <description><![CDATA[The 2026 American Academy of Neurology Annual Meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, emerging therapies, and ongoing challenges in access, cost, and real-world implementation. 
]]></description>
      <pubDate>Fri, 1 May 2026 15:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/big-ideas-from-the-2026-american-academy-of-neurology-annual-meeting-aan-whats-changing-in-brain-health-and-why-it-matters-9I762MbK</link>
      <enclosure length="1673551" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e722abd4-b7c7-44f0-a381-452b4b30f258/group-item/b7089248-3d00-4cbb-bd69-c1dbecc4b063/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Big Ideas from the 2026 American Academy of Neurology Annual Meeting (AAN): What’s Changing in Brain Health and Why It Matters</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>The 2026 American Academy of Neurology Annual Meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, emerging therapies, and ongoing challenges in access, cost, and real-world implementation.</itunes:summary>
      <itunes:subtitle>The 2026 American Academy of Neurology Annual Meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, emerging therapies, and ongoing challenges in access, cost, and real-world implementation.</itunes:subtitle>
      <itunes:keywords>the 2026 american academy of neurology annual meeting 2026 highlights neurology’s shift toward biomarker-driven diagnosis, personalized care, and ongoing challenges in access, and real-world implementation., cost, emerging therapies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>419</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8345e9eb-9f3f-46ed-a87e-181497fe32f8</guid>
      <title>Wrap-Up: Vyvgart Targets Four Populations at AAN 2026</title>
      <description><![CDATA[AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks. 
]]></description>
      <pubDate>Fri, 1 May 2026 14:56:31 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/wrap-up-vyvgart-targets-four-populations-at-aan-2026-nHPc2CQd</link>
      <enclosure length="1553597" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/cbe6716c-195a-42fb-82d0-57b2a68293df/group-item/db3116dc-8d1e-4546-b71f-b7cafda5ac48/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Wrap-Up: Vyvgart Targets Four Populations at AAN 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks.</itunes:summary>
      <itunes:subtitle>AAN 2026 highlights transformative ADAPT data, expanding Vyvgart across MG subtypes and CIDP, signaling targeted biologics, pediatric advances, and urgent updates to managed care coverage frameworks.</itunes:subtitle>
      <itunes:keywords>and urgent updates to managed care coverage frameworks., aan 2026 highlights transformative adapt data, expanding vyvgart across mg subtypes and cidp, pediatric advances, signaling targeted biologics</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>418</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dce4e775-3c38-47ef-a212-f6afafe637c9</guid>
      <title>Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP</title>
      <description><![CDATA[Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies. 
]]></description>
      <pubDate>Thu, 30 Apr 2026 15:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/vyvgart-hytrulo-challenges-the-step-therapy-model-in-treatment-naive-cidp-I3Wjz_Z4</link>
      <enclosure length="1493411" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/70d01c1b-f48b-4de0-8701-1bc74ae005cf/group-item/87812ab4-d1bb-41ab-990c-0eaff2e8006e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Vyvgart Hytrulo Challenges the Step Therapy Model in Treatment-Naive CIDP</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies.</itunes:summary>
      <itunes:subtitle>Post hoc ADHERE analysis shows Vyvgart Hytrulo delivers early responses in 87.5% of treatment-naive CIDP patients, challenging step-therapy policies and prompting reconsideration of first-line treatment strategies.</itunes:subtitle>
      <itunes:keywords>challenging step-therapy policies and prompting reconsideration of first-line treatment strategies., post hoc adhere analysis shows vyvgart hytrulo delivers early responses in 87.5% of treatment-naive cidp patients</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>417</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a38eaf64-96e7-45ca-9709-22ab5506cc34</guid>
      <title>Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis</title>
      <description><![CDATA[At AAN Annual Meeting 2026, efgartigimod alfa showed durable adolescent gMG responses, with 80% achieving minimal symptom expression by cycle two and consistent improvements across treatment cycles. 
]]></description>
      <pubDate>Thu, 30 Apr 2026 14:02:59 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/efgartigimod-builds-a-pediatric-track-record-in-myasthenia-gravis-Tx8ZfhEg-xeWxWYaT</link>
      <enclosure length="1302821" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5beeb88f-d5e8-4d04-aec0-8bbd14c3169d/group-item/90ad7430-db1e-454d-82c8-2e9e3e2de78c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>At AAN Annual Meeting 2026, efgartigimod alfa showed durable adolescent gMG responses, with 80% achieving minimal symptom expression by cycle two and consistent improvements across treatment cycles.</itunes:summary>
      <itunes:subtitle>At AAN Annual Meeting 2026, efgartigimod alfa showed durable adolescent gMG responses, with 80% achieving minimal symptom expression by cycle two and consistent improvements across treatment cycles.</itunes:subtitle>
      <itunes:keywords>at aan annual meeting 2026, efgartigimod alfa showed durable adolescent gmg responses, with 80% achieving minimal symptom expression by cycle two and consistent improvements across treatment cycles.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>416</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">59312926-36a0-4d33-b11d-5ec589e12ddb</guid>
      <title>Pixee Wins FDA Nod For Next-Gen AR Knee Surgery Tech</title>
      <description><![CDATA[Pixee Medical’s Knee+ NexSight gains U.S. Food and Drug Administration 510(k) clearance, bringing lightweight AR-guided knee replacement to U.S. operating rooms, aiming to improve precision, efficiency, and outpatient surgical access. 
]]></description>
      <pubDate>Wed, 29 Apr 2026 18:35:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pixee-wins-fda-nod-for-next-gen-ar-knee-surgery-tech-YIHGCHS9</link>
      <enclosure length="1192480" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/08c23b21-5adc-477b-8568-9ff97a02c2c4/group-item/28b5adfc-faa4-4638-959a-cb8a053ffa7b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pixee Wins FDA Nod For Next-Gen AR Knee Surgery Tech</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>Pixee Medical’s Knee+ NexSight gains U.S. Food and Drug Administration 510(k) clearance, bringing lightweight AR-guided knee replacement to U.S. operating rooms, aiming to improve precision, efficiency, and outpatient surgical access.</itunes:summary>
      <itunes:subtitle>Pixee Medical’s Knee+ NexSight gains U.S. Food and Drug Administration 510(k) clearance, bringing lightweight AR-guided knee replacement to U.S. operating rooms, aiming to improve precision, efficiency, and outpatient surgical access.</itunes:subtitle>
      <itunes:keywords>pixee medical’s knee+ nexsight gains u.s. food and drug administration 510(k) clearance, and outpatient surgical access., bringing lightweight ar-guided knee replacement to u.s. operating rooms, efficiency, aiming to improve precision</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>415</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7998fdec-ecd2-4611-9b30-186ee123092f</guid>
      <title>Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis</title>
      <description><![CDATA[At AAN Annual Meeting 2026, ADAPT Jr showed efgartigimod alfa delivered durable adolescent gMG improvements, with 80% achieving minimal symptom expression by cycle two and consistent responses. 
]]></description>
      <pubDate>Wed, 29 Apr 2026 17:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/efgartigimod-builds-a-pediatric-track-record-in-myasthenia-gravis-H7RaDhYG</link>
      <enclosure length="1438240" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b00facf7-be47-427a-8ff9-bd15778aea0d/group-item/20fd547c-b25e-4d10-ac0c-ec08d310c4a0/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Efgartigimod Builds a Pediatric Track Record in Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>At AAN Annual Meeting 2026, ADAPT Jr showed efgartigimod alfa delivered durable adolescent gMG improvements, with 80% achieving minimal symptom expression by cycle two and consistent responses.</itunes:summary>
      <itunes:subtitle>At AAN Annual Meeting 2026, ADAPT Jr showed efgartigimod alfa delivered durable adolescent gMG improvements, with 80% achieving minimal symptom expression by cycle two and consistent responses.</itunes:subtitle>
      <itunes:keywords>at aan annual meeting 2026, adapt jr showed efgartigimod alfa delivered durable adolescent gmg improvements, with 80% achieving minimal symptom expression by cycle two and consistent responses.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>414</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">63a5acdd-2b28-4dda-a0fd-88fab5b7526f</guid>
      <title>Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC</title>
      <description><![CDATA[Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability. 
]]></description>
      <pubDate>Wed, 29 Apr 2026 15:50:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sunvozertinib-shows-promising-first-line-pfs-benefit-in-egfr-exon-20-insertion-nsclc-UCrCektf</link>
      <enclosure length="1879187" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e594d85d-2ca1-4b98-9e25-e252f9293863/group-item/22eb63ab-8a66-4826-b361-616a7c2f7973/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sunvozertinib Shows Promising First-Line PFS Benefit in EGFR Exon 20 Insertion NSCLC</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.</itunes:summary>
      <itunes:subtitle>Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>413</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3d2fa785-a8f3-4650-a4fc-8e5f042fb14d</guid>
      <title>Bridging the Gap: Understanding CMS’ Delay of the BALANCE Model and the Extension of the GLP-1 Bridge</title>
      <description><![CDATA[Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability. 
]]></description>
      <pubDate>Wed, 29 Apr 2026 15:14:06 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bridging-the-gap-understanding-cms-delay-of-the-balance-model-and-the-extension-of-the-glp-1-bridge-KMUdX424</link>
      <enclosure length="1811478" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4cbc6e8d-ad90-49a0-aa1d-e78ca83a38e9/group-item/24fb8913-aa4d-4778-a316-6c2b06a993be/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bridging the Gap: Understanding CMS’ Delay of the BALANCE Model and the Extension of the GLP-1 Bridge</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:53</itunes:duration>
      <itunes:summary>Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.</itunes:summary>
      <itunes:subtitle>Medicare delays BALANCE Part D rollout, extending GLP-1 Bridge access through 2027, balancing obesity treatment access for seniors with payer concerns over cost, utilization, and sustainability.</itunes:subtitle>
      <itunes:keywords>balancing obesity treatment access for seniors with payer concerns over cost, and sustainability., extending glp-1 bridge access through 2027, medicare delays balance part d rollout, utilization</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>412</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">05d3eb32-5921-4f25-974e-71d36847a832</guid>
      <title>The New Frontier in Neurological Research: Are GLP-1s Changing the Game?</title>
      <description><![CDATA[GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results. 
]]></description>
      <pubDate>Tue, 28 Apr 2026 17:05:55 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-new-frontier-in-neurological-research-are-glp-1s-changing-the-game-4tzyE6Rp</link>
      <enclosure length="1826942" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5e468220-d077-46d5-a048-33e070b7ce1b/group-item/d2ab47e5-80ce-49ca-8f14-1a9fc70f8b24/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The New Frontier in Neurological Research: Are GLP-1s Changing the Game?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.</itunes:summary>
      <itunes:subtitle>GLP-1 receptor agonists are emerging as potential Alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.</itunes:subtitle>
      <itunes:keywords>glp-1 receptor agonists are emerging as potential alzheimer’s therapies, targeting metabolic dysfunction and inflammation, signaling a shift beyond amyloid-focused treatments despite mixed clinical trial results.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>411</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">73e72dc3-78cf-417a-94a1-0d91d652a0ce</guid>
      <title>Ocular Myasthenia Gravis Gets Its First Targeted Biologic Candidate</title>
      <description><![CDATA[New Phase 3 data highlight efgartigimod’s targeted efficacy in ocular myasthenia gravis, signaling a shift toward precision therapies that reduce treatment burden and improve patient-centered outcomes. 
]]></description>
      <pubDate>Tue, 28 Apr 2026 16:35:07 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ocular-myasthenia-gravis-gets-its-first-targeted-biologic-candidate-Xb5iXyd_</link>
      <enclosure length="1973646" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3b505449-0e53-469a-9e97-2472a161f167/group-item/97301d2b-bcc3-4738-9f54-403db57dfe6d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ocular Myasthenia Gravis Gets Its First Targeted Biologic Candidate</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:03</itunes:duration>
      <itunes:summary>New Phase 3 data highlight efgartigimod’s targeted efficacy in ocular myasthenia gravis, signaling a shift toward precision therapies that reduce treatment burden and improve patient-centered outcomes.</itunes:summary>
      <itunes:subtitle>New Phase 3 data highlight efgartigimod’s targeted efficacy in ocular myasthenia gravis, signaling a shift toward precision therapies that reduce treatment burden and improve patient-centered outcomes.</itunes:subtitle>
      <itunes:keywords>signaling a shift toward precision therapies that reduce treatment burden and improve patient-centered outcomes., new phase 3 data highlight efgartigimod’s targeted efficacy in ocular myasthenia gravis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>410</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">286097df-2208-4aa4-b8ee-504785a002c9</guid>
      <title>Vyvgart Crosses the Antibody Line in Seronegative Myasthenia Gravis</title>
      <description><![CDATA[Phase 3 ADAPT SERON data show efgartigimod improves function in seronegative generalized myasthenia gravis, with FDA priority review potentially expanding targeted treatment options for underserved patients. 
]]></description>
      <pubDate>Mon, 27 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/vyvgart-crosses-the-antibody-line-in-seronegative-myasthenia-gravis-F3Ql3OyO</link>
      <enclosure length="1952748" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/67b5cf13-82a6-4b4b-b54c-fa96a2fa9abe/group-item/541463b6-3453-43e5-99a4-2e4372944186/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Vyvgart Crosses the Antibody Line in Seronegative Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Phase 3 ADAPT SERON data show efgartigimod improves function in seronegative generalized myasthenia gravis, with FDA priority review potentially expanding targeted treatment options for underserved patients.</itunes:summary>
      <itunes:subtitle>Phase 3 ADAPT SERON data show efgartigimod improves function in seronegative generalized myasthenia gravis, with FDA priority review potentially expanding targeted treatment options for underserved patients.</itunes:subtitle>
      <itunes:keywords>with fda priority review potentially expanding targeted treatment options for underserved patients., phase 3 adapt seron data show efgartigimod improves function in seronegative generalized myasthenia gravis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>409</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ef9c936e-00f0-4c31-a2af-759b6db3b1b8</guid>
      <title>Can Carboplatin Be Safely Omitted in Neoadjuvant HER2-Positive Breast Cancer? Evidence, Patient Selection, and Practice Impact</title>
      <description><![CDATA[Reconsidering carboplatin in neoadjuvant HER2-positive breast cancer may reduce toxicity and resource use while maintaining outcomes, emphasizing individualized treatment decisions, patient experience, and careful monitoring. 
]]></description>
      <pubDate>Mon, 27 Apr 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/can-carboplatin-be-safely-omitted-in-neoadjuvant-her2-positive-breast-cancer-evidence-patient-selection-and-practice-impact-lWzshy1e</link>
      <enclosure length="1689016" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fff63feb-f053-4abe-8be7-085a46dfaec2/group-item/7ff5c5bc-6446-4690-858a-a685bff59b41/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Can Carboplatin Be Safely Omitted in Neoadjuvant HER2-Positive Breast Cancer? Evidence, Patient Selection, and Practice Impact</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Reconsidering carboplatin in neoadjuvant HER2-positive breast cancer may reduce toxicity and resource use while maintaining outcomes, emphasizing individualized treatment decisions, patient experience, and careful monitoring.</itunes:summary>
      <itunes:subtitle>Reconsidering carboplatin in neoadjuvant HER2-positive breast cancer may reduce toxicity and resource use while maintaining outcomes, emphasizing individualized treatment decisions, patient experience, and careful monitoring.</itunes:subtitle>
      <itunes:keywords>and careful monitoring., patient experience, reconsidering carboplatin in neoadjuvant her2-positive breast cancer may reduce toxicity and resource use while maintaining outcomes, emphasizing individualized treatment decisions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>408</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ec2a2edc-b220-4097-abf5-3742292f364e</guid>
      <title>Sexual Health After Cancer: Why Survivorship Care Must Include Intimacy and Recovery</title>
      <description><![CDATA[Sexual health after cancer is often neglected, requiring routine discussion, multidisciplinary care, and better access to support addressing intimacy, body image, fertility, and quality-of-life challenges. 
]]></description>
      <pubDate>Mon, 27 Apr 2026 14:54:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sexual-health-after-cancer-why-survivorship-care-must-include-intimacy-and-recovery-l_c1yD3j</link>
      <enclosure length="1506785" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/04062af2-d85c-45f6-9f57-c6c6337e6eb8/group-item/3d01fa70-67fb-4f6e-9742-7ce697a293b1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sexual Health After Cancer: Why Survivorship Care Must Include Intimacy and Recovery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Sexual health after cancer is often neglected, requiring routine discussion, multidisciplinary care, and better access to support addressing intimacy, body image, fertility, and quality-of-life challenges.</itunes:summary>
      <itunes:subtitle>Sexual health after cancer is often neglected, requiring routine discussion, multidisciplinary care, and better access to support addressing intimacy, body image, fertility, and quality-of-life challenges.</itunes:subtitle>
      <itunes:keywords>requiring routine discussion, and better access to support addressing intimacy, body image, and quality-of-life challenges., sexual health after cancer is often neglected, multidisciplinary care, fertility</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>407</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2575f291-b9e4-46ce-a376-2dcc22288688</guid>
      <title>Research Needed for Younger Breast Cancer Survivors’ Progress</title>
      <description><![CDATA[Younger breast cancer survivors face unique medical and psychosocial challenges, driving need for targeted research, personalized care plans, and multidisciplinary support to improve long-term outcomes and quality of life. 
]]></description>
      <pubDate>Fri, 24 Apr 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/research-needed-for-younger-breast-cancer-survivors-progress-1zUub9rJ</link>
      <enclosure length="998129" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e3b07ba8-465c-4d90-9801-1a5c4da083e8/group-item/f05a1b0a-cf2d-4a4a-b44d-0e411528a8d3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Research Needed for Younger Breast Cancer Survivors’ Progress</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:02</itunes:duration>
      <itunes:summary>Younger breast cancer survivors face unique medical and psychosocial challenges, driving need for targeted research, personalized care plans, and multidisciplinary support to improve long-term outcomes and quality of life.</itunes:summary>
      <itunes:subtitle>Younger breast cancer survivors face unique medical and psychosocial challenges, driving need for targeted research, personalized care plans, and multidisciplinary support to improve long-term outcomes and quality of life.</itunes:subtitle>
      <itunes:keywords>younger breast cancer survivors face unique medical and psychosocial challenges, and multidisciplinary support to improve long-term outcomes and quality of life., personalized care plans, driving need for targeted research</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>406</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">010cab42-505b-4d45-9436-2c79385d047b</guid>
      <title>Body Mass Index May Influence Outcomes in Head and Neck Cancer</title>
      <description><![CDATA[Overweight BMI in head and neck cancer may be linked to better outcomes, prompting reconsideration of weight’s role in prognosis, treatment planning, and nutritional support strategies. 
]]></description>
      <pubDate>Fri, 24 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/body-mass-index-may-influence-outcomes-in-head-and-neck-cancer-OTFmbFpx</link>
      <enclosure length="1537296" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a2ec9911-e2e1-4a44-bf06-7018af45d87e/group-item/6d7e7f23-d550-4e35-b361-d28665350219/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Body Mass Index May Influence Outcomes in Head and Neck Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Overweight BMI in head and neck cancer may be linked to better outcomes, prompting reconsideration of weight’s role in prognosis, treatment planning, and nutritional support strategies.</itunes:summary>
      <itunes:subtitle>Overweight BMI in head and neck cancer may be linked to better outcomes, prompting reconsideration of weight’s role in prognosis, treatment planning, and nutritional support strategies.</itunes:subtitle>
      <itunes:keywords>prompting reconsideration of weight’s role in prognosis, overweight bmi in head and neck cancer may be linked to better outcomes, treatment planning, and nutritional support strategies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>405</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5e6df9c6-fd26-4b6b-b774-34a8f30d413b</guid>
      <title>Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis</title>
      <description><![CDATA[Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications. 
]]></description>
      <pubDate>Fri, 24 Apr 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rethinking-oral-corticosteroid-therapy-for-myasthenia-gravis-18c8CkjH</link>
      <enclosure length="1701554" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/27ac28b0-e3a4-42ca-86bb-ab3692dc2bf0/group-item/0632eb1f-ad3b-49e9-81b0-8d3f93f9d9bf/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rethinking Oral Corticosteroid Therapy for Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications.</itunes:summary>
      <itunes:subtitle>Oral corticosteroids remain central in myasthenia gravis, but clinicians are shifting toward individualized dosing, combination therapies, and safer long-term strategies to reduce treatment burden and complications.</itunes:subtitle>
      <itunes:keywords>oral corticosteroids remain central in myasthenia gravis, combination therapies, but clinicians are shifting toward individualized dosing, and safer long-term strategies to reduce treatment burden and complications.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>404</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b0b350f9-c594-4e09-83cf-bbd8d8755aea</guid>
      <title>FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer</title>
      <description><![CDATA[Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier recurrence detection, and broader access to advanced diagnostic imaging. 
]]></description>
      <pubDate>Fri, 24 Apr 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-pylarify-truvu-to-expand-psma-pet-imaging-access-for-prostate-cancer-bS6qCtjl</link>
      <enclosure length="1802283" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/10be7f1a-62ee-494a-959a-1426dbea1e45/group-item/d21eba44-759a-4484-972c-029f98f3e2cc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves Pylarify TruVu to Expand PSMA-PET Imaging Access for Prostate Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier recurrence detection, and broader access to advanced diagnostic imaging.</itunes:summary>
      <itunes:subtitle>Food and Drug Administration approved Pylarify TruVu, improving PSMA-PET availability and reliability, enabling better prostate cancer staging, earlier recurrence detection, and broader access to advanced diagnostic imaging.</itunes:subtitle>
      <itunes:keywords>enabling better prostate cancer staging, food and drug administration approved pylarify truvu, earlier recurrence detection, improving psma-pet availability and reliability, and broader access to advanced diagnostic imaging.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>403</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">48899a2c-f630-45d6-acaf-676758acefc3</guid>
      <title>Innovating for the Patient: Highlights from the 2026 AAN Annual Meeting</title>
      <description><![CDATA[The American Academy of Neurology Annual Meeting 2026 highlighted advances in precision medicine, AI integration, gene therapies, and collaborative approaches shaping future neurological care and research. 
]]></description>
      <pubDate>Fri, 24 Apr 2026 13:36:43 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/innovating-for-the-patient-highlights-from-the-2026-aan-annual-meeting-NwseeDD5</link>
      <enclosure length="1868738" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2c6a212e-4aca-4765-855a-720c382fdd07/group-item/f379fad6-5aa7-4eb0-8edd-46aa8bd36101/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Innovating for the Patient: Highlights from the 2026 AAN Annual Meeting</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:56</itunes:duration>
      <itunes:summary>The American Academy of Neurology Annual Meeting 2026 highlighted advances in precision medicine, AI integration, gene therapies, and collaborative approaches shaping future neurological care and research.</itunes:summary>
      <itunes:subtitle>The American Academy of Neurology Annual Meeting 2026 highlighted advances in precision medicine, AI integration, gene therapies, and collaborative approaches shaping future neurological care and research.</itunes:subtitle>
      <itunes:keywords>and collaborative approaches shaping future neurological care and research., the american academy of neurology annual meeting 2026 highlighted advances in precision medicine, gene therapies, ai integration</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>402</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">15549a27-de82-4736-b89a-4008062ef575</guid>
      <title>The 30-30-30 Diet: An Innovative Approach to Weight Loss</title>
      <description><![CDATA[The 30-30-30 diet promotes early protein intake and light exercise to support weight loss, but flexibility and long-term consistency remain key for sustainable results. 
]]></description>
      <pubDate>Thu, 23 Apr 2026 19:05:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-30-30-30-diet-an-innovative-approach-to-weight-loss-xzR_QcDo</link>
      <enclosure length="1495083" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7e908227-ba2d-42bc-a5a7-a8f3245ce3ce/group-item/a13f3ee8-ce95-4f41-a9a6-691a541d2cd3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The 30-30-30 Diet: An Innovative Approach to Weight Loss</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>The 30-30-30 diet promotes early protein intake and light exercise to support weight loss, but flexibility and long-term consistency remain key for sustainable results.</itunes:summary>
      <itunes:subtitle>The 30-30-30 diet promotes early protein intake and light exercise to support weight loss, but flexibility and long-term consistency remain key for sustainable results.</itunes:subtitle>
      <itunes:keywords>but flexibility and long-term consistency remain key for sustainable results., the 30-30-30 diet promotes early protein intake and light exercise to support weight loss</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>401</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8017f462-a731-4d71-bec2-fe72758a157a</guid>
      <title>Weight Loss Drugs May Risk Bone Health and Malnutrition</title>
      <description><![CDATA[Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations. 
]]></description>
      <pubDate>Thu, 23 Apr 2026 18:10:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/weight-loss-drugs-may-risk-bone-health-and-malnutrition-FNxvG49W</link>
      <enclosure length="1402714" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/aff3aac4-b62f-4c09-8fe0-ecc26f62a00c/group-item/b527624b-520a-4b05-b9a1-b1d605c3bfbc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Weight Loss Drugs May Risk Bone Health and Malnutrition</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:27</itunes:duration>
      <itunes:summary>Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.</itunes:summary>
      <itunes:subtitle>Rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss, prompting clinicians to monitor nutrition, especially in vulnerable populations.</itunes:subtitle>
      <itunes:keywords>prompting clinicians to monitor nutrition, especially in vulnerable populations., rising use of semaglutide and tirzepatide highlights risks of malnutrition and bone loss</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>400</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">04c38ade-feb9-410e-b52a-dcfb370e5b68</guid>
      <title>Pregabalin vs. Duloxetine: Enhancing Painful Diabetic Neuropathy Care</title>
      <description><![CDATA[Combining pregabalin and duloxetine may improve pain control in diabetic neuropathy when monotherapy fails, enabling better symptom relief with lower doses and fewer side effects. 
]]></description>
      <pubDate>Thu, 23 Apr 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pregabalin-vs-duloxetine-enhancing-painful-diabetic-neuropathy-care-xTLdx9u1</link>
      <enclosure length="1431135" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5f3a3c80-9405-4c4f-9bc2-2a4357aa0a77/group-item/7b33dc46-d393-46bc-bf07-bd75131a590b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pregabalin vs. Duloxetine: Enhancing Painful Diabetic Neuropathy Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Combining pregabalin and duloxetine may improve pain control in diabetic neuropathy when monotherapy fails, enabling better symptom relief with lower doses and fewer side effects.</itunes:summary>
      <itunes:subtitle>Combining pregabalin and duloxetine may improve pain control in diabetic neuropathy when monotherapy fails, enabling better symptom relief with lower doses and fewer side effects.</itunes:subtitle>
      <itunes:keywords>enabling better symptom relief with lower doses and fewer side effects., combining pregabalin and duloxetine may improve pain control in diabetic neuropathy when monotherapy fails</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>399</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">55f90938-a70d-4c52-b410-389c07057e9e</guid>
      <title>Understanding Variability in Exercise Response</title>
      <description><![CDATA[Individual gut microbiota differences shape metabolic responses to exercise, suggesting personalized activity plans could improve outcomes for patients with type 2 diabetes and other metabolic disorders. 
]]></description>
      <pubDate>Thu, 23 Apr 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-variability-in-exercise-response-lTM5_WAU</link>
      <enclosure length="1736245" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7292bec2-2384-4eaf-97a1-0f028639d0e5/group-item/8c3ae2e1-056f-48c8-bb48-dc480f4c6932/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Variability in Exercise Response</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Individual gut microbiota differences shape metabolic responses to exercise, suggesting personalized activity plans could improve outcomes for patients with type 2 diabetes and other metabolic disorders.</itunes:summary>
      <itunes:subtitle>Individual gut microbiota differences shape metabolic responses to exercise, suggesting personalized activity plans could improve outcomes for patients with type 2 diabetes and other metabolic disorders.</itunes:subtitle>
      <itunes:keywords>suggesting personalized activity plans could improve outcomes for patients with type 2 diabetes and other metabolic disorders., individual gut microbiota differences shape metabolic responses to exercise</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>398</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c7d2a423-0d14-4c4a-b524-6ac05e7c8f56</guid>
      <title>FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen</title>
      <description><![CDATA[FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems. 
]]></description>
      <pubDate>Thu, 23 Apr 2026 14:20:17 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-expands-zepbound-label-to-allow-use-with-eli-lillys-kwikpen-taKYGT5r</link>
      <enclosure length="1838645" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f32f0137-e75a-4364-b046-73e614493829/group-item/ae431a00-ff82-4198-bb1e-78f915d5cbc1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Expands Zepbound Label To Allow Use With Eli Lilly’s KwikPen</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.</itunes:summary>
      <itunes:subtitle>FDA updates Zepbound labeling, pairing tirzepatide with KwikPen for weight management and cardiovascular risk reduction, improving usability, adherence, and access for patients, clinicians, pharmacies, and healthcare systems.</itunes:subtitle>
      <itunes:keywords>adherence, fda updates zepbound labeling, improving usability, and access for patients, clinicians, and healthcare systems., pairing tirzepatide with kwikpen for weight management and cardiovascular risk reduction, pharmacies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>397</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">81c7a2c6-a085-4eaa-9794-9e21d874ee8b</guid>
      <title>EPA’s Exclusion Of Lives Saved From Pollution Costs Is Misguided</title>
      <description><![CDATA[Critics say Environmental Protection Agency cost analyses omit lives saved from cleaner air, potentially weakening regulations, distorting policy decisions, and undermining public health protections and accountability. 
]]></description>
      <pubDate>Wed, 22 Apr 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/epas-exclusion-of-lives-saved-from-pollution-costs-is-misguided-yGjgZYdS</link>
      <enclosure length="1386831" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2d227d80-98db-4ffa-9726-38881b580c47/group-item/308c4d87-9d76-487e-90fa-1c48d0dac6c1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>EPA’s Exclusion Of Lives Saved From Pollution Costs Is Misguided</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>Critics say Environmental Protection Agency cost analyses omit lives saved from cleaner air, potentially weakening regulations, distorting policy decisions, and undermining public health protections and accountability.</itunes:summary>
      <itunes:subtitle>Critics say Environmental Protection Agency cost analyses omit lives saved from cleaner air, potentially weakening regulations, distorting policy decisions, and undermining public health protections and accountability.</itunes:subtitle>
      <itunes:keywords>and undermining public health protections and accountability., distorting policy decisions, critics say environmental protection agency cost analyses omit lives saved from cleaner air, potentially weakening regulations</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>396</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1a5a71a4-935f-4858-a76d-bebaef831fb9</guid>
      <title>Hybrid GI Workforce: Enhancing Clinician Autonomy and Satisfaction</title>
      <description><![CDATA[Gastroenterology is shifting to hybrid care models combining in-person and telehealth services, aiming to reduce burnout, improve clinician autonomy, and sustain high-quality, patient-centered digestive care delivery. 
]]></description>
      <pubDate>Wed, 22 Apr 2026 18:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hybrid-gi-workforce-enhancing-clinician-autonomy-and-satisfaction-rS5opTRN</link>
      <enclosure length="1255592" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7e40d770-25a4-4ef4-9cec-9e0b598d97fc/group-item/41b194d6-cea7-4b7d-88c3-b6207a42602f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Hybrid GI Workforce: Enhancing Clinician Autonomy and Satisfaction</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Gastroenterology is shifting to hybrid care models combining in-person and telehealth services, aiming to reduce burnout, improve clinician autonomy, and sustain high-quality, patient-centered digestive care delivery.</itunes:summary>
      <itunes:subtitle>Gastroenterology is shifting to hybrid care models combining in-person and telehealth services, aiming to reduce burnout, improve clinician autonomy, and sustain high-quality, patient-centered digestive care delivery.</itunes:subtitle>
      <itunes:keywords>patient-centered digestive care delivery., improve clinician autonomy, aiming to reduce burnout, and sustain high-quality, gastroenterology is shifting to hybrid care models combining in-person and telehealth services</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>395</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c79d891b-5262-4d05-a7b2-95da76bf553a</guid>
      <title>Tirzepatide May Not Increase Risk of Depression or Suicidal Ideation</title>
      <description><![CDATA[Tirzepatide shows no increased risk of depression or suicidal thoughts in trials, supporting its psychological safety and giving clinicians greater confidence when prescribing weight management therapy. 
]]></description>
      <pubDate>Wed, 22 Apr 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/tirzepatide-may-not-increase-risk-of-depression-or-suicidal-ideation-swiYPdBc</link>
      <enclosure length="987680" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e09f6760-73cf-4a93-9b4d-a56f04f1bca6/group-item/366d302b-a6a6-49bf-a205-13896c9e0cac/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Tirzepatide May Not Increase Risk of Depression or Suicidal Ideation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:01</itunes:duration>
      <itunes:summary>Tirzepatide shows no increased risk of depression or suicidal thoughts in trials, supporting its psychological safety and giving clinicians greater confidence when prescribing weight management therapy.</itunes:summary>
      <itunes:subtitle>Tirzepatide shows no increased risk of depression or suicidal thoughts in trials, supporting its psychological safety and giving clinicians greater confidence when prescribing weight management therapy.</itunes:subtitle>
      <itunes:keywords>supporting its psychological safety and giving clinicians greater confidence when prescribing weight management therapy., tirzepatide shows no increased risk of depression or suicidal thoughts in trials</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>394</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0031e23b-ec9d-430c-aa20-d320e206eb0a</guid>
      <title>While Cancer Mortality Declines in Under-50s, Colorectal Deaths Are Concerning</title>
      <description><![CDATA[Cancer deaths are declining among adults under 50, yet rising colorectal cancer mortality in younger groups highlights urgent need for earlier screening, awareness, and targeted prevention strategies. 
]]></description>
      <pubDate>Wed, 22 Apr 2026 14:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/while-cancer-mortality-declines-in-under-50s-colorectal-deaths-are-concerning-S_aBqEyp</link>
      <enclosure length="1534371" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/84eafaa1-2a60-4593-8bbc-437a68d099fe/group-item/c0edc61b-ea84-4582-bd46-359a4075d607/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>While Cancer Mortality Declines in Under-50s, Colorectal Deaths Are Concerning</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:35</itunes:duration>
      <itunes:summary>Cancer deaths are declining among adults under 50, yet rising colorectal cancer mortality in younger groups highlights urgent need for earlier screening, awareness, and targeted prevention strategies.</itunes:summary>
      <itunes:subtitle>Cancer deaths are declining among adults under 50, yet rising colorectal cancer mortality in younger groups highlights urgent need for earlier screening, awareness, and targeted prevention strategies.</itunes:subtitle>
      <itunes:keywords>yet rising colorectal cancer mortality in younger groups highlights urgent need for earlier screening, and targeted prevention strategies., cancer deaths are declining among adults under 50, awareness</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>393</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">72ddb228-e9ae-4370-8c9d-0f58a5ec2628</guid>
      <title>Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC): Clinical Outcomes and Recurrence</title>
      <description><![CDATA[Early-stage pancreatic cancer care remains challenging after surgery, with growing emphasis on long-term surveillance to detect recurrence earlier, guide follow-up strategies, and improve patient outcomes. 
]]></description>
      <pubDate>Wed, 22 Apr 2026 13:40:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/early-stage-pancreatic-ductal-adenocarcinoma-pdac-clinical-outcomes-and-recurrence-94dbE5RH</link>
      <enclosure length="1548163" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/29f441e9-0303-4d0b-aa20-316e2d2432e6/group-item/332775f3-6c4c-4a3c-86a6-a92a2f5aee64/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Early-Stage Pancreatic Ductal Adenocarcinoma (PDAC): Clinical Outcomes and Recurrence</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Early-stage pancreatic cancer care remains challenging after surgery, with growing emphasis on long-term surveillance to detect recurrence earlier, guide follow-up strategies, and improve patient outcomes.</itunes:summary>
      <itunes:subtitle>Early-stage pancreatic cancer care remains challenging after surgery, with growing emphasis on long-term surveillance to detect recurrence earlier, guide follow-up strategies, and improve patient outcomes.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>392</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3c43342f-64c7-4f7c-a1e9-7db6fcb87519</guid>
      <title>Low‑Dose Lithium for Mild Cognitive Impairment: What a Pilot Trial Shows About Safety and Feasibility</title>
      <description><![CDATA[Pilot trial shows low-dose lithium in mild cognitive impairment is feasible, informing larger studies while highlighting cautious hope for delaying cognitive decline and preventing progression to dementia. 
]]></description>
      <pubDate>Tue, 21 Apr 2026 18:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/lowdose-lithium-for-mild-cognitive-impairment-what-a-pilot-trial-shows-about-safety-and-feasibility-xC_QLEwQ</link>
      <enclosure length="1764666" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e2a109ab-bbce-4ad9-a39c-3e160b53e671/group-item/f1017e95-d643-45b8-80f5-c062a7822f9e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Low‑Dose Lithium for Mild Cognitive Impairment: What a Pilot Trial Shows About Safety and Feasibility</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Pilot trial shows low-dose lithium in mild cognitive impairment is feasible, informing larger studies while highlighting cautious hope for delaying cognitive decline and preventing progression to dementia.</itunes:summary>
      <itunes:subtitle>Pilot trial shows low-dose lithium in mild cognitive impairment is feasible, informing larger studies while highlighting cautious hope for delaying cognitive decline and preventing progression to dementia.</itunes:subtitle>
      <itunes:keywords>informing larger studies while highlighting cautious hope for delaying cognitive decline and preventing progression to dementia., pilot trial shows low-dose lithium in mild cognitive impairment is feasible</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>391</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6f35a72e-8651-4d25-bc41-4654c38eb59d</guid>
      <title>The Importance of Mental Health for HCPs: Why Every Shift Needs a Mental Reset for Q2 2026</title>
      <description><![CDATA[Healthcare professionals face high stress and burnout, impacting care quality; brief mental resets and supportive workplace cultures improve well-being, resilience, and patient safety across healthcare systems. 
]]></description>
      <pubDate>Tue, 21 Apr 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-importance-of-mental-health-for-hcps-why-every-shift-needs-a-mental-reset-for-q2-2026-105DrnwR</link>
      <enclosure length="1796013" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fcf79e32-5463-47c2-a2f2-19628d593414/group-item/f743fb70-67ad-4e78-9f0a-981ba2a88de1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Importance of Mental Health for HCPs: Why Every Shift Needs a Mental Reset for Q2 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>Healthcare professionals face high stress and burnout, impacting care quality; brief mental resets and supportive workplace cultures improve well-being, resilience, and patient safety across healthcare systems.</itunes:summary>
      <itunes:subtitle>Healthcare professionals face high stress and burnout, impacting care quality; brief mental resets and supportive workplace cultures improve well-being, resilience, and patient safety across healthcare systems.</itunes:subtitle>
      <itunes:keywords>resilience, impacting care quality; brief mental resets and supportive workplace cultures improve well-being, and patient safety across healthcare systems., healthcare professionals face high stress and burnout</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>390</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">90791afb-a277-4935-aa81-c841112971d1</guid>
      <title>T-DXd Tolerability in Community-Treated HER2-Low Metastatic Breast Cancer: What Real-World Practice Is Showing</title>
      <description><![CDATA[Trastuzumab Deruxtecan is becoming standard for HER2-low metastatic breast cancer, with safe community use requiring careful monitoring, patient education, and early management of serious lung-related side effects. 
]]></description>
      <pubDate>Tue, 21 Apr 2026 15:45:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/t-dxd-tolerability-in-community-treated-her2-low-metastatic-breast-cancer-what-real-world-practice-is-showing-Zx44h1D3</link>
      <enclosure length="1732065" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f85cc297-fa71-4395-bacd-9a040a25c4c7/group-item/89ac69f0-920e-4e71-bc6a-3f10bcb4d233/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>T-DXd Tolerability in Community-Treated HER2-Low Metastatic Breast Cancer: What Real-World Practice Is Showing</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Trastuzumab Deruxtecan is becoming standard for HER2-low metastatic breast cancer, with safe community use requiring careful monitoring, patient education, and early management of serious lung-related side effects.</itunes:summary>
      <itunes:subtitle>Trastuzumab Deruxtecan is becoming standard for HER2-low metastatic breast cancer, with safe community use requiring careful monitoring, patient education, and early management of serious lung-related side effects.</itunes:subtitle>
      <itunes:keywords>and early management of serious lung-related side effects., trastuzumab deruxtecan is becoming standard for her2-low metastatic breast cancer, with safe community use requiring careful monitoring, patient education</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>389</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4fa71e91-5d99-44e1-8133-7368ed975010</guid>
      <title>The Gap Between Cancer Treatment And Survivorship Support</title>
      <description><![CDATA[Cancer survivors often face persistent physical, emotional, and financial challenges after treatment, highlighting gaps in coordinated survivorship care and the need for better support, planning, and resources. 
]]></description>
      <pubDate>Tue, 21 Apr 2026 14:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-gap-between-cancer-treatment-and-survivorship-support-Kw9JvStf</link>
      <enclosure length="1678149" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5516c534-a6f0-46a7-bfe2-b96516aca257/group-item/581956cd-f6d3-4a7b-a979-7090d7cbe2e1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Gap Between Cancer Treatment And Survivorship Support</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>Cancer survivors often face persistent physical, emotional, and financial challenges after treatment, highlighting gaps in coordinated survivorship care and the need for better support, planning, and resources.</itunes:summary>
      <itunes:subtitle>Cancer survivors often face persistent physical, emotional, and financial challenges after treatment, highlighting gaps in coordinated survivorship care and the need for better support, planning, and resources.</itunes:subtitle>
      <itunes:keywords>planning, emotional, and financial challenges after treatment, highlighting gaps in coordinated survivorship care and the need for better support, cancer survivors often face persistent physical, and resources.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>388</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2932cbfa-b78f-4912-8a8b-9928fb22c44c</guid>
      <title>Ultra‑Hypofractionated Radiation Therapy for Locally Advanced Breast Cancer</title>
      <description><![CDATA[Ultra-hypofractionated radiation for locally advanced breast cancer shortens treatment duration, easing patient burden and improving access, while requiring careful selection to balance convenience with long-term safety outcomes. 
]]></description>
      <pubDate>Tue, 21 Apr 2026 13:14:45 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ultrahypofractionated-radiation-therapy-for-locally-advanced-breast-cancer-3w8Dh0Fc</link>
      <enclosure length="1620470" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2fd87c8d-5a75-481c-b969-e8cfc20299c4/group-item/425dd443-36ba-4093-b406-da959df88355/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ultra‑Hypofractionated Radiation Therapy for Locally Advanced Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Ultra-hypofractionated radiation for locally advanced breast cancer shortens treatment duration, easing patient burden and improving access, while requiring careful selection to balance convenience with long-term safety outcomes.</itunes:summary>
      <itunes:subtitle>Ultra-hypofractionated radiation for locally advanced breast cancer shortens treatment duration, easing patient burden and improving access, while requiring careful selection to balance convenience with long-term safety outcomes.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>387</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cdb9564f-a42e-4f78-b70c-82b926c17ba7</guid>
      <title>Matched Sibling Donors Remain the Gold Standard for PTCy‑Based Allogeneic Stem Cell Transplantation</title>
      <description><![CDATA[Matched sibling donors remain preferred for allogeneic transplantation with PTCy, offering better immune compatibility, fewer complications, and predictable outcomes, though alternative donors expand access for patients without matches. 
]]></description>
      <pubDate>Mon, 20 Apr 2026 18:35:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/matched-sibling-donors-remain-the-gold-standard-for-ptcybased-allogeneic-stem-cell-transplantation-qq1MqnLd</link>
      <enclosure length="1951076" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/81b83523-69d8-49a3-9661-1a12b2dcd6ee/group-item/df81b0b3-4527-41b1-8f83-ba32ae815f21/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Matched Sibling Donors Remain the Gold Standard for PTCy‑Based Allogeneic Stem Cell Transplantation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:01</itunes:duration>
      <itunes:summary>Matched sibling donors remain preferred for allogeneic transplantation with PTCy, offering better immune compatibility, fewer complications, and predictable outcomes, though alternative donors expand access for patients without matches.</itunes:summary>
      <itunes:subtitle>Matched sibling donors remain preferred for allogeneic transplantation with PTCy, offering better immune compatibility, fewer complications, and predictable outcomes, though alternative donors expand access for patients without matches.</itunes:subtitle>
      <itunes:keywords>though alternative donors expand access for patients without matches., offering better immune compatibility, matched sibling donors remain preferred for allogeneic transplantation with ptcy, fewer complications, and predictable outcomes</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>386</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2fb6cf66-575c-4170-ad84-a6cd60eb500d</guid>
      <title>Accountable Care Org Savings: Hard To Measure, Hard To Find</title>
      <description><![CDATA[Accountable Care Organizations show modest, uncertain Medicare savings, often influenced by coding, patient selection, and administrative costs, highlighting challenges in proving true value from payment reform models. 
]]></description>
      <pubDate>Mon, 20 Apr 2026 17:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/accountable-care-org-savings-hard-to-measure-hard-to-find-Tdsbj144</link>
      <enclosure length="1081303" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/515ec925-bb80-4e60-8eb0-9ce7aca10d35/group-item/801c1fd9-9e58-4976-aca3-b4d6f798673e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Accountable Care Org Savings: Hard To Measure, Hard To Find</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:07</itunes:duration>
      <itunes:summary>Accountable Care Organizations show modest, uncertain Medicare savings, often influenced by coding, patient selection, and administrative costs, highlighting challenges in proving true value from payment reform models.</itunes:summary>
      <itunes:subtitle>Accountable Care Organizations show modest, uncertain Medicare savings, often influenced by coding, patient selection, and administrative costs, highlighting challenges in proving true value from payment reform models.</itunes:subtitle>
      <itunes:keywords>patient selection, uncertain medicare savings, accountable care organizations show modest, often influenced by coding, highlighting challenges in proving true value from payment reform models., and administrative costs</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>385</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fa3e7540-ab70-47c9-80e2-b1b0e67bb599</guid>
      <title>MiniMed 780G Pump Secures CE Mark With Abbott Instinct Sensor</title>
      <description><![CDATA[MiniMed 780G now integrates with Abbott Instinct continuous glucose monitor, expanding sensor choice, improving flexibility, and advancing interoperability in automated diabetes management systems. 
]]></description>
      <pubDate>Mon, 20 Apr 2026 16:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/minimed-780g-pump-secures-ce-mark-with-abbott-instinct-sensor-8rQa_93W</link>
      <enclosure length="1445345" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4c9f8ae6-8249-4a4a-8fe4-1f5135b69663/group-item/700366f7-6703-4efd-9a54-a7199b98560b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>MiniMed 780G Pump Secures CE Mark With Abbott Instinct Sensor</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:30</itunes:duration>
      <itunes:summary>MiniMed 780G now integrates with Abbott Instinct continuous glucose monitor, expanding sensor choice, improving flexibility, and advancing interoperability in automated diabetes management systems.</itunes:summary>
      <itunes:subtitle>MiniMed 780G now integrates with Abbott Instinct continuous glucose monitor, expanding sensor choice, improving flexibility, and advancing interoperability in automated diabetes management systems.</itunes:subtitle>
      <itunes:keywords>and advancing interoperability in automated diabetes management systems., minimed 780g now integrates with abbott instinct continuous glucose monitor, expanding sensor choice, improving flexibility</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>384</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">adce28b5-fa5d-4343-ba8f-0d04f4e60f1f</guid>
      <title>Blood Pressure Metric Could Help Predict Dementia Risk</title>
      <description><![CDATA[Emerging blood pressure metrics, including variability and vascular aging signals, may help predict dementia risk earlier, enabling proactive prevention through improved monitoring, lifestyle changes, and personalized care strategies. 
]]></description>
      <pubDate>Mon, 20 Apr 2026 15:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/blood-pressure-metric-could-help-predict-dementia-risk-PrOTVr8K</link>
      <enclosure length="1717019" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/dba7749c-65ce-4bc1-88e0-87c329c92f4d/group-item/68ba0132-886d-483d-b8a2-8c72a8cb47dc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Blood Pressure Metric Could Help Predict Dementia Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Emerging blood pressure metrics, including variability and vascular aging signals, may help predict dementia risk earlier, enabling proactive prevention through improved monitoring, lifestyle changes, and personalized care strategies.</itunes:summary>
      <itunes:subtitle>Emerging blood pressure metrics, including variability and vascular aging signals, may help predict dementia risk earlier, enabling proactive prevention through improved monitoring, lifestyle changes, and personalized care strategies.</itunes:subtitle>
      <itunes:keywords>emerging blood pressure metrics, including variability and vascular aging signals, enabling proactive prevention through improved monitoring, may help predict dementia risk earlier, lifestyle changes, and personalized care strategies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>383</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0b31a91c-afd8-4d74-b0ed-41dd29a8bc63</guid>
      <title>FDA Approves Avlayah In Hunter Syndrome Neurologic Manifestations</title>
      <description><![CDATA[FDA approved Avlayah for pediatric Hunter syndrome, delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve developmental outcomes in affected children. 
]]></description>
      <pubDate>Mon, 20 Apr 2026 14:28:03 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-avlayah-in-hunter-syndrome-neurologic-manifestations-6te9oz1r</link>
      <enclosure length="1722034" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5af271d7-5c6f-4c6e-a5eb-d46a43c44344/group-item/bf0ad13f-802d-4c40-add4-c6a06711502c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves Avlayah In Hunter Syndrome Neurologic Manifestations</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>FDA approved Avlayah for pediatric Hunter syndrome, delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve developmental outcomes in affected children.</itunes:summary>
      <itunes:subtitle>FDA approved Avlayah for pediatric Hunter syndrome, delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve developmental outcomes in affected children.</itunes:subtitle>
      <itunes:keywords>delivering enzyme therapy across the blood-brain barrier to address neurologic symptoms and improve developmental outcomes in affected children., fda approved avlayah for pediatric hunter syndrome</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>382</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9e700475-0d87-492b-9a5a-cc788e7bade7</guid>
      <title>State Spending Growth Benchmarks &amp; Hospital Revenue</title>
      <description><![CDATA[State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better data to effectively control hospital prices and premiums. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 19:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/state-spending-growth-benchmarks-hospital-revenue-np1avIxV</link>
      <enclosure length="1640532" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/85bbe3e4-c2d9-4f6e-9274-ef828319013b/group-item/6a2dca9e-ca8c-4369-8ae8-b5be08af26a4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>State Spending Growth Benchmarks &amp; Hospital Revenue</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better data to effectively control hospital prices and premiums.</itunes:summary>
      <itunes:subtitle>State healthcare spending benchmarks alone show limited impact on costs, highlighting need for stronger enforcement, complementary pricing policies, and better data to effectively control hospital prices and premiums.</itunes:subtitle>
      <itunes:keywords>highlighting need for stronger enforcement, and better data to effectively control hospital prices and premiums., complementary pricing policies, state healthcare spending benchmarks alone show limited impact on costs</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>381</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">417c5aa5-ec0d-48c5-802e-6394e5a72c20</guid>
      <title>IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx</title>
      <description><![CDATA[IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ioa-244p110-pi3k-stops-breast-tumor-progression-mono-combo-tx-eMKn5dfd</link>
      <enclosure length="1362172" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/988ea74f-663a-4c2e-9cfe-fbb415734226/group-item/04776c5a-2c0d-49cc-b145-691f405b4a0b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>IOA-244(p110δ PI3K) Stops Breast Tumor Progression Mono/Combo Tx</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.</itunes:summary>
      <itunes:subtitle>IOA-244, a selective PI3Kδ inhibitor, shows potential to slow breast cancer by targeting tumor cells and microenvironment, offering safer therapy and biomarker-guided combination strategies.</itunes:subtitle>
      <itunes:keywords>ioa-244, a selective pi3kδ inhibitor, offering safer therapy and biomarker-guided combination strategies., shows potential to slow breast cancer by targeting tumor cells and microenvironment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>380</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dbc09c25-74f9-4428-8815-3cca5f73c0de</guid>
      <title>Early, Personalized Cholesterol Screening and LDL-Lowering: What the New Guidelines Mean for Clinicians, Patients, and Payers</title>
      <description><![CDATA[New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/early-personalized-cholesterol-screening-and-ldl-lowering-what-the-new-guidelines-mean-for-clinicians-patients-and-payers-ueX9fXJ5</link>
      <enclosure length="1148176" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/93bbce20-c75e-4ce9-b5b5-b8b7d81aa650/group-item/de823452-08c4-4c8c-b9d2-0fa6ce4e7486/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Early, Personalized Cholesterol Screening and LDL-Lowering: What the New Guidelines Mean for Clinicians, Patients, and Payers</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:11</itunes:duration>
      <itunes:summary>New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns.</itunes:summary>
      <itunes:subtitle>New cholesterol guidelines emphasize earlier screening, personalized risk assessment, and aggressive LDL reduction, incorporating genetic factors like lipoprotein(a) to improve prevention, while raising cost, access, and overdiagnosis concerns.</itunes:subtitle>
      <itunes:keywords>and aggressive ldl reduction, personalized risk assessment, and overdiagnosis concerns., while raising cost, access, new cholesterol guidelines emphasize earlier screening, incorporating genetic factors like lipoprotein(a) to improve prevention</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>379</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c7fdd107-a1bd-4447-b92d-99826883c188</guid>
      <title>Psilocybin-Assisted Therapy: Promise, Safety, and the Path to Clinical Adoption</title>
      <description><![CDATA[Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory, and access challenges while ensuring durable, equitable patient outcomes. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 16:10:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psilocybin-assisted-therapy-promise-safety-and-the-path-to-clinical-adoption-X8u_Pjpd</link>
      <enclosure length="1743350" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/c181be66-a3fa-441e-9e9a-018aec387442/group-item/0b17c1ac-e831-4ac2-b059-ee3bc39e03b7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psilocybin-Assisted Therapy: Promise, Safety, and the Path to Clinical Adoption</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory, and access challenges while ensuring durable, equitable patient outcomes.</itunes:summary>
      <itunes:subtitle>Psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, training, regulatory, and access challenges while ensuring durable, equitable patient outcomes.</itunes:subtitle>
      <itunes:keywords>equitable patient outcomes., and access challenges while ensuring durable, psilocybin-assisted therapy shows promise for treatment-resistant mental disorders, but widespread adoption depends on resolving safety, regulatory, training</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>378</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3769ebb2-8ab0-41bb-9d0d-41c24abcd1ee</guid>
      <title>Budgetary Impact Of The MSSP On Traditional Medicare</title>
      <description><![CDATA[Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, equity, and program design. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/budgetary-impact-of-the-mssp-on-traditional-medicare-ApUWWy3w</link>
      <enclosure length="1519742" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/247cf436-9d90-4ac3-bcb9-d3af8dd2607d/group-item/258220f2-0e87-4b22-bbdb-c1974b7bec0a/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Budgetary Impact Of The MSSP On Traditional Medicare</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, equity, and program design.</itunes:summary>
      <itunes:subtitle>Medicare Shared Savings Program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, equity, and program design.</itunes:subtitle>
      <itunes:keywords>medicare shared savings program shows net savings over a decade, but results vary, highlighting benefits of value-based care alongside concerns about costs, and program design., equity</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>377</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8e2dea68-b934-4c52-b08c-d647246d67d3</guid>
      <title>Ketamine-Assisted MORE For Opioid Use Disorder: RCT</title>
      <description><![CDATA[Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but raises safety, training, and access challenges. 
]]></description>
      <pubDate>Fri, 17 Apr 2026 13:24:32 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ketamine-assisted-more-for-opioid-use-disorder-rct-FZbIp6o1</link>
      <enclosure length="1328735" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e4406ee2-eaab-4d4a-88a6-4df2249782b5/group-item/1193c348-9937-4c8b-9879-4ea380eafce5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ketamine-Assisted MORE For Opioid Use Disorder: RCT</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but raises safety, training, and access challenges.</itunes:summary>
      <itunes:subtitle>Ketamine-assisted psychotherapy combined with mindfulness-based MORE shows promise for opioid use disorder by reducing cravings and improving regulation, but raises safety, training, and access challenges.</itunes:subtitle>
      <itunes:keywords>ketamine-assisted psychotherapy combined with mindfulness-based more shows promise for opioid use disorder by reducing cravings and improving regulation, and access challenges., training, but raises safety</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>376</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">409c88db-072c-4baa-95e2-6892ab03e875</guid>
      <title>Catheter Extraction Of Right-Sided IE Without Surgery</title>
      <description><![CDATA[Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 19:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/catheter-extraction-of-right-sided-ie-without-surgery-uYsd5NXe</link>
      <enclosure length="1729976" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/cc302d84-e231-41af-ab68-b37138d5aabf/group-item/df9c6390-39e9-4050-90ad-a4515dc9589c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Catheter Extraction Of Right-Sided IE Without Surgery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management.</itunes:summary>
      <itunes:subtitle>Catheter-based aspiration offers a less invasive option for right-sided infective endocarditis, enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management.</itunes:subtitle>
      <itunes:keywords>enabling vegetation removal and infection control in high-risk patients while requiring careful selection and multidisciplinary management., catheter-based aspiration offers a less invasive option for right-sided infective endocarditis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>375</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8e81c3c8-c785-467f-acac-23f1f7003cb8</guid>
      <title>AI, 3D Body-Volume Scan Improve Metabolic Syndrome Risk Precision</title>
      <description><![CDATA[AI-enhanced 3D body scans improve metabolic syndrome risk detection beyond BMI by capturing fat distribution, enabling earlier, personalized interventions while raising challenges in cost, access, and algorithm fairness. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 18:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-3d-body-volume-scan-improve-metabolic-syndrome-risk-precision-MHXlHxvH</link>
      <enclosure length="1845750" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6180d836-7e3f-4054-9f44-02013e3b3759/group-item/b7cc3466-b30f-4c37-82c2-bd0dbe257eca/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI, 3D Body-Volume Scan Improve Metabolic Syndrome Risk Precision</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>AI-enhanced 3D body scans improve metabolic syndrome risk detection beyond BMI by capturing fat distribution, enabling earlier, personalized interventions while raising challenges in cost, access, and algorithm fairness.</itunes:summary>
      <itunes:subtitle>AI-enhanced 3D body scans improve metabolic syndrome risk detection beyond BMI by capturing fat distribution, enabling earlier, personalized interventions while raising challenges in cost, access, and algorithm fairness.</itunes:subtitle>
      <itunes:keywords>personalized interventions while raising challenges in cost, access, ai-enhanced 3d body scans improve metabolic syndrome risk detection beyond bmi by capturing fat distribution, enabling earlier, and algorithm fairness.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>374</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e56407d9-c665-4bfa-87a8-e5a88a4405f6</guid>
      <title>Best Late-Line Treatments for Metastatic Colorectal Cancer</title>
      <description><![CDATA[In metastatic colorectal cancer, late-line therapy choices balance survival, toxicity, and convenience; SUNLIGHT data suggest neutropenia may signal effective drug exposure, guiding individualized treatment and supportive care decisions. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 16:45:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/best-late-line-treatments-for-metastatic-colorectal-cancer-DaZwYEPc</link>
      <enclosure length="1510129" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/78bfc27c-afc9-4656-8760-8010b70a80eb/group-item/06736018-e990-4e9f-b16c-8b860aacfdf0/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Best Late-Line Treatments for Metastatic Colorectal Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>In metastatic colorectal cancer, late-line therapy choices balance survival, toxicity, and convenience; SUNLIGHT data suggest neutropenia may signal effective drug exposure, guiding individualized treatment and supportive care decisions.</itunes:summary>
      <itunes:subtitle>In metastatic colorectal cancer, late-line therapy choices balance survival, toxicity, and convenience; SUNLIGHT data suggest neutropenia may signal effective drug exposure, guiding individualized treatment and supportive care decisions.</itunes:subtitle>
      <itunes:keywords>and convenience; sunlight data suggest neutropenia may signal effective drug exposure, toxicity, late-line therapy choices balance survival, guiding individualized treatment and supportive care decisions., in metastatic colorectal cancer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>373</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">728c37e1-2e2d-4b07-8a69-8dcb4aae946c</guid>
      <title>THP Noninferior To TCbHP For pCR In HER2+ Early Breast Cancer</title>
      <description><![CDATA[THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy, improve tolerability, and streamline care delivery. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 15:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/thp-noninferior-to-tcbhp-for-pcr-in-her2-early-breast-cancer-HEm01muO</link>
      <enclosure length="1821509" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/02daefcf-3da7-46ad-b764-8384cb6b5a4f/group-item/ed0e8edb-0e6c-42df-8db9-bbba79923b25/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>THP Noninferior To TCbHP For pCR In HER2+ Early Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:53</itunes:duration>
      <itunes:summary>THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy, improve tolerability, and streamline care delivery.</itunes:summary>
      <itunes:subtitle>THP regimen matches TCbHP in pCR for HER2-positive early breast cancer, while reducing toxicity, supporting de-escalation strategies that preserve efficacy, improve tolerability, and streamline care delivery.</itunes:subtitle>
      <itunes:keywords>while reducing toxicity, thp regimen matches tcbhp in pcr for her2-positive early breast cancer, and streamline care delivery., supporting de-escalation strategies that preserve efficacy, improve tolerability</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>372</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">be810c5a-cda9-4f67-bc58-8f857a92e06e</guid>
      <title>Phase 2b Biomarker Analysis: BCMA CAR-T in Myasthenia Gravis</title>
      <description><![CDATA[BCMA-directed CAR-T therapy shows promise in myasthenia gravis by selectively targeting plasma cells, improving outcomes, and prompting biomarker-guided care, outpatient delivery models, and health system adaptation. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 14:51:32 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/phase-2b-biomarker-analysis-bcma-car-t-in-myasthenia-gravis-k2UEYDP_</link>
      <enclosure length="1641786" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5d65ab44-34b3-40d7-ac1a-4c33a65b6755/group-item/cf87ca3f-0325-48a6-ba65-a72827ac0e67/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Phase 2b Biomarker Analysis: BCMA CAR-T in Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>BCMA-directed CAR-T therapy shows promise in myasthenia gravis by selectively targeting plasma cells, improving outcomes, and prompting biomarker-guided care, outpatient delivery models, and health system adaptation.</itunes:summary>
      <itunes:subtitle>BCMA-directed CAR-T therapy shows promise in myasthenia gravis by selectively targeting plasma cells, improving outcomes, and prompting biomarker-guided care, outpatient delivery models, and health system adaptation.</itunes:subtitle>
      <itunes:keywords>and prompting biomarker-guided care, outpatient delivery models, and health system adaptation., bcma-directed car-t therapy shows promise in myasthenia gravis by selectively targeting plasma cells, improving outcomes</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>371</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">064aa043-4e8c-4a86-b6a7-5d5a91221dcd</guid>
      <title>MIND Diet Adherence Linked to Slower Structural Brain Atrophy</title>
      <description><![CDATA[MIND diet adherence may slow brain atrophy and cognitive decline, encouraging clinicians and policymakers to integrate preventive nutrition counseling, expand access, and prioritize brain-healthy dietary interventions in care. 
]]></description>
      <pubDate>Thu, 16 Apr 2026 13:31:56 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mind-diet-adherence-linked-to-slower-structural-brain-atrophy-GaCeRug4</link>
      <enclosure length="1505950" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/99cf1e1e-202a-471b-9b42-ae55f1227b96/group-item/9109f349-28aa-4332-a3cf-73b073b325ae/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>MIND Diet Adherence Linked to Slower Structural Brain Atrophy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>MIND diet adherence may slow brain atrophy and cognitive decline, encouraging clinicians and policymakers to integrate preventive nutrition counseling, expand access, and prioritize brain-healthy dietary interventions in care.</itunes:summary>
      <itunes:subtitle>MIND diet adherence may slow brain atrophy and cognitive decline, encouraging clinicians and policymakers to integrate preventive nutrition counseling, expand access, and prioritize brain-healthy dietary interventions in care.</itunes:subtitle>
      <itunes:keywords>and prioritize brain-healthy dietary interventions in care., encouraging clinicians and policymakers to integrate preventive nutrition counseling, expand access, mind diet adherence may slow brain atrophy and cognitive decline</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>370</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d044bff6-e289-46fd-881d-a70690b8fdfc</guid>
      <title>Online Sports Betting: A Public Health And Policy Issue 2026</title>
      <description><![CDATA[Widespread online sports betting raises addiction and mental health risks, prompting stronger regulation, clinician screening, consumer protections, and public health strategies to reduce gambling-related harm and costs. 
]]></description>
      <pubDate>Mon, 6 Apr 2026 16:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/online-sports-betting-a-public-health-and-policy-issue-2026-ncAsByeL</link>
      <enclosure length="1673133" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0d40fea9-0c55-4992-b304-1fe012d0fcf6/group-item/a6bb96a3-481e-4978-a4bf-b654f87a7ebc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Online Sports Betting: A Public Health And Policy Issue 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>Widespread online sports betting raises addiction and mental health risks, prompting stronger regulation, clinician screening, consumer protections, and public health strategies to reduce gambling-related harm and costs.</itunes:summary>
      <itunes:subtitle>Widespread online sports betting raises addiction and mental health risks, prompting stronger regulation, clinician screening, consumer protections, and public health strategies to reduce gambling-related harm and costs.</itunes:subtitle>
      <itunes:keywords>and public health strategies to reduce gambling-related harm and costs., clinician screening, widespread online sports betting raises addiction and mental health risks, consumer protections, prompting stronger regulation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>369</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ece3872a-af1d-4c23-ba8d-72d1104f8533</guid>
      <title>Eating Disorder Symptoms Linked to Problematic Smartphone Use in 2026</title>
      <description><![CDATA[Heavy smartphone and social media use is increasingly linked to eating disorder symptoms, requiring integrated screening, digital habit assessment, and coordinated mental health strategies to improve diagnosis and recovery outcomes. 
]]></description>
      <pubDate>Mon, 6 Apr 2026 14:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/eating-disorder-symptoms-linked-to-problematic-smartphone-use-in-2026-70F0oCEx</link>
      <enclosure length="1309091" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f10c93f6-cde5-49b2-8672-0f7a4cff860b/group-item/b3761eec-c26a-4184-8a89-d8a2a3342cf4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Eating Disorder Symptoms Linked to Problematic Smartphone Use in 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Heavy smartphone and social media use is increasingly linked to eating disorder symptoms, requiring integrated screening, digital habit assessment, and coordinated mental health strategies to improve diagnosis and recovery outcomes.</itunes:summary>
      <itunes:subtitle>Heavy smartphone and social media use is increasingly linked to eating disorder symptoms, requiring integrated screening, digital habit assessment, and coordinated mental health strategies to improve diagnosis and recovery outcomes.</itunes:subtitle>
      <itunes:keywords>digital habit assessment, heavy smartphone and social media use is increasingly linked to eating disorder symptoms, requiring integrated screening, and coordinated mental health strategies to improve diagnosis and recovery outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>368</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a6916189-af9b-4988-927d-b409ffe96972</guid>
      <title>AI Stethoscope May Aid Peripartum Cardiomyopathy Diagnosis</title>
      <description><![CDATA[AI-enabled digital stethoscopes may enable early detection of peripartum cardiomyopathy, improving bedside screening, accelerating diagnosis, reducing complications, and expanding equitable access to cardiac care for pregnant patients. 
]]></description>
      <pubDate>Mon, 6 Apr 2026 13:12:48 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-stethoscope-may-aid-peripartum-cardiomyopathy-diagnosis-r296l6FJ</link>
      <enclosure length="1816493" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/998da081-0088-4157-a70c-30b7641d42c2/group-item/2edd4c1b-8a49-469c-86f3-56e83b097072/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI Stethoscope May Aid Peripartum Cardiomyopathy Diagnosis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:53</itunes:duration>
      <itunes:summary>AI-enabled digital stethoscopes may enable early detection of peripartum cardiomyopathy, improving bedside screening, accelerating diagnosis, reducing complications, and expanding equitable access to cardiac care for pregnant patients.</itunes:summary>
      <itunes:subtitle>AI-enabled digital stethoscopes may enable early detection of peripartum cardiomyopathy, improving bedside screening, accelerating diagnosis, reducing complications, and expanding equitable access to cardiac care for pregnant patients.</itunes:subtitle>
      <itunes:keywords>accelerating diagnosis, reducing complications, ai-enabled digital stethoscopes may enable early detection of peripartum cardiomyopathy, and expanding equitable access to cardiac care for pregnant patients., improving bedside screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>367</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bd3ce3ba-7193-4573-962b-3ad3c6fbe156</guid>
      <title>Understanding Trial Termination Factors in Head and Neck Research</title>
      <description><![CDATA[High failure rates in HNSCC clinical trials, driven by strategic decisions and poor recruitment, delay innovative treatments, highlighting need for improved trial design, diversity, and real-world data. 
]]></description>
      <pubDate>Fri, 3 Apr 2026 19:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-trial-termination-factors-in-head-and-neck-research-srzkQPP6</link>
      <enclosure length="2157130" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d19330b0-8cf4-428c-806a-a4f2d0552a72/group-item/b6690911-1b03-4bea-a275-ba8afed6c2a9/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Trial Termination Factors in Head and Neck Research</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:14</itunes:duration>
      <itunes:summary>High failure rates in HNSCC clinical trials, driven by strategic decisions and poor recruitment, delay innovative treatments, highlighting need for improved trial design, diversity, and real-world data.</itunes:summary>
      <itunes:subtitle>High failure rates in HNSCC clinical trials, driven by strategic decisions and poor recruitment, delay innovative treatments, highlighting need for improved trial design, diversity, and real-world data.</itunes:subtitle>
      <itunes:keywords>and real-world data., high failure rates in hnscc clinical trials, driven by strategic decisions and poor recruitment, highlighting need for improved trial design, delay innovative treatments, diversity</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>366</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ac252ef5-4d52-4c10-a5bc-9ec3f4dba5d3</guid>
      <title>Mitochondrial DNA Profiling in Blood and CSF for ALS Insights</title>
      <description><![CDATA[Mitochondrial DNA profiling in blood and cerebrospinal fluid offers biomarkers for ALS progression, enabling earlier diagnosis, personalized treatment strategies, improved monitoring, and more targeted future therapeutic research. 
]]></description>
      <pubDate>Fri, 3 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mitochondrial-dna-profiling-in-blood-and-csf-for-als-insights-mwgYQGQL</link>
      <enclosure length="1704480" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f0e278d7-09e4-4662-aaec-99b01c0c5b01/group-item/e4819962-eba7-4be3-889d-1eafd0675184/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mitochondrial DNA Profiling in Blood and CSF for ALS Insights</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Mitochondrial DNA profiling in blood and cerebrospinal fluid offers biomarkers for ALS progression, enabling earlier diagnosis, personalized treatment strategies, improved monitoring, and more targeted future therapeutic research.</itunes:summary>
      <itunes:subtitle>Mitochondrial DNA profiling in blood and cerebrospinal fluid offers biomarkers for ALS progression, enabling earlier diagnosis, personalized treatment strategies, improved monitoring, and more targeted future therapeutic research.</itunes:subtitle>
      <itunes:keywords>mitochondrial dna profiling in blood and cerebrospinal fluid offers biomarkers for als progression, improved monitoring, enabling earlier diagnosis, and more targeted future therapeutic research., personalized treatment strategies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>365</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ab34ed94-f955-4936-bd38-6b699d6d57df</guid>
      <title>Ischemic Stroke: Faster Treatment Requires Better Logistics</title>
      <description><![CDATA[Ischemic stroke demands rapid treatment; improving EMS routing, hospital coordination, telemedicine, and logistics reduces delays, limits disability, addresses inequities, and strengthens outcomes across stroke care systems. 
]]></description>
      <pubDate>Fri, 3 Apr 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ischemic-stroke-faster-treatment-requires-better-logistics-MZ5mJlgg</link>
      <enclosure length="1426119" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f8e58bf5-d676-45cc-abcb-7eeb7cd62b27/group-item/833f155e-72a0-413c-ab07-61745cb02b50/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ischemic Stroke: Faster Treatment Requires Better Logistics</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Ischemic stroke demands rapid treatment; improving EMS routing, hospital coordination, telemedicine, and logistics reduces delays, limits disability, addresses inequities, and strengthens outcomes across stroke care systems.</itunes:summary>
      <itunes:subtitle>Ischemic stroke demands rapid treatment; improving EMS routing, hospital coordination, telemedicine, and logistics reduces delays, limits disability, addresses inequities, and strengthens outcomes across stroke care systems.</itunes:subtitle>
      <itunes:keywords>addresses inequities, and strengthens outcomes across stroke care systems., and logistics reduces delays, telemedicine, ischemic stroke demands rapid treatment; improving ems routing, limits disability, hospital coordination</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>364</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fb365f94-9a47-4db5-88c5-1b8c8507be9a</guid>
      <title>Pegzilarginase: Accelerated Approval For Arginase 1 Deficiency (ARG1-D) Hyperargininemia</title>
      <description><![CDATA[Pegzilarginase, first disease-modifying therapy for Arginase 1 deficiency, lowers toxic arginine levels, slows neurological damage, and transforms care through enzyme replacement, accelerated approval, and multidisciplinary support. 
]]></description>
      <pubDate>Fri, 3 Apr 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pegzilarginase-accelerated-approval-for-arginase-1-deficiency-arg1-d-hyperargininemia-kB524nVB</link>
      <enclosure length="2019621" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0a31c445-f18c-400c-b80b-a2a2c674e8ac/group-item/51855d90-d69c-4543-968f-ddfb77f8487d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pegzilarginase: Accelerated Approval For Arginase 1 Deficiency (ARG1-D) Hyperargininemia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Pegzilarginase, first disease-modifying therapy for Arginase 1 deficiency, lowers toxic arginine levels, slows neurological damage, and transforms care through enzyme replacement, accelerated approval, and multidisciplinary support.</itunes:summary>
      <itunes:subtitle>Pegzilarginase, first disease-modifying therapy for Arginase 1 deficiency, lowers toxic arginine levels, slows neurological damage, and transforms care through enzyme replacement, accelerated approval, and multidisciplinary support.</itunes:subtitle>
      <itunes:keywords>slows neurological damage, accelerated approval, pegzilarginase, and multidisciplinary support., and transforms care through enzyme replacement, first disease-modifying therapy for arginase 1 deficiency, lowers toxic arginine levels</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>363</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c5394731-6537-4257-989c-20c5ba9ebccc</guid>
      <title>A New Biological Front in MS: Fenebrutinib For Primary Progressive Multiple Sclerosis (PPMS)</title>
      <description><![CDATA[Fenebrutinib, an oral BTK inhibitor, shows non-inferiority to ocrelizumab in PPMS, targeting CNS inflammation, reducing infusion burden, and expanding equitable, scalable progressive multiple sclerosis care. 
]]></description>
      <pubDate>Fri, 3 Apr 2026 13:05:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/a-new-biological-front-in-ms-fenebrutinib-for-primary-progressive-multiple-sclerosis-ppms-rCjd71iu</link>
      <enclosure length="1895487" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0ddb154b-a233-420f-a68c-6f53325635ac/group-item/441e08c6-96af-4e24-be2a-41fbc5124567/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>A New Biological Front in MS: Fenebrutinib For Primary Progressive Multiple Sclerosis (PPMS)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>Fenebrutinib, an oral BTK inhibitor, shows non-inferiority to ocrelizumab in PPMS, targeting CNS inflammation, reducing infusion burden, and expanding equitable, scalable progressive multiple sclerosis care.</itunes:summary>
      <itunes:subtitle>Fenebrutinib, an oral BTK inhibitor, shows non-inferiority to ocrelizumab in PPMS, targeting CNS inflammation, reducing infusion burden, and expanding equitable, scalable progressive multiple sclerosis care.</itunes:subtitle>
      <itunes:keywords>shows non-inferiority to ocrelizumab in ppms, an oral btk inhibitor, reducing infusion burden, fenebrutinib, scalable progressive multiple sclerosis care., targeting cns inflammation, and expanding equitable</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>362</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6f79de94-8b9c-4edc-ad36-4dff3bd042b9</guid>
      <title>Symptom Transitions Predict TB Risk In Serial Active Case-Finding</title>
      <description><![CDATA[Serial symptom monitoring and targeted screening improve early tuberculosis detection, enabling faster diagnosis, reduced transmission, smarter triage, and timely treatment for high-risk and underserved populations worldwide. 
]]></description>
      <pubDate>Thu, 2 Apr 2026 19:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/symptom-transitions-predict-tb-risk-in-serial-active-case-finding-nF5Y8PKr</link>
      <enclosure length="1479200" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8b7338fd-a830-44ad-816d-79f3a60bf68f/group-item/c2e0b000-c720-4ce5-a3ff-47224d56da82/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Symptom Transitions Predict TB Risk In Serial Active Case-Finding</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Serial symptom monitoring and targeted screening improve early tuberculosis detection, enabling faster diagnosis, reduced transmission, smarter triage, and timely treatment for high-risk and underserved populations worldwide.</itunes:summary>
      <itunes:subtitle>Serial symptom monitoring and targeted screening improve early tuberculosis detection, enabling faster diagnosis, reduced transmission, smarter triage, and timely treatment for high-risk and underserved populations worldwide.</itunes:subtitle>
      <itunes:keywords>serial symptom monitoring and targeted screening improve early tuberculosis detection, reduced transmission, smarter triage, and timely treatment for high-risk and underserved populations worldwide., enabling faster diagnosis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>361</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">533d1daa-f58e-4dcd-88d3-c1b92ef4d7e6</guid>
      <title>Lipid Management Challenges In CKD, HIV, And Cancer Care</title>
      <description><![CDATA[Managing lipids in CKD, HIV, and cancer requires individualized therapy, careful drug interaction monitoring, multidisciplinary coordination, and balanced cardiovascular prevention to ensure safety, adherence, and long-term outcomes. 
]]></description>
      <pubDate>Thu, 2 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/lipid-management-challenges-in-ckd-hiv-and-cancer-care-vp7uRGEQ</link>
      <enclosure length="1686508" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7fa3a2b1-2d19-42b2-afb5-d2da0c9848c8/group-item/14276935-8ccd-41c4-9215-eafc1b123443/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Lipid Management Challenges In CKD, HIV, And Cancer Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Managing lipids in CKD, HIV, and cancer requires individualized therapy, careful drug interaction monitoring, multidisciplinary coordination, and balanced cardiovascular prevention to ensure safety, adherence, and long-term outcomes.</itunes:summary>
      <itunes:subtitle>Managing lipids in CKD, HIV, and cancer requires individualized therapy, careful drug interaction monitoring, multidisciplinary coordination, and balanced cardiovascular prevention to ensure safety, adherence, and long-term outcomes.</itunes:subtitle>
      <itunes:keywords>adherence, multidisciplinary coordination, careful drug interaction monitoring, hiv, and cancer requires individualized therapy, managing lipids in ckd, and balanced cardiovascular prevention to ensure safety, and long-term outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>360</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">eeaff570-72c3-4bbe-a99b-3760c259bb5d</guid>
      <title>Medication Adherence: The Missing Link In Cholesterol Care</title>
      <description><![CDATA[Cholesterol therapy adherence ensures long-term cardiovascular protection by promoting consistent medication use, addressing barriers, improving care coordination, reducing disparities, and preventing avoidable heart attacks, strokes, and healthcare costs. 
]]></description>
      <pubDate>Thu, 2 Apr 2026 16:13:52 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/medication-adherence-the-missing-link-in-cholesterol-care-sZs44r2W</link>
      <enclosure length="2165907" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9e195440-97bd-401c-af23-d90aef3f8a8c/group-item/cf00e438-aa6a-4aee-9d2d-cf4d79ff1df7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Medication Adherence: The Missing Link In Cholesterol Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:15</itunes:duration>
      <itunes:summary>Cholesterol therapy adherence ensures long-term cardiovascular protection by promoting consistent medication use, addressing barriers, improving care coordination, reducing disparities, and preventing avoidable heart attacks, strokes, and healthcare costs.</itunes:summary>
      <itunes:subtitle>Cholesterol therapy adherence ensures long-term cardiovascular protection by promoting consistent medication use, addressing barriers, improving care coordination, reducing disparities, and preventing avoidable heart attacks, strokes, and healthcare costs.</itunes:subtitle>
      <itunes:keywords>and healthcare costs., reducing disparities, cholesterol therapy adherence ensures long-term cardiovascular protection by promoting consistent medication use, strokes, improving care coordination, and preventing avoidable heart attacks, addressing barriers</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>359</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a97d94b4-64fe-49a9-82d6-463bf7c7d9b4</guid>
      <title>MyLungHealth Tool May Enhance Lung Cancer Screening Eligibility</title>
      <description><![CDATA[MyLungHealth integrates with EHR workflows to identify lung cancer screening eligibility, increase low-dose CT orders, enhance early detection, and improve outcomes for high-risk primary care patients. 
]]></description>
      <pubDate>Wed, 1 Apr 2026 19:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mylunghealth-tool-may-enhance-lung-cancer-screening-eligibility-Z2dZvWoX</link>
      <enclosure length="1375964" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0f57713c-2937-478e-b21b-521ecc85b7a5/group-item/6afbd1d4-1a79-4d64-b401-8ac3449214e1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>MyLungHealth Tool May Enhance Lung Cancer Screening Eligibility</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>MyLungHealth integrates with EHR workflows to identify lung cancer screening eligibility, increase low-dose CT orders, enhance early detection, and improve outcomes for high-risk primary care patients.</itunes:summary>
      <itunes:subtitle>MyLungHealth integrates with EHR workflows to identify lung cancer screening eligibility, increase low-dose CT orders, enhance early detection, and improve outcomes for high-risk primary care patients.</itunes:subtitle>
      <itunes:keywords>increase low-dose ct orders, mylunghealth integrates with ehr workflows to identify lung cancer screening eligibility, and improve outcomes for high-risk primary care patients., enhance early detection</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>358</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c65a863e-0a11-42f1-b97b-3b72ae3535d6</guid>
      <title>New Collaborations and Treatments in MASLD and MASH</title>
      <description><![CDATA[Emerging MASLD and MASH treatments emphasize multidisciplinary collaboration, improving early detection, coordinated care, and disease management for patients with metabolic disorders while reducing progression and healthcare burden. 
]]></description>
      <pubDate>Wed, 1 Apr 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-collaborations-and-treatments-in-masld-and-mash-NyhMcgMk</link>
      <enclosure length="1960271" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9b28e892-2dbc-4c6f-8e39-e8c2a213e639/group-item/b230162a-6ecc-4dba-91e6-72aa4606c0d6/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Collaborations and Treatments in MASLD and MASH</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Emerging MASLD and MASH treatments emphasize multidisciplinary collaboration, improving early detection, coordinated care, and disease management for patients with metabolic disorders while reducing progression and healthcare burden.</itunes:summary>
      <itunes:subtitle>Emerging MASLD and MASH treatments emphasize multidisciplinary collaboration, improving early detection, coordinated care, and disease management for patients with metabolic disorders while reducing progression and healthcare burden.</itunes:subtitle>
      <itunes:keywords>and disease management for patients with metabolic disorders while reducing progression and healthcare burden., coordinated care, emerging masld and mash treatments emphasize multidisciplinary collaboration, improving early detection</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>357</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">be6bfafb-fe21-4547-b64b-f52287bab961</guid>
      <title>Early Cognitive Factors May Affect Return to Work After Stroke</title>
      <description><![CDATA[Early cognitive screening after ischemic stroke helps predict return-to-work potential, guiding rehabilitation planning, aligning expectations, and improving functional recovery through integrated cognitive and vocational care strategies. 
]]></description>
      <pubDate>Wed, 1 Apr 2026 16:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/early-cognitive-factors-may-affect-return-to-work-after-stroke-azuOBgUy</link>
      <enclosure length="1493829" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0dea32c0-db1e-45a0-b0e1-decb89a94640/group-item/8dd75eb7-37e3-48a2-8330-e4a927a699aa/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Early Cognitive Factors May Affect Return to Work After Stroke</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Early cognitive screening after ischemic stroke helps predict return-to-work potential, guiding rehabilitation planning, aligning expectations, and improving functional recovery through integrated cognitive and vocational care strategies.</itunes:summary>
      <itunes:subtitle>Early cognitive screening after ischemic stroke helps predict return-to-work potential, guiding rehabilitation planning, aligning expectations, and improving functional recovery through integrated cognitive and vocational care strategies.</itunes:subtitle>
      <itunes:keywords>guiding rehabilitation planning, and improving functional recovery through integrated cognitive and vocational care strategies., aligning expectations, early cognitive screening after ischemic stroke helps predict return-to-work potential</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>356</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">032c089f-7c64-4c6a-8c30-6089ac86b7d0</guid>
      <title>Optical Genome Mapping May Improve Risk Stratification in Myelofibrosis</title>
      <description><![CDATA[Optical Genome Mapping improves genetic risk assessment in myelofibrosis, enabling personalized treatment decisions, earlier intervention, better monitoring, and more efficient healthcare resource use for high-risk patients. 
]]></description>
      <pubDate>Wed, 1 Apr 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/optical-genome-mapping-may-improve-risk-stratification-in-myelofibrosis-rPlXf4dq</link>
      <enclosure length="1463736" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3002d329-c25c-438b-9249-d29de432b45a/group-item/52794673-91ea-4512-b587-03a44c2b27a4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Optical Genome Mapping May Improve Risk Stratification in Myelofibrosis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Optical Genome Mapping improves genetic risk assessment in myelofibrosis, enabling personalized treatment decisions, earlier intervention, better monitoring, and more efficient healthcare resource use for high-risk patients.</itunes:summary>
      <itunes:subtitle>Optical Genome Mapping improves genetic risk assessment in myelofibrosis, enabling personalized treatment decisions, earlier intervention, better monitoring, and more efficient healthcare resource use for high-risk patients.</itunes:subtitle>
      <itunes:keywords>earlier intervention, enabling personalized treatment decisions, better monitoring, and more efficient healthcare resource use for high-risk patients., optical genome mapping improves genetic risk assessment in myelofibrosis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>355</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1d46c64c-5dbb-4aab-a248-dcd33bff031d</guid>
      <title>Blood-Based Biomarkers Among Notable Alzheimer’s Advances</title>
      <description><![CDATA[Blood-based Alzheimer’s biomarkers enable earlier, less invasive diagnosis, expanding screening and research opportunities while raising concerns about accuracy, equity, access, counseling, and health system readiness for implementation. 
]]></description>
      <pubDate>Wed, 1 Apr 2026 13:23:38 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/blood-based-biomarkers-among-notable-alzheimers-advances-csI7Iyg_</link>
      <enclosure length="1889218" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4e399fe5-9fb3-41d6-8edc-a0c004b9ffda/group-item/872fa5bf-cb6c-4a56-94e1-a0d7490ccd3f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Blood-Based Biomarkers Among Notable Alzheimer’s Advances</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>Blood-based Alzheimer’s biomarkers enable earlier, less invasive diagnosis, expanding screening and research opportunities while raising concerns about accuracy, equity, access, counseling, and health system readiness for implementation.</itunes:summary>
      <itunes:subtitle>Blood-based Alzheimer’s biomarkers enable earlier, less invasive diagnosis, expanding screening and research opportunities while raising concerns about accuracy, equity, access, counseling, and health system readiness for implementation.</itunes:subtitle>
      <itunes:keywords>blood-based alzheimer’s biomarkers enable earlier, less invasive diagnosis, and health system readiness for implementation., counseling, equity, access, expanding screening and research opportunities while raising concerns about accuracy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>354</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c2ffc8f1-9aba-41ca-bb74-1f5cd40b06d8</guid>
      <title>Impact of Biosimilar Competition on Out-of-Pocket Costs for Biologics</title>
      <description><![CDATA[Biosimilar competition lowers out-of-pocket costs for Medicare patients on biologics, improving access, adherence, and outcomes while helping healthcare systems reduce spending on high-cost therapies. 
]]></description>
      <pubDate>Tue, 31 Mar 2026 19:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-biosimilar-competition-on-out-of-pocket-costs-for-biologics-T2o45uBp</link>
      <enclosure length="1622978" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9e99e7c6-b7e6-4317-997a-49306049aa62/group-item/02feb3c4-dc28-4ffc-82aa-b3b895e28a9c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Biosimilar Competition on Out-of-Pocket Costs for Biologics</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Biosimilar competition lowers out-of-pocket costs for Medicare patients on biologics, improving access, adherence, and outcomes while helping healthcare systems reduce spending on high-cost therapies.</itunes:summary>
      <itunes:subtitle>Biosimilar competition lowers out-of-pocket costs for Medicare patients on biologics, improving access, adherence, and outcomes while helping healthcare systems reduce spending on high-cost therapies.</itunes:subtitle>
      <itunes:keywords>adherence, improving access, biosimilar competition lowers out-of-pocket costs for medicare patients on biologics, and outcomes while helping healthcare systems reduce spending on high-cost therapies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>353</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">946881b4-5320-4abc-8f69-7c7a6a4830c6</guid>
      <title>Miracle Drugs: Breakthroughs Or Overhyped In Medicine?</title>
      <description><![CDATA[New incretin-based weight loss medicines transform obesity and diabetes care, offering significant metabolic benefits while raising critical questions about safety, long-term use, cost, access, and equitable treatment. 
]]></description>
      <pubDate>Tue, 31 Mar 2026 18:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/miracle-drugs-breakthroughs-or-overhyped-in-medicine-gj5mEG_Y</link>
      <enclosure length="1679821" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6904047c-0bf2-4054-8f83-ac5a8653555d/group-item/5137968c-8015-4c35-8f80-bfb3b9fa1158/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Miracle Drugs: Breakthroughs Or Overhyped In Medicine?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>New incretin-based weight loss medicines transform obesity and diabetes care, offering significant metabolic benefits while raising critical questions about safety, long-term use, cost, access, and equitable treatment.</itunes:summary>
      <itunes:subtitle>New incretin-based weight loss medicines transform obesity and diabetes care, offering significant metabolic benefits while raising critical questions about safety, long-term use, cost, access, and equitable treatment.</itunes:subtitle>
      <itunes:keywords>new incretin-based weight loss medicines transform obesity and diabetes care, offering significant metabolic benefits while raising critical questions about safety, access, cost, and equitable treatment., long-term use</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>352</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a7333030-fb98-42d7-b111-1dedf55ad22e</guid>
      <title>Cardiovascular Intelligence Software Receives U.S. Food and Drug Administration Clearance</title>
      <description><![CDATA[Argos Infinity FDA clearance enables real-time cardiovascular monitoring and decision support, improving early detection of hemodynamic instability, enhancing perioperative and ICU care, workflows, and patient safety outcomes. 
]]></description>
      <pubDate>Tue, 31 Mar 2026 17:45:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cardiovascular-intelligence-software-receives-us-food-and-drug-administration-clearance-g0KeA31P</link>
      <enclosure length="1159879" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/379303d0-bcbc-4e2d-8726-0b6239f28272/group-item/ec6d83bf-8012-465d-8ea5-2e649e5d2ab0/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cardiovascular Intelligence Software Receives U.S. Food and Drug Administration Clearance</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>Argos Infinity FDA clearance enables real-time cardiovascular monitoring and decision support, improving early detection of hemodynamic instability, enhancing perioperative and ICU care, workflows, and patient safety outcomes.</itunes:summary>
      <itunes:subtitle>Argos Infinity FDA clearance enables real-time cardiovascular monitoring and decision support, improving early detection of hemodynamic instability, enhancing perioperative and ICU care, workflows, and patient safety outcomes.</itunes:subtitle>
      <itunes:keywords>workflows, improving early detection of hemodynamic instability, argos infinity fda clearance enables real-time cardiovascular monitoring and decision support, enhancing perioperative and icu care, and patient safety outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>351</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">de97b6e3-dcba-406c-b13d-b027d56ed7b8</guid>
      <title>Mobile Self-Regulation App May Enhance Weight Loss Results</title>
      <description><![CDATA[Mobile weight loss apps can support obesity management by tracking diet and exercise, encouraging healthier habits, complementing surgical options, and aiding clinicians and policymakers in prevention efforts. 
]]></description>
      <pubDate>Tue, 31 Mar 2026 14:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mobile-self-regulation-app-may-enhance-weight-loss-results-KO9Q0kgD</link>
      <enclosure length="1475021" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fad2a6ec-c8c4-4de1-8320-b4f9388d09bb/group-item/fdcb73ef-afa7-4337-bc07-a195871eed61/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mobile Self-Regulation App May Enhance Weight Loss Results</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Mobile weight loss apps can support obesity management by tracking diet and exercise, encouraging healthier habits, complementing surgical options, and aiding clinicians and policymakers in prevention efforts.</itunes:summary>
      <itunes:subtitle>Mobile weight loss apps can support obesity management by tracking diet and exercise, encouraging healthier habits, complementing surgical options, and aiding clinicians and policymakers in prevention efforts.</itunes:subtitle>
      <itunes:keywords>and aiding clinicians and policymakers in prevention efforts., mobile weight loss apps can support obesity management by tracking diet and exercise, complementing surgical options, encouraging healthier habits</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>350</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bee43020-cd27-4b1b-9250-902f980f7cf0</guid>
      <title>Men’s Hair Regrowth: Effective Treatments, Costs, and Benefits</title>
      <description><![CDATA[Comprehensive overview of men’s hair regrowth options, including medications, hair systems, and surgical restoration, highlighting effectiveness, costs, risks, and personalized treatment planning for androgenetic alopecia management. 
]]></description>
      <pubDate>Tue, 31 Mar 2026 13:05:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mens-hair-regrowth-effective-treatments-costs-and-benefits-_LKx7kwt</link>
      <enclosure length="1976154" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1e90434d-8fce-4bd3-8e46-4d286dc5bc33/group-item/d0785179-cb13-46dc-a5fb-e535846a714f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Men’s Hair Regrowth: Effective Treatments, Costs, and Benefits</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:03</itunes:duration>
      <itunes:summary>Comprehensive overview of men’s hair regrowth options, including medications, hair systems, and surgical restoration, highlighting effectiveness, costs, risks, and personalized treatment planning for androgenetic alopecia management.</itunes:summary>
      <itunes:subtitle>Comprehensive overview of men’s hair regrowth options, including medications, hair systems, and surgical restoration, highlighting effectiveness, costs, risks, and personalized treatment planning for androgenetic alopecia management.</itunes:subtitle>
      <itunes:keywords>risks, and surgical restoration, hair systems, costs, highlighting effectiveness, and personalized treatment planning for androgenetic alopecia management., including medications, comprehensive overview of men’s hair regrowth options</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>349</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cc75d127-83f5-449d-8909-c205ddddb462</guid>
      <title>Acetylcholine Receptor-Positive Myasthenia Gravis in Very Old</title>
      <description><![CDATA[AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care. 
]]></description>
      <pubDate>Mon, 30 Mar 2026 14:16:13 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/acetylcholine-receptor-positive-myasthenia-gravis-in-very-old-XKFjXd3X-Xae5RaFl</link>
      <enclosure length="1856617" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/873251ad-6760-4869-870d-b51217d72f56/group-item/47c4bb82-5431-48dd-bb4b-c040f43e96a3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Acetylcholine Receptor-Positive Myasthenia Gravis in Very Old</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:56</itunes:duration>
      <itunes:summary>AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care.</itunes:summary>
      <itunes:subtitle>AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care.</itunes:subtitle>
      <itunes:keywords>and support coordinated multidisciplinary care., preserve function, achr-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, reduce medication risks</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>348</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">88b15e0a-8ba5-45e2-9bd4-9cb3ad7444fa</guid>
      <title>Acetylcholine Receptor-Positive Myasthenia Gravis in Very Old</title>
      <description><![CDATA[AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care. 
]]></description>
      <pubDate>Fri, 27 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/acetylcholine-receptor-positive-myasthenia-gravis-in-very-old-lUQc1duv</link>
      <enclosure length="1869156" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1bb55f75-f878-4a28-8c37-13dcbb70b965/group-item/e1d3320e-f843-407c-b656-cda21b650a35/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Acetylcholine Receptor-Positive Myasthenia Gravis in Very Old</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:56</itunes:duration>
      <itunes:summary>AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care.</itunes:summary>
      <itunes:subtitle>AChR-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, preserve function, reduce medication risks, and support coordinated multidisciplinary care.</itunes:subtitle>
      <itunes:keywords>and support coordinated multidisciplinary care., preserve function, achr-positive myasthenia gravis in adults over 80 requires geriatric-adapted diagnosis and treatment to prevent crises, reduce medication risks</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>347</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9f97935d-e5df-4f78-a195-af2cecd93cbb</guid>
      <title>Lumbar ESP Block: Injection Plane Selection &amp; Tulgar Sequence</title>
      <description><![CDATA[Lumbar erector spinae plane block refinements, including injection plane selection and Tulgar sequence, improve anesthetic spread, optimize pain control, reduce opioids, and enhance postoperative recovery outcomes. 
]]></description>
      <pubDate>Fri, 27 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/lumbar-esp-block-injection-plane-selection-tulgar-sequence-cBYllRv_</link>
      <enclosure length="2157548" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d139aafb-ef5a-4a5e-902b-7b72f0f832e8/group-item/c98e12e9-e0d3-4a07-9931-39cae7c074ae/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Lumbar ESP Block: Injection Plane Selection &amp; Tulgar Sequence</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:14</itunes:duration>
      <itunes:summary>Lumbar erector spinae plane block refinements, including injection plane selection and Tulgar sequence, improve anesthetic spread, optimize pain control, reduce opioids, and enhance postoperative recovery outcomes.</itunes:summary>
      <itunes:subtitle>Lumbar erector spinae plane block refinements, including injection plane selection and Tulgar sequence, improve anesthetic spread, optimize pain control, reduce opioids, and enhance postoperative recovery outcomes.</itunes:subtitle>
      <itunes:keywords>optimize pain control, and enhance postoperative recovery outcomes., reduce opioids, lumbar erector spinae plane block refinements, improve anesthetic spread, including injection plane selection and tulgar sequence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>346</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b6357812-92f9-43c0-9888-e9de63e75fb3</guid>
      <title>60% Of Physicians Who Treat Sickle Cell Disease Report Burnout</title>
      <description><![CDATA[High burnout among sickle cell disease specialists threatens care access, quality, and equity, highlighting urgent need for workforce support, payment reform, multidisciplinary teams, and institutional investment. 
]]></description>
      <pubDate>Fri, 27 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/60-of-physicians-who-treat-sickle-cell-disease-report-burnout-HK99d9AB</link>
      <enclosure length="1080467" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8b6cef3d-5ec4-4272-90a9-30631564df87/group-item/f5734243-325b-4169-8521-107df4f294fe/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>60% Of Physicians Who Treat Sickle Cell Disease Report Burnout</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:07</itunes:duration>
      <itunes:summary>High burnout among sickle cell disease specialists threatens care access, quality, and equity, highlighting urgent need for workforce support, payment reform, multidisciplinary teams, and institutional investment.</itunes:summary>
      <itunes:subtitle>High burnout among sickle cell disease specialists threatens care access, quality, and equity, highlighting urgent need for workforce support, payment reform, multidisciplinary teams, and institutional investment.</itunes:subtitle>
      <itunes:keywords>and institutional investment., highlighting urgent need for workforce support, payment reform, and equity, multidisciplinary teams, high burnout among sickle cell disease specialists threatens care access, quality</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>345</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">de66620d-7b9d-4f63-ab5c-e0001c89837e</guid>
      <title>Subtle Early-Onset Cancer (EOC) Burden Rise, Significant Mortality Drop</title>
      <description><![CDATA[Rising early-onset cancer incidence alongside declining mortality is reshaping prevention, screening, and survivorship strategies, driving focus on equity, long-term care, workforce planning, and health system adaptation. 
]]></description>
      <pubDate>Fri, 27 Mar 2026 14:42:42 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/subtle-early-onset-cancer-eoc-burden-rise-significant-mortality-drop-6xe_P813</link>
      <enclosure length="1648892" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1a8cddef-2566-4056-8053-4f3b5d0d30f5/group-item/ac82cb24-9f33-4445-ab87-a3fa46bccd8e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Subtle Early-Onset Cancer (EOC) Burden Rise, Significant Mortality Drop</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Rising early-onset cancer incidence alongside declining mortality is reshaping prevention, screening, and survivorship strategies, driving focus on equity, long-term care, workforce planning, and health system adaptation.</itunes:summary>
      <itunes:subtitle>Rising early-onset cancer incidence alongside declining mortality is reshaping prevention, screening, and survivorship strategies, driving focus on equity, long-term care, workforce planning, and health system adaptation.</itunes:subtitle>
      <itunes:keywords>driving focus on equity, rising early-onset cancer incidence alongside declining mortality is reshaping prevention, workforce planning, and survivorship strategies, and health system adaptation., long-term care, screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>344</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">02e108d6-c75c-4d7c-b77c-919efed66a43</guid>
      <title>Incretin Agonists And CPAP In Adults With Diabetes, Obesity, OSA</title>
      <description><![CDATA[Incretin agonists like tirzepatide may reduce obstructive sleep apnea severity in adults with obesity and type 2 diabetes, complementing CPAP and supporting integrated, patient-centered sleep and metabolic care. 
]]></description>
      <pubDate>Thu, 26 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/incretin-agonists-and-cpap-in-adults-with-diabetes-obesity-osa-JUCvUL06</link>
      <enclosure length="1867484" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d077d6c1-fb07-4577-bab8-ecfa04977555/group-item/fcbb1fde-402b-4f59-9e34-358ff4a13e21/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Incretin Agonists And CPAP In Adults With Diabetes, Obesity, OSA</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:56</itunes:duration>
      <itunes:summary>Incretin agonists like tirzepatide may reduce obstructive sleep apnea severity in adults with obesity and type 2 diabetes, complementing CPAP and supporting integrated, patient-centered sleep and metabolic care.</itunes:summary>
      <itunes:subtitle>Incretin agonists like tirzepatide may reduce obstructive sleep apnea severity in adults with obesity and type 2 diabetes, complementing CPAP and supporting integrated, patient-centered sleep and metabolic care.</itunes:subtitle>
      <itunes:keywords>incretin agonists like tirzepatide may reduce obstructive sleep apnea severity in adults with obesity and type 2 diabetes, complementing cpap and supporting integrated, patient-centered sleep and metabolic care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>343</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">33ac724b-1880-46a5-8ca1-eafd34dad53a</guid>
      <title>Remote Lung Sound Monitoring Feasibility After COPD Exacerbation</title>
      <description><![CDATA[Remote lung sound monitoring for COPD enables real-time detection of exacerbations, supports proactive care, reduces hospitalizations, improves outcomes, and enhances healthcare efficiency and cost savings. 
]]></description>
      <pubDate>Thu, 26 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/remote-lung-sound-monitoring-feasibility-after-copd-exacerbation-LKfuhvri</link>
      <enclosure length="1558194" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/c6891537-dcd4-4ae2-8889-3c69733a4e73/group-item/f214562e-322b-4e3b-887c-1e8f8254b9b5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Remote Lung Sound Monitoring Feasibility After COPD Exacerbation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>Remote lung sound monitoring for COPD enables real-time detection of exacerbations, supports proactive care, reduces hospitalizations, improves outcomes, and enhances healthcare efficiency and cost savings.</itunes:summary>
      <itunes:subtitle>Remote lung sound monitoring for COPD enables real-time detection of exacerbations, supports proactive care, reduces hospitalizations, improves outcomes, and enhances healthcare efficiency and cost savings.</itunes:subtitle>
      <itunes:keywords>improves outcomes, remote lung sound monitoring for copd enables real-time detection of exacerbations, reduces hospitalizations, supports proactive care, and enhances healthcare efficiency and cost savings.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>342</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">65713246-a39b-48b2-9fd6-b252c0ed9598</guid>
      <title>Novel Oral Agent Lowers HbA1c, Improves Beta-Cell Function in T2D</title>
      <description><![CDATA[A novel oral diabetes therapy shows durable HbA1c reduction and beta-cell preservation after short treatment, potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies. 
]]></description>
      <pubDate>Thu, 26 Mar 2026 14:52:20 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/novel-oral-agent-lowers-hba1c-improves-beta-cell-function-in-t2d-ruaJCNF4</link>
      <enclosure length="1982841" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3edc20b8-f994-4347-8cd4-16d344f8b63f/group-item/29c23731-8c05-404b-828c-5273d69efeda/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Novel Oral Agent Lowers HbA1c, Improves Beta-Cell Function in T2D</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:03</itunes:duration>
      <itunes:summary>A novel oral diabetes therapy shows durable HbA1c reduction and beta-cell preservation after short treatment, potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies.</itunes:summary>
      <itunes:subtitle>A novel oral diabetes therapy shows durable HbA1c reduction and beta-cell preservation after short treatment, potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies.</itunes:subtitle>
      <itunes:keywords>potentially shifting type 2 diabetes care toward disease-modifying, accessible, and longer-lasting management strategies., a novel oral diabetes therapy shows durable hba1c reduction and beta-cell preservation after short treatment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>341</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cbfcf0b6-fb06-412f-9f67-32710f323b07</guid>
      <title>Causes of Polycystic Ovary Syndrome (PCOS): Key Factors</title>
      <description><![CDATA[Polycystic ovary syndrome requires early diagnosis and integrated care addressing hormones, insulin resistance, mental health, and metabolic risk to improve fertility, symptoms, and lifelong health outcomes. 
]]></description>
      <pubDate>Wed, 25 Mar 2026 19:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/causes-of-polycystic-ovary-syndrome-pcos-key-factors-__pKKqlQ</link>
      <enclosure length="1666864" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/737ad396-bd5c-4267-932f-b9cd1aee072d/group-item/c3a08104-3d6b-4e58-823e-d5adb1c7b218/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Causes of Polycystic Ovary Syndrome (PCOS): Key Factors</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>Polycystic ovary syndrome requires early diagnosis and integrated care addressing hormones, insulin resistance, mental health, and metabolic risk to improve fertility, symptoms, and lifelong health outcomes.</itunes:summary>
      <itunes:subtitle>Polycystic ovary syndrome requires early diagnosis and integrated care addressing hormones, insulin resistance, mental health, and metabolic risk to improve fertility, symptoms, and lifelong health outcomes.</itunes:subtitle>
      <itunes:keywords>symptoms, and lifelong health outcomes., polycystic ovary syndrome requires early diagnosis and integrated care addressing hormones, mental health, and metabolic risk to improve fertility, insulin resistance</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>340</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5f1a7f10-d4fa-4a1e-9d5d-e7f3138d5d51</guid>
      <title>Experts Call for Dietary Fiber to Be Formally Recognized as an Essential Nutrient</title>
      <description><![CDATA[Recognizing dietary fiber as an essential nutrient could strengthen nutrition policies, improve food labeling, boost intake, and reduce risks of diabetes, cardiovascular disease, obesity, and colorectal cancer. 
]]></description>
      <pubDate>Wed, 25 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/experts-call-for-dietary-fiber-to-be-formally-recognized-as-an-essential-nutrient-ESQSGo5c</link>
      <enclosure length="1433225" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/ccbd42ef-bf24-4ff4-8f5d-324be67a5d0b/group-item/37b13e14-92e0-47a4-9a05-40cd8ed3e30f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Experts Call for Dietary Fiber to Be Formally Recognized as an Essential Nutrient</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Recognizing dietary fiber as an essential nutrient could strengthen nutrition policies, improve food labeling, boost intake, and reduce risks of diabetes, cardiovascular disease, obesity, and colorectal cancer.</itunes:summary>
      <itunes:subtitle>Recognizing dietary fiber as an essential nutrient could strengthen nutrition policies, improve food labeling, boost intake, and reduce risks of diabetes, cardiovascular disease, obesity, and colorectal cancer.</itunes:subtitle>
      <itunes:keywords>cardiovascular disease, obesity, and reduce risks of diabetes, and colorectal cancer., boost intake, recognizing dietary fiber as an essential nutrient could strengthen nutrition policies, improve food labeling</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>339</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">020e31ac-ac8f-47b3-b8c4-b85d47ef7370</guid>
      <title>Why Baseline Mental Health Matters in Injured Workers: Improving Recovery and Return-to-Work Outcomes in Occupational Medicine in 2026</title>
      <description><![CDATA[Baseline mental health significantly influences injured workers’ recovery, pain, and return-to-work outcomes, making early psychosocial screening, behavioral support, and whole-person occupational care essential for faster, sustainable rehabilitation. 
]]></description>
      <pubDate>Wed, 25 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/why-baseline-mental-health-matters-in-injured-workers-improving-recovery-and-return-to-work-outcomes-in-occupational-medicine-in-2026-JIdgWHQe</link>
      <enclosure length="1483380" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2dd31344-afa7-45a6-a26e-fcc61de01d2e/group-item/03a5b2a5-11db-445f-a745-3b790d3f95fc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Why Baseline Mental Health Matters in Injured Workers: Improving Recovery and Return-to-Work Outcomes in Occupational Medicine in 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Baseline mental health significantly influences injured workers’ recovery, pain, and return-to-work outcomes, making early psychosocial screening, behavioral support, and whole-person occupational care essential for faster, sustainable rehabilitation.</itunes:summary>
      <itunes:subtitle>Baseline mental health significantly influences injured workers’ recovery, pain, and return-to-work outcomes, making early psychosocial screening, behavioral support, and whole-person occupational care essential for faster, sustainable rehabilitation.</itunes:subtitle>
      <itunes:keywords>making early psychosocial screening, baseline mental health significantly influences injured workers’ recovery, and whole-person occupational care essential for faster, pain, and return-to-work outcomes, behavioral support, sustainable rehabilitation.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>338</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0a758219-0572-43b8-8b73-a18745e281e7</guid>
      <title>Immunometabolic Topography of Bacterial Control in TB Granulomas</title>
      <description><![CDATA[Tuberculosis granuloma immunometabolic topography shapes bacterial persistence and treatment response, highlighting need for host-directed therapies, improved diagnostics, and precision approaches to shorten therapy and reduce transmission. 
]]></description>
      <pubDate>Wed, 25 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/immunometabolic-topography-of-bacterial-control-in-tb-granulomas-W1N4lAee</link>
      <enclosure length="1516398" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5d8a1df1-50e3-4e0b-acaa-f28ca555d6ac/group-item/cf1be5dc-35d2-4ade-abdc-e502cbfa49df/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Immunometabolic Topography of Bacterial Control in TB Granulomas</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Tuberculosis granuloma immunometabolic topography shapes bacterial persistence and treatment response, highlighting need for host-directed therapies, improved diagnostics, and precision approaches to shorten therapy and reduce transmission.</itunes:summary>
      <itunes:subtitle>Tuberculosis granuloma immunometabolic topography shapes bacterial persistence and treatment response, highlighting need for host-directed therapies, improved diagnostics, and precision approaches to shorten therapy and reduce transmission.</itunes:subtitle>
      <itunes:keywords>and precision approaches to shorten therapy and reduce transmission., improved diagnostics, highlighting need for host-directed therapies, tuberculosis granuloma immunometabolic topography shapes bacterial persistence and treatment response</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>337</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e5bde7fc-3d68-4283-83fd-4c7ca1848fb6</guid>
      <title>Self-Care, Self-Compassion Key To Reducing Clinician Burnout</title>
      <description><![CDATA[Clinician burnout threatens patient safety and workforce stability, requiring practical self-care, self-compassion, and organizational reforms to improve well-being, retention, and sustainable high-quality health care delivery. 
]]></description>
      <pubDate>Wed, 25 Mar 2026 13:39:37 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/self-care-self-compassion-key-to-reducing-clinician-burnout-QmiYe0N9</link>
      <enclosure length="1025296" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e14439a8-e4e0-41fe-ab16-82ce8d1fa8ed/group-item/9c51b7aa-c378-4a4b-a171-29e04bb82ecb/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Self-Care, Self-Compassion Key To Reducing Clinician Burnout</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:04</itunes:duration>
      <itunes:summary>Clinician burnout threatens patient safety and workforce stability, requiring practical self-care, self-compassion, and organizational reforms to improve well-being, retention, and sustainable high-quality health care delivery.</itunes:summary>
      <itunes:subtitle>Clinician burnout threatens patient safety and workforce stability, requiring practical self-care, self-compassion, and organizational reforms to improve well-being, retention, and sustainable high-quality health care delivery.</itunes:subtitle>
      <itunes:keywords>requiring practical self-care, clinician burnout threatens patient safety and workforce stability, retention, and organizational reforms to improve well-being, self-compassion, and sustainable high-quality health care delivery.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>336</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4a47271d-e823-4a04-b4d9-a2e7660ab588</guid>
      <title>Trauma Type, Onset Age, Sex Effects On Transdiagnostic Traits</title>
      <description><![CDATA[Trauma shapes emotional regulation, trust, and stress responses across many conditions, influencing treatment outcomes and daily functioning, highlighting need for trauma-informed, transdiagnostic, and personalized care approaches. 
]]></description>
      <pubDate>Tue, 24 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/trauma-type-onset-age-sex-effects-on-transdiagnostic-traits-83YMsqBF</link>
      <enclosure length="2010844" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b1f9d43a-b4bd-4913-8c54-5a54d8a262cc/group-item/a4bfb2c9-1357-4471-b86a-8aa54a958305/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Trauma Type, Onset Age, Sex Effects On Transdiagnostic Traits</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:05</itunes:duration>
      <itunes:summary>Trauma shapes emotional regulation, trust, and stress responses across many conditions, influencing treatment outcomes and daily functioning, highlighting need for trauma-informed, transdiagnostic, and personalized care approaches.</itunes:summary>
      <itunes:subtitle>Trauma shapes emotional regulation, trust, and stress responses across many conditions, influencing treatment outcomes and daily functioning, highlighting need for trauma-informed, transdiagnostic, and personalized care approaches.</itunes:subtitle>
      <itunes:keywords>transdiagnostic, and personalized care approaches., influencing treatment outcomes and daily functioning, trauma shapes emotional regulation, trust, highlighting need for trauma-informed, and stress responses across many conditions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>335</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4c34c023-163b-44fd-ac4e-3aed31cbfdeb</guid>
      <title>Grip Strength in Schizophrenia and Current/Remitted Depression</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Tue, 24 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/grip-strength-in-schizophrenia-and-current-remitted-depression-pBDSbecd</link>
      <enclosure length="1694867" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e30a5910-bc4f-4b96-b3a7-3574b30900a8/group-item/39e33428-8afa-4aa8-909b-155f3c9537fb/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Grip Strength in Schizophrenia and Current/Remitted Depression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>334</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b9a737fa-6867-40f6-8152-bbf2b9cafca3</guid>
      <title>Anxious Attachment Style: How It Can Impact Relationships</title>
      <description><![CDATA[Anxious attachment influences how people seek closeness and handle conflict, increasing relationship stress and mental health strain, while targeted therapy, skills, and support can build emotional security. 
]]></description>
      <pubDate>Tue, 24 Mar 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/anxious-attachment-style-how-it-can-impact-relationships-rlg2yk1e</link>
      <enclosure length="1764666" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/ca33ef4d-898a-49d5-b561-c4d7001d1d7a/group-item/edbdf511-dcb3-480d-bb97-a3fe45826f03/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Anxious Attachment Style: How It Can Impact Relationships</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Anxious attachment influences how people seek closeness and handle conflict, increasing relationship stress and mental health strain, while targeted therapy, skills, and support can build emotional security.</itunes:summary>
      <itunes:subtitle>Anxious attachment influences how people seek closeness and handle conflict, increasing relationship stress and mental health strain, while targeted therapy, skills, and support can build emotional security.</itunes:subtitle>
      <itunes:keywords>anxious attachment influences how people seek closeness and handle conflict, skills, and support can build emotional security., increasing relationship stress and mental health strain, while targeted therapy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>333</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">25804c88-3aad-452e-ba35-453053d30df9</guid>
      <title>RNA Therapy Enhances Cardiac Self-Repair After Injury</title>
      <description><![CDATA[An RNA-based therapy may enhance heart repair after heart attack by reducing inflammation and scarring, potentially improving recovery, preserving heart function, and lowering long-term heart failure risk. 
]]></description>
      <pubDate>Tue, 24 Mar 2026 15:20:38 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rna-therapy-enhances-cardiac-self-repair-after-injury-_Cpry1nX</link>
      <enclosure length="1682746" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0a8dbacc-10a7-46c2-a98a-580f1d17cc37/group-item/b750ae13-22a9-4a3f-acc6-56d677ed321d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>RNA Therapy Enhances Cardiac Self-Repair After Injury</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>An RNA-based therapy may enhance heart repair after heart attack by reducing inflammation and scarring, potentially improving recovery, preserving heart function, and lowering long-term heart failure risk.</itunes:summary>
      <itunes:subtitle>An RNA-based therapy may enhance heart repair after heart attack by reducing inflammation and scarring, potentially improving recovery, preserving heart function, and lowering long-term heart failure risk.</itunes:subtitle>
      <itunes:keywords>preserving heart function, and lowering long-term heart failure risk., potentially improving recovery, an rna-based therapy may enhance heart repair after heart attack by reducing inflammation and scarring</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>332</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">47d49d28-7bae-4d33-9a8d-5ee165659d66</guid>
      <title>Psychosocial Symptoms Equal Motor Burden In Early Parkinson’s</title>
      <description><![CDATA[Psychosocial symptoms in early Parkinson’s disease can equal motor disability, requiring routine screening, integrated mental health care, and multidisciplinary support to improve quality of life and long-term outcomes. 
]]></description>
      <pubDate>Tue, 24 Mar 2026 14:38:32 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psychosocial-symptoms-equal-motor-burden-in-early-parkinsons-gsDJL6VX</link>
      <enclosure length="1543984" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2b94053f-8057-49fe-adec-75a9d9fdc009/group-item/333a0d8b-b138-4722-9818-fa97f49500e1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psychosocial Symptoms Equal Motor Burden In Early Parkinson’s</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Psychosocial symptoms in early Parkinson’s disease can equal motor disability, requiring routine screening, integrated mental health care, and multidisciplinary support to improve quality of life and long-term outcomes.</itunes:summary>
      <itunes:subtitle>Psychosocial symptoms in early Parkinson’s disease can equal motor disability, requiring routine screening, integrated mental health care, and multidisciplinary support to improve quality of life and long-term outcomes.</itunes:subtitle>
      <itunes:keywords>integrated mental health care, requiring routine screening, psychosocial symptoms in early parkinson’s disease can equal motor disability, and multidisciplinary support to improve quality of life and long-term outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>331</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e22b249c-9a76-4300-bce0-76e1359ddc38</guid>
      <title>When To Start Prostate Cancer Screening In Men: Considerations</title>
      <description><![CDATA[Prostate cancer screening with PSA testing requires personalized timing and shared decision-making to balance early detection benefits against overdiagnosis, unnecessary procedures, and treatment-related side effects. 
]]></description>
      <pubDate>Mon, 23 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/when-to-start-prostate-cancer-screening-in-men-considerations-KuSx48Gd</link>
      <enclosure length="2007501" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/12a43316-db7c-4aed-bce0-e253f9cf7a3a/group-item/f44995d3-8547-4e98-af90-a011b24bee79/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>When To Start Prostate Cancer Screening In Men: Considerations</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:05</itunes:duration>
      <itunes:summary>Prostate cancer screening with PSA testing requires personalized timing and shared decision-making to balance early detection benefits against overdiagnosis, unnecessary procedures, and treatment-related side effects.</itunes:summary>
      <itunes:subtitle>Prostate cancer screening with PSA testing requires personalized timing and shared decision-making to balance early detection benefits against overdiagnosis, unnecessary procedures, and treatment-related side effects.</itunes:subtitle>
      <itunes:keywords>prostate cancer screening with psa testing requires personalized timing and shared decision-making to balance early detection benefits against overdiagnosis, and treatment-related side effects., unnecessary procedures</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>330</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">efb31f5d-3638-4683-9cda-0c3c92197392</guid>
      <title>Why Young Men Are Struggling With Erectile Dysfunction</title>
      <description><![CDATA[Erectile dysfunction in younger men often signals underlying physical or psychological health issues, making early evaluation, lifestyle changes, mental health support, and safe treatment essential for long-term wellbeing. 
]]></description>
      <pubDate>Mon, 23 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/why-young-men-are-struggling-with-erectile-dysfunction-1bTx4mJ2</link>
      <enclosure length="1688598" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/44d8aece-f026-4342-8a3a-209f2692ddf1/group-item/7e999e6a-8c14-4a39-93d0-2b4653be4a51/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Why Young Men Are Struggling With Erectile Dysfunction</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Erectile dysfunction in younger men often signals underlying physical or psychological health issues, making early evaluation, lifestyle changes, mental health support, and safe treatment essential for long-term wellbeing.</itunes:summary>
      <itunes:subtitle>Erectile dysfunction in younger men often signals underlying physical or psychological health issues, making early evaluation, lifestyle changes, mental health support, and safe treatment essential for long-term wellbeing.</itunes:subtitle>
      <itunes:keywords>making early evaluation, mental health support, erectile dysfunction in younger men often signals underlying physical or psychological health issues, lifestyle changes, and safe treatment essential for long-term wellbeing.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>329</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">64469e2d-0657-4bd9-a46c-61693c38c853</guid>
      <title>Why Patients Are Choosing Telemedicine For Diabetes Care</title>
      <description><![CDATA[Telemedicine improves diabetes care through remote monitoring, frequent follow-ups, and data-driven decisions, but requires hybrid care models, clear safety protocols, and equitable digital access to ensure effectiveness. 
]]></description>
      <pubDate>Mon, 23 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/why-patients-are-choosing-telemedicine-for-diabetes-care-2SB02qGu</link>
      <enclosure length="1827360" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/02dd6129-78c1-4fde-bc90-c86f1a3f2323/group-item/0e080d7c-6875-4745-a4b1-cf668feed3f3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Why Patients Are Choosing Telemedicine For Diabetes Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Telemedicine improves diabetes care through remote monitoring, frequent follow-ups, and data-driven decisions, but requires hybrid care models, clear safety protocols, and equitable digital access to ensure effectiveness.</itunes:summary>
      <itunes:subtitle>Telemedicine improves diabetes care through remote monitoring, frequent follow-ups, and data-driven decisions, but requires hybrid care models, clear safety protocols, and equitable digital access to ensure effectiveness.</itunes:subtitle>
      <itunes:keywords>frequent follow-ups, telemedicine improves diabetes care through remote monitoring, and equitable digital access to ensure effectiveness., clear safety protocols, and data-driven decisions, but requires hybrid care models</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>328</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2eed0790-9246-4f70-ae71-53a2cd5f8abe</guid>
      <title>Innate Rotavirus Sensing By Intestinal Epithelium Causes Diarrhea</title>
      <description><![CDATA[Rotavirus diarrhea is partly driven by intestinal antiviral responses that alter fluid transport, explaining watery stools and reinforcing hydration-first care, vaccination, and cautious use of symptom-suppressing treatments. 
]]></description>
      <pubDate>Mon, 23 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/innate-rotavirus-sensing-by-intestinal-epithelium-causes-diarrhea-sMxC1w3Q</link>
      <enclosure length="1473349" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fd2141a5-ccfe-4910-8a18-1ddbf9fb580e/group-item/f6e1703e-c73c-422b-a6a4-8c0ec1632d65/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Innate Rotavirus Sensing By Intestinal Epithelium Causes Diarrhea</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Rotavirus diarrhea is partly driven by intestinal antiviral responses that alter fluid transport, explaining watery stools and reinforcing hydration-first care, vaccination, and cautious use of symptom-suppressing treatments.</itunes:summary>
      <itunes:subtitle>Rotavirus diarrhea is partly driven by intestinal antiviral responses that alter fluid transport, explaining watery stools and reinforcing hydration-first care, vaccination, and cautious use of symptom-suppressing treatments.</itunes:subtitle>
      <itunes:keywords>and cautious use of symptom-suppressing treatments., explaining watery stools and reinforcing hydration-first care, vaccination, rotavirus diarrhea is partly driven by intestinal antiviral responses that alter fluid transport</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>327</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2ba6c089-4115-4d4d-a4b6-cc3eb7b12669</guid>
      <title>Small Changes That Make A Big Difference In Men’s Health</title>
      <description><![CDATA[Small, consistent habits like better sleep, regular movement, mental health care, and routine monitoring can significantly improve men’s health, preventing chronic disease and supporting long-term well-being and resilience. 
]]></description>
      <pubDate>Mon, 23 Mar 2026 15:03:43 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/small-changes-that-make-a-big-difference-in-mens-health-pdqk2sFK</link>
      <enclosure length="1963197" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8789bf04-e797-4b77-8cc4-d32716069ed1/group-item/e240da02-29e9-4672-9cb1-f2080a4ac79c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Small Changes That Make A Big Difference In Men’s Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Small, consistent habits like better sleep, regular movement, mental health care, and routine monitoring can significantly improve men’s health, preventing chronic disease and supporting long-term well-being and resilience.</itunes:summary>
      <itunes:subtitle>Small, consistent habits like better sleep, regular movement, mental health care, and routine monitoring can significantly improve men’s health, preventing chronic disease and supporting long-term well-being and resilience.</itunes:subtitle>
      <itunes:keywords>and routine monitoring can significantly improve men’s health, preventing chronic disease and supporting long-term well-being and resilience., consistent habits like better sleep, small, regular movement, mental health care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>326</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9f5b7567-0268-41b2-acee-32442261afcb</guid>
      <title>Aging With Grace: Clinician’s Guide To Healthy Aging</title>
      <description><![CDATA[Healthy aging focuses on preserving function, independence, and quality of life through personalized care, fall prevention, medication simplification, and strong social and healthcare support systems. 
]]></description>
      <pubDate>Fri, 20 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/aging-with-grace-clinicians-guide-to-healthy-aging-BwUJbns0-a78ubSSt</link>
      <enclosure length="1437404" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/22d09bec-1c23-414f-bf8e-722f1e90b98c/group-item/7abd7efd-baaa-497f-8a3a-85325bee5181/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Aging With Grace: Clinician’s Guide To Healthy Aging</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Healthy aging focuses on preserving function, independence, and quality of life through personalized care, fall prevention, medication simplification, and strong social and healthcare support systems.</itunes:summary>
      <itunes:subtitle>Healthy aging focuses on preserving function, independence, and quality of life through personalized care, fall prevention, medication simplification, and strong social and healthcare support systems.</itunes:subtitle>
      <itunes:keywords>healthy aging focuses on preserving function, independence, fall prevention, and quality of life through personalized care, and strong social and healthcare support systems., medication simplification</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>325</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">dc9cbf90-e56c-47f5-a687-99403c444aeb</guid>
      <title>If Cannabis Helps Sleep, Why Does Science Say It Doesn’t?</title>
      <description><![CDATA[Cannabis is widely used for sleep, but evidence shows limited long-term benefit, placebo-driven perceptions, and risks like tolerance, cognitive impairment, and delayed access to proven insomnia treatments. 
]]></description>
      <pubDate>Fri, 20 Mar 2026 17:42:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/if-cannabis-helps-sleep-why-does-science-say-it-doesnt-lZCkw_vz</link>
      <enclosure length="1740425" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7782347a-5293-47b5-9134-2f0ac5b9d33b/group-item/9456cf8b-0231-49da-a558-2de3c72365c4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>If Cannabis Helps Sleep, Why Does Science Say It Doesn’t?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Cannabis is widely used for sleep, but evidence shows limited long-term benefit, placebo-driven perceptions, and risks like tolerance, cognitive impairment, and delayed access to proven insomnia treatments.</itunes:summary>
      <itunes:subtitle>Cannabis is widely used for sleep, but evidence shows limited long-term benefit, placebo-driven perceptions, and risks like tolerance, cognitive impairment, and delayed access to proven insomnia treatments.</itunes:subtitle>
      <itunes:keywords>cognitive impairment, cannabis is widely used for sleep, but evidence shows limited long-term benefit, and delayed access to proven insomnia treatments., and risks like tolerance, placebo-driven perceptions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>324</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">14d7f230-67f8-43e9-a6b3-3f835ff311bb</guid>
      <title>When To See A Doctor For Heavy Menstrual Bleeding?</title>
      <description><![CDATA[Heavy menstrual bleeding is common and treatable, signaling underlying causes. Early evaluation prevents anemia, improves quality of life, and supports safe, personalized management based on symptoms and goals. 
]]></description>
      <pubDate>Thu, 19 Mar 2026 19:10:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/when-to-see-a-doctor-for-heavy-menstrual-bleeding-3tkqQPJI</link>
      <enclosure length="2084823" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/03e2547b-be17-4a67-8ddb-1aa37b06ae21/group-item/488bdac9-6be5-4f19-8659-30e42492a68e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>When To See A Doctor For Heavy Menstrual Bleeding?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:10</itunes:duration>
      <itunes:summary>Heavy menstrual bleeding is common and treatable, signaling underlying causes. Early evaluation prevents anemia, improves quality of life, and supports safe, personalized management based on symptoms and goals.</itunes:summary>
      <itunes:subtitle>Heavy menstrual bleeding is common and treatable, signaling underlying causes. Early evaluation prevents anemia, improves quality of life, and supports safe, personalized management based on symptoms and goals.</itunes:subtitle>
      <itunes:keywords>heavy menstrual bleeding is common and treatable, signaling underlying causes. early evaluation prevents anemia, improves quality of life, and supports safe, personalized management based on symptoms and goals.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>323</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9b513644-2a92-4061-b6bc-e654e8c4061a</guid>
      <title>Sex Differences Could Shape Future Cancer Immunotherapy</title>
      <description><![CDATA[Sex differences influence immunotherapy response and toxicity; integrating sex-aware strategies into trials, monitoring, and care pathways can improve precision, safety, outcomes, and value across cancer treatment. 
]]></description>
      <pubDate>Thu, 19 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sex-differences-could-shape-future-cancer-immunotherapy-1mmTpZ9V</link>
      <enclosure length="1745022" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b97b2163-6709-47f0-932c-a7fdd8b65fdb/group-item/4b012a83-228f-4a75-8ed0-406b2f299032/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sex Differences Could Shape Future Cancer Immunotherapy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:49</itunes:duration>
      <itunes:summary>Sex differences influence immunotherapy response and toxicity; integrating sex-aware strategies into trials, monitoring, and care pathways can improve precision, safety, outcomes, and value across cancer treatment.</itunes:summary>
      <itunes:subtitle>Sex differences influence immunotherapy response and toxicity; integrating sex-aware strategies into trials, monitoring, and care pathways can improve precision, safety, outcomes, and value across cancer treatment.</itunes:subtitle>
      <itunes:keywords>outcomes, sex differences influence immunotherapy response and toxicity; integrating sex-aware strategies into trials, monitoring, and care pathways can improve precision, safety, and value across cancer treatment.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>322</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a26fffed-9c4f-49a1-a9c4-27521b2ad85f</guid>
      <title>Vertical Transmission of Hepatitis C in Opioid-Using Mothers</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Thu, 19 Mar 2026 16:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/vertical-transmission-of-hepatitis-c-in-opioid-using-mothers-95Kt8iyP</link>
      <enclosure length="1658923" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b7b7eeb3-27bc-4776-862e-1f7a3f8d0700/group-item/e5c3cbcb-1df7-466f-8e23-0b04c961c421/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Vertical Transmission of Hepatitis C in Opioid-Using Mothers</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>321</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">68f4aa55-b8a1-4e20-b716-7384b554af6b</guid>
      <title>Hearing Impairment Associated With Lower Vision Rehab Gains</title>
      <description><![CDATA[Dual vision and hearing loss reduces rehabilitation gains by limiting communication, safety, and learning; effective care requires integrated screening, accessible teaching methods, and coordinated vision–hearing services. 
]]></description>
      <pubDate>Thu, 19 Mar 2026 15:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hearing-impairment-associated-with-lower-vision-rehab-gains-bYaHlqLU</link>
      <enclosure length="2557535" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/bb772d79-26b7-4b93-a738-b2d507ad5a5d/group-item/0c1d4dc5-476c-4a27-8773-01c50cb430cd/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Hearing Impairment Associated With Lower Vision Rehab Gains</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:39</itunes:duration>
      <itunes:summary>Dual vision and hearing loss reduces rehabilitation gains by limiting communication, safety, and learning; effective care requires integrated screening, accessible teaching methods, and coordinated vision–hearing services.</itunes:summary>
      <itunes:subtitle>Dual vision and hearing loss reduces rehabilitation gains by limiting communication, safety, and learning; effective care requires integrated screening, accessible teaching methods, and coordinated vision–hearing services.</itunes:subtitle>
      <itunes:keywords>accessible teaching methods, safety, dual vision and hearing loss reduces rehabilitation gains by limiting communication, and coordinated vision–hearing services., and learning; effective care requires integrated screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>320</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ff5c2d03-b9d8-4b78-8a0c-47d15c85848d</guid>
      <title>Collagen Supplements Benefit Skin, Bone &amp; Musculoskeletal Health</title>
      <description><![CDATA[Collagen supplements offer modest support for skin, joints, and bones, but results vary; best used alongside nutrition, exercise, and evidence-based care, not as standalone solutions. 
]]></description>
      <pubDate>Thu, 19 Mar 2026 14:39:21 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/collagen-supplements-benefit-skin-bone-musculoskeletal-health-owqzNgzC-ufpZzlg6</link>
      <enclosure length="1659341" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8567ca16-bbed-42d8-b794-b6dee6a736cd/group-item/96de5266-9f5c-44b3-9a0e-01c4d31af943/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Collagen Supplements Benefit Skin, Bone &amp; Musculoskeletal Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Collagen supplements offer modest support for skin, joints, and bones, but results vary; best used alongside nutrition, exercise, and evidence-based care, not as standalone solutions.</itunes:summary>
      <itunes:subtitle>Collagen supplements offer modest support for skin, joints, and bones, but results vary; best used alongside nutrition, exercise, and evidence-based care, not as standalone solutions.</itunes:subtitle>
      <itunes:keywords>and bones, but results vary; best used alongside nutrition, joints, not as standalone solutions., collagen supplements offer modest support for skin, and evidence-based care, exercise</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>319</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">97fce571-9c32-47c5-ab9b-6ce4e21ce3e7</guid>
      <title>Clinical Practices Use AI Even When Clinicians Don’t Know</title>
      <description><![CDATA[Hidden artificial intelligence in healthcare workflows can influence decisions, access, and workload; transparency, oversight, and continuous monitoring are essential to reduce bias, protect safety, and ensure accountability. 
]]></description>
      <pubDate>Wed, 18 Mar 2026 19:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/clinical-practices-use-ai-even-when-clinicians-dont-know-nQB3kLaq-mapgPHCg</link>
      <enclosure length="1347961" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/13b89079-e8e2-421d-855a-0dfcfb2b7a4c/group-item/2675e6a2-e29c-43f5-9b69-05e06520d695/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Clinical Practices Use AI Even When Clinicians Don’t Know</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:24</itunes:duration>
      <itunes:summary>Hidden artificial intelligence in healthcare workflows can influence decisions, access, and workload; transparency, oversight, and continuous monitoring are essential to reduce bias, protect safety, and ensure accountability.</itunes:summary>
      <itunes:subtitle>Hidden artificial intelligence in healthcare workflows can influence decisions, access, and workload; transparency, oversight, and continuous monitoring are essential to reduce bias, protect safety, and ensure accountability.</itunes:subtitle>
      <itunes:keywords>oversight, protect safety, and workload; transparency, hidden artificial intelligence in healthcare workflows can influence decisions, and ensure accountability., access, and continuous monitoring are essential to reduce bias</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>318</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9cf5226d-0ccc-4048-8a08-03dee9bb3804</guid>
      <title>The Real Reason Men Don’t Seek Medical Care From Doctors</title>
      <description><![CDATA[Men often delay care due to cultural norms and practical barriers; redesigning accessible, trust-based healthcare and communication can improve prevention, early treatment, outcomes, and system-wide efficiency. 
]]></description>
      <pubDate>Wed, 18 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-real-reason-men-dont-seek-medical-care-from-doctors-I0IqLjbQ</link>
      <enclosure length="1256846" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/603d2915-aee8-4b24-a426-4b1bdf5256a4/group-item/eb802779-0202-409c-86f9-219f587dc83e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Real Reason Men Don’t Seek Medical Care From Doctors</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Men often delay care due to cultural norms and practical barriers; redesigning accessible, trust-based healthcare and communication can improve prevention, early treatment, outcomes, and system-wide efficiency.</itunes:summary>
      <itunes:subtitle>Men often delay care due to cultural norms and practical barriers; redesigning accessible, trust-based healthcare and communication can improve prevention, early treatment, outcomes, and system-wide efficiency.</itunes:subtitle>
      <itunes:keywords>men often delay care due to cultural norms and practical barriers; redesigning accessible, outcomes, trust-based healthcare and communication can improve prevention, early treatment, and system-wide efficiency.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>317</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0e3bd89d-f5d0-45b5-bbfd-c0c5136efa2f</guid>
      <title>Central Obesity Shows Spatial Clustering Across Botswana</title>
      <description><![CDATA[Central obesity in Botswana shows geographic clustering, increasing cardiometabolic risks; targeted, place-based screening, prevention, and community interventions can improve early detection, reduce complications, and strengthen equitable healthcare delivery. 
]]></description>
      <pubDate>Wed, 18 Mar 2026 16:20:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/central-obesity-shows-spatial-clustering-across-botswana-YRUxqTls</link>
      <enclosure length="1996216" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d3651e94-dedd-4a48-b4f4-7a6255b0ff47/group-item/8e216698-c7ac-460d-ae4a-9e9f4591729b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Central Obesity Shows Spatial Clustering Across Botswana</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:04</itunes:duration>
      <itunes:summary>Central obesity in Botswana shows geographic clustering, increasing cardiometabolic risks; targeted, place-based screening, prevention, and community interventions can improve early detection, reduce complications, and strengthen equitable healthcare delivery.</itunes:summary>
      <itunes:subtitle>Central obesity in Botswana shows geographic clustering, increasing cardiometabolic risks; targeted, place-based screening, prevention, and community interventions can improve early detection, reduce complications, and strengthen equitable healthcare delivery.</itunes:subtitle>
      <itunes:keywords>central obesity in botswana shows geographic clustering, and strengthen equitable healthcare delivery., prevention, and community interventions can improve early detection, reduce complications, place-based screening, increasing cardiometabolic risks; targeted</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>316</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7a5389c9-05b3-48a8-bfd5-94b1933dc805</guid>
      <title>Strategies To Get Men To Take Their Health Seriously</title>
      <description><![CDATA[Improving men’s health requires convenient access, clear communication, and preventive care engagement to detect risks early, reduce complications, and support long-term wellbeing across diverse populations and life stages. 
]]></description>
      <pubDate>Wed, 18 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/strategies-to-get-men-to-take-their-health-seriously-o5ajhgno</link>
      <enclosure length="2017532" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7e05bea2-2d95-4c73-a712-812dc58bd1d0/group-item/fcd3dde5-fa94-412f-88d8-5026e6ad994b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Strategies To Get Men To Take Their Health Seriously</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Improving men’s health requires convenient access, clear communication, and preventive care engagement to detect risks early, reduce complications, and support long-term wellbeing across diverse populations and life stages.</itunes:summary>
      <itunes:subtitle>Improving men’s health requires convenient access, clear communication, and preventive care engagement to detect risks early, reduce complications, and support long-term wellbeing across diverse populations and life stages.</itunes:subtitle>
      <itunes:keywords>clear communication, improving men’s health requires convenient access, and preventive care engagement to detect risks early, and support long-term wellbeing across diverse populations and life stages., reduce complications</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>315</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">538494cc-e4d3-4f4e-b889-32392710e936</guid>
      <title>Collagen Supplements Benefit Skin, Bone &amp; Musculoskeletal Health</title>
      <description><![CDATA[Collagen supplements may modestly support skin, bone, and joint health, but benefits vary; best used alongside nutrition, exercise, and evidence-based care rather than as standalone solutions. 
]]></description>
      <pubDate>Wed, 18 Mar 2026 13:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/collagen-supplements-benefit-skin-bone-musculoskeletal-health-6S7pzUjV</link>
      <enclosure length="1839899" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/99eae50e-e902-441b-89e6-8457cc778711/group-item/007ef4f0-a390-45e2-bfca-d3bbe8301db4/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Collagen Supplements Benefit Skin, Bone &amp; Musculoskeletal Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Collagen supplements may modestly support skin, bone, and joint health, but benefits vary; best used alongside nutrition, exercise, and evidence-based care rather than as standalone solutions.</itunes:summary>
      <itunes:subtitle>Collagen supplements may modestly support skin, bone, and joint health, but benefits vary; best used alongside nutrition, exercise, and evidence-based care rather than as standalone solutions.</itunes:subtitle>
      <itunes:keywords>but benefits vary; best used alongside nutrition, and evidence-based care rather than as standalone solutions., bone, collagen supplements may modestly support skin, exercise, and joint health</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>314</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c2006386-db98-42ac-8e01-082fea24749a</guid>
      <title>Assessing Quality Of Life After Food Allergy Immunotherapy</title>
      <description><![CDATA[Food allergy immunotherapy can improve quality of life by reducing reaction risk, but treatment demands, reactions, and daily routines require balanced expectations, monitoring, and patient-centered decision-making. 
]]></description>
      <pubDate>Tue, 17 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/assessing-quality-of-life-after-food-allergy-immunotherapy-_cfPMZL0</link>
      <enclosure length="1402296" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/62b2b373-32f7-481d-9099-75d87b571c9a/group-item/577d664b-68ca-406e-a664-587f75dba1ea/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Assessing Quality Of Life After Food Allergy Immunotherapy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:27</itunes:duration>
      <itunes:summary>Food allergy immunotherapy can improve quality of life by reducing reaction risk, but treatment demands, reactions, and daily routines require balanced expectations, monitoring, and patient-centered decision-making.</itunes:summary>
      <itunes:subtitle>Food allergy immunotherapy can improve quality of life by reducing reaction risk, but treatment demands, reactions, and daily routines require balanced expectations, monitoring, and patient-centered decision-making.</itunes:subtitle>
      <itunes:keywords>and daily routines require balanced expectations, monitoring, but treatment demands, and patient-centered decision-making., reactions, food allergy immunotherapy can improve quality of life by reducing reaction risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>313</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b3e4d1f9-6d77-487c-be40-dd7ab8456c3e</guid>
      <title>New 5-Minute Screening Tool for Endometriosis Detection</title>
      <description><![CDATA[A five-minute screening tool helps identify high-risk endometriosis earlier, enabling faster evaluation, symptom management, and referral to improve quality of life and reduce diagnostic delays. 
]]></description>
      <pubDate>Tue, 17 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-5-minute-screening-tool-for-endometriosis-detection-fiiWZ_2G-2ST9xqTt</link>
      <enclosure length="1630083" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2648f831-ac7f-4876-8a96-fa733ad43972/group-item/c41c53ea-4301-49eb-afb2-503ed87d4d2c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New 5-Minute Screening Tool for Endometriosis Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>A five-minute screening tool helps identify high-risk endometriosis earlier, enabling faster evaluation, symptom management, and referral to improve quality of life and reduce diagnostic delays.</itunes:summary>
      <itunes:subtitle>A five-minute screening tool helps identify high-risk endometriosis earlier, enabling faster evaluation, symptom management, and referral to improve quality of life and reduce diagnostic delays.</itunes:subtitle>
      <itunes:keywords>and referral to improve quality of life and reduce diagnostic delays., enabling faster evaluation, a five-minute screening tool helps identify high-risk endometriosis earlier, symptom management</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>312</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1851e9d2-012d-4411-a751-0c7fddf91f97</guid>
      <title>7 Side Effects You May Experience On Oral Contraceptives</title>
      <description><![CDATA[Oral contraceptives commonly cause manageable side effects affecting comfort, adherence, and safety; clear counseling, risk screening, and personalized adjustments help maintain effective, consistent contraception and overall health outcomes. 
]]></description>
      <pubDate>Tue, 17 Mar 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/7-side-effects-you-may-experience-on-oral-contraceptives-Qfjzwt8f-hBlMn5Rn</link>
      <enclosure length="1666028" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d1998e2e-c135-4217-b414-7e32e170bc85/group-item/6e69c80c-fe93-4899-8883-9c73101c4724/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>7 Side Effects You May Experience On Oral Contraceptives</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>Oral contraceptives commonly cause manageable side effects affecting comfort, adherence, and safety; clear counseling, risk screening, and personalized adjustments help maintain effective, consistent contraception and overall health outcomes.</itunes:summary>
      <itunes:subtitle>Oral contraceptives commonly cause manageable side effects affecting comfort, adherence, and safety; clear counseling, risk screening, and personalized adjustments help maintain effective, consistent contraception and overall health outcomes.</itunes:subtitle>
      <itunes:keywords>adherence, oral contraceptives commonly cause manageable side effects affecting comfort, and personalized adjustments help maintain effective, and safety; clear counseling, consistent contraception and overall health outcomes., risk screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>311</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">71c1b532-6305-42bc-bba7-63fb29087f14</guid>
      <title>Psychology Of Habit Formation And Sustainable Health Change</title>
      <description><![CDATA[Habit formation is central to sustainable behavior change in healthcare, helping patients turn small, repeatable actions into routines that improve adherence, outcomes, and long-term management of chronic conditions. 
]]></description>
      <pubDate>Tue, 17 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psychology-of-habit-formation-and-sustainable-health-change-zj9XBowy</link>
      <enclosure length="1831540" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/3bc1798b-f615-453c-8cb5-4104ad2780a7/group-item/d1dfb15d-8632-4568-985a-80c980daf1de/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psychology Of Habit Formation And Sustainable Health Change</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Habit formation is central to sustainable behavior change in healthcare, helping patients turn small, repeatable actions into routines that improve adherence, outcomes, and long-term management of chronic conditions.</itunes:summary>
      <itunes:subtitle>Habit formation is central to sustainable behavior change in healthcare, helping patients turn small, repeatable actions into routines that improve adherence, outcomes, and long-term management of chronic conditions.</itunes:subtitle>
      <itunes:keywords>outcomes, and long-term management of chronic conditions., repeatable actions into routines that improve adherence, helping patients turn small, habit formation is central to sustainable behavior change in healthcare</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>310</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">abbf3f59-9f9f-47f6-b563-d4ae25ed67e7</guid>
      <title>Clinical Practices Use AI Even When Clinicians Don’t Know</title>
      <description><![CDATA[Hidden AI tools embedded in clinical systems subtly influence decisions, workflows, and access to care, raising concerns about transparency, bias, patient safety, and accountability in healthcare delivery. 
]]></description>
      <pubDate>Tue, 17 Mar 2026 13:45:59 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/clinical-practices-use-ai-even-when-clinicians-dont-know-vqSRxBpI</link>
      <enclosure length="1730812" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/ba961835-c69d-42dc-bb6f-40b8990c83bb/group-item/b9e0a181-8b81-4ae3-8731-4b19b07dee0f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Clinical Practices Use AI Even When Clinicians Don’t Know</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>Hidden AI tools embedded in clinical systems subtly influence decisions, workflows, and access to care, raising concerns about transparency, bias, patient safety, and accountability in healthcare delivery.</itunes:summary>
      <itunes:subtitle>Hidden AI tools embedded in clinical systems subtly influence decisions, workflows, and access to care, raising concerns about transparency, bias, patient safety, and accountability in healthcare delivery.</itunes:subtitle>
      <itunes:keywords>bias, workflows, hidden ai tools embedded in clinical systems subtly influence decisions, and accountability in healthcare delivery., patient safety, raising concerns about transparency, and access to care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>309</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d58d9a26-474a-49ee-8f19-a90154bd07e6</guid>
      <title>Associations Of Healthy Lifestyle Factors With Infertility Risk</title>
      <description><![CDATA[Lifestyle habits—including diet, exercise, sleep, and substance use—significantly influence fertility by affecting hormones, ovulation, and sperm health, making preconception lifestyle care essential for improving conception outcomes. 
]]></description>
      <pubDate>Mon, 16 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/associations-of-healthy-lifestyle-factors-with-infertility-risk-WPTzaS05</link>
      <enclosure length="1809388" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8b9097c0-dc9c-4cdc-8895-47474f222663/group-item/be459134-8d3a-4dec-9106-2429f3483f32/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Associations Of Healthy Lifestyle Factors With Infertility Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:53</itunes:duration>
      <itunes:summary>Lifestyle habits—including diet, exercise, sleep, and substance use—significantly influence fertility by affecting hormones, ovulation, and sperm health, making preconception lifestyle care essential for improving conception outcomes.</itunes:summary>
      <itunes:subtitle>Lifestyle habits—including diet, exercise, sleep, and substance use—significantly influence fertility by affecting hormones, ovulation, and sperm health, making preconception lifestyle care essential for improving conception outcomes.</itunes:subtitle>
      <itunes:keywords>making preconception lifestyle care essential for improving conception outcomes., and substance use—significantly influence fertility by affecting hormones, and sperm health, exercise, ovulation, lifestyle habits—including diet, sleep</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>308</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d979d30b-2a35-440f-88a9-92678c11a67a</guid>
      <title>The Mechanisms of Resistance: A Deeper Dive into Multimodal Escape in Multiple Myeloma</title>
      <description><![CDATA[GPRC5D-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions. 
]]></description>
      <pubDate>Mon, 16 Mar 2026 16:30:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-mechanisms-of-resistance-a-deeper-dive-into-multimodal-escape-in-multiple-myeloma-qLncycaG</link>
      <enclosure length="1672297" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/33851e16-1550-44fb-84ff-80aaa0c973f6/group-item/b3a6c7ba-985a-4ce5-9ef8-34221ff427c6/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Mechanisms of Resistance: A Deeper Dive into Multimodal Escape in Multiple Myeloma</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>GPRC5D-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions.</itunes:summary>
      <itunes:subtitle>GPRC5D-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions.</itunes:subtitle>
      <itunes:keywords>gprc5d-targeted immunotherapies offer new hope for relapsed multiple myeloma, but tumors increasingly evade treatment through multimodal antigenic escape, challenging long-term control and therapy sequencing decisions.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>307</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6dbc1618-12ff-4e5f-b69e-72d46cf84e6a</guid>
      <title>Interferon Gamma Signaling Drives Drug Resistance in AML</title>
      <description><![CDATA[Emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies. 
]]></description>
      <pubDate>Mon, 16 Mar 2026 15:15:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/interferon-gamma-signaling-drives-drug-resistance-in-aml-G7xO7Bge</link>
      <enclosure length="1932268" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/7fc8045d-ea2e-4197-9fbe-167605c3a446/group-item/fb2ceb67-9fd4-4b16-a0bf-06a1736ecac7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Interferon Gamma Signaling Drives Drug Resistance in AML</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:00</itunes:duration>
      <itunes:summary>Emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies.</itunes:summary>
      <itunes:subtitle>Emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, suggesting immune pathways influence relapse risk, therapy response, and future precision treatment strategies.</itunes:subtitle>
      <itunes:keywords>and future precision treatment strategies., emerging research links interferon gamma signaling to drug resistance in acute myeloid leukemia, therapy response, suggesting immune pathways influence relapse risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>306</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">43ddf298-9750-4aef-950e-1cfefcd799c9</guid>
      <title>Dual Eligibility, Medicare Type Linked To Poststroke Care Quality</title>
      <description><![CDATA[Insurance type influences access to high-quality poststroke care; dual-eligible and Medicare Advantage patients are less likely than traditional Medicare beneficiaries to receive top-rated skilled nursing or home health services. 
]]></description>
      <pubDate>Mon, 16 Mar 2026 14:25:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/dual-eligibility-medicare-type-linked-to-poststroke-care-quality-voixUOYX</link>
      <enclosure length="1500098" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a729d1ee-8869-42f8-bc49-f36c8dc0b781/group-item/82d06793-4448-4cdf-9de1-fbab64fdde0e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Dual Eligibility, Medicare Type Linked To Poststroke Care Quality</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Insurance type influences access to high-quality poststroke care; dual-eligible and Medicare Advantage patients are less likely than traditional Medicare beneficiaries to receive top-rated skilled nursing or home health services.</itunes:summary>
      <itunes:subtitle>Insurance type influences access to high-quality poststroke care; dual-eligible and Medicare Advantage patients are less likely than traditional Medicare beneficiaries to receive top-rated skilled nursing or home health services.</itunes:subtitle>
      <itunes:keywords>insurance type influences access to high-quality poststroke care; dual-eligible and medicare advantage patients are less likely than traditional medicare beneficiaries to receive top-rated skilled nursing or home health services.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>305</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">87b447b6-f279-4f00-ba2e-512d0a61d7ea</guid>
      <title>7 Side Effects You May Experience On Oral Contraceptives</title>
      <description><![CDATA[Oral contraceptives may cause yeast infections, dryness, libido changes, spotting, breast tenderness, mood shifts, or rare blood clots, requiring counseling, monitoring, and personalized adjustments to maintain safety and adherence. 
]]></description>
      <pubDate>Mon, 16 Mar 2026 13:38:38 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/7-side-effects-you-may-experience-on-oral-contraceptives-LC_RDXps</link>
      <enclosure length="1436568" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fcd9b59c-5332-4ca5-bf94-0c4b742834a1/group-item/6e25024c-da0d-4619-aae7-0d894f80e194/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>7 Side Effects You May Experience On Oral Contraceptives</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Oral contraceptives may cause yeast infections, dryness, libido changes, spotting, breast tenderness, mood shifts, or rare blood clots, requiring counseling, monitoring, and personalized adjustments to maintain safety and adherence.</itunes:summary>
      <itunes:subtitle>Oral contraceptives may cause yeast infections, dryness, libido changes, spotting, breast tenderness, mood shifts, or rare blood clots, requiring counseling, monitoring, and personalized adjustments to maintain safety and adherence.</itunes:subtitle>
      <itunes:keywords>spotting, monitoring, oral contraceptives may cause yeast infections, libido changes, requiring counseling, breast tenderness, and personalized adjustments to maintain safety and adherence., dryness, mood shifts, or rare blood clots</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>304</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f2990827-f7a2-4f7a-b1ff-94d5c1a112fe</guid>
      <title>New 5-Minute Screening Tool for Endometriosis Detection</title>
      <description><![CDATA[A five-minute screening questionnaire helps primary care identify patients at risk for endometriosis earlier, guiding timely treatment, counseling, and specialist referral to reduce years-long diagnostic delays. 
]]></description>
      <pubDate>Fri, 13 Mar 2026 17:59:57 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-5-minute-screening-tool-for-endometriosis-detection-UsyKg4E9</link>
      <enclosure length="1351723" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/14699975-e9b0-46c7-b5cb-edd86754b80c/group-item/3b38872d-dac6-44a5-9036-65a5d1215a1d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New 5-Minute Screening Tool for Endometriosis Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:24</itunes:duration>
      <itunes:summary>A five-minute screening questionnaire helps primary care identify patients at risk for endometriosis earlier, guiding timely treatment, counseling, and specialist referral to reduce years-long diagnostic delays.</itunes:summary>
      <itunes:subtitle>A five-minute screening questionnaire helps primary care identify patients at risk for endometriosis earlier, guiding timely treatment, counseling, and specialist referral to reduce years-long diagnostic delays.</itunes:subtitle>
      <itunes:keywords>guiding timely treatment, counseling, a five-minute screening questionnaire helps primary care identify patients at risk for endometriosis earlier, and specialist referral to reduce years-long diagnostic delays.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>303</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">aee95d22-b663-412d-9e5b-dcf51ef8292e</guid>
      <title>Radionuclide Therapy May Enhance Cancer Cell Death Pathways</title>
      <description><![CDATA[Radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers. 
]]></description>
      <pubDate>Thu, 12 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/radionuclide-therapy-may-enhance-cancer-cell-death-pathways-8gnO1NQi</link>
      <enclosure length="1638443" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1402792c-98c9-469e-97cb-87e9dc4bb012/group-item/e371b6b6-b58e-4a26-9de3-0d4be5e638f8/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Radionuclide Therapy May Enhance Cancer Cell Death Pathways</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers.</itunes:summary>
      <itunes:subtitle>Radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity, and overcome resistance in aggressive cancers.</itunes:subtitle>
      <itunes:keywords>and overcome resistance in aggressive cancers., radionuclide-stimulated dynamic therapy activates light-sensitive drugs with radiopharmaceuticals to produce cancer-killing reactive oxygen species, reprogram tumor immunity</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>302</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">82972f8d-74d3-4ec4-bbf4-8cdf8ea15931</guid>
      <title>Impact of Hysterotomy Location on Uterine Wound Repair</title>
      <description><![CDATA[Cesarean incision location and layered uterine closure significantly influence scar healing, affecting bleeding, infection risk, and future pregnancy complications such as uterine rupture, placenta accreta, and infertility. 
]]></description>
      <pubDate>Thu, 12 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-hysterotomy-location-on-uterine-wound-repair-0cXW49bg</link>
      <enclosure length="1119755" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/83ce8840-b967-46d9-93f0-d0c1db51ffc6/group-item/1de9a76b-32af-42f6-80fc-dbf7974f58e2/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Hysterotomy Location on Uterine Wound Repair</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:09</itunes:duration>
      <itunes:summary>Cesarean incision location and layered uterine closure significantly influence scar healing, affecting bleeding, infection risk, and future pregnancy complications such as uterine rupture, placenta accreta, and infertility.</itunes:summary>
      <itunes:subtitle>Cesarean incision location and layered uterine closure significantly influence scar healing, affecting bleeding, infection risk, and future pregnancy complications such as uterine rupture, placenta accreta, and infertility.</itunes:subtitle>
      <itunes:keywords>placenta accreta, and future pregnancy complications such as uterine rupture, cesarean incision location and layered uterine closure significantly influence scar healing, affecting bleeding, infection risk, and infertility.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>301</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6cebea75-b284-4d65-918d-11eb36424652</guid>
      <title>Endocrinology in 2026: Emerging Innovations and What Healthcare Professionals Need to Know</title>
      <description><![CDATA[Advances in endocrinology are introducing safer therapies and minimally invasive treatments for hormonal disorders, improving patient outcomes, reducing healthcare costs, and reshaping clinical approaches to endocrine care. 
]]></description>
      <pubDate>Thu, 12 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/endocrinology-in-2026-emerging-innovations-and-what-healthcare-professionals-need-to-know-U_lmwcKo</link>
      <enclosure length="1470423" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/33d5acf8-224e-4c17-b310-38da2b5b973a/group-item/bf7f28d5-9e89-40e2-a913-596a039b91eb/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Endocrinology in 2026: Emerging Innovations and What Healthcare Professionals Need to Know</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Advances in endocrinology are introducing safer therapies and minimally invasive treatments for hormonal disorders, improving patient outcomes, reducing healthcare costs, and reshaping clinical approaches to endocrine care.</itunes:summary>
      <itunes:subtitle>Advances in endocrinology are introducing safer therapies and minimally invasive treatments for hormonal disorders, improving patient outcomes, reducing healthcare costs, and reshaping clinical approaches to endocrine care.</itunes:subtitle>
      <itunes:keywords>improving patient outcomes, reducing healthcare costs, and reshaping clinical approaches to endocrine care., advances in endocrinology are introducing safer therapies and minimally invasive treatments for hormonal disorders</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>300</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f01c7546-daba-41bb-b7ce-91e251201d04</guid>
      <title>FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC</title>
      <description><![CDATA[The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk. 
]]></description>
      <pubDate>Thu, 12 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-priority-review-for-post-neoadjuvant-t-dxd-in-her2-early-bc-s_JBTItv</link>
      <enclosure length="2100705" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/da450c14-0b11-40a7-9151-c83f37ea65cd/group-item/6330d272-2fd6-43c2-9fac-df48809e2c43/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Priority Review for Post-Neoadjuvant T-DXd in HER2+ Early BC</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:11</itunes:duration>
      <itunes:summary>The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk.</itunes:summary>
      <itunes:subtitle>The FDA granted Priority Review to trastuzumab deruxtecan for high-risk HER2-positive early breast cancer with residual disease, signaling a potential new standard to reduce recurrence risk.</itunes:subtitle>
      <itunes:keywords>signaling a potential new standard to reduce recurrence risk., the fda granted priority review to trastuzumab deruxtecan for high-risk her2-positive early breast cancer with residual disease</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>298</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1054e3a3-e03d-4876-8675-246d0280892e</guid>
      <title>Severe Asthma Biologic Selection: Guideline Aids Clinicians</title>
      <description><![CDATA[New CHEST guidance helps clinicians match severe asthma patients to targeted biologic therapies using biomarkers, aiming to reduce steroid dependence, prevent exacerbations, and improve long-term disease control. 
]]></description>
      <pubDate>Thu, 12 Mar 2026 14:59:44 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/severe-asthma-biologic-selection-guideline-aids-clinicians-6Vywm6aT</link>
      <enclosure length="1854110" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6b26c20d-0aab-49b6-88a9-11b826ffc38e/group-item/ba9fafc8-fbb0-49e0-9147-02043e20c350/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Severe Asthma Biologic Selection: Guideline Aids Clinicians</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>New CHEST guidance helps clinicians match severe asthma patients to targeted biologic therapies using biomarkers, aiming to reduce steroid dependence, prevent exacerbations, and improve long-term disease control.</itunes:summary>
      <itunes:subtitle>New CHEST guidance helps clinicians match severe asthma patients to targeted biologic therapies using biomarkers, aiming to reduce steroid dependence, prevent exacerbations, and improve long-term disease control.</itunes:subtitle>
      <itunes:keywords>prevent exacerbations, aiming to reduce steroid dependence, new chest guidance helps clinicians match severe asthma patients to targeted biologic therapies using biomarkers, and improve long-term disease control.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>299</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2c11bae7-0c3b-4f21-af78-36f0ee421f23</guid>
      <title>Detecting Pheochromocytoma Before Heart And Kidney Damage</title>
      <description><![CDATA[Pheochromocytoma causes episodic catecholamine surges leading to severe hypertension, headaches, palpitations, and sweating; early recognition and targeted testing prevent heart and kidney damage and improve outcomes. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/detecting-pheochromocytoma-before-heart-and-kidney-damage-53ndGM31</link>
      <enclosure length="1845750" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/654b179d-1f8c-4458-bd97-e0a72b8465f5/group-item/cf2838a1-9baf-43c8-a112-858534a14b4e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Detecting Pheochromocytoma Before Heart And Kidney Damage</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>Pheochromocytoma causes episodic catecholamine surges leading to severe hypertension, headaches, palpitations, and sweating; early recognition and targeted testing prevent heart and kidney damage and improve outcomes.</itunes:summary>
      <itunes:subtitle>Pheochromocytoma causes episodic catecholamine surges leading to severe hypertension, headaches, palpitations, and sweating; early recognition and targeted testing prevent heart and kidney damage and improve outcomes.</itunes:subtitle>
      <itunes:keywords>and sweating; early recognition and targeted testing prevent heart and kidney damage and improve outcomes., palpitations, headaches, pheochromocytoma causes episodic catecholamine surges leading to severe hypertension</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>297</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ba1dac78-c594-4400-8667-d2cce85ba36d</guid>
      <title>Obesity Severity and BP Patterns in African American Women</title>
      <description><![CDATA[Obesity severity alters blood pressure patterns in African American women, increasing masked hypertension, variability, and nighttime elevation, highlighting the need for accurate measurement, personalized monitoring, and integrated treatment strategies. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/obesity-severity-and-bp-patterns-in-african-american-women-zB0DxeRH</link>
      <enclosure length="1485470" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/850cdd3e-fb42-41e2-a5d3-ec6fb4861068/group-item/af65a786-a993-4005-bed2-c0a2ada07a94/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Obesity Severity and BP Patterns in African American Women</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Obesity severity alters blood pressure patterns in African American women, increasing masked hypertension, variability, and nighttime elevation, highlighting the need for accurate measurement, personalized monitoring, and integrated treatment strategies.</itunes:summary>
      <itunes:subtitle>Obesity severity alters blood pressure patterns in African American women, increasing masked hypertension, variability, and nighttime elevation, highlighting the need for accurate measurement, personalized monitoring, and integrated treatment strategies.</itunes:subtitle>
      <itunes:keywords>and nighttime elevation, highlighting the need for accurate measurement, obesity severity alters blood pressure patterns in african american women, variability, and integrated treatment strategies., increasing masked hypertension, personalized monitoring</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>296</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9d4db073-102e-4cf0-b4b8-fa8ae1c0c642</guid>
      <title>Why Breast Cancer Is Increasing In Younger Women, Explained</title>
      <description><![CDATA[Breast cancer diagnoses are rising in women under 50, prompting earlier risk evaluation, symptom awareness, fertility counseling, and survivorship planning to address unique biological, reproductive, and long-term care needs. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/why-breast-cancer-is-increasing-in-younger-women-explained-Fc5hsU07</link>
      <enclosure length="1168238" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/1f92fd00-874f-4d71-8486-18facfda13f4/group-item/f245ebb1-f581-4fa9-b894-4185c913257f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Why Breast Cancer Is Increasing In Younger Women, Explained</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>Breast cancer diagnoses are rising in women under 50, prompting earlier risk evaluation, symptom awareness, fertility counseling, and survivorship planning to address unique biological, reproductive, and long-term care needs.</itunes:summary>
      <itunes:subtitle>Breast cancer diagnoses are rising in women under 50, prompting earlier risk evaluation, symptom awareness, fertility counseling, and survivorship planning to address unique biological, reproductive, and long-term care needs.</itunes:subtitle>
      <itunes:keywords>and survivorship planning to address unique biological, breast cancer diagnoses are rising in women under 50, reproductive, prompting earlier risk evaluation, and long-term care needs., fertility counseling, symptom awareness</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>295</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2bc6a698-650a-4cd4-94fb-b24961d57829</guid>
      <title>Alzheimer’s Disease: Diagnosis, Biomarkers, Early Detection</title>
      <description><![CDATA[Alzheimer’s biomarkers detect amyloid, tau, and neuronal injury earlier than symptoms, improving diagnostic accuracy and treatment eligibility while raising new challenges around counseling, access, ethics, and health system capacity. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 15:25:24 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/alzheimers-disease-diagnosis-biomarkers-early-detection-iYBxEo6O</link>
      <enclosure length="1828614" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6aa499b6-72b8-4871-9522-37c4e7b80df8/group-item/98c1c320-f7ba-4134-a2f7-c038ab03d607/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Alzheimer’s Disease: Diagnosis, Biomarkers, Early Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Alzheimer’s biomarkers detect amyloid, tau, and neuronal injury earlier than symptoms, improving diagnostic accuracy and treatment eligibility while raising new challenges around counseling, access, ethics, and health system capacity.</itunes:summary>
      <itunes:subtitle>Alzheimer’s biomarkers detect amyloid, tau, and neuronal injury earlier than symptoms, improving diagnostic accuracy and treatment eligibility while raising new challenges around counseling, access, ethics, and health system capacity.</itunes:subtitle>
      <itunes:keywords>alzheimer’s biomarkers detect amyloid, and health system capacity., ethics, tau, improving diagnostic accuracy and treatment eligibility while raising new challenges around counseling, access, and neuronal injury earlier than symptoms</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>294</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fccf4dbe-ff41-48cc-bfd2-d6593a9376a2</guid>
      <title>Fremanezumab Reduces Prolonged Sporadic Hemiplegic Migraine Rate</title>
      <description><![CDATA[Fremanezumab, a CGRP-targeting preventive therapy, may reduce prolonged sporadic hemiplegic migraine attacks, offering a promising option for patients with stroke-like symptoms and limited disease-specific treatments. 
]]></description>
      <pubDate>Wed, 11 Mar 2026 13:54:07 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fremanezumab-reduces-prolonged-sporadic-hemiplegic-migraine-rate-tQ4kngZ6</link>
      <enclosure length="2250335" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/be9599fd-f775-4e9a-bd92-d87207bbd464/group-item/8fafcf55-238f-4be0-b134-3aef83491296/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Fremanezumab Reduces Prolonged Sporadic Hemiplegic Migraine Rate</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:20</itunes:duration>
      <itunes:summary>Fremanezumab, a CGRP-targeting preventive therapy, may reduce prolonged sporadic hemiplegic migraine attacks, offering a promising option for patients with stroke-like symptoms and limited disease-specific treatments.</itunes:summary>
      <itunes:subtitle>Fremanezumab, a CGRP-targeting preventive therapy, may reduce prolonged sporadic hemiplegic migraine attacks, offering a promising option for patients with stroke-like symptoms and limited disease-specific treatments.</itunes:subtitle>
      <itunes:keywords>offering a promising option for patients with stroke-like symptoms and limited disease-specific treatments., fremanezumab, a cgrp-targeting preventive therapy, may reduce prolonged sporadic hemiplegic migraine attacks</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>293</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">34bacbe6-7d35-4199-a33f-50b01f0905e7</guid>
      <title>Investigational Stent Retriever Boosts Distal Stroke Reperfusion</title>
      <description><![CDATA[A novel stroke technique uses a stent retriever as a distal filter to capture emboli during carotid occlusion treatment, improving reperfusion, first-pass success, and procedural efficiency. 
]]></description>
      <pubDate>Tue, 10 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/investigational-stent-retriever-boosts-distal-stroke-reperfusion-KpkMTTJq-9uYv78z_</link>
      <enclosure length="735651" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a18d7c42-4be4-4476-bc66-522507e4455b/group-item/529cf5b9-22f4-4faa-9bd8-8addb74460e9/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Investigational Stent Retriever Boosts Distal Stroke Reperfusion</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:45</itunes:duration>
      <itunes:summary>A novel stroke technique uses a stent retriever as a distal filter to capture emboli during carotid occlusion treatment, improving reperfusion, first-pass success, and procedural efficiency.</itunes:summary>
      <itunes:subtitle>A novel stroke technique uses a stent retriever as a distal filter to capture emboli during carotid occlusion treatment, improving reperfusion, first-pass success, and procedural efficiency.</itunes:subtitle>
      <itunes:keywords>improving reperfusion, first-pass success, a novel stroke technique uses a stent retriever as a distal filter to capture emboli during carotid occlusion treatment, and procedural efficiency.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>292</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c083c612-4403-4b4f-b8ab-fe952f77be82</guid>
      <title>Understanding Amyloid’s Role In Alzheimer’s Disease Pathology</title>
      <description><![CDATA[Amyloid buildup is a key Alzheimer’s marker, enabling earlier diagnosis and targeted treatments, but it does not fully explain disease progression and requires careful interpretation, monitoring, and individualized care. 
]]></description>
      <pubDate>Tue, 10 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-amyloids-role-in-alzheimers-disease-pathology-iF_1qIBC</link>
      <enclosure length="1788490" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2c478f3b-13dd-4c63-90db-8e176ebcf134/group-item/d9d20bec-6806-4b68-b80f-7bf68e3a53f5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Amyloid’s Role In Alzheimer’s Disease Pathology</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:51</itunes:duration>
      <itunes:summary>Amyloid buildup is a key Alzheimer’s marker, enabling earlier diagnosis and targeted treatments, but it does not fully explain disease progression and requires careful interpretation, monitoring, and individualized care.</itunes:summary>
      <itunes:subtitle>Amyloid buildup is a key Alzheimer’s marker, enabling earlier diagnosis and targeted treatments, but it does not fully explain disease progression and requires careful interpretation, monitoring, and individualized care.</itunes:subtitle>
      <itunes:keywords>monitoring, and individualized care., amyloid buildup is a key alzheimer’s marker, enabling earlier diagnosis and targeted treatments, but it does not fully explain disease progression and requires careful interpretation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>291</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">85c59913-43a8-4846-9f5c-d3d22d3f7067</guid>
      <title>Ibrutinib With Immunochemotherapy/ASCT Improves MCL Survival</title>
      <description><![CDATA[Adding ibrutinib to frontline therapy improves failure-free survival in younger mantle cell lymphoma patients and may reduce routine transplant use, though infection and blood toxicity risks increase. 
]]></description>
      <pubDate>Tue, 10 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ibrutinib-with-immunochemotherapy-asct-improves-mcl-survival-35w7LJzx</link>
      <enclosure length="1802283" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6233ba8d-330f-4ad3-8f1b-137579cae020/group-item/3c61b1e9-d2e2-43d6-ab6d-b3665125e5c5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ibrutinib With Immunochemotherapy/ASCT Improves MCL Survival</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>Adding ibrutinib to frontline therapy improves failure-free survival in younger mantle cell lymphoma patients and may reduce routine transplant use, though infection and blood toxicity risks increase.</itunes:summary>
      <itunes:subtitle>Adding ibrutinib to frontline therapy improves failure-free survival in younger mantle cell lymphoma patients and may reduce routine transplant use, though infection and blood toxicity risks increase.</itunes:subtitle>
      <itunes:keywords>though infection and blood toxicity risks increase., adding ibrutinib to frontline therapy improves failure-free survival in younger mantle cell lymphoma patients and may reduce routine transplant use</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>290</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4633953e-3519-40be-83a1-98c5a18a13dc</guid>
      <title>Maternal Diabetes Linked to Increased Childhood Epilepsy Risk</title>
      <description><![CDATA[Maternal diabetes during pregnancy is linked to higher childhood epilepsy risk, highlighting the importance of glucose control, coordinated prenatal care, and early developmental monitoring for exposed children. 
]]></description>
      <pubDate>Tue, 10 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/maternal-diabetes-linked-to-increased-childhood-epilepsy-risk-16jZkD86</link>
      <enclosure length="1306165" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d4ef3fa9-6e4b-4037-b75e-67fb4e88b26e/group-item/e133fbcc-9637-4810-bb66-ba79406625d5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Maternal Diabetes Linked to Increased Childhood Epilepsy Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Maternal diabetes during pregnancy is linked to higher childhood epilepsy risk, highlighting the importance of glucose control, coordinated prenatal care, and early developmental monitoring for exposed children.</itunes:summary>
      <itunes:subtitle>Maternal diabetes during pregnancy is linked to higher childhood epilepsy risk, highlighting the importance of glucose control, coordinated prenatal care, and early developmental monitoring for exposed children.</itunes:subtitle>
      <itunes:keywords>maternal diabetes during pregnancy is linked to higher childhood epilepsy risk, and early developmental monitoring for exposed children., coordinated prenatal care, highlighting the importance of glucose control</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>289</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c0b10ad4-33ff-456d-8dce-02806a4b30a8</guid>
      <title>Teclistamab–Daratumumab Approved for Relapsed/Refractory Myeloma</title>
      <description><![CDATA[Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss. 
]]></description>
      <pubDate>Tue, 10 Mar 2026 14:05:59 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/teclistamabdaratumumab-approved-for-relapsed-refractory-myeloma-uOAlptbX</link>
      <enclosure length="1607096" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/dd0ceef4-b282-4597-b8c6-0f6514513430/group-item/482f66c0-18dc-4646-9d70-403305475663/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Teclistamab–Daratumumab Approved for Relapsed/Refractory Myeloma</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:summary>
      <itunes:subtitle>Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:subtitle>
      <itunes:keywords>long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>288</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f2c7f27a-8ad1-4899-be00-5d26ed568f65</guid>
      <title>Long-Term Levothyroxine Use May Reduce CV Risk In Older Adults</title>
      <description><![CDATA[Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss. 
]]></description>
      <pubDate>Mon, 9 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/long-term-levothyroxine-use-may-reduce-cv-risk-in-older-adults-6LQ_l26D</link>
      <enclosure length="1261861" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/939c4c87-3db1-4547-93d2-9c054fd8f978/group-item/87601842-6916-47bb-a040-a63390c1d9ba/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Long-Term Levothyroxine Use May Reduce CV Risk In Older Adults</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:summary>
      <itunes:subtitle>Long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:subtitle>
      <itunes:keywords>long-term levothyroxine therapy in older adults may modestly reduce cardiovascular risk when carefully monitored, but clinicians must balance benefits with risks like atrial fibrillation and bone loss.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>287</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4cc3c201-0493-4515-ae98-e1b7c2847469</guid>
      <title>Driving Change With Data For Clinicians And Policymakers</title>
      <description><![CDATA[Healthcare data is transforming care by guiding clinical decisions, revealing disparities, integrating social determinants, and helping policymakers target resources to improve outcomes and expand equitable access. 
]]></description>
      <pubDate>Mon, 9 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/driving-change-with-data-for-clinicians-and-policymakers-TgM_MupF</link>
      <enclosure length="1334586" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/85c2febf-ef9e-46cf-b004-8c192a423cb6/group-item/e66257e7-dadd-4e7c-acd9-470517c07335/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Driving Change With Data For Clinicians And Policymakers</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Healthcare data is transforming care by guiding clinical decisions, revealing disparities, integrating social determinants, and helping policymakers target resources to improve outcomes and expand equitable access.</itunes:summary>
      <itunes:subtitle>Healthcare data is transforming care by guiding clinical decisions, revealing disparities, integrating social determinants, and helping policymakers target resources to improve outcomes and expand equitable access.</itunes:subtitle>
      <itunes:keywords>integrating social determinants, revealing disparities, and helping policymakers target resources to improve outcomes and expand equitable access., healthcare data is transforming care by guiding clinical decisions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>286</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a2c24c3d-bc75-4c5b-83c2-9d97a12f48d6</guid>
      <title>Adolescent Self-Harm Increased In The Post-Pandemic Era</title>
      <description><![CDATA[Post-pandemic studies show rising adolescent self-harm, signaling urgent need for early screening, school-based mental health support, family involvement, and faster access to coordinated treatment and crisis care. 
]]></description>
      <pubDate>Mon, 9 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/adolescent-self-harm-increased-in-the-post-pandemic-era-oHe6vqFr</link>
      <enclosure length="1545238" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a08ee739-06c7-48f8-bd62-c7046465cd3f/group-item/1839b47d-feae-472d-9a5a-d9452c531560/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Adolescent Self-Harm Increased In The Post-Pandemic Era</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Post-pandemic studies show rising adolescent self-harm, signaling urgent need for early screening, school-based mental health support, family involvement, and faster access to coordinated treatment and crisis care.</itunes:summary>
      <itunes:subtitle>Post-pandemic studies show rising adolescent self-harm, signaling urgent need for early screening, school-based mental health support, family involvement, and faster access to coordinated treatment and crisis care.</itunes:subtitle>
      <itunes:keywords>school-based mental health support, signaling urgent need for early screening, family involvement, post-pandemic studies show rising adolescent self-harm, and faster access to coordinated treatment and crisis care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>285</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">da0556d4-7810-42d0-9b38-46edb9c42155</guid>
      <title>Proposed CMS Limits On Peripheral Nerve Blocks For Chronic Pain</title>
      <description><![CDATA[Proposed Medicare policies could restrict coverage for many peripheral nerve block procedures used in chronic pain care, raising concerns about reduced access to non-opioid treatments. 
]]></description>
      <pubDate>Mon, 9 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/proposed-cms-limits-on-peripheral-nerve-blocks-for-chronic-pain-adqJ7DVD</link>
      <enclosure length="1513473" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/21bab728-da44-4329-8f31-ebc19786e1be/group-item/d0a9cc8f-46f7-49f3-98c6-60dd99bd4373/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Proposed CMS Limits On Peripheral Nerve Blocks For Chronic Pain</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Proposed Medicare policies could restrict coverage for many peripheral nerve block procedures used in chronic pain care, raising concerns about reduced access to non-opioid treatments.</itunes:summary>
      <itunes:subtitle>Proposed Medicare policies could restrict coverage for many peripheral nerve block procedures used in chronic pain care, raising concerns about reduced access to non-opioid treatments.</itunes:subtitle>
      <itunes:keywords>raising concerns about reduced access to non-opioid treatments., proposed medicare policies could restrict coverage for many peripheral nerve block procedures used in chronic pain care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>284</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">09600bbe-4e5e-4943-bc81-dd0b418d9bcf</guid>
      <title>Sports Psychology Approaches In Addiction Recovery</title>
      <description><![CDATA[Sports psychology techniques like goal setting, visualization, and mindfulness are being integrated into addiction recovery, helping athletes and high performers build resilience, maintain structure, and support long-term sobriety. 
]]></description>
      <pubDate>Mon, 9 Mar 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sports-psychology-approaches-in-addiction-recovery-XVz9gjHd</link>
      <enclosure length="1827360" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4317069d-6d90-477b-a458-adc85405c1e5/group-item/8b04587f-ecc0-44e8-9db4-2e5fe5301f68/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sports Psychology Approaches In Addiction Recovery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Sports psychology techniques like goal setting, visualization, and mindfulness are being integrated into addiction recovery, helping athletes and high performers build resilience, maintain structure, and support long-term sobriety.</itunes:summary>
      <itunes:subtitle>Sports psychology techniques like goal setting, visualization, and mindfulness are being integrated into addiction recovery, helping athletes and high performers build resilience, maintain structure, and support long-term sobriety.</itunes:subtitle>
      <itunes:keywords>maintain structure, visualization, and support long-term sobriety., helping athletes and high performers build resilience, and mindfulness are being integrated into addiction recovery, sports psychology techniques like goal setting</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>283</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2b98734e-67b3-47d8-9039-99b4e8183f65</guid>
      <title>Medically-Induced Menopause: Implications for Breast Cancer</title>
      <description><![CDATA[Medically induced menopause from breast cancer treatment causes abrupt hormone loss, triggering intense symptoms, fertility challenges, and long-term bone and heart risks, requiring coordinated survivorship care. 
]]></description>
      <pubDate>Fri, 6 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/medically-induced-menopause-implications-for-breast-cancer-y0LjzE1r-5aPRbHiX</link>
      <enclosure length="1727050" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9458088a-118c-47af-97c0-abf431f915d9/group-item/8f99a8d4-7e73-46d9-9e41-f3c7665d026c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Medically-Induced Menopause: Implications for Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Medically induced menopause from breast cancer treatment causes abrupt hormone loss, triggering intense symptoms, fertility challenges, and long-term bone and heart risks, requiring coordinated survivorship care.</itunes:summary>
      <itunes:subtitle>Medically induced menopause from breast cancer treatment causes abrupt hormone loss, triggering intense symptoms, fertility challenges, and long-term bone and heart risks, requiring coordinated survivorship care.</itunes:subtitle>
      <itunes:keywords>triggering intense symptoms, fertility challenges, medically induced menopause from breast cancer treatment causes abrupt hormone loss, and long-term bone and heart risks, requiring coordinated survivorship care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>281</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">826baef1-fc98-4ad4-b8d2-fa5b6b122aaa</guid>
      <title>Individualized Therapy Key to Standards of Care for Obesity Drugs</title>
      <description><![CDATA[New obesity care standards emphasize individualized pharmacotherapy alongside lifestyle changes, using shared decision-making to match medications with patients’ conditions, improving weight loss, comorbidities, and long-term health outcomes. 
]]></description>
      <pubDate>Fri, 6 Mar 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/individualized-therapy-key-to-standards-of-care-for-obesity-drugs-TEnDlO_j</link>
      <enclosure length="1650981" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/bb04eb02-bdce-46f2-96b6-64029f6655cd/group-item/aae6d2a1-33b1-4245-a657-376434ba0b02/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Individualized Therapy Key to Standards of Care for Obesity Drugs</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>New obesity care standards emphasize individualized pharmacotherapy alongside lifestyle changes, using shared decision-making to match medications with patients’ conditions, improving weight loss, comorbidities, and long-term health outcomes.</itunes:summary>
      <itunes:subtitle>New obesity care standards emphasize individualized pharmacotherapy alongside lifestyle changes, using shared decision-making to match medications with patients’ conditions, improving weight loss, comorbidities, and long-term health outcomes.</itunes:subtitle>
      <itunes:keywords>improving weight loss, using shared decision-making to match medications with patients’ conditions, comorbidities, new obesity care standards emphasize individualized pharmacotherapy alongside lifestyle changes, and long-term health outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>280</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6a00a929-1977-4036-b2a9-6cc974951d50</guid>
      <title>Investigational Stent Retriever Boosts Distal Stroke Reperfusion</title>
      <description><![CDATA[A novel stent-retriever filter technique may improve stroke treatment by capturing emboli during carotid occlusion procedures, reducing intervention time and increasing successful first-pass brain reperfusion. 
]]></description>
      <pubDate>Fri, 6 Mar 2026 17:38:15 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/investigational-stent-retriever-boosts-distal-stroke-reperfusion-v3hiZyHS</link>
      <enclosure length="1621306" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a179abf1-9e2c-472f-b293-206e6b077566/group-item/d09fd42f-3047-4daa-bbc6-941b983aa4af/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Investigational Stent Retriever Boosts Distal Stroke Reperfusion</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>A novel stent-retriever filter technique may improve stroke treatment by capturing emboli during carotid occlusion procedures, reducing intervention time and increasing successful first-pass brain reperfusion.</itunes:summary>
      <itunes:subtitle>A novel stent-retriever filter technique may improve stroke treatment by capturing emboli during carotid occlusion procedures, reducing intervention time and increasing successful first-pass brain reperfusion.</itunes:subtitle>
      <itunes:keywords>a novel stent-retriever filter technique may improve stroke treatment by capturing emboli during carotid occlusion procedures, reducing intervention time and increasing successful first-pass brain reperfusion.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>279</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">302de55b-6bfc-4951-84ec-6a35f51a527c</guid>
      <title>Chronic Hives: Symptoms, Diagnoses &amp; New Treatments</title>
      <description><![CDATA[Chronic urticaria causes recurring itchy welts and swelling lasting six weeks or longer, disrupting sleep and daily life. New guideline-based treatments and targeted therapies are improving long-term symptom control. 
]]></description>
      <pubDate>Thu, 5 Mar 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/chronic-hives-symptoms-diagnoses-new-treatments-uDIBlTnY</link>
      <enclosure length="1203347" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/4d9d2cff-d8b1-4b72-bda5-361fac05e67e/group-item/86caa728-bde4-4acc-b013-5c1c263c0c58/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Chronic Hives: Symptoms, Diagnoses &amp; New Treatments</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:15</itunes:duration>
      <itunes:summary>Chronic urticaria causes recurring itchy welts and swelling lasting six weeks or longer, disrupting sleep and daily life. New guideline-based treatments and targeted therapies are improving long-term symptom control.</itunes:summary>
      <itunes:subtitle>Chronic urticaria causes recurring itchy welts and swelling lasting six weeks or longer, disrupting sleep and daily life. New guideline-based treatments and targeted therapies are improving long-term symptom control.</itunes:subtitle>
      <itunes:keywords>disrupting sleep and daily life. new guideline-based treatments and targeted therapies are improving long-term symptom control., chronic urticaria causes recurring itchy welts and swelling lasting six weeks or longer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>278</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cdbf65a7-97bf-4536-8a63-a2f96e3e984b</guid>
      <title>9 Home Remedies To Help Manage Fibroids: At-Home Options</title>
      <description><![CDATA[Fibroids are common uterine growths that may cause bleeding, pain, or pressure. At-home strategies can ease symptoms, but medical evaluation remains essential for severe bleeding, pain, or fertility concerns. 
]]></description>
      <pubDate>Thu, 5 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/9-home-remedies-to-help-manage-fibroids-at-home-options-_j4s_M09</link>
      <enclosure length="1207527" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6ace1d61-5431-4bd1-965c-94d34fb0ad32/group-item/334876af-10c6-477b-8f02-305717620dc5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>9 Home Remedies To Help Manage Fibroids: At-Home Options</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:15</itunes:duration>
      <itunes:summary>Fibroids are common uterine growths that may cause bleeding, pain, or pressure. At-home strategies can ease symptoms, but medical evaluation remains essential for severe bleeding, pain, or fertility concerns.</itunes:summary>
      <itunes:subtitle>Fibroids are common uterine growths that may cause bleeding, pain, or pressure. At-home strategies can ease symptoms, but medical evaluation remains essential for severe bleeding, pain, or fertility concerns.</itunes:subtitle>
      <itunes:keywords>fibroids are common uterine growths that may cause bleeding, or pressure. at-home strategies can ease symptoms, or fertility concerns., but medical evaluation remains essential for severe bleeding, pain</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>277</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fae4f125-8785-4a9c-be16-766728f4c208</guid>
      <title>Integrated Nurse Mgmt Lowers Pain Interference, Rural PC (Pilot)</title>
      <description><![CDATA[Pilot research shows nurse-led care management in rural primary care may reduce chronic pain interference, improving daily function through continuous support, safer medication use, and coordinated non-drug therapies. 
]]></description>
      <pubDate>Thu, 5 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/integrated-nurse-mgmt-lowers-pain-interference-rural-pc-pilot-N2e3pL33</link>
      <enclosure length="1077541" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/52cde39c-2f2f-4e8c-8849-501489ee2e86/group-item/d043f022-0efb-48f7-a834-f021f7ab11f5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Integrated Nurse Mgmt Lowers Pain Interference, Rural PC (Pilot)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:07</itunes:duration>
      <itunes:summary>Pilot research shows nurse-led care management in rural primary care may reduce chronic pain interference, improving daily function through continuous support, safer medication use, and coordinated non-drug therapies.</itunes:summary>
      <itunes:subtitle>Pilot research shows nurse-led care management in rural primary care may reduce chronic pain interference, improving daily function through continuous support, safer medication use, and coordinated non-drug therapies.</itunes:subtitle>
      <itunes:keywords>pilot research shows nurse-led care management in rural primary care may reduce chronic pain interference, improving daily function through continuous support, safer medication use, and coordinated non-drug therapies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>276</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">43e31bd2-8dd7-4b08-be18-50234e5bf9ff</guid>
      <title>Metabolic Fingerprints Predict Early Arterial Damage in HIV</title>
      <description><![CDATA[Blood metabolic fingerprints may detect early arterial damage in people with HIV before imaging changes appear, enabling earlier cardiovascular risk prevention alongside long-term antiretroviral care. 
]]></description>
      <pubDate>Thu, 5 Mar 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/metabolic-fingerprints-predict-early-arterial-damage-in-hiv-Lt5W4nyR</link>
      <enclosure length="1960689" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0c8bc3ff-cc7a-44a1-b45d-a7572dd9210c/group-item/a037f487-4284-46a5-a320-dd20b11c5c83/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Metabolic Fingerprints Predict Early Arterial Damage in HIV</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Blood metabolic fingerprints may detect early arterial damage in people with HIV before imaging changes appear, enabling earlier cardiovascular risk prevention alongside long-term antiretroviral care.</itunes:summary>
      <itunes:subtitle>Blood metabolic fingerprints may detect early arterial damage in people with HIV before imaging changes appear, enabling earlier cardiovascular risk prevention alongside long-term antiretroviral care.</itunes:subtitle>
      <itunes:keywords>blood metabolic fingerprints may detect early arterial damage in people with hiv before imaging changes appear, enabling earlier cardiovascular risk prevention alongside long-term antiretroviral care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>275</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">968c4921-1115-44b8-92c3-2764ba94d8a4</guid>
      <title>Medically-Induced Menopause: Implications for Breast Cancer</title>
      <description><![CDATA[Medically induced menopause from breast cancer treatment triggers abrupt hormone loss, intensifying symptoms, affecting fertility, and increasing long term bone, cardiovascular, and survivorship care challenges. 
]]></description>
      <pubDate>Thu, 5 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/medically-induced-menopause-implications-for-breast-cancer-ol_opcCD</link>
      <enclosure length="1600408" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e41ce227-47b1-46f1-9b42-3dd1c031bd83/group-item/56b17e3a-daf6-497e-92e9-a1c30439cf3a/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Medically-Induced Menopause: Implications for Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Medically induced menopause from breast cancer treatment triggers abrupt hormone loss, intensifying symptoms, affecting fertility, and increasing long term bone, cardiovascular, and survivorship care challenges.</itunes:summary>
      <itunes:subtitle>Medically induced menopause from breast cancer treatment triggers abrupt hormone loss, intensifying symptoms, affecting fertility, and increasing long term bone, cardiovascular, and survivorship care challenges.</itunes:subtitle>
      <itunes:keywords>medically induced menopause from breast cancer treatment triggers abrupt hormone loss, intensifying symptoms, affecting fertility, and survivorship care challenges., and increasing long term bone, cardiovascular</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>274</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5205e459-de9c-4306-bd6c-d86360d2d770</guid>
      <title>Valcare Reports First US Transseptal Implant Of Amend Annuloplasty</title>
      <description><![CDATA[First U.S. transseptal AMEND annuloplasty implantation expands minimally invasive options for high-risk mitral regurgitation patients, replicating surgical repair anatomy without sternotomy and reshaping structural heart care. 
]]></description>
      <pubDate>Wed, 4 Mar 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/valcare-reports-first-us-transseptal-implant-of-amend-annuloplasty-jdD86lL1</link>
      <enclosure length="1879605" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/01b3cc9f-21b3-40c1-b5a3-c2d4d8069e90/group-item/9409383d-152f-4c3b-943e-eac165f0597d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Valcare Reports First US Transseptal Implant Of Amend Annuloplasty</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>First U.S. transseptal AMEND annuloplasty implantation expands minimally invasive options for high-risk mitral regurgitation patients, replicating surgical repair anatomy without sternotomy and reshaping structural heart care.</itunes:summary>
      <itunes:subtitle>First U.S. transseptal AMEND annuloplasty implantation expands minimally invasive options for high-risk mitral regurgitation patients, replicating surgical repair anatomy without sternotomy and reshaping structural heart care.</itunes:subtitle>
      <itunes:keywords>first u.s. transseptal amend annuloplasty implantation expands minimally invasive options for high-risk mitral regurgitation patients, replicating surgical repair anatomy without sternotomy and reshaping structural heart care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>273</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ecf788ef-accd-49f9-93bf-0294a9760b20</guid>
      <title>Ferroptosis Biology And Role In Liver Disease: Implications</title>
      <description><![CDATA[Ferroptosis, an iron-driven lipid oxidation death pathway, shapes liver injury, fibrosis, and cancer, offering dual therapeutic potential to protect hepatocytes or selectively eliminate resistant tumor cells. 
]]></description>
      <pubDate>Wed, 4 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ferroptosis-biology-and-role-in-liver-disease-implications-djXQa19S</link>
      <enclosure length="1348797" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/11350cf0-250f-4cad-9f6e-6a843b811363/group-item/3225192e-c3f1-4a98-b654-1154f2a36e10/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ferroptosis Biology And Role In Liver Disease: Implications</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:24</itunes:duration>
      <itunes:summary>Ferroptosis, an iron-driven lipid oxidation death pathway, shapes liver injury, fibrosis, and cancer, offering dual therapeutic potential to protect hepatocytes or selectively eliminate resistant tumor cells.</itunes:summary>
      <itunes:subtitle>Ferroptosis, an iron-driven lipid oxidation death pathway, shapes liver injury, fibrosis, and cancer, offering dual therapeutic potential to protect hepatocytes or selectively eliminate resistant tumor cells.</itunes:subtitle>
      <itunes:keywords>fibrosis, offering dual therapeutic potential to protect hepatocytes or selectively eliminate resistant tumor cells., and cancer, ferroptosis, an iron-driven lipid oxidation death pathway, shapes liver injury</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>272</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7d5703fb-f871-4b94-92c5-ad3a96c01cf5</guid>
      <title>Molecular Signature Predicting Polycythemia Vera Progression</title>
      <description><![CDATA[A newly identified molecular signature in polycythemia vera improves prediction of disease progression, enabling biologically informed risk stratification, personalized monitoring, and earlier intervention for high-risk patients. 
]]></description>
      <pubDate>Wed, 4 Mar 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/molecular-signature-predicting-polycythemia-vera-progression-Yye9Cc7M</link>
      <enclosure length="2180536" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/69199164-aea0-4a80-88c3-c31aa5b7dde7/group-item/9239037d-03b4-48ea-b763-c7ef9f2271c6/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Molecular Signature Predicting Polycythemia Vera Progression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:16</itunes:duration>
      <itunes:summary>A newly identified molecular signature in polycythemia vera improves prediction of disease progression, enabling biologically informed risk stratification, personalized monitoring, and earlier intervention for high-risk patients.</itunes:summary>
      <itunes:subtitle>A newly identified molecular signature in polycythemia vera improves prediction of disease progression, enabling biologically informed risk stratification, personalized monitoring, and earlier intervention for high-risk patients.</itunes:subtitle>
      <itunes:keywords>enabling biologically informed risk stratification, and earlier intervention for high-risk patients., a newly identified molecular signature in polycythemia vera improves prediction of disease progression, personalized monitoring</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>271</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ecfd9c5c-a835-43cf-acc9-2db23cf06c02</guid>
      <title>Medicaid Expansion Prevents Thousands Of Breast Cancer Deaths</title>
      <description><![CDATA[Medicaid expansion improves breast cancer outcomes by increasing early-stage diagnoses, reducing late-stage disease, narrowing racial disparities, lowering mortality, and stabilizing health systems through earlier, affordable access to care. 
]]></description>
      <pubDate>Wed, 4 Mar 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/medicaid-expansion-prevents-thousands-of-breast-cancer-deaths-Nunr5gqV</link>
      <enclosure length="1703226" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fcdd7394-4075-44cb-b655-49d3b8699924/group-item/649249a2-21da-4362-a0b7-3def153b3d5d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Medicaid Expansion Prevents Thousands Of Breast Cancer Deaths</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Medicaid expansion improves breast cancer outcomes by increasing early-stage diagnoses, reducing late-stage disease, narrowing racial disparities, lowering mortality, and stabilizing health systems through earlier, affordable access to care.</itunes:summary>
      <itunes:subtitle>Medicaid expansion improves breast cancer outcomes by increasing early-stage diagnoses, reducing late-stage disease, narrowing racial disparities, lowering mortality, and stabilizing health systems through earlier, affordable access to care.</itunes:subtitle>
      <itunes:keywords>affordable access to care., medicaid expansion improves breast cancer outcomes by increasing early-stage diagnoses, reducing late-stage disease, narrowing racial disparities, lowering mortality, and stabilizing health systems through earlier</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>270</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ed3d90c5-a628-4692-8f8d-01c49690eded</guid>
      <title>A Stanford Study: Why mRNA COVID Vaccines Can Trigger Heart Inflammation</title>
      <description><![CDATA[New research clarifies rare mRNA vaccine–associated myocarditis arises from brief innate immune overactivation, guiding safer dosing, monitoring strategies, and next-generation vaccine design while preserving public confidence. 
]]></description>
      <pubDate>Wed, 4 Mar 2026 14:33:48 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/a-stanford-study-why-mrna-covid-vaccines-can-trigger-heart-inflammation-k2hEzZfS</link>
      <enclosure length="1929342" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/92385da1-5b84-48f5-a1d2-edfd256afeaa/group-item/0b4b2399-52cc-4b1d-b5c5-3fe3d3c3082e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>A Stanford Study: Why mRNA COVID Vaccines Can Trigger Heart Inflammation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:00</itunes:duration>
      <itunes:summary>New research clarifies rare mRNA vaccine–associated myocarditis arises from brief innate immune overactivation, guiding safer dosing, monitoring strategies, and next-generation vaccine design while preserving public confidence.</itunes:summary>
      <itunes:subtitle>New research clarifies rare mRNA vaccine–associated myocarditis arises from brief innate immune overactivation, guiding safer dosing, monitoring strategies, and next-generation vaccine design while preserving public confidence.</itunes:subtitle>
      <itunes:keywords>monitoring strategies, and next-generation vaccine design while preserving public confidence., guiding safer dosing, new research clarifies rare mrna vaccine–associated myocarditis arises from brief innate immune overactivation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>269</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4a1b1c03-a04d-4532-b801-81ccca8028e3</guid>
      <title>Ocular Toxicity From New Oncology Agents: Safety Review</title>
      <description><![CDATA[Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control. 
]]></description>
      <pubDate>Tue, 3 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ocular-toxicity-from-new-oncology-agents-safety-review-6xWPlgI8</link>
      <enclosure length="1498008" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b9d5df92-7d88-4c61-a744-18ef2e4492b3/group-item/6e3027c9-42b9-4411-a671-15578445c4fe/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ocular Toxicity From New Oncology Agents: Safety Review</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.</itunes:summary>
      <itunes:subtitle>Wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, requiring early recognition, multidisciplinary coordination, and proactive monitoring to protect vision without compromising cancer control.</itunes:subtitle>
      <itunes:keywords>multidisciplinary coordination, wider use of targeted cancer drugs and immunotherapies is elevating ocular toxicity risk, and proactive monitoring to protect vision without compromising cancer control., requiring early recognition</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>268</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">786185de-4149-408b-a9ac-264f35f29acd</guid>
      <title>Anifrolumab in the Real-World Management of Systemic Lupus Erythematosus</title>
      <description><![CDATA[Real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab, supporting earlier targeted therapy, steroid reduction, and evolving care pathways for systemic lupus erythematosus. 
]]></description>
      <pubDate>Tue, 3 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/anifrolumab-in-the-real-world-management-of-systemic-lupus-erythematosus-zsIYiaws</link>
      <enclosure length="1721616" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/d10af913-3297-4e02-a613-62c01b1b8e07/group-item/87f8cc36-a749-4f60-95d0-5828a5c0106b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Anifrolumab in the Real-World Management of Systemic Lupus Erythematosus</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab, supporting earlier targeted therapy, steroid reduction, and evolving care pathways for systemic lupus erythematosus.</itunes:summary>
      <itunes:subtitle>Real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab, supporting earlier targeted therapy, steroid reduction, and evolving care pathways for systemic lupus erythematosus.</itunes:subtitle>
      <itunes:keywords>steroid reduction, supporting earlier targeted therapy, and evolving care pathways for systemic lupus erythematosus., real-world data show about one-quarter of lupus patients achieve six-month remission with anifrolumab</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>267</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">747fe4ae-245f-47aa-a6b7-7647f8f2f9df</guid>
      <title>Microglia And Sleep Disorders: Explained For Clinicians</title>
      <description><![CDATA[Research links sleep disruption to microglial activation, reframing insomnia as neuro-immune stress that may drive inflammation, cognitive fog, mood symptoms, and long-term brain vulnerability. 
]]></description>
      <pubDate>Tue, 3 Mar 2026 16:38:56 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/microglia-and-sleep-disorders-explained-for-clinicians-QYGqR_ko-X_cglG1u</link>
      <enclosure length="1947732" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/95d4360b-3ef9-4806-8451-617e254943f8/group-item/4110e4fb-ac0b-4c63-9367-5e83abc16258/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Microglia And Sleep Disorders: Explained For Clinicians</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:01</itunes:duration>
      <itunes:summary>Research links sleep disruption to microglial activation, reframing insomnia as neuro-immune stress that may drive inflammation, cognitive fog, mood symptoms, and long-term brain vulnerability.</itunes:summary>
      <itunes:subtitle>Research links sleep disruption to microglial activation, reframing insomnia as neuro-immune stress that may drive inflammation, cognitive fog, mood symptoms, and long-term brain vulnerability.</itunes:subtitle>
      <itunes:keywords>mood symptoms, reframing insomnia as neuro-immune stress that may drive inflammation, and long-term brain vulnerability., cognitive fog, research links sleep disruption to microglial activation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>266</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e7d57eb5-6d0a-4782-b0e7-ab493a3b601e</guid>
      <title>Speed-Based Cognitive Training Lowers Alzheimer’s, Dementia Risk</title>
      <description><![CDATA[Long-term data from the ACTIVE trial suggest speed-based cognitive training with boosters may lower dementia risk, supporting scalable, nonpharmacologic prevention strategies for at-risk older adults. 
]]></description>
      <pubDate>Tue, 3 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/speed-based-cognitive-training-lowers-alzheimers-dementia-risk-KcdXewgL</link>
      <enclosure length="2032160" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/facf1f7d-dad4-442d-892a-62666cc69ce2/group-item/3a589a2d-c662-4783-b4a4-8037afbf4c93/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Speed-Based Cognitive Training Lowers Alzheimer’s, Dementia Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Long-term data from the ACTIVE trial suggest speed-based cognitive training with boosters may lower dementia risk, supporting scalable, nonpharmacologic prevention strategies for at-risk older adults.</itunes:summary>
      <itunes:subtitle>Long-term data from the ACTIVE trial suggest speed-based cognitive training with boosters may lower dementia risk, supporting scalable, nonpharmacologic prevention strategies for at-risk older adults.</itunes:subtitle>
      <itunes:keywords>supporting scalable, nonpharmacologic prevention strategies for at-risk older adults., long-term data from the active trial suggest speed-based cognitive training with boosters may lower dementia risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>265</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1c7de55c-801c-4885-908b-3d8e9a2088b6</guid>
      <title>The Clinical and Regulatory Milestone of Zongertinib in First-Line NSCLC</title>
      <description><![CDATA[FDA grants accelerated first-line approval to zongertinib, a selective oral HER2 TKI, redefining treatment for HER2-mutant metastatic NSCLC with high response rates and precision-first strategy. 
]]></description>
      <pubDate>Tue, 3 Mar 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-clinical-and-regulatory-milestone-of-zongertinib-in-first-line-nsclc-52095Rqj</link>
      <enclosure length="2011262" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b1aa458c-3ef2-476e-b9f5-6d25696b642c/group-item/d99b631c-0c78-4b98-82c8-30ecc9133c11/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Clinical and Regulatory Milestone of Zongertinib in First-Line NSCLC</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:05</itunes:duration>
      <itunes:summary>FDA grants accelerated first-line approval to zongertinib, a selective oral HER2 TKI, redefining treatment for HER2-mutant metastatic NSCLC with high response rates and precision-first strategy.</itunes:summary>
      <itunes:subtitle>FDA grants accelerated first-line approval to zongertinib, a selective oral HER2 TKI, redefining treatment for HER2-mutant metastatic NSCLC with high response rates and precision-first strategy.</itunes:subtitle>
      <itunes:keywords>a selective oral her2 tki, fda grants accelerated first-line approval to zongertinib, redefining treatment for her2-mutant metastatic nsclc with high response rates and precision-first strategy.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>264</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3cc87027-c18e-43f7-9a76-1231ee847c68</guid>
      <title>FDA Approves CT Angiography System For Cardiac Conduction Imaging</title>
      <description><![CDATA[FDA-cleared CTA software creates patient-specific 3D cardiac conduction maps for planning and live guidance, aiming to reduce conduction injury, pacing complications, and procedural uncertainty. 
]]></description>
      <pubDate>Mon, 2 Mar 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-ct-angiography-system-for-cardiac-conduction-imaging-Una2bXi7</link>
      <enclosure length="1262279" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e2387f09-9a17-4b93-a862-6104c878d64c/group-item/f5875ae4-7718-4514-97da-65ec7fb49664/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves CT Angiography System For Cardiac Conduction Imaging</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>FDA-cleared CTA software creates patient-specific 3D cardiac conduction maps for planning and live guidance, aiming to reduce conduction injury, pacing complications, and procedural uncertainty.</itunes:summary>
      <itunes:subtitle>FDA-cleared CTA software creates patient-specific 3D cardiac conduction maps for planning and live guidance, aiming to reduce conduction injury, pacing complications, and procedural uncertainty.</itunes:subtitle>
      <itunes:keywords>aiming to reduce conduction injury, and procedural uncertainty., fda-cleared cta software creates patient-specific 3d cardiac conduction maps for planning and live guidance, pacing complications</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>263</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c6dd5544-31f8-41e9-9e4e-392d1923fcaa</guid>
      <title>Gut Microbiota, Immunoglobulin A, and Vaccine Efficacy</title>
      <description><![CDATA[Gut microbiota and IgA shape vaccine effectiveness. Disrupted mucosal immunity may reduce response, guiding clinicians to evaluate nonresponse, personalize vaccination, and protect vulnerable populations. 
]]></description>
      <pubDate>Mon, 2 Mar 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/gut-microbiota-immunoglobulin-a-and-vaccine-efficacy-tTj7ypbm</link>
      <enclosure length="1807716" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5847adcc-83ad-4271-b746-b0d4ffd3fd07/group-item/a4ca537e-90b8-4d91-bbd8-f86d8836d7f1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Gut Microbiota, Immunoglobulin A, and Vaccine Efficacy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>Gut microbiota and IgA shape vaccine effectiveness. Disrupted mucosal immunity may reduce response, guiding clinicians to evaluate nonresponse, personalize vaccination, and protect vulnerable populations.</itunes:summary>
      <itunes:subtitle>Gut microbiota and IgA shape vaccine effectiveness. Disrupted mucosal immunity may reduce response, guiding clinicians to evaluate nonresponse, personalize vaccination, and protect vulnerable populations.</itunes:subtitle>
      <itunes:keywords>guiding clinicians to evaluate nonresponse, gut microbiota and iga shape vaccine effectiveness. disrupted mucosal immunity may reduce response, and protect vulnerable populations., personalize vaccination</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>262</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0e8881a3-5da4-48a0-91ef-410f81294da2</guid>
      <title>Spirituality and Harmful or Hazardous Alcohol and Other Drug Use</title>
      <description><![CDATA[Patient-centered integration of spirituality into substance use care can enhance prevention and recovery, provided boundaries, autonomy, and evidence-based treatments remain central to clinical decision making. 
]]></description>
      <pubDate>Mon, 2 Mar 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/spirituality-and-harmful-or-hazardous-alcohol-and-other-drug-use-rtC1_izL</link>
      <enclosure length="1059569" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a2ce93a6-a972-4383-87c7-34daba354d5a/group-item/6f7054ce-c395-434a-8fec-62d2ad4b0044/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Spirituality and Harmful or Hazardous Alcohol and Other Drug Use</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:06</itunes:duration>
      <itunes:summary>Patient-centered integration of spirituality into substance use care can enhance prevention and recovery, provided boundaries, autonomy, and evidence-based treatments remain central to clinical decision making.</itunes:summary>
      <itunes:subtitle>Patient-centered integration of spirituality into substance use care can enhance prevention and recovery, provided boundaries, autonomy, and evidence-based treatments remain central to clinical decision making.</itunes:subtitle>
      <itunes:keywords>autonomy, patient-centered integration of spirituality into substance use care can enhance prevention and recovery, provided boundaries, and evidence-based treatments remain central to clinical decision making.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>261</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">578d3ef6-4ff4-42a6-a3f8-f01ab442de06</guid>
      <title>Microglia And Sleep Disorders: Explained For Clinicians</title>
      <description><![CDATA[Emerging evidence links sleep disruption to microglial activation, connecting fragmented sleep with inflammation, cognitive impairment, mood symptoms, and potential long-term neurodegenerative vulnerability, reframing insomnia as neuro-immune stress. 
]]></description>
      <pubDate>Mon, 2 Mar 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/microglia-and-sleep-disorders-explained-for-clinicians-it8hN3e0</link>
      <enclosure length="1617545" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/413da41f-5cd0-4b00-95d0-5f62c18217df/group-item/5bcaa48e-7e68-45c0-a070-b6bc57c423ce/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Microglia And Sleep Disorders: Explained For Clinicians</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Emerging evidence links sleep disruption to microglial activation, connecting fragmented sleep with inflammation, cognitive impairment, mood symptoms, and potential long-term neurodegenerative vulnerability, reframing insomnia as neuro-immune stress.</itunes:summary>
      <itunes:subtitle>Emerging evidence links sleep disruption to microglial activation, connecting fragmented sleep with inflammation, cognitive impairment, mood symptoms, and potential long-term neurodegenerative vulnerability, reframing insomnia as neuro-immune stress.</itunes:subtitle>
      <itunes:keywords>cognitive impairment, mood symptoms, reframing insomnia as neuro-immune stress., emerging evidence links sleep disruption to microglial activation, and potential long-term neurodegenerative vulnerability, connecting fragmented sleep with inflammation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>260</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">75f6ecf4-474b-4fc5-8860-5b0ec42cf68d</guid>
      <title>Researchers Find COVID mRNA Vaccines Boost Cancer Survival</title>
      <description><![CDATA[COVID-19 mRNA vaccination near immunotherapy initiation may enhance cancer survival by reprogramming tumor immunity, potentially transforming “cold” tumors and reshaping oncology practice, policy, and research priorities. 
]]></description>
      <pubDate>Mon, 2 Mar 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/researchers-find-covid-mrna-vaccines-boost-cancer-survival-RE4c_a_T</link>
      <enclosure length="1905936" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2be335d1-4f6c-4ed2-b98c-42e62dc7cc5e/group-item/720a219b-20a5-4e54-b756-17f50bb4decd/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Researchers Find COVID mRNA Vaccines Boost Cancer Survival</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:59</itunes:duration>
      <itunes:summary>COVID-19 mRNA vaccination near immunotherapy initiation may enhance cancer survival by reprogramming tumor immunity, potentially transforming “cold” tumors and reshaping oncology practice, policy, and research priorities.</itunes:summary>
      <itunes:subtitle>COVID-19 mRNA vaccination near immunotherapy initiation may enhance cancer survival by reprogramming tumor immunity, potentially transforming “cold” tumors and reshaping oncology practice, policy, and research priorities.</itunes:subtitle>
      <itunes:keywords>covid-19 mrna vaccination near immunotherapy initiation may enhance cancer survival by reprogramming tumor immunity, potentially transforming “cold” tumors and reshaping oncology practice, and research priorities., policy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>259</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4989a5b1-66a3-480a-8825-fe09cb4885a6</guid>
      <title>Rheumatology Retractions Rise ‘Substantially’ Over Decades</title>
      <description><![CDATA[Rising rheumatology article retractions, largely driven by misconduct, threaten evidence integrity, clinical decision making, patient safety, and trust in research guiding lifelong autoimmune disease treatment. 
]]></description>
      <pubDate>Fri, 27 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rheumatology-retractions-rise-substantially-over-decades-tTAXRdqE</link>
      <enclosure length="1960271" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/547792eb-95e6-4c72-8b51-d1a2487d98a3/group-item/288d065d-48a7-421a-b72d-d4705ac0e209/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rheumatology Retractions Rise ‘Substantially’ Over Decades</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Rising rheumatology article retractions, largely driven by misconduct, threaten evidence integrity, clinical decision making, patient safety, and trust in research guiding lifelong autoimmune disease treatment.</itunes:summary>
      <itunes:subtitle>Rising rheumatology article retractions, largely driven by misconduct, threaten evidence integrity, clinical decision making, patient safety, and trust in research guiding lifelong autoimmune disease treatment.</itunes:subtitle>
      <itunes:keywords>clinical decision making, largely driven by misconduct, patient safety, threaten evidence integrity, and trust in research guiding lifelong autoimmune disease treatment., rising rheumatology article retractions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>258</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7d185a63-43d5-495e-9697-feea5362f409</guid>
      <title>Off-Label Treatment Approaches for Alopecia Areata</title>
      <description><![CDATA[Off-label therapies for alopecia areata expand options beyond approved treatments, balancing access, safety, monitoring, and equity while evidence gaps complicate shared decision making and long-term outcomes. 
]]></description>
      <pubDate>Fri, 27 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/off-label-treatment-approaches-for-alopecia-areata-Xr3lIJ1F</link>
      <enclosure length="1174090" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/223fa825-4d44-4cc5-b69a-6d7dd15e3d88/group-item/0a21dc73-e57e-4585-9e4e-438fd1858c99/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Off-Label Treatment Approaches for Alopecia Areata</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:13</itunes:duration>
      <itunes:summary>Off-label therapies for alopecia areata expand options beyond approved treatments, balancing access, safety, monitoring, and equity while evidence gaps complicate shared decision making and long-term outcomes.</itunes:summary>
      <itunes:subtitle>Off-label therapies for alopecia areata expand options beyond approved treatments, balancing access, safety, monitoring, and equity while evidence gaps complicate shared decision making and long-term outcomes.</itunes:subtitle>
      <itunes:keywords>balancing access, monitoring, safety, off-label therapies for alopecia areata expand options beyond approved treatments, and equity while evidence gaps complicate shared decision making and long-term outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>257</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bdec1363-bfe3-4100-b4a3-f2a443402a02</guid>
      <title>PBMs, Policy, and the Human Cost of Delay in Metabolic Care</title>
      <description><![CDATA[Administrative barriers and benefit design delays in metabolic care restrict access to GLP-1 and incretin therapies, worsening diabetes and obesity outcomes while widening equity gaps. 
]]></description>
      <pubDate>Fri, 27 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pbms-policy-and-the-human-cost-of-delay-in-metabolic-care-OhbPFmsy</link>
      <enclosure length="1902175" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5183d4ce-6105-4c49-814a-3b349d30e528/group-item/a97d77de-ea9a-4e26-a35b-d7f1524aa0ae/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>PBMs, Policy, and the Human Cost of Delay in Metabolic Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>Administrative barriers and benefit design delays in metabolic care restrict access to GLP-1 and incretin therapies, worsening diabetes and obesity outcomes while widening equity gaps.</itunes:summary>
      <itunes:subtitle>Administrative barriers and benefit design delays in metabolic care restrict access to GLP-1 and incretin therapies, worsening diabetes and obesity outcomes while widening equity gaps.</itunes:subtitle>
      <itunes:keywords>worsening diabetes and obesity outcomes while widening equity gaps., administrative barriers and benefit design delays in metabolic care restrict access to glp-1 and incretin therapies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>256</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">95ef5fc6-2e4d-4da1-b1e7-028c78d1b773</guid>
      <title>Aging With Grace: Clinician’s Guide To Healthy Aging</title>
      <description><![CDATA[Healthy aging prioritizes function, independence, and dignity through routine functional assessment, deprescribing, fall prevention, sensory support, caregiver engagement, and team-based, community-connected care aligned with patient goals. 
]]></description>
      <pubDate>Fri, 27 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/aging-with-grace-clinicians-guide-to-healthy-aging-CII5qh_v</link>
      <enclosure length="1640114" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9bb2ed37-bd11-49f2-8f13-73083432447e/group-item/a0f907a7-1e08-4ba7-823b-d2ee4ed7227a/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Aging With Grace: Clinician’s Guide To Healthy Aging</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Healthy aging prioritizes function, independence, and dignity through routine functional assessment, deprescribing, fall prevention, sensory support, caregiver engagement, and team-based, community-connected care aligned with patient goals.</itunes:summary>
      <itunes:subtitle>Healthy aging prioritizes function, independence, and dignity through routine functional assessment, deprescribing, fall prevention, sensory support, caregiver engagement, and team-based, community-connected care aligned with patient goals.</itunes:subtitle>
      <itunes:keywords>caregiver engagement, independence, sensory support, healthy aging prioritizes function, deprescribing, fall prevention, community-connected care aligned with patient goals., and dignity through routine functional assessment, and team-based</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>255</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e40c7b74-edea-4373-8e0b-21895f62f109</guid>
      <title>Long-Term Risk of Inflammatory Bowel Disease in IBS Patients</title>
      <description><![CDATA[Long-term data show some irritable bowel syndrome patients later develop inflammatory bowel disease, underscoring risk-stratified follow-up, red flag recognition, and targeted testing to prevent delayed diagnosis. 
]]></description>
      <pubDate>Fri, 27 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/long-term-risk-of-inflammatory-bowel-disease-in-ibs-patients-ZQYjBMoL</link>
      <enclosure length="2053894" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/0468ba7d-27ba-497c-a059-0601ed1e5b69/group-item/9395bfdb-6b1d-4767-8097-c4464725a9a9/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Long-Term Risk of Inflammatory Bowel Disease in IBS Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:08</itunes:duration>
      <itunes:summary>Long-term data show some irritable bowel syndrome patients later develop inflammatory bowel disease, underscoring risk-stratified follow-up, red flag recognition, and targeted testing to prevent delayed diagnosis.</itunes:summary>
      <itunes:subtitle>Long-term data show some irritable bowel syndrome patients later develop inflammatory bowel disease, underscoring risk-stratified follow-up, red flag recognition, and targeted testing to prevent delayed diagnosis.</itunes:subtitle>
      <itunes:keywords>underscoring risk-stratified follow-up, red flag recognition, long-term data show some irritable bowel syndrome patients later develop inflammatory bowel disease, and targeted testing to prevent delayed diagnosis.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>254</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6e12a0fe-b173-4d56-9a04-3792107c949f</guid>
      <title>Acute Optic Neuritis: Visual Outcomes After Plasma Exchange</title>
      <description><![CDATA[Acute optic neuritis demands rapid escalation to plasma exchange in high-risk or steroid-refractory patients, preserving vision by removing pathogenic antibodies before irreversible optic nerve damage occurs. 
]]></description>
      <pubDate>Thu, 26 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/acute-optic-neuritis-visual-outcomes-after-plasma-exchange-GFprTd9o</link>
      <enclosure length="1115158" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/91cf9a1a-8ad4-4b10-b55e-30a18c4df2ed/group-item/34f43183-a879-4702-9303-ff19df0a869f/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Acute Optic Neuritis: Visual Outcomes After Plasma Exchange</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:09</itunes:duration>
      <itunes:summary>Acute optic neuritis demands rapid escalation to plasma exchange in high-risk or steroid-refractory patients, preserving vision by removing pathogenic antibodies before irreversible optic nerve damage occurs.</itunes:summary>
      <itunes:subtitle>Acute optic neuritis demands rapid escalation to plasma exchange in high-risk or steroid-refractory patients, preserving vision by removing pathogenic antibodies before irreversible optic nerve damage occurs.</itunes:subtitle>
      <itunes:keywords>acute optic neuritis demands rapid escalation to plasma exchange in high-risk or steroid-refractory patients, preserving vision by removing pathogenic antibodies before irreversible optic nerve damage occurs.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>253</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b9aac60b-80db-4acd-9404-f373ad63936d</guid>
      <title>Importance of Biopsy in Suspected Metastatic Breast Cancer</title>
      <description><![CDATA[In suspected metastatic breast cancer, tissue biopsy confirms diagnosis, updates receptor status, guides targeted therapy, prevents misclassification, enables trial access, and supports timely, personalized treatment decisions. 
]]></description>
      <pubDate>Thu, 26 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/importance-of-biopsy-in-suspected-metastatic-breast-cancer-J3bVzHyA</link>
      <enclosure length="2080225" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/e8443538-75bb-4f3d-86c9-fc26a055e786/group-item/c8ae652b-025b-4c9d-8013-2bdaeb1b53d7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Importance of Biopsy in Suspected Metastatic Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:09</itunes:duration>
      <itunes:summary>In suspected metastatic breast cancer, tissue biopsy confirms diagnosis, updates receptor status, guides targeted therapy, prevents misclassification, enables trial access, and supports timely, personalized treatment decisions.</itunes:summary>
      <itunes:subtitle>In suspected metastatic breast cancer, tissue biopsy confirms diagnosis, updates receptor status, guides targeted therapy, prevents misclassification, enables trial access, and supports timely, personalized treatment decisions.</itunes:subtitle>
      <itunes:keywords>prevents misclassification, enables trial access, personalized treatment decisions., in suspected metastatic breast cancer, and supports timely, updates receptor status, tissue biopsy confirms diagnosis, guides targeted therapy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>252</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9826efa2-7fb1-4446-8941-76687acf97b9</guid>
      <title>New Risk Score May Predict Pain Outcomes Effectively</title>
      <description><![CDATA[A new biopsychosocial risk score predicts persistent, widespread, or high-impact chronic pain, enabling earlier personalized care, safer prescribing, and better health system planning for vulnerable patients. 
]]></description>
      <pubDate>Thu, 26 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-risk-score-may-predict-pain-outcomes-effectively-T2sQKXdL</link>
      <enclosure length="2021293" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6b98459c-b626-4092-9b7c-0350097ad8d0/group-item/de383bcf-3d98-4d37-bcc6-8607346c6d89/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Risk Score May Predict Pain Outcomes Effectively</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>A new biopsychosocial risk score predicts persistent, widespread, or high-impact chronic pain, enabling earlier personalized care, safer prescribing, and better health system planning for vulnerable patients.</itunes:summary>
      <itunes:subtitle>A new biopsychosocial risk score predicts persistent, widespread, or high-impact chronic pain, enabling earlier personalized care, safer prescribing, and better health system planning for vulnerable patients.</itunes:subtitle>
      <itunes:keywords>widespread, or high-impact chronic pain, safer prescribing, and better health system planning for vulnerable patients., enabling earlier personalized care, a new biopsychosocial risk score predicts persistent</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>251</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2ae86814-eebb-4001-87d3-eb2e39cc9898</guid>
      <title>Menopausal Hormone Therapy May Enhance Weight Loss With Tirzepatide</title>
      <description><![CDATA[Emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, offering a synergistic, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging. 
]]></description>
      <pubDate>Thu, 26 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/menopausal-hormone-therapy-may-enhance-weight-loss-with-tirzepatide-891WPlVH</link>
      <enclosure length="2095690" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6736ff93-0901-41bd-8cf0-b0bffe91fec5/group-item/c8262c20-5a3c-4021-9fcc-d27878068b8e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Menopausal Hormone Therapy May Enhance Weight Loss With Tirzepatide</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:10</itunes:duration>
      <itunes:summary>Emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, offering a synergistic, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging.</itunes:summary>
      <itunes:subtitle>Emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, offering a synergistic, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging.</itunes:subtitle>
      <itunes:keywords>emerging evidence suggests menopausal hormone therapy enhances tirzepatide-driven weight loss in postmenopausal women, hormone-informed approach to obesity, metabolic risk reduction, and healthier aging., offering a synergistic</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>250</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4f0fe46e-42a2-46f1-b62c-db0c68b9d7d9</guid>
      <title>Treatment Approaches For Polycystic Ovary Syndrome (PCOS)</title>
      <description><![CDATA[Polycystic ovary syndrome requires individualized, stepwise care addressing menstrual irregularity, androgen symptoms, fertility goals, metabolic risk, and mental health through long-term, coordinated multidisciplinary management. 
]]></description>
      <pubDate>Thu, 26 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/treatment-approaches-for-polycystic-ovary-syndrome-pcos-LkZhdNuF</link>
      <enclosure length="1194988" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2e37a432-58b9-4a22-8d09-8e8d21348c96/group-item/1cfc16a7-7789-4766-a8ad-4e93478cc404/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Treatment Approaches For Polycystic Ovary Syndrome (PCOS)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>Polycystic ovary syndrome requires individualized, stepwise care addressing menstrual irregularity, androgen symptoms, fertility goals, metabolic risk, and mental health through long-term, coordinated multidisciplinary management.</itunes:summary>
      <itunes:subtitle>Polycystic ovary syndrome requires individualized, stepwise care addressing menstrual irregularity, androgen symptoms, fertility goals, metabolic risk, and mental health through long-term, coordinated multidisciplinary management.</itunes:subtitle>
      <itunes:keywords>coordinated multidisciplinary management., fertility goals, stepwise care addressing menstrual irregularity, metabolic risk, and mental health through long-term, androgen symptoms, polycystic ovary syndrome requires individualized</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>249</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">47838501-3ca9-48a5-9198-d615ecc77013</guid>
      <title>COVID-19 Vaccines May Not Impact Fertility, Large Study Indicates</title>
      <description><![CDATA[A large Swedish study finds COVID-19 vaccination does not reduce fertility or childbirth rates, providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide. 
]]></description>
      <pubDate>Wed, 25 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/covid-19-vaccines-may-not-impact-fertility-large-study-indicates-JylGZqDI-HRB3S_Pq</link>
      <enclosure length="1261025" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/636ab1ac-431a-48de-ac73-ec468e87370a/group-item/a01a227a-cab2-4c70-ac7e-9c56e7848c99/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>COVID-19 Vaccines May Not Impact Fertility, Large Study Indicates</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>A large Swedish study finds COVID-19 vaccination does not reduce fertility or childbirth rates, providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide.</itunes:summary>
      <itunes:subtitle>A large Swedish study finds COVID-19 vaccination does not reduce fertility or childbirth rates, providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide.</itunes:subtitle>
      <itunes:keywords>providing strong evidence to counter misinformation and reassure women and healthcare providers worldwide., a large swedish study finds covid-19 vaccination does not reduce fertility or childbirth rates</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>248</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3276b248-41c6-418d-8d01-467c0d7223d7</guid>
      <title>Early Air Pollution and Home Dampness May Increase Childhood Asthma Risk</title>
      <description><![CDATA[Early-life exposure to air pollution and household dampness increases childhood asthma risk by altering lung development and immunity, highlighting urgent needs for cleaner air and healthier housing. 
]]></description>
      <pubDate>Wed, 25 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/early-air-pollution-and-home-dampness-may-increase-childhood-asthma-risk-T21MzySi-Pb8GGWu0</link>
      <enclosure length="1269803" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/23c3681e-b5b2-4f11-95b6-9dfefe035827/group-item/9dee88c0-bfcd-425f-9b3d-01aa6d9854d3/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Early Air Pollution and Home Dampness May Increase Childhood Asthma Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:19</itunes:duration>
      <itunes:summary>Early-life exposure to air pollution and household dampness increases childhood asthma risk by altering lung development and immunity, highlighting urgent needs for cleaner air and healthier housing.</itunes:summary>
      <itunes:subtitle>Early-life exposure to air pollution and household dampness increases childhood asthma risk by altering lung development and immunity, highlighting urgent needs for cleaner air and healthier housing.</itunes:subtitle>
      <itunes:keywords>early-life exposure to air pollution and household dampness increases childhood asthma risk by altering lung development and immunity, highlighting urgent needs for cleaner air and healthier housing.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>247</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c6c92d55-8db8-46a0-aebd-e3d2c6edc69b</guid>
      <title>The Street-Based Care Imperative: Psychiatric Support and Clinical Integrity for the Unsheltered</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Wed, 25 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-street-based-care-imperative-psychiatric-support-and-clinical-integrity-for-the-unsheltered-hdzVJjCG-wwCJT6Uh</link>
      <enclosure length="1728304" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/8a1b94a2-3a1f-491c-84a3-f8670e2e08b5/group-item/94f808c6-0e1e-412d-a21e-53ad3909d56c/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Street-Based Care Imperative: Psychiatric Support and Clinical Integrity for the Unsheltered</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>246</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f5984eb5-c257-4fa5-a658-b644dabd124c</guid>
      <title>U.S. Mothers May Struggle With Recovery From Postpartum Depression</title>
      <description><![CDATA[A large study finds U.S. mothers experience persistent postpartum depression without recovery, highlighting systemic failures in paid leave, childcare, and healthcare compared with the UK and Australia. 
]]></description>
      <pubDate>Wed, 25 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/u-s-mothers-may-struggle-with-recovery-from-postpartum-depression-XOZW9SLH</link>
      <enclosure length="1067092" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/65250c40-a9ba-4b0d-b15d-f2b67def6b29/group-item/47fd2e98-20aa-4c21-9751-e922484eca3a/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>U.S. Mothers May Struggle With Recovery From Postpartum Depression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:06</itunes:duration>
      <itunes:summary>A large study finds U.S. mothers experience persistent postpartum depression without recovery, highlighting systemic failures in paid leave, childcare, and healthcare compared with the UK and Australia.</itunes:summary>
      <itunes:subtitle>A large study finds U.S. mothers experience persistent postpartum depression without recovery, highlighting systemic failures in paid leave, childcare, and healthcare compared with the UK and Australia.</itunes:subtitle>
      <itunes:keywords>childcare, highlighting systemic failures in paid leave, a large study finds u.s. mothers experience persistent postpartum depression without recovery, and healthcare compared with the uk and australia.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>245</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1655690d-bba4-4562-9271-b1ec25a6e15f</guid>
      <title>AI Reveals Hidden Communication Among Gut Microbes: The Microbial Code</title>
      <description><![CDATA[Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies. 
]]></description>
      <pubDate>Wed, 25 Feb 2026 14:00:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-reveals-hidden-communication-among-gut-microbes-the-microbial-code-PvIWXbpl</link>
      <enclosure length="1567807" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/62a903a9-0556-46a7-81ba-3f84b2ab56d8/group-item/34790b99-f7f7-4445-bd71-6c7ff9eb51d2/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI Reveals Hidden Communication Among Gut Microbes: The Microbial Code</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:summary>
      <itunes:subtitle>Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:subtitle>
      <itunes:keywords>rotavirus infection triggers sweeping mrna and lncrna transcriptomic shifts in ma104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>244</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">25b022fd-a93f-4b5a-ae6d-785714a3e34d</guid>
      <title>Comprehensive Analysis of Rotavirus-Induced Transcriptomic Alterations</title>
      <description><![CDATA[Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies. 
]]></description>
      <pubDate>Tue, 24 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/comprehensive-analysis-of-rotavirus-induced-transcriptomic-alterations-O5L8GQM4</link>
      <enclosure length="1212124" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2b50fbe9-175b-4330-b19f-64015f43f936/group-item/001cb2af-2f62-4f6e-a499-3e8b869840f8/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Comprehensive Analysis of Rotavirus-Induced Transcriptomic Alterations</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:15</itunes:duration>
      <itunes:summary>Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:summary>
      <itunes:subtitle>Rotavirus infection triggers sweeping mRNA and lncRNA transcriptomic shifts in MA104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:subtitle>
      <itunes:keywords>rotavirus infection triggers sweeping mrna and lncrna transcriptomic shifts in ma104 cells, reshaping immune and metabolic pathways and revealing novel molecular targets for vaccines and antiviral therapies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>243</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0f40ba34-9090-4137-86a3-eab2b4df3ded</guid>
      <title>Long-Term Management of Atopic Dermatitis: The Role of Tralokinumab</title>
      <description><![CDATA[Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy. 
]]></description>
      <pubDate>Tue, 24 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/long-term-management-of-atopic-dermatitis-the-role-of-tralokinumab-EUhrPMuD</link>
      <enclosure length="1429881" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f809a1de-85b6-4973-8d3f-f9b606df11ab/group-item/30ec60f2-801d-4dcd-bdcc-e51d24273bdc/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Long-Term Management of Atopic Dermatitis: The Role of Tralokinumab</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy.</itunes:summary>
      <itunes:subtitle>Six-year ECZTEND data show tralokinumab delivers sustained skin clearance, itch reduction, and consistent safety in atopic dermatitis, supporting long-term IL-13–targeted therapy as a durable management strategy.</itunes:subtitle>
      <itunes:keywords>and consistent safety in atopic dermatitis, six-year ecztend data show tralokinumab delivers sustained skin clearance, itch reduction, supporting long-term il-13–targeted therapy as a durable management strategy.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>242</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c2435657-3405-4488-bb43-2e95234bdee0</guid>
      <title>The Future of Pediatric Oncology: ATR Inhibition and the Evolution of Hepatoblastoma Management</title>
      <description><![CDATA[ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm. 
]]></description>
      <pubDate>Tue, 24 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-future-of-pediatric-oncology-atr-inhibition-and-the-evolution-of-hepatoblastoma-management-_TrlirdO</link>
      <enclosure length="1530609" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f412f715-4b55-4f39-8d29-de2b76e6456b/group-item/4e8791cc-8499-4411-8bd9-3ef344c64029/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Future of Pediatric Oncology: ATR Inhibition and the Evolution of Hepatoblastoma Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:35</itunes:duration>
      <itunes:summary>ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.</itunes:summary>
      <itunes:subtitle>ATR inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.</itunes:subtitle>
      <itunes:keywords>atr inhibitors offer a promising targeted therapy for high-risk hepatoblastoma, exploiting tumor replication stress to improve survival while potentially reducing cisplatin-related toxicity and long-term harm.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>241</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">99125dd6-39ea-447c-a802-f41209fdf7c9</guid>
      <title>Early Air Pollution and Home Dampness May Increase Childhood Asthma Risk</title>
      <description><![CDATA[Early-life exposure to air pollution and home dampness increases childhood asthma risk, underscoring the need for prevention-focused policies, healthier housing, and environmental screening in pediatric care. 
]]></description>
      <pubDate>Tue, 24 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/early-air-pollution-and-home-dampness-may-increase-childhood-asthma-risk-pFlwzdiU</link>
      <enclosure length="2048043" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/75d348e1-d09d-4f5c-95c7-c0419c1a4276/group-item/da72c45b-43c8-4b3e-a2fd-7e84cf580a49/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Early Air Pollution and Home Dampness May Increase Childhood Asthma Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:07</itunes:duration>
      <itunes:summary>Early-life exposure to air pollution and home dampness increases childhood asthma risk, underscoring the need for prevention-focused policies, healthier housing, and environmental screening in pediatric care.</itunes:summary>
      <itunes:subtitle>Early-life exposure to air pollution and home dampness increases childhood asthma risk, underscoring the need for prevention-focused policies, healthier housing, and environmental screening in pediatric care.</itunes:subtitle>
      <itunes:keywords>underscoring the need for prevention-focused policies, and environmental screening in pediatric care., healthier housing, early-life exposure to air pollution and home dampness increases childhood asthma risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>240</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">707fba51-c3da-463f-b414-bf2c44fd7284</guid>
      <title>The Street-Based Care Imperative: Psychiatric Support and Clinical Integrity for the Unsheltered</title>
      <description><![CDATA[Street psychiatry delivers field-based mental healthcare to unsheltered individuals, addressing complex psychiatric and aging needs while reducing emergency dependence through sustainable funding and integrated, dignity-centered care models. 
]]></description>
      <pubDate>Tue, 24 Feb 2026 16:09:14 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-street-based-care-imperative-psychiatric-support-and-clinical-integrity-for-the-unsheltered-cVO0P8dk</link>
      <enclosure length="1875425" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/728aa6e7-ea2f-4dfa-920e-b67f3015c533/group-item/62229bc8-48db-4585-b301-213315b1b769/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Street-Based Care Imperative: Psychiatric Support and Clinical Integrity for the Unsheltered</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Street psychiatry delivers field-based mental healthcare to unsheltered individuals, addressing complex psychiatric and aging needs while reducing emergency dependence through sustainable funding and integrated, dignity-centered care models.</itunes:summary>
      <itunes:subtitle>Street psychiatry delivers field-based mental healthcare to unsheltered individuals, addressing complex psychiatric and aging needs while reducing emergency dependence through sustainable funding and integrated, dignity-centered care models.</itunes:subtitle>
      <itunes:keywords>street psychiatry delivers field-based mental healthcare to unsheltered individuals, addressing complex psychiatric and aging needs while reducing emergency dependence through sustainable funding and integrated, dignity-centered care models.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>239</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f57b01d1-626f-4d59-a1bd-9da69435098a</guid>
      <title>Strategies to Enhance Focus in ADHD Management</title>
      <description><![CDATA[Comprehensive ADHD management blends medication, behavioral therapy, environmental adjustments, digital tools, and system supports to improve focus, functioning, and long-term outcomes across school, work, and home. 
]]></description>
      <pubDate>Mon, 23 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/strategies-to-enhance-focus-in-adhd-management-tY_R4AHi</link>
      <enclosure length="1838645" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/43f5f3cd-d21b-4f03-ac76-980e05a71ab3/group-item/f248b630-92be-4153-9fea-78d440dd28b7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Strategies to Enhance Focus in ADHD Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Comprehensive ADHD management blends medication, behavioral therapy, environmental adjustments, digital tools, and system supports to improve focus, functioning, and long-term outcomes across school, work, and home.</itunes:summary>
      <itunes:subtitle>Comprehensive ADHD management blends medication, behavioral therapy, environmental adjustments, digital tools, and system supports to improve focus, functioning, and long-term outcomes across school, work, and home.</itunes:subtitle>
      <itunes:keywords>comprehensive adhd management blends medication, functioning, environmental adjustments, and long-term outcomes across school, and home., work, and system supports to improve focus, digital tools, behavioral therapy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>238</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">12ea89ac-2fd3-4d66-83e7-4e39be46fd6b</guid>
      <title>Combat Deployment Linked to Onset of Fibromyalgia in PTSD Patients</title>
      <description><![CDATA[Combat-related PTSD significantly increases fibromyalgia risk, highlighting a bidirectional link between psychological trauma and chronic pain, and underscoring the need for integrated, multidisciplinary veteran care. 
]]></description>
      <pubDate>Mon, 23 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/combat-deployment-linked-to-onset-of-fibromyalgia-in-ptsd-patients-APjoiWmZ</link>
      <enclosure length="1304075" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/49664b27-fed8-4828-9f99-1044f5e2b541/group-item/7c614ec2-8aa5-4a6c-bd6c-72506b05ac8d/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Combat Deployment Linked to Onset of Fibromyalgia in PTSD Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Combat-related PTSD significantly increases fibromyalgia risk, highlighting a bidirectional link between psychological trauma and chronic pain, and underscoring the need for integrated, multidisciplinary veteran care.</itunes:summary>
      <itunes:subtitle>Combat-related PTSD significantly increases fibromyalgia risk, highlighting a bidirectional link between psychological trauma and chronic pain, and underscoring the need for integrated, multidisciplinary veteran care.</itunes:subtitle>
      <itunes:keywords>and underscoring the need for integrated, combat-related ptsd significantly increases fibromyalgia risk, highlighting a bidirectional link between psychological trauma and chronic pain, multidisciplinary veteran care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>237</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e89dd6e6-fe86-48ad-baf8-b3371f2d9b9b</guid>
      <title>Safety and Adherence of Biologic Treatment in Elderly Psoriasis Patients</title>
      <description><![CDATA[Real-world data show biologics effectively improve psoriasis in older adults, though infections, malignancy risk, and adherence barriers require vigilant screening, caregiver support, and multidisciplinary care. 
]]></description>
      <pubDate>Mon, 23 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/safety-and-adherence-of-biologic-treatment-in-elderly-psoriasis-patients-q4oPfCsS</link>
      <enclosure length="2073538" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2f61b7cf-e5aa-43cf-85b0-e8e4a570b3d8/group-item/7b63135f-6a5a-41f8-b6c2-3fe445b26dc7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Safety and Adherence of Biologic Treatment in Elderly Psoriasis Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:09</itunes:duration>
      <itunes:summary>Real-world data show biologics effectively improve psoriasis in older adults, though infections, malignancy risk, and adherence barriers require vigilant screening, caregiver support, and multidisciplinary care.</itunes:summary>
      <itunes:subtitle>Real-world data show biologics effectively improve psoriasis in older adults, though infections, malignancy risk, and adherence barriers require vigilant screening, caregiver support, and multidisciplinary care.</itunes:subtitle>
      <itunes:keywords>caregiver support, real-world data show biologics effectively improve psoriasis in older adults, though infections, and multidisciplinary care., and adherence barriers require vigilant screening, malignancy risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>236</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bbe0fb8e-12af-4810-ae8e-5b902e72a5e7</guid>
      <title>New Non-Surgical Contraceptive Implant Administered via Tiny Needles</title>
      <description><![CDATA[A novel non-surgical contraceptive implant uses injectable self-assembling microcrystals to form a long-acting, retrievable depot, expanding access, enabling self-administration, and reducing procedural barriers worldwide. 
]]></description>
      <pubDate>Mon, 23 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-non-surgical-contraceptive-implant-administered-via-tiny-needles-QRSZ15cX</link>
      <enclosure length="1595393" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f2703490-32dc-485a-b551-bc40ad281f06/group-item/041840ce-2749-4f8d-8eb3-7676b39fa1a7/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Non-Surgical Contraceptive Implant Administered via Tiny Needles</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>A novel non-surgical contraceptive implant uses injectable self-assembling microcrystals to form a long-acting, retrievable depot, expanding access, enabling self-administration, and reducing procedural barriers worldwide.</itunes:summary>
      <itunes:subtitle>A novel non-surgical contraceptive implant uses injectable self-assembling microcrystals to form a long-acting, retrievable depot, expanding access, enabling self-administration, and reducing procedural barriers worldwide.</itunes:subtitle>
      <itunes:keywords>enabling self-administration, and reducing procedural barriers worldwide., expanding access, retrievable depot, a novel non-surgical contraceptive implant uses injectable self-assembling microcrystals to form a long-acting</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>235</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">81fe7ecf-9e98-4647-9bfa-86723dbec0cc</guid>
      <title>COVID-19 Vaccines May Not Impact Fertility, Large Study Indicates</title>
      <description><![CDATA[A large Swedish study confirms COVID-19 vaccines do not reduce fertility or childbirth rates, providing evidence to counter misinformation and reassure women, clinicians, and policymakers. 
]]></description>
      <pubDate>Mon, 23 Feb 2026 15:07:45 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/covid-19-vaccines-may-not-impact-fertility-large-study-indicates-ruy_wERE</link>
      <enclosure length="2005411" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6e025e90-0f72-4df1-a47a-c30e959be5e7/group-item/ecba86ce-95fb-47eb-8f23-4191c9269dfb/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>COVID-19 Vaccines May Not Impact Fertility, Large Study Indicates</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:05</itunes:duration>
      <itunes:summary>A large Swedish study confirms COVID-19 vaccines do not reduce fertility or childbirth rates, providing evidence to counter misinformation and reassure women, clinicians, and policymakers.</itunes:summary>
      <itunes:subtitle>A large Swedish study confirms COVID-19 vaccines do not reduce fertility or childbirth rates, providing evidence to counter misinformation and reassure women, clinicians, and policymakers.</itunes:subtitle>
      <itunes:keywords>and policymakers., providing evidence to counter misinformation and reassure women, a large swedish study confirms covid-19 vaccines do not reduce fertility or childbirth rates, clinicians</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>234</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ba50b834-9e91-4692-a5a6-8efec22a6595</guid>
      <title>Evolution of GLP-1 Medications in Clinical Practice</title>
      <description><![CDATA[GLP-1 medications are transforming diabetes and obesity care, offering significant weight loss and cardiometabolic benefits while raising important considerations around safety, long-term use, cost, and equitable access. 
]]></description>
      <pubDate>Fri, 20 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/evolution-of-glp-1-medications-in-clinical-practice-Boh3Y8qr</link>
      <enclosure length="1841989" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/2abbf932-a187-452d-b99b-a1a76d9a952d/group-item/2c4a5e6f-87b6-4940-ae5e-05ed7f1fecbe/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Evolution of GLP-1 Medications in Clinical Practice</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>GLP-1 medications are transforming diabetes and obesity care, offering significant weight loss and cardiometabolic benefits while raising important considerations around safety, long-term use, cost, and equitable access.</itunes:summary>
      <itunes:subtitle>GLP-1 medications are transforming diabetes and obesity care, offering significant weight loss and cardiometabolic benefits while raising important considerations around safety, long-term use, cost, and equitable access.</itunes:subtitle>
      <itunes:keywords>and equitable access., cost, glp-1 medications are transforming diabetes and obesity care, offering significant weight loss and cardiometabolic benefits while raising important considerations around safety, long-term use</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>233</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a88731cf-de89-474e-bc3c-1daa8a8776d1</guid>
      <title>Pulmonary Embolism: Care Gaps Identified Amid Progress</title>
      <description><![CDATA[Women with pulmonary embolism are less likely to receive catheter-based thrombectomy than men, highlighting potential care disparities and the need for standardized, equitable treatment pathways. 
]]></description>
      <pubDate>Fri, 20 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pulmonary-embolism-care-gaps-identified-amid-progress-bj56anTT</link>
      <enclosure length="1500098" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/fa1a1f74-f3f5-4342-970e-fb5d2a76f54d/group-item/44c48f46-28c6-470c-9715-05367fcd5105/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pulmonary Embolism: Care Gaps Identified Amid Progress</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Women with pulmonary embolism are less likely to receive catheter-based thrombectomy than men, highlighting potential care disparities and the need for standardized, equitable treatment pathways.</itunes:summary>
      <itunes:subtitle>Women with pulmonary embolism are less likely to receive catheter-based thrombectomy than men, highlighting potential care disparities and the need for standardized, equitable treatment pathways.</itunes:subtitle>
      <itunes:keywords>women with pulmonary embolism are less likely to receive catheter-based thrombectomy than men, highlighting potential care disparities and the need for standardized, equitable treatment pathways.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>232</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">08251caa-344a-4368-b4d1-f3f4648e0bae</guid>
      <title>Sex Hormones May Influence Heart Disease Risk in Type 2 Diabetes</title>
      <description><![CDATA[Emerging research links sex hormones to cardiovascular risk differences in type 2 diabetes, highlighting opportunities for personalized heart disease prevention beyond traditional risk factors. 
]]></description>
      <pubDate>Fri, 20 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sex-hormones-may-influence-heart-disease-risk-in-type-2-diabetes-xy0Ihzpz</link>
      <enclosure length="1770100" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/9df6886b-7178-4879-b05e-9068008fe080/group-item/6043f766-0609-4e3f-ba13-7cc3c9ecadc1/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sex Hormones May Influence Heart Disease Risk in Type 2 Diabetes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Emerging research links sex hormones to cardiovascular risk differences in type 2 diabetes, highlighting opportunities for personalized heart disease prevention beyond traditional risk factors.</itunes:summary>
      <itunes:subtitle>Emerging research links sex hormones to cardiovascular risk differences in type 2 diabetes, highlighting opportunities for personalized heart disease prevention beyond traditional risk factors.</itunes:subtitle>
      <itunes:keywords>emerging research links sex hormones to cardiovascular risk differences in type 2 diabetes, highlighting opportunities for personalized heart disease prevention beyond traditional risk factors.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>231</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4a96c6b1-be87-4ef6-bef4-0fa34af38801</guid>
      <title>Subcutaneous Opioids May Reduce IV Reliance in Emergencies</title>
      <description><![CDATA[In emergency medicine, the need for effective pain management is critical, especially for patients in acute distress. Traditionally, intravenous (IV) opioids have been the go-to solution for managing severe pain. However, emerging practices are beginning to shift towards subcutaneous administration, which offers a promising alternative that could change how pain relief is approached in emergency settings. 
]]></description>
      <pubDate>Fri, 20 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/subcutaneous-opioids-may-reduce-iv-reliance-in-emergencies-S9f4vbAc</link>
      <enclosure length="1501352" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a9d62914-b173-46e9-a74b-39cd7b1ea8aa/group-item/2dddf12e-4d58-4a30-80e4-b9c3add2747a/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Subcutaneous Opioids May Reduce IV Reliance in Emergencies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>In emergency medicine, the need for effective pain management is critical, especially for patients in acute distress. Traditionally, intravenous (IV) opioids have been the go-to solution for managing severe pain. However, emerging practices are beginning to shift towards subcutaneous administration, which offers a promising alternative that could change how pain relief is approached in emergency settings.</itunes:summary>
      <itunes:subtitle>In emergency medicine, the need for effective pain management is critical, especially for patients in acute distress. Traditionally, intravenous (IV) opioids have been the go-to solution for managing severe pain. However, emerging practices are beginning to shift towards subcutaneous administration, which offers a promising alternative that could change how pain relief is approached in emergency settings.</itunes:subtitle>
      <itunes:keywords>emerging practices are beginning to shift towards subcutaneous administration, which offers a promising alternative that could change how pain relief is approached in emergency settings., in emergency medicine, intravenous (iv) opioids have been the go-to solution for managing severe pain. however, the need for effective pain management is critical, especially for patients in acute distress. traditionally</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>230</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">12e2faef-645d-42eb-b484-530f7af1fdf5</guid>
      <title>Accurate Diagnosis of Psoriasis: Essential Clinical Insights</title>
      <description><![CDATA[Psoriasis, a chronic skin condition that causes red, itchy, and scaly patches, is often misunderstood and misdiagnosed. Recent discussions among healthcare professionals highlight the importance of accurate diagnosis, as effective treatment depends on properly identifying the condition 
]]></description>
      <pubDate>Fri, 20 Feb 2026 13:56:22 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/accurate-diagnosis-of-psoriasis-essential-clinical-insights-ZLcU6Uo_</link>
      <enclosure length="1704898" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/85523294-5223-4434-b91c-667c17ae1ec6/group-item/4b2b50d5-bbc5-472f-b97a-8f72e1108e2b/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Accurate Diagnosis of Psoriasis: Essential Clinical Insights</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Psoriasis, a chronic skin condition that causes red, itchy, and scaly patches, is often misunderstood and misdiagnosed. Recent discussions among healthcare professionals highlight the importance of accurate diagnosis, as effective treatment depends on properly identifying the condition</itunes:summary>
      <itunes:subtitle>Psoriasis, a chronic skin condition that causes red, itchy, and scaly patches, is often misunderstood and misdiagnosed. Recent discussions among healthcare professionals highlight the importance of accurate diagnosis, as effective treatment depends on properly identifying the condition</itunes:subtitle>
      <itunes:keywords>itchy, psoriasis, as effective treatment depends on properly identifying the condition, is often misunderstood and misdiagnosed. recent discussions among healthcare professionals highlight the importance of accurate diagnosis, a chronic skin condition that causes red, and scaly patches</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>229</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ed83a9dd-1010-4227-bfc9-03964d40c510</guid>
      <title>Portable MRI Offers Greater Access for MS Patients, With Some Resolution Considerations</title>
      <description><![CDATA[Portable MRI technology promises faster, more accessible imaging for multiple sclerosis patients, enabling earlier diagnosis, improved monitoring, reduced healthcare costs, and greater convenience outside traditional hospital settings. 
]]></description>
      <pubDate>Thu, 19 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/portable-mri-offers-greater-access-for-ms-patients-with-some-resolution-considerations-4OElDjBW</link>
      <enclosure length="1498008" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/5856e7b8-5018-49e3-8616-8d42b6665479/group-item/54193eb5-d3b7-4696-87ea-bd8806b89656/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Portable MRI Offers Greater Access for MS Patients, With Some Resolution Considerations</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Portable MRI technology promises faster, more accessible imaging for multiple sclerosis patients, enabling earlier diagnosis, improved monitoring, reduced healthcare costs, and greater convenience outside traditional hospital settings.</itunes:summary>
      <itunes:subtitle>Portable MRI technology promises faster, more accessible imaging for multiple sclerosis patients, enabling earlier diagnosis, improved monitoring, reduced healthcare costs, and greater convenience outside traditional hospital settings.</itunes:subtitle>
      <itunes:keywords>reduced healthcare costs, improved monitoring, enabling earlier diagnosis, more accessible imaging for multiple sclerosis patients, and greater convenience outside traditional hospital settings., portable mri technology promises faster</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>228</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cc22c7bd-ed5e-45e1-aae1-36289d94db3a</guid>
      <title>FDA Approves Pembrolizumab for PD-L1-Positive Ovarian Cancer</title>
      <description><![CDATA[FDA approves pembrolizumab combinations for PD-L1–positive, platinum-resistant ovarian cancer, improving progression-free and overall survival, offering new hope for patients with limited treatment options. 
]]></description>
      <pubDate>Thu, 19 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-pembrolizumab-for-pd-l1-positive-ovarian-cancer-6B_jeJUz</link>
      <enclosure length="1788908" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/6bd9af5d-850d-4d8a-9755-1bfe8fc4d9ff/group-item/2ab6bf1f-2c7a-4e7d-89ed-5fb02fcd9030/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves Pembrolizumab for PD-L1-Positive Ovarian Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:51</itunes:duration>
      <itunes:summary>FDA approves pembrolizumab combinations for PD-L1–positive, platinum-resistant ovarian cancer, improving progression-free and overall survival, offering new hope for patients with limited treatment options.</itunes:summary>
      <itunes:subtitle>FDA approves pembrolizumab combinations for PD-L1–positive, platinum-resistant ovarian cancer, improving progression-free and overall survival, offering new hope for patients with limited treatment options.</itunes:subtitle>
      <itunes:keywords>offering new hope for patients with limited treatment options., fda approves pembrolizumab combinations for pd-l1–positive, improving progression-free and overall survival, platinum-resistant ovarian cancer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>227</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4266c5c1-6c3c-4b1d-bc6d-f4084a928b4c</guid>
      <title>Assessing Safety of Advanced Therapies for Crohn’s Disease</title>
      <description><![CDATA[Real-world evidence shows advanced Crohn’s therapies have similar risks for serious infections, VTE, and cardiovascular events, supporting treatment decisions based primarily on effectiveness. 
]]></description>
      <pubDate>Thu, 19 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/assessing-safety-of-advanced-therapies-for-crohns-disease-tdr3IVNm</link>
      <enclosure length="1855363" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/f15cf13a-3a2c-42c0-93ac-3d4acb4def03/group-item/48610977-ae38-4543-a3bd-a08c4dc840b5/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Assessing Safety of Advanced Therapies for Crohn’s Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>Real-world evidence shows advanced Crohn’s therapies have similar risks for serious infections, VTE, and cardiovascular events, supporting treatment decisions based primarily on effectiveness.</itunes:summary>
      <itunes:subtitle>Real-world evidence shows advanced Crohn’s therapies have similar risks for serious infections, VTE, and cardiovascular events, supporting treatment decisions based primarily on effectiveness.</itunes:subtitle>
      <itunes:keywords>real-world evidence shows advanced crohn’s therapies have similar risks for serious infections, vte, and cardiovascular events, supporting treatment decisions based primarily on effectiveness.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>226</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">418f308c-7ffa-4450-8d7b-e094b7bd1acb</guid>
      <title>Emotional Discomfort Linked to Poor Stroke Recovery Outcomes</title>
      <description><![CDATA[Research shows stroke survivors who suppress emotions face poorer physical and cognitive recovery, highlighting need for routine mental health screening, open communication, and integrated emotional support. 
]]></description>
      <pubDate>Thu, 19 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/emotional-discomfort-linked-to-poor-stroke-recovery-outcomes-4UQWiig4</link>
      <enclosure length="2026727" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/b2ea8d14-9d70-4c81-9f1f-cfe09d7c4ad6/group-item/0417ac4b-9bbc-45fc-9cd2-0a4faed4563e/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Emotional Discomfort Linked to Poor Stroke Recovery Outcomes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Research shows stroke survivors who suppress emotions face poorer physical and cognitive recovery, highlighting need for routine mental health screening, open communication, and integrated emotional support.</itunes:summary>
      <itunes:subtitle>Research shows stroke survivors who suppress emotions face poorer physical and cognitive recovery, highlighting need for routine mental health screening, open communication, and integrated emotional support.</itunes:subtitle>
      <itunes:keywords>and integrated emotional support., research shows stroke survivors who suppress emotions face poorer physical and cognitive recovery, open communication, highlighting need for routine mental health screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>225</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">230958bd-de5c-49e5-bd8a-76cd5c7cc051</guid>
      <title>AASM Releases First Guideline for Inpatient OSA Management</title>
      <description><![CDATA[The American Academy of Sleep Medicine released first inpatient obstructive sleep apnea guidelines, promoting hospital screening, continued PAP therapy, specialist consultation, and structured discharge planning. 
]]></description>
      <pubDate>Thu, 19 Feb 2026 14:59:22 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/aasm-releases-first-guideline-for-inpatient-osa-management-vMsgdeAM</link>
      <enclosure length="1391011" type="audio/mpeg" url="https://cdn.simplecast.com/media/audio/transcoded/5e2c7dbd-4e72-4e52-a363-3f8c7ae5b4b2/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/audio/group/a2e967a2-8957-4946-a401-4ad9183d5f1c/group-item/8da41e36-4c2b-48f0-a231-908a4d738580/128_default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AASM Releases First Guideline for Inpatient OSA Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>The American Academy of Sleep Medicine released first inpatient obstructive sleep apnea guidelines, promoting hospital screening, continued PAP therapy, specialist consultation, and structured discharge planning.</itunes:summary>
      <itunes:subtitle>The American Academy of Sleep Medicine released first inpatient obstructive sleep apnea guidelines, promoting hospital screening, continued PAP therapy, specialist consultation, and structured discharge planning.</itunes:subtitle>
      <itunes:keywords>promoting hospital screening, specialist consultation, the american academy of sleep medicine released first inpatient obstructive sleep apnea guidelines, and structured discharge planning., continued pap therapy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>224</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">65796792-b703-41e6-8a04-0ebf1c279d1f</guid>
      <title>Financial Incentives Linked to Improved Glycemic Control in Type 2 Diabetes</title>
      <description><![CDATA[Financial incentives, including medication discounts, may improve adherence and outcomes for low-income adults with poorly controlled type 2 diabetes, reducing complications and healthcare costs. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/financial-incentives-linked-to-improved-glycemic-control-in-type-2-diabetes-_vvHcGK5</link>
      <enclosure length="1382652" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c4c6d536-f4c4-4a8b-9c44-495cf4e97203/audio/1ebee17b-0a4d-49a3-a64c-d774b9b0da0c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Financial Incentives Linked to Improved Glycemic Control in Type 2 Diabetes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>Financial incentives, including medication discounts, may improve adherence and outcomes for low-income adults with poorly controlled type 2 diabetes, reducing complications and healthcare costs.</itunes:summary>
      <itunes:subtitle>Financial incentives, including medication discounts, may improve adherence and outcomes for low-income adults with poorly controlled type 2 diabetes, reducing complications and healthcare costs.</itunes:subtitle>
      <itunes:keywords>may improve adherence and outcomes for low-income adults with poorly controlled type 2 diabetes, including medication discounts, financial incentives, reducing complications and healthcare costs.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>223</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1590b5ba-2f50-490f-b117-b3bb1fea9187</guid>
      <title>Certain Antiplatelet Medications May Be Associated With Worse Outcomes in Intracranial Hemorrhage</title>
      <description><![CDATA[New research suggests certain antiplatelet medications may worsen outcomes after brain bleeds, prompting clinicians to reassess prescribing decisions and emergency management strategies. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/certain-antiplatelet-medications-may-be-associated-with-worse-outcomes-in-intracranial-hemorrhage-xpE_Xlzm</link>
      <enclosure length="1483798" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/15e5cb14-ac86-4e29-9fd9-e7eab2ed76a0/audio/edd344b4-53a6-45df-b060-c2fad2297a9d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Certain Antiplatelet Medications May Be Associated With Worse Outcomes in Intracranial Hemorrhage</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>New research suggests certain antiplatelet medications may worsen outcomes after brain bleeds, prompting clinicians to reassess prescribing decisions and emergency management strategies.</itunes:summary>
      <itunes:subtitle>New research suggests certain antiplatelet medications may worsen outcomes after brain bleeds, prompting clinicians to reassess prescribing decisions and emergency management strategies.</itunes:subtitle>
      <itunes:keywords>prompting clinicians to reassess prescribing decisions and emergency management strategies., new research suggests certain antiplatelet medications may worsen outcomes after brain bleeds</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>222</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b7be3479-ca6d-4678-acf3-d25810cf6c89</guid>
      <title>Surgical and Personalized Treatment Strategies for Mitral Regurgitation in Octogenarians</title>
      <description><![CDATA[Rising numbers of elderly Americans with mitral regurgitation are driving personalized treatment strategies, balancing surgery and minimally invasive options to improve outcomes and quality of life. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/surgical-and-personalized-treatment-strategies-for-mitral-regurgitation-in-octogenarians-U7mU22Tn</link>
      <enclosure length="1389757" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0f3b5c60-8715-466a-b94c-5e1d013ddc20/audio/c2e6c505-a1ca-4a5e-b86e-413392649ced/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Surgical and Personalized Treatment Strategies for Mitral Regurgitation in Octogenarians</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>Rising numbers of elderly Americans with mitral regurgitation are driving personalized treatment strategies, balancing surgery and minimally invasive options to improve outcomes and quality of life.</itunes:summary>
      <itunes:subtitle>Rising numbers of elderly Americans with mitral regurgitation are driving personalized treatment strategies, balancing surgery and minimally invasive options to improve outcomes and quality of life.</itunes:subtitle>
      <itunes:keywords>balancing surgery and minimally invasive options to improve outcomes and quality of life., rising numbers of elderly americans with mitral regurgitation are driving personalized treatment strategies</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>221</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a14b3178-9f9d-4d9b-9dbf-823365de1b5a</guid>
      <title>Distinct Molecular Subtypes in Alzheimer’s Disease Inform Personalized Treatment Strategies</title>
      <description><![CDATA[New Alzheimer’s research identifies molecularly distinct patient subgroups, paving the way for personalized treatments tailored to biological profiles, lifestyles, and individual care needs. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/distinct-molecular-subtypes-in-alzheimers-disease-inform-personalized-treatment-strategies-SP0WI8Tv</link>
      <enclosure length="1389757" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1cf02e2f-f52b-44b9-a960-9409a60939b1/audio/20ed750b-c5d3-4626-8527-59e614d92c64/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Distinct Molecular Subtypes in Alzheimer’s Disease Inform Personalized Treatment Strategies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>New Alzheimer’s research identifies molecularly distinct patient subgroups, paving the way for personalized treatments tailored to biological profiles, lifestyles, and individual care needs.</itunes:summary>
      <itunes:subtitle>New Alzheimer’s research identifies molecularly distinct patient subgroups, paving the way for personalized treatments tailored to biological profiles, lifestyles, and individual care needs.</itunes:subtitle>
      <itunes:keywords>new alzheimer’s research identifies molecularly distinct patient subgroups, lifestyles, paving the way for personalized treatments tailored to biological profiles, and individual care needs.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>220</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">54dfc092-d1a8-4aa1-bbcd-f8d7f4fad805</guid>
      <title>Steatotic Liver Disease: Using Biological Aging Metrics to Enhance Risk Stratification</title>
      <description><![CDATA[Biological aging metrics may transform steatotic liver disease care, enabling better risk assessment, earlier interventions, and more personalized treatment strategies beyond chronological age alone. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/steatotic-liver-disease-using-biological-aging-metrics-to-enhance-risk-stratification-iNgWaLKj</link>
      <enclosure length="1619216" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d7ef7c59-f678-4b56-b7ab-2986c3e0af24/audio/5b434113-cf13-42bf-832a-d623a517b604/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Steatotic Liver Disease: Using Biological Aging Metrics to Enhance Risk Stratification</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Biological aging metrics may transform steatotic liver disease care, enabling better risk assessment, earlier interventions, and more personalized treatment strategies beyond chronological age alone.</itunes:summary>
      <itunes:subtitle>Biological aging metrics may transform steatotic liver disease care, enabling better risk assessment, earlier interventions, and more personalized treatment strategies beyond chronological age alone.</itunes:subtitle>
      <itunes:keywords>enabling better risk assessment, and more personalized treatment strategies beyond chronological age alone., earlier interventions, biological aging metrics may transform steatotic liver disease care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>219</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">92ae5781-8b1a-4197-b2fa-ecb237fd0d2a</guid>
      <title>Hormone Therapy After 65: Weighing Benefits Against Cancer and Heart Risks</title>
      <description><![CDATA[New insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, prompting personalized discussions about timing, benefits, and safer menopause management. 
]]></description>
      <pubDate>Wed, 18 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hormone-therapy-after-65-weighing-benefits-against-cancer-and-heart-risks-k5zuuCA3</link>
      <enclosure length="1584526" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/773681c0-614a-46db-b8ac-e97f46cb4706/audio/0d2c6a3d-d74a-4431-94e8-f1490abade4b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Hormone Therapy After 65: Weighing Benefits Against Cancer and Heart Risks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>New insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, prompting personalized discussions about timing, benefits, and safer menopause management.</itunes:summary>
      <itunes:subtitle>New insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, prompting personalized discussions about timing, benefits, and safer menopause management.</itunes:subtitle>
      <itunes:keywords>prompting personalized discussions about timing, new insights suggest starting hormone therapy after age 65 may raise cancer and heart risks, and safer menopause management., benefits</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>218</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f47f0391-fc91-445d-b494-6223b1a0f09c</guid>
      <title>Do Sleep Trackers Enhance Rest or Increase Sleep Anxiety?</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Tue, 17 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/do-sleep-trackers-enhance-rest-or-increase-sleep-anxiety-faxDvrQg</link>
      <enclosure length="875249" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/fe68aaba-e3da-41bc-bfa0-c37eeafac54e/audio/6cb354c3-c3d1-44b2-abf0-c23f96dc64dc/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Do Sleep Trackers Enhance Rest or Increase Sleep Anxiety?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:54</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>217</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6e275655-21c0-4d0e-a80e-cad9a282aade</guid>
      <title>Plant-Based Diet Linked to Lower Risk of Chronic Kidney Disease</title>
      <description><![CDATA[A recent study suggests the plant-based EAT-Lancet diet may lower chronic kidney disease risk, linking healthier eating patterns with improved kidney outcomes and environmental sustainability benefits. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/plant-based-diet-linked-to-lower-risk-of-chronic-kidney-disease-zKdT1Vv6</link>
      <enclosure length="1601244" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5b347e74-0a4a-4524-8eca-c4fbabaea2c6/audio/2ad97aa1-4077-4285-950c-27ccb540e796/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Plant-Based Diet Linked to Lower Risk of Chronic Kidney Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>A recent study suggests the plant-based EAT-Lancet diet may lower chronic kidney disease risk, linking healthier eating patterns with improved kidney outcomes and environmental sustainability benefits.</itunes:summary>
      <itunes:subtitle>A recent study suggests the plant-based EAT-Lancet diet may lower chronic kidney disease risk, linking healthier eating patterns with improved kidney outcomes and environmental sustainability benefits.</itunes:subtitle>
      <itunes:keywords>a recent study suggests the plant-based eat-lancet diet may lower chronic kidney disease risk, linking healthier eating patterns with improved kidney outcomes and environmental sustainability benefits.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>216</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">68f2a3ea-b189-4d8a-b21a-a6e0071dc38d</guid>
      <title>Understanding the Impact of Clear Communication in Healthcare</title>
      <description><![CDATA[Growing emphasis on clear researcher-public communication underscores need for accessible health information, building trust, countering misinformation, and empowering patients to make informed treatment decisions. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-the-impact-of-clear-communication-in-healthcare-3N32vGgs</link>
      <enclosure length="1228425" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1d259f1e-3d8a-419b-95cc-1243e0ea649a/audio/2b389a13-27d2-45ed-9526-b8700b02142c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding the Impact of Clear Communication in Healthcare</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:16</itunes:duration>
      <itunes:summary>Growing emphasis on clear researcher-public communication underscores need for accessible health information, building trust, countering misinformation, and empowering patients to make informed treatment decisions.</itunes:summary>
      <itunes:subtitle>Growing emphasis on clear researcher-public communication underscores need for accessible health information, building trust, countering misinformation, and empowering patients to make informed treatment decisions.</itunes:subtitle>
      <itunes:keywords>growing emphasis on clear researcher-public communication underscores need for accessible health information, countering misinformation, and empowering patients to make informed treatment decisions., building trust</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>215</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">04d0cfb0-8b8b-4c16-872a-67a496ca569e</guid>
      <title>New Research Targets Antibiotic-Resistant Bacteria and Strengthens Immune Defense</title>
      <description><![CDATA[Rising antibiotic resistance in Streptococcus pneumoniae highlights urgent need to understand its protective capsule, guiding innovative vaccines, improved treatments, and strategies to preserve antibiotic effectiveness. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-research-targets-antibiotic-resistant-bacteria-and-strengthens-immune-defense-qecf3tNW</link>
      <enclosure length="1467497" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d9166f13-1ddc-4f98-b17d-454c984c2365/audio/a66d8524-d3c4-4a8e-a0d5-d4d30822c3b5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Research Targets Antibiotic-Resistant Bacteria and Strengthens Immune Defense</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Rising antibiotic resistance in Streptococcus pneumoniae highlights urgent need to understand its protective capsule, guiding innovative vaccines, improved treatments, and strategies to preserve antibiotic effectiveness.</itunes:summary>
      <itunes:subtitle>Rising antibiotic resistance in Streptococcus pneumoniae highlights urgent need to understand its protective capsule, guiding innovative vaccines, improved treatments, and strategies to preserve antibiotic effectiveness.</itunes:subtitle>
      <itunes:keywords>rising antibiotic resistance in streptococcus pneumoniae highlights urgent need to understand its protective capsule, improved treatments, guiding innovative vaccines, and strategies to preserve antibiotic effectiveness.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>214</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8fb90ed8-98de-43f3-a567-5ce7917eb38b</guid>
      <title>Genes and Proteins Influence Tissue-Specific Mechanisms in Type 2 Diabetes</title>
      <description><![CDATA[New research reveals Type 2 diabetes involves genetic activity across multiple tissues, advancing understanding of disease mechanisms and supporting more personalized, inclusive prevention and treatment strategies. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/genes-and-proteins-influence-tissue-specific-mechanisms-in-type-2-diabetes-u94mniPG</link>
      <enclosure length="1892144" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/12b63675-91ba-4f6c-bd90-8d98a056ec98/audio/35a6021b-e3cf-41a6-bf3f-0da24b277639/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Genes and Proteins Influence Tissue-Specific Mechanisms in Type 2 Diabetes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>New research reveals Type 2 diabetes involves genetic activity across multiple tissues, advancing understanding of disease mechanisms and supporting more personalized, inclusive prevention and treatment strategies.</itunes:summary>
      <itunes:subtitle>New research reveals Type 2 diabetes involves genetic activity across multiple tissues, advancing understanding of disease mechanisms and supporting more personalized, inclusive prevention and treatment strategies.</itunes:subtitle>
      <itunes:keywords>new research reveals type 2 diabetes involves genetic activity across multiple tissues, inclusive prevention and treatment strategies., advancing understanding of disease mechanisms and supporting more personalized</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>213</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">04b8439e-9829-4012-a908-8a98434b07a8</guid>
      <title>Mobile-Enabled Community Care Enhances Management of Uncontrolled Hypertension</title>
      <description><![CDATA[Community health workers are improving hypertension management in remote areas, expanding access to care and offering sustainable solutions to reduce heart attack and stroke risks. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mobile-enabled-community-care-enhances-management-of-uncontrolled-hypertension-FpaxdBW3</link>
      <enclosure length="1618798" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e4929257-0647-4c29-a922-82c8b57559ec/audio/e5c72a83-af4b-413c-9cee-cd1b4d26769a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mobile-Enabled Community Care Enhances Management of Uncontrolled Hypertension</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Community health workers are improving hypertension management in remote areas, expanding access to care and offering sustainable solutions to reduce heart attack and stroke risks.</itunes:summary>
      <itunes:subtitle>Community health workers are improving hypertension management in remote areas, expanding access to care and offering sustainable solutions to reduce heart attack and stroke risks.</itunes:subtitle>
      <itunes:keywords>expanding access to care and offering sustainable solutions to reduce heart attack and stroke risks., community health workers are improving hypertension management in remote areas</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>212</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e571b7b0-1ac6-4af0-ae19-5ccb11fdd1b7</guid>
      <title>Geographic Inequalities in Interventional Oncology: A Current Concern</title>
      <description><![CDATA[Geographic inequalities in interventional oncology limit access to non-surgical cancer treatments, underscoring the need for targeted funding, improved referrals, and equitable expansion of services. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/geographic-inequalities-in-interventional-oncology-a-current-concern-by00jwsc-uh9815lb</link>
      <enclosure length="1653907" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/ced37963-edb6-4ab7-be45-663c9e9a33d6/audio/65a62e69-5faf-4827-ba41-2103ce9b35f0/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Geographic Inequalities in Interventional Oncology: A Current Concern</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Geographic inequalities in interventional oncology limit access to non-surgical cancer treatments, underscoring the need for targeted funding, improved referrals, and equitable expansion of services.</itunes:summary>
      <itunes:subtitle>Geographic inequalities in interventional oncology limit access to non-surgical cancer treatments, underscoring the need for targeted funding, improved referrals, and equitable expansion of services.</itunes:subtitle>
      <itunes:keywords>improved referrals, geographic inequalities in interventional oncology limit access to non-surgical cancer treatments, and equitable expansion of services., underscoring the need for targeted funding</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>210</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4e6fb91d-3105-488e-b3d4-401134e45cfc</guid>
      <title>Daily Step Count Linked to Depressive Symptoms in Major Depressive Disorder</title>
      <description><![CDATA[Emerging research links smartphone-tracked physical activity with improved depression management, offering clinicians new data-driven tools to personalize care and support mental health treatment strategies. 
]]></description>
      <pubDate>Tue, 17 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/daily-step-count-linked-to-depressive-symptoms-in-major-depressive-disorder-NHRmMM8T</link>
      <enclosure length="1151102" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b1251e13-6982-41cb-a367-626ad64ed45c/audio/febb325b-b796-434a-afa9-92714aace6c2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Daily Step Count Linked to Depressive Symptoms in Major Depressive Disorder</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:11</itunes:duration>
      <itunes:summary>Emerging research links smartphone-tracked physical activity with improved depression management, offering clinicians new data-driven tools to personalize care and support mental health treatment strategies.</itunes:summary>
      <itunes:subtitle>Emerging research links smartphone-tracked physical activity with improved depression management, offering clinicians new data-driven tools to personalize care and support mental health treatment strategies.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>211</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b18018a6-7a49-4431-9432-cc55916b3cd0</guid>
      <title>Your Next Primary Care Visit May Be Through an AI Tool</title>
      <description><![CDATA[A growing U.S. primary care physician shortage leaves patients facing long waits, prompting expanded telehealth and AI solutions to maintain access and continuity of care. 
]]></description>
      <pubDate>Mon, 16 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/your-next-primary-care-visit-may-be-through-an-ai-tool-e_Jsj7bH</link>
      <enclosure length="1665192" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/256f7621-6175-43e8-8f39-86b0ebb9e443/audio/779c43d5-c6b8-40f4-819f-ca81baaf8fdf/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Your Next Primary Care Visit May Be Through an AI Tool</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>A growing U.S. primary care physician shortage leaves patients facing long waits, prompting expanded telehealth and AI solutions to maintain access and continuity of care.</itunes:summary>
      <itunes:subtitle>A growing U.S. primary care physician shortage leaves patients facing long waits, prompting expanded telehealth and AI solutions to maintain access and continuity of care.</itunes:subtitle>
      <itunes:keywords>a growing u.s. primary care physician shortage leaves patients facing long waits, prompting expanded telehealth and ai solutions to maintain access and continuity of care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>209</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b151a40d-81b9-44ff-9c8a-fd9278fd6ce1</guid>
      <title>Omega-3 Fish Oil Supplements May Backfire Without Key Enzyme</title>
      <description><![CDATA[New research suggests omega-3 supplements’ role in colorectal cancer prevention may depend on ALOX15 enzyme levels, highlighting the growing importance of personalized, genetics-informed nutrition guidance. 
]]></description>
      <pubDate>Mon, 16 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/omega-3-fish-oil-supplements-may-backfire-without-key-enzyme-LVlAMqCQ</link>
      <enclosure length="1509711" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/088f5491-8efa-4b5e-91c9-b7bac243bba0/audio/29505948-7067-4cc4-8f9e-910bd410a51e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Omega-3 Fish Oil Supplements May Backfire Without Key Enzyme</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>New research suggests omega-3 supplements’ role in colorectal cancer prevention may depend on ALOX15 enzyme levels, highlighting the growing importance of personalized, genetics-informed nutrition guidance.</itunes:summary>
      <itunes:subtitle>New research suggests omega-3 supplements’ role in colorectal cancer prevention may depend on ALOX15 enzyme levels, highlighting the growing importance of personalized, genetics-informed nutrition guidance.</itunes:subtitle>
      <itunes:keywords>genetics-informed nutrition guidance., new research suggests omega-3 supplements’ role in colorectal cancer prevention may depend on alox15 enzyme levels, highlighting the growing importance of personalized</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>208</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">467652cc-76cf-4808-9046-2b7d2808e665</guid>
      <title>Personalized Approaches for Managing Epiretinal Membranes</title>
      <description><![CDATA[Advances in retinal imaging are transforming epiretinal membrane surgery decisions, shifting focus beyond visual acuity to patient symptoms and anatomical detail for more personalized care. 
]]></description>
      <pubDate>Mon, 16 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/personalized-approaches-for-managing-epiretinal-membranes-UOq_hHva</link>
      <enclosure length="1629247" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/4c0694a7-ea05-4cd1-bfd9-c852d18fc250/audio/39cedc03-f027-4ead-94fa-d921a1b57a18/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Personalized Approaches for Managing Epiretinal Membranes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Advances in retinal imaging are transforming epiretinal membrane surgery decisions, shifting focus beyond visual acuity to patient symptoms and anatomical detail for more personalized care.</itunes:summary>
      <itunes:subtitle>Advances in retinal imaging are transforming epiretinal membrane surgery decisions, shifting focus beyond visual acuity to patient symptoms and anatomical detail for more personalized care.</itunes:subtitle>
      <itunes:keywords>shifting focus beyond visual acuity to patient symptoms and anatomical detail for more personalized care., advances in retinal imaging are transforming epiretinal membrane surgery decisions</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>207</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ed457781-9bbb-4286-bc74-ca5e9d2cc22e</guid>
      <title>Hypoxia Drives Skeletal Muscle’s Anti-Cancer Effects in Co-Culture</title>
      <description><![CDATA[New research reveals skeletal muscle resists cancer metastasis, offering insights into protective mechanisms that could inspire innovative treatments and improve outcomes for patients with advanced cancers. 
]]></description>
      <pubDate>Mon, 16 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hypoxia-drives-skeletal-muscles-anti-cancer-effects-in-co-culture-H9H5gHHY</link>
      <enclosure length="1200003" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/71d23eb0-b006-4394-91b3-285fafbd0ba7/audio/c9014cbf-4802-4c52-9262-1a5aea1a02f7/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Hypoxia Drives Skeletal Muscle’s Anti-Cancer Effects in Co-Culture</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>New research reveals skeletal muscle resists cancer metastasis, offering insights into protective mechanisms that could inspire innovative treatments and improve outcomes for patients with advanced cancers.</itunes:summary>
      <itunes:subtitle>New research reveals skeletal muscle resists cancer metastasis, offering insights into protective mechanisms that could inspire innovative treatments and improve outcomes for patients with advanced cancers.</itunes:subtitle>
      <itunes:keywords>new research reveals skeletal muscle resists cancer metastasis, offering insights into protective mechanisms that could inspire innovative treatments and improve outcomes for patients with advanced cancers.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>206</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">45ed51d0-ca30-4caf-8d1d-7d4f564a028d</guid>
      <title>Dermoscopic Features of Pigmented Bowen Disease (pBD) in Darker Skin (Type IV): Clinical Insights</title>
      <description><![CDATA[Pigmented Bowen disease can appear differently on darker skin, highlighting the need for improved clinician awareness, tailored training, and earlier diagnosis to enhance equitable skin cancer care. 
]]></description>
      <pubDate>Thu, 12 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/dermoscopic-features-of-pigmented-bowen-disease-pbd-in-darker-skin-type-iv-clinical-insights-dhtKrs1B</link>
      <enclosure length="1068346" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c4785348-4feb-4e22-b82b-d0c69205294b/audio/c053133b-be4a-4b01-91b5-cd740f3a362c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Dermoscopic Features of Pigmented Bowen Disease (pBD) in Darker Skin (Type IV): Clinical Insights</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:06</itunes:duration>
      <itunes:summary>Pigmented Bowen disease can appear differently on darker skin, highlighting the need for improved clinician awareness, tailored training, and earlier diagnosis to enhance equitable skin cancer care.</itunes:summary>
      <itunes:subtitle>Pigmented Bowen disease can appear differently on darker skin, highlighting the need for improved clinician awareness, tailored training, and earlier diagnosis to enhance equitable skin cancer care.</itunes:subtitle>
      <itunes:keywords>highlighting the need for improved clinician awareness, tailored training, and earlier diagnosis to enhance equitable skin cancer care., pigmented bowen disease can appear differently on darker skin</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>204</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a94b66dc-e551-4ce2-a834-e96b6acd6a64</guid>
      <title>Nationwide Chia Seed Recall Over Potential Salmonella Contamination</title>
      <description><![CDATA[A nationwide recall of organic chia seeds over salmonella concerns underscores ongoing food safety vigilance, urging consumers to check products and follow public health guidance. 
]]></description>
      <pubDate>Thu, 12 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/nationwide-chia-seed-recall-over-potential-salmonella-contamination-iNUH45IW</link>
      <enclosure length="1396026" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/23fbc392-7f27-4c01-990b-95f3b7df79d2/audio/3d419dae-53d1-4a2a-84a1-5fb63e335bd2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Nationwide Chia Seed Recall Over Potential Salmonella Contamination</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:27</itunes:duration>
      <itunes:summary>A nationwide recall of organic chia seeds over salmonella concerns underscores ongoing food safety vigilance, urging consumers to check products and follow public health guidance.</itunes:summary>
      <itunes:subtitle>A nationwide recall of organic chia seeds over salmonella concerns underscores ongoing food safety vigilance, urging consumers to check products and follow public health guidance.</itunes:subtitle>
      <itunes:keywords>a nationwide recall of organic chia seeds over salmonella concerns underscores ongoing food safety vigilance, urging consumers to check products and follow public health guidance.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>203</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c6ab6399-987f-468f-a075-12b16f6b9a0e</guid>
      <title>Exploring the Link Between Nature Exposure and Reduced Self-Reported Pain: Evidence for Holistic Health</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Thu, 12 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/exploring-the-link-between-nature-exposure-and-reduced-self-reported-pain-evidence-for-holistic-health-JvP5YvCj</link>
      <enclosure length="1641368" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1ed05dcc-e0ed-408e-9bd8-fcbb803e2e6a/audio/30d8bdd0-7d83-4461-aef0-687b795db13d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Exploring the Link Between Nature Exposure and Reduced Self-Reported Pain: Evidence for Holistic Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>202</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3ed118ca-6e0c-45d0-bf9e-e8d821ed1d13</guid>
      <title>Impact of Psychological Interventions on Schizophrenia and Substance Use</title>
      <description><![CDATA[Substance use disorder commonly co-occurs with schizophrenia, demanding integrated treatment approaches that address both conditions simultaneously to improve outcomes and reduce healthcare burdens. 
]]></description>
      <pubDate>Thu, 12 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-psychological-interventions-on-schizophrenia-and-substance-use-ZrQ4wZNt</link>
      <enclosure length="1488813" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/14332de3-8a60-4536-b1af-166e23d876e9/audio/1d8dac49-a108-45fb-b367-d5f76b51b2e6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Psychological Interventions on Schizophrenia and Substance Use</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Substance use disorder commonly co-occurs with schizophrenia, demanding integrated treatment approaches that address both conditions simultaneously to improve outcomes and reduce healthcare burdens.</itunes:summary>
      <itunes:subtitle>Substance use disorder commonly co-occurs with schizophrenia, demanding integrated treatment approaches that address both conditions simultaneously to improve outcomes and reduce healthcare burdens.</itunes:subtitle>
      <itunes:keywords>substance use disorder commonly co-occurs with schizophrenia, demanding integrated treatment approaches that address both conditions simultaneously to improve outcomes and reduce healthcare burdens.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>201</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">48aa0355-9f6c-4f47-b0f9-d18132a64184</guid>
      <title>KDM5B and CRL4B Complexes May Promote Tumor Progression in ER+ Breast Cancer</title>
      <description><![CDATA[Research links cholesterol metabolism to estrogen receptor–positive breast cancer progression, suggesting metabolic health and cholesterol management may shape personalized treatments and prevention strategies for women. 
]]></description>
      <pubDate>Thu, 12 Feb 2026 14:15:24 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/kdm5b-and-crl4b-complexes-may-promote-tumor-progression-in-er-breast-cancer-AFNpdG7T</link>
      <enclosure length="1782638" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/dbbda2e4-547e-4c0c-9700-1e4180b42eae/audio/92939862-7cb2-4b97-a0e0-90001176cb7f/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>KDM5B and CRL4B Complexes May Promote Tumor Progression in ER+ Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:51</itunes:duration>
      <itunes:summary>Research links cholesterol metabolism to estrogen receptor–positive breast cancer progression, suggesting metabolic health and cholesterol management may shape personalized treatments and prevention strategies for women.</itunes:summary>
      <itunes:subtitle>Research links cholesterol metabolism to estrogen receptor–positive breast cancer progression, suggesting metabolic health and cholesterol management may shape personalized treatments and prevention strategies for women.</itunes:subtitle>
      <itunes:keywords>research links cholesterol metabolism to estrogen receptor–positive breast cancer progression, suggesting metabolic health and cholesterol management may shape personalized treatments and prevention strategies for women.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>200</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d4be934f-b2d6-4223-8517-f34ed73e69cb</guid>
      <title>Ultra-High-Dose Methylcobalamin: Safety in ALS Patients</title>
      <description><![CDATA[Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ultra-high-dose-methylcobalamin-safety-in-als-patients-0hggjjpa-nI7lqxXS</link>
      <enclosure length="1116412" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/6570c58d-c330-4351-9bcb-3e23b260b88c/audio/0a76f098-e169-47bc-b3bf-f341df26c4eb/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ultra-High-Dose Methylcobalamin: Safety in ALS Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:09</itunes:duration>
      <itunes:summary>Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families.</itunes:summary>
      <itunes:subtitle>Ultra-high dose methylcobalamin is being studied as a potential ALS therapy, offering hope for slowing disease progression and expanding treatment options for patients and families.</itunes:subtitle>
      <itunes:keywords>offering hope for slowing disease progression and expanding treatment options for patients and families., ultra-high dose methylcobalamin is being studied as a potential als therapy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>199</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e7a3e886-0d0a-4492-bcee-d44ac9ab541f</guid>
      <title>Bacteria’s Ancient Viral Defenses Could Unlock New Infection-Fighting Strategies</title>
      <description><![CDATA[Ancient bacterial defenses against viruses could inspire innovative antivirals, offering targeted treatments amid antibiotic resistance and advancing healthcare, public health preparedness, and food safety strategies. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bacterias-ancient-viral-defenses-could-unlock-new-infection-fighting-strategies-uvtv68qt-BRQSnr0i</link>
      <enclosure length="1287775" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5c14fda4-c030-43b6-a46b-1168406fe74a/audio/ec5facb2-592f-4abc-81e6-81aaf9a7acf5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bacteria’s Ancient Viral Defenses Could Unlock New Infection-Fighting Strategies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:20</itunes:duration>
      <itunes:summary>Ancient bacterial defenses against viruses could inspire innovative antivirals, offering targeted treatments amid antibiotic resistance and advancing healthcare, public health preparedness, and food safety strategies.</itunes:summary>
      <itunes:subtitle>Ancient bacterial defenses against viruses could inspire innovative antivirals, offering targeted treatments amid antibiotic resistance and advancing healthcare, public health preparedness, and food safety strategies.</itunes:subtitle>
      <itunes:keywords>offering targeted treatments amid antibiotic resistance and advancing healthcare, and food safety strategies., public health preparedness, ancient bacterial defenses against viruses could inspire innovative antivirals</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>198</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">707746a9-95c2-4d95-8702-ca3395a8836d</guid>
      <title>The Social and Psychological Impact of Male Factor Infertility</title>
      <description><![CDATA[Male infertility affects emotional wellbeing and relationships, underscoring the need to reduce stigma, encourage open dialogue, and provide inclusive, couple-centered fertility care and support. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-social-and-psychological-impact-of-male-factor-infertility-gf8cxpig-6Ig2rvyt</link>
      <enclosure length="1127278" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/75217b26-56c6-4fd5-ba02-76c2cf74d976/audio/0c5500ce-955d-40b7-81f7-7025e07e53f5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Social and Psychological Impact of Male Factor Infertility</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:10</itunes:duration>
      <itunes:summary>Male infertility affects emotional wellbeing and relationships, underscoring the need to reduce stigma, encourage open dialogue, and provide inclusive, couple-centered fertility care and support.</itunes:summary>
      <itunes:subtitle>Male infertility affects emotional wellbeing and relationships, underscoring the need to reduce stigma, encourage open dialogue, and provide inclusive, couple-centered fertility care and support.</itunes:subtitle>
      <itunes:keywords>male infertility affects emotional wellbeing and relationships, couple-centered fertility care and support., encourage open dialogue, and provide inclusive, underscoring the need to reduce stigma</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>197</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d31c9f06-ec44-4497-9f9c-ec33a7aef04d</guid>
      <title>Mediterranean Diet May Shield Women From All Stroke Types</title>
      <description><![CDATA[Following a Mediterranean diet rich in fruits, vegetables, fish, and healthy fats may lower stroke risk in women, supporting dietary prevention strategies globally. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mediterranean-diet-may-shield-women-from-all-stroke-types-C1sgBw6w</link>
      <enclosure length="1604170" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0ba8951f-1e2e-4dd0-9bd1-a101a5017bae/audio/7ee96c14-fb07-41bb-9532-db658eb3bfa5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mediterranean Diet May Shield Women From All Stroke Types</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Following a Mediterranean diet rich in fruits, vegetables, fish, and healthy fats may lower stroke risk in women, supporting dietary prevention strategies globally.</itunes:summary>
      <itunes:subtitle>Following a Mediterranean diet rich in fruits, vegetables, fish, and healthy fats may lower stroke risk in women, supporting dietary prevention strategies globally.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>196</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6f9ebb37-568a-422d-bf5f-a00065e09b43</guid>
      <title>Five-Year Survival Rate for All Cancers May Reach 70%</title>
      <description><![CDATA[U.S. cancer cases are projected to surpass two million by 2026, stressing prevention and resource planning, even as survival rates continue improving across many cancer types. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/five-year-survival-rate-for-all-cancers-may-reach-70-XdqMBZbv</link>
      <enclosure length="1876261" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/fd702ee6-5c0b-449f-9937-20fd8b6b56a5/audio/8b7fdce5-7de3-45bd-a3df-8ce399731178/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Five-Year Survival Rate for All Cancers May Reach 70%</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>U.S. cancer cases are projected to surpass two million by 2026, stressing prevention and resource planning, even as survival rates continue improving across many cancer types.</itunes:summary>
      <itunes:subtitle>U.S. cancer cases are projected to surpass two million by 2026, stressing prevention and resource planning, even as survival rates continue improving across many cancer types.</itunes:subtitle>
      <itunes:keywords>stressing prevention and resource planning, even as survival rates continue improving across many cancer types., u.s. cancer cases are projected to surpass two million by 2026</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>195</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">459a67e1-a471-4d23-9e8f-4eb17780ec17</guid>
      <title>Plasma Proteome Linked to Sex-Specific Mental Health Risks in Teens</title>
      <description><![CDATA[New research shows sex differences influence how blood proteins relate to adolescent mental health, highlighting the need for personalized, biologically informed approaches to youth mental healthcare. 
]]></description>
      <pubDate>Wed, 11 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/plasma-proteome-linked-to-sex-specific-mental-health-risks-in-teens-eJyvqgWt</link>
      <enclosure length="1171582" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/155d303c-3bd8-46f0-a267-0d950f4050bf/audio/c248da10-2996-47b4-8a32-ff5b67666495/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Plasma Proteome Linked to Sex-Specific Mental Health Risks in Teens</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:13</itunes:duration>
      <itunes:summary>New research shows sex differences influence how blood proteins relate to adolescent mental health, highlighting the need for personalized, biologically informed approaches to youth mental healthcare.</itunes:summary>
      <itunes:subtitle>New research shows sex differences influence how blood proteins relate to adolescent mental health, highlighting the need for personalized, biologically informed approaches to youth mental healthcare.</itunes:subtitle>
      <itunes:keywords>new research shows sex differences influence how blood proteins relate to adolescent mental health, biologically informed approaches to youth mental healthcare., highlighting the need for personalized</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>194</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f44d07ef-d9e3-4919-99a2-a339fd5a8389</guid>
      <title>Isotretinoin Use in Acne Linked to Possible Hematuria Risks</title>
      <description><![CDATA[Rare reports link isotretinoin to hematuria, highlighting the need for patient education, routine urine monitoring, and vigilant management to ensure acne treatment safety overall outcomes. 
]]></description>
      <pubDate>Tue, 10 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/isotretinoin-use-in-acne-linked-to-possible-hematuria-risks-bVzYaocz</link>
      <enclosure length="1046194" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c69b98e4-cea0-4602-a4b5-f3a8e7840745/audio/25a3afae-a2f1-4f74-b8c2-08435f208514/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Isotretinoin Use in Acne Linked to Possible Hematuria Risks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:05</itunes:duration>
      <itunes:summary>Rare reports link isotretinoin to hematuria, highlighting the need for patient education, routine urine monitoring, and vigilant management to ensure acne treatment safety overall outcomes.</itunes:summary>
      <itunes:subtitle>Rare reports link isotretinoin to hematuria, highlighting the need for patient education, routine urine monitoring, and vigilant management to ensure acne treatment safety overall outcomes.</itunes:subtitle>
      <itunes:keywords>routine urine monitoring, and vigilant management to ensure acne treatment safety overall outcomes., rare reports link isotretinoin to hematuria, highlighting the need for patient education</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>193</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">424ec9ff-5da9-429e-a3ba-78f80a669ee6</guid>
      <title>Novel Repressive Roles of Estrogen Receptor β in Aggressive Breast Cancer</title>
      <description><![CDATA[Research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread, opening doors to targeted therapies and improved outcomes for patients with this aggressive disease. 
]]></description>
      <pubDate>Tue, 10 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/novel-repressive-roles-of-estrogen-receptor-in-aggressive-breast-cancer-ECc7fpDp</link>
      <enclosure length="1550671" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e822bc75-69d2-4244-bb46-3d940e6ab4ed/audio/e9426a0d-673f-4ed9-97e5-1d78bf14979b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Novel Repressive Roles of Estrogen Receptor β in Aggressive Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread, opening doors to targeted therapies and improved outcomes for patients with this aggressive disease.</itunes:summary>
      <itunes:subtitle>Research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread, opening doors to targeted therapies and improved outcomes for patients with this aggressive disease.</itunes:subtitle>
      <itunes:keywords>opening doors to targeted therapies and improved outcomes for patients with this aggressive disease., research identifies estrogen receptor beta as a potential brake on inflammatory breast cancer spread</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>192</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9fe4675e-cf6a-40b2-b321-eb7e7bc8cae5</guid>
      <title>Ultra-High-Dose Methylcobalamin: Safety in ALS Patients</title>
      <description><![CDATA[Researchers are exploring ultra-high dose methylcobalamin for ALS, offering potential new treatment options that may slow disease progression and bring hope to patients and families. 
]]></description>
      <pubDate>Tue, 10 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ultra-high-dose-methylcobalamin-safety-in-als-patients-p4_SG1Dg</link>
      <enclosure length="1369695" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/20870523-237d-4885-9885-4a295d74a174/audio/f26da045-fff6-4c72-bf7f-a90b6d005861/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ultra-High-Dose Methylcobalamin: Safety in ALS Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Researchers are exploring ultra-high dose methylcobalamin for ALS, offering potential new treatment options that may slow disease progression and bring hope to patients and families.</itunes:summary>
      <itunes:subtitle>Researchers are exploring ultra-high dose methylcobalamin for ALS, offering potential new treatment options that may slow disease progression and bring hope to patients and families.</itunes:subtitle>
      <itunes:keywords>researchers are exploring ultra-high dose methylcobalamin for als, offering potential new treatment options that may slow disease progression and bring hope to patients and families.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>191</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b7712f8f-0042-4b1b-93d2-c6492397e85c</guid>
      <title>Bacteria’s Ancient Viral Defenses Could Unlock New Infection-Fighting Strategies</title>
      <description><![CDATA[Ancient bacterial defenses against viruses inspire novel antiviral strategies, offering alternatives amid antibiotic resistance and promising safer, targeted treatments for human health and food safety. 
]]></description>
      <pubDate>Tue, 10 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bacterias-ancient-viral-defenses-could-unlock-new-infection-fighting-strategies-bp_j7jIz</link>
      <enclosure length="1599154" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a4ed2a04-1f5d-478b-8567-5e76accd0367/audio/82a72670-dc14-4ede-9647-06299aa088c4/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bacteria’s Ancient Viral Defenses Could Unlock New Infection-Fighting Strategies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Ancient bacterial defenses against viruses inspire novel antiviral strategies, offering alternatives amid antibiotic resistance and promising safer, targeted treatments for human health and food safety.</itunes:summary>
      <itunes:subtitle>Ancient bacterial defenses against viruses inspire novel antiviral strategies, offering alternatives amid antibiotic resistance and promising safer, targeted treatments for human health and food safety.</itunes:subtitle>
      <itunes:keywords>ancient bacterial defenses against viruses inspire novel antiviral strategies, targeted treatments for human health and food safety., offering alternatives amid antibiotic resistance and promising safer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>190</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d759da3e-4398-439a-987a-41d51b475252</guid>
      <title>The Social and Psychological Impact of Male Factor Infertility</title>
      <description><![CDATA[Male factor infertility carries emotional and social impacts, highlighting the need to reduce stigma, support men’s mental health, and promote inclusive, couple-centered fertility care. 
]]></description>
      <pubDate>Tue, 10 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-social-and-psychological-impact-of-male-factor-infertility-MWKNteAI</link>
      <enclosure length="1416088" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c03203d4-63b5-479e-a079-7f02cd0740dd/audio/d52e5993-5df3-4ebe-ab6e-5f212ab52748/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Social and Psychological Impact of Male Factor Infertility</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>Male factor infertility carries emotional and social impacts, highlighting the need to reduce stigma, support men’s mental health, and promote inclusive, couple-centered fertility care.</itunes:summary>
      <itunes:subtitle>Male factor infertility carries emotional and social impacts, highlighting the need to reduce stigma, support men’s mental health, and promote inclusive, couple-centered fertility care.</itunes:subtitle>
      <itunes:keywords>support men’s mental health, male factor infertility carries emotional and social impacts, couple-centered fertility care., and promote inclusive, highlighting the need to reduce stigma</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>189</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4d07baee-57f5-45f0-81d0-f1a0025b91cb</guid>
      <title>Link Between Sjögren Syndrome and Breast Cancer Risk in Women</title>
      <description><![CDATA[Study suggests women with Sjögren syndrome face higher breast cancer risk, underscoring the need for heightened screening awareness, personalized care, and informed patient–provider discussions. 
]]></description>
      <pubDate>Mon, 9 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/link-between-sjogren-syndrome-and-breast-cancer-risk-in-women-Yjwnc4mD</link>
      <enclosure length="1042433" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/3ef78f8d-6424-46b3-88b9-f03994ecb878/audio/48bd0704-b33d-48a1-9188-2fb9cbb96968/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Link Between Sjögren Syndrome and Breast Cancer Risk in Women</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:05</itunes:duration>
      <itunes:summary>Study suggests women with Sjögren syndrome face higher breast cancer risk, underscoring the need for heightened screening awareness, personalized care, and informed patient–provider discussions.</itunes:summary>
      <itunes:subtitle>Study suggests women with Sjögren syndrome face higher breast cancer risk, underscoring the need for heightened screening awareness, personalized care, and informed patient–provider discussions.</itunes:subtitle>
      <itunes:keywords>underscoring the need for heightened screening awareness, personalized care, and informed patient–provider discussions., study suggests women with sjögren syndrome face higher breast cancer risk</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>188</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2e565d2e-2bb7-44d1-a3c6-08982770488e</guid>
      <title>Sociodemographic Factors Impacting Prostate Cancer Testing</title>
      <description><![CDATA[Genomic testing enables personalized prostate cancer treatment, but disparities in access persist, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances. 
]]></description>
      <pubDate>Mon, 9 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/sociodemographic-factors-impacting-prostate-cancer-testing-WO5qev4E</link>
      <enclosure length="1770936" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a2d265c3-d276-4111-a662-484a95d61ad3/audio/176444bb-139b-4e27-b088-9937068ead54/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Sociodemographic Factors Impacting Prostate Cancer Testing</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Genomic testing enables personalized prostate cancer treatment, but disparities in access persist, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances.</itunes:summary>
      <itunes:subtitle>Genomic testing enables personalized prostate cancer treatment, but disparities in access persist, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances.</itunes:subtitle>
      <itunes:keywords>genomic testing enables personalized prostate cancer treatment, highlighting the need for equitable policies ensuring all patients benefit from precision medicine advances., but disparities in access persist</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>187</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">02cd8573-433c-463e-ae48-c84163f9861f</guid>
      <title>De-Escalating Antibiotics Safe for Community-Onset Sepsis Patients</title>
      <description><![CDATA[Safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, lower side effects, and maintain recovery, prompting hospitals to rethink antibiotic de-escalation practices nationwide. 
]]></description>
      <pubDate>Mon, 9 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/de-escalating-antibiotics-safe-for-community-onset-sepsis-patients-KiK0XKF3</link>
      <enclosure length="1872918" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/6728cc98-e4ae-444c-96a2-106039bffd3b/audio/b774e59f-d31e-408d-b9dd-0e798596ac81/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>De-Escalating Antibiotics Safe for Community-Onset Sepsis Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, lower side effects, and maintain recovery, prompting hospitals to rethink antibiotic de-escalation practices nationwide.</itunes:summary>
      <itunes:subtitle>Safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, lower side effects, and maintain recovery, prompting hospitals to rethink antibiotic de-escalation practices nationwide.</itunes:subtitle>
      <itunes:keywords>and maintain recovery, safely reducing broad-spectrum antibiotics in improving sepsis patients may curb resistance, prompting hospitals to rethink antibiotic de-escalation practices nationwide., lower side effects</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>186</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a58d0cbb-6311-48f6-848a-d8495c1bb524</guid>
      <title>Impact of Preoperative Therapy on Early Breast Cancer Outcomes</title>
      <description><![CDATA[Breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care. 
]]></description>
      <pubDate>Mon, 9 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-preoperative-therapy-on-early-breast-cancer-outcomes-y9Ogmce6</link>
      <enclosure length="1590795" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a76c507a-8716-48de-bfa9-064d307048a4/audio/c64818a1-18f5-4ee6-919e-e49d6441e230/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Preoperative Therapy on Early Breast Cancer Outcomes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care.</itunes:summary>
      <itunes:subtitle>Breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care.</itunes:subtitle>
      <itunes:keywords>breast cancer patients receiving neoadjuvant therapy show changing quality-of-life needs, emphasizing personalized emotional support to improve wellbeing, treatment adherence, and overall outcomes throughout care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>185</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">88028dd8-97a9-48c9-84b3-990493f4e59e</guid>
      <title>Identifying Risk Factors for Treatment Resistance in Postpartum Depression</title>
      <description><![CDATA[Treatment-resistant postpartum depression leaves some mothers without relief, highlighting urgent needs for identifying risk factors, personalized care, and better support to improve recovery for families. 
]]></description>
      <pubDate>Mon, 9 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/identifying-risk-factors-for-treatment-resistance-in-postpartum-depression-dcohJQhh</link>
      <enclosure length="1614619" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c7cca358-98b4-43a4-9814-af67a463f7e9/audio/f0a6f01c-abbe-47b9-b98f-bc5223cf3462/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Identifying Risk Factors for Treatment Resistance in Postpartum Depression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Treatment-resistant postpartum depression leaves some mothers without relief, highlighting urgent needs for identifying risk factors, personalized care, and better support to improve recovery for families.</itunes:summary>
      <itunes:subtitle>Treatment-resistant postpartum depression leaves some mothers without relief, highlighting urgent needs for identifying risk factors, personalized care, and better support to improve recovery for families.</itunes:subtitle>
      <itunes:keywords>treatment-resistant postpartum depression leaves some mothers without relief, personalized care, and better support to improve recovery for families., highlighting urgent needs for identifying risk factors</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>184</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9a89057d-d2e7-4a64-8886-e4fc86046b57</guid>
      <title>Chronic Conditions Affect Most Patients With Commercial Insurance</title>
      <description><![CDATA[Many commercially insured Americans live with chronic conditions, driving higher healthcare costs and underscoring the need for improved prevention, management strategies, and informed policy decisions. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/chronic-conditions-affect-most-patients-with-commercial-insurance-YrBHVJ0j</link>
      <enclosure length="1278998" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/692a6ea9-b223-4d41-9636-4f7cb27fd01c/audio/bfcc984e-c1e3-42f0-a6d6-19e0e5831538/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Chronic Conditions Affect Most Patients With Commercial Insurance</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:19</itunes:duration>
      <itunes:summary>Many commercially insured Americans live with chronic conditions, driving higher healthcare costs and underscoring the need for improved prevention, management strategies, and informed policy decisions.</itunes:summary>
      <itunes:subtitle>Many commercially insured Americans live with chronic conditions, driving higher healthcare costs and underscoring the need for improved prevention, management strategies, and informed policy decisions.</itunes:subtitle>
      <itunes:keywords>and informed policy decisions., many commercially insured americans live with chronic conditions, management strategies, driving higher healthcare costs and underscoring the need for improved prevention</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>183</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bf68bd1a-3923-4917-a871-fa7ccfdfbb43</guid>
      <title>Discover and Access Mental Health Services Available in Your Area</title>
      <description><![CDATA[Navigating mental health services is increasingly vital as anxiety and depression rise, helping individuals overcome access barriers, find timely care, and connect with support resources. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/discover-and-access-mental-health-services-available-in-your-area-AhupdLun</link>
      <enclosure length="1536461" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c22fb490-5099-45a3-876b-ae6d87cce54c/audio/f00a33e7-919a-410f-87a1-1d5c21290050/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Discover and Access Mental Health Services Available in Your Area</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Navigating mental health services is increasingly vital as anxiety and depression rise, helping individuals overcome access barriers, find timely care, and connect with support resources.</itunes:summary>
      <itunes:subtitle>Navigating mental health services is increasingly vital as anxiety and depression rise, helping individuals overcome access barriers, find timely care, and connect with support resources.</itunes:subtitle>
      <itunes:keywords>navigating mental health services is increasingly vital as anxiety and depression rise, find timely care, and connect with support resources., helping individuals overcome access barriers</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>182</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">aa7630dc-0753-4789-9c0a-a0f4024a1b44</guid>
      <title>Persistent Chlamydia trachomatis Infections Among South African Youth: Emerging Public Health Concerns</title>
      <description><![CDATA[Chlamydia, the world’s most common bacterial STI, disproportionately affects young women in South Africa, underscoring urgent needs for targeted screening, education, prevention, and treatment access. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/persistent-chlamydia-trachomatis-infections-among-south-african-youth-emerging-public-health-concerns-_eOI7S0I</link>
      <enclosure length="1291536" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/90d6d7b8-67b2-4f18-8d23-3f976ef2b1bb/audio/f42d9344-785a-4f9b-ba6a-0d64dd504068/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Persistent Chlamydia trachomatis Infections Among South African Youth: Emerging Public Health Concerns</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:20</itunes:duration>
      <itunes:summary>Chlamydia, the world’s most common bacterial STI, disproportionately affects young women in South Africa, underscoring urgent needs for targeted screening, education, prevention, and treatment access.</itunes:summary>
      <itunes:subtitle>Chlamydia, the world’s most common bacterial STI, disproportionately affects young women in South Africa, underscoring urgent needs for targeted screening, education, prevention, and treatment access.</itunes:subtitle>
      <itunes:keywords>chlamydia, and treatment access., prevention, underscoring urgent needs for targeted screening, education, the world’s most common bacterial sti, disproportionately affects young women in south africa</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>181</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9e249a01-3f59-4328-9073-5891539f8238</guid>
      <title>Trustworthiness Concerns in Study on Depression Treatments</title>
      <description><![CDATA[Evaluating evidence behind depression therapies, including interpersonal therapy, CBT, and medication, is crucial to ensure trustworthy research guides treatment choices for patients, clinicians, and policymakers. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/trustworthiness-concerns-in-study-on-depression-treatments-3gZ7rSTK</link>
      <enclosure length="1082975" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/693eda74-51f9-4194-9316-317970f2b51d/audio/e715eb54-0139-4891-b300-1548d1479b62/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Trustworthiness Concerns in Study on Depression Treatments</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:07</itunes:duration>
      <itunes:summary>Evaluating evidence behind depression therapies, including interpersonal therapy, CBT, and medication, is crucial to ensure trustworthy research guides treatment choices for patients, clinicians, and policymakers.</itunes:summary>
      <itunes:subtitle>Evaluating evidence behind depression therapies, including interpersonal therapy, CBT, and medication, is crucial to ensure trustworthy research guides treatment choices for patients, clinicians, and policymakers.</itunes:subtitle>
      <itunes:keywords>and policymakers., evaluating evidence behind depression therapies, including interpersonal therapy, clinicians, and medication, is crucial to ensure trustworthy research guides treatment choices for patients, cbt</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>180</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5c72c3a2-337a-4045-8173-ea20d7fd072b</guid>
      <title>Promising Nasal Vaccine Offers Strong Protection Against H5N1</title>
      <description><![CDATA[A nasal spray vaccine shows promise against bird flu, potentially blocking H5N1 infections, reducing transmission, and strengthening pandemic preparedness beyond traditional influenza shots. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/promising-nasal-vaccine-offers-strong-protection-against-h5n1-oJr8eli7</link>
      <enclosure length="1758815" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7fe45f11-a7ec-4459-b352-a7ee25a1f649/audio/1ffaa649-7d28-4eac-97ee-67d15aa7cab8/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Promising Nasal Vaccine Offers Strong Protection Against H5N1</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:49</itunes:duration>
      <itunes:summary>A nasal spray vaccine shows promise against bird flu, potentially blocking H5N1 infections, reducing transmission, and strengthening pandemic preparedness beyond traditional influenza shots.</itunes:summary>
      <itunes:subtitle>A nasal spray vaccine shows promise against bird flu, potentially blocking H5N1 infections, reducing transmission, and strengthening pandemic preparedness beyond traditional influenza shots.</itunes:subtitle>
      <itunes:keywords>and strengthening pandemic preparedness beyond traditional influenza shots., reducing transmission, a nasal spray vaccine shows promise against bird flu, potentially blocking h5n1 infections</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>179</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f145ce73-e831-47ef-a7e4-96ca6b0fb4d3</guid>
      <title>Impact of Remote Measurement-Based Care on Mental Health</title>
      <description><![CDATA[EMA and remote measurement-based care use technology to monitor mental health in real time, enabling more personalized treatment, better outcomes, and improved patient engagement. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-remote-measurement-based-care-on-mental-health-ZYOTbUay</link>
      <enclosure length="1650981" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/539631c7-a476-4046-9ce1-b2360f266c10/audio/06f8a150-b759-462a-92db-1cfe84741dcb/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Remote Measurement-Based Care on Mental Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>EMA and remote measurement-based care use technology to monitor mental health in real time, enabling more personalized treatment, better outcomes, and improved patient engagement.</itunes:summary>
      <itunes:subtitle>EMA and remote measurement-based care use technology to monitor mental health in real time, enabling more personalized treatment, better outcomes, and improved patient engagement.</itunes:subtitle>
      <itunes:keywords>better outcomes, and improved patient engagement., enabling more personalized treatment, ema and remote measurement-based care use technology to monitor mental health in real time</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>178</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">59018a35-fc3b-4041-a426-6cb0774f68d7</guid>
      <title>Finding Rest Amid Eczema Disruption: Effective Strategies</title>
      <description><![CDATA[Breaking the itch-sleep cycle in eczema is key, as better nighttime management can reduce flare-ups, improve sleep quality, mental wellbeing, and overall quality of life. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/finding-rest-amid-eczema-disruption-effective-strategies-kqObMmPT</link>
      <enclosure length="2019621" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a220caa2-fcca-4d20-8377-d5bf00d939d0/audio/e70355d0-859a-4526-b59b-0aea7a356b22/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Finding Rest Amid Eczema Disruption: Effective Strategies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Breaking the itch-sleep cycle in eczema is key, as better nighttime management can reduce flare-ups, improve sleep quality, mental wellbeing, and overall quality of life.</itunes:summary>
      <itunes:subtitle>Breaking the itch-sleep cycle in eczema is key, as better nighttime management can reduce flare-ups, improve sleep quality, mental wellbeing, and overall quality of life.</itunes:subtitle>
      <itunes:keywords>mental wellbeing, improve sleep quality, as better nighttime management can reduce flare-ups, and overall quality of life., breaking the itch-sleep cycle in eczema is key</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>177</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">878bfc40-5c1d-443a-a9db-7b73b87321c7</guid>
      <title>Genetic Links to Sustained Antidepressant Use in Depression</title>
      <description><![CDATA[Study reveals many patients with major depressive disorder don’t respond to initial antidepressants, underscoring urgent need for personalized treatments that reflect individual differences in depression care. 
]]></description>
      <pubDate>Fri, 6 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/genetic-links-to-sustained-antidepressant-use-in-depression-wt9cO6hf</link>
      <enclosure length="943794" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/6e6d5dbb-0e82-4baa-98d8-92704ae6f9e6/audio/0d11c9c6-3206-44f5-88f6-1774af4b1b3f/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Genetic Links to Sustained Antidepressant Use in Depression</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:58</itunes:duration>
      <itunes:summary>Study reveals many patients with major depressive disorder don’t respond to initial antidepressants, underscoring urgent need for personalized treatments that reflect individual differences in depression care.</itunes:summary>
      <itunes:subtitle>Study reveals many patients with major depressive disorder don’t respond to initial antidepressants, underscoring urgent need for personalized treatments that reflect individual differences in depression care.</itunes:subtitle>
      <itunes:keywords>underscoring urgent need for personalized treatments that reflect individual differences in depression care., study reveals many patients with major depressive disorder don’t respond to initial antidepressants</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>176</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ab91a43b-a4ac-4f0b-9217-482e67fbf2b6</guid>
      <title>Deep Learning May Enhance Mismatch Repair Prediction in Colorectal Cancer</title>
      <description><![CDATA[A new deep learning model accelerates colorectal cancer MMR testing, using automated lesion segmentation and transformers to enable faster, cost-effective screening and treatment decisions clinically. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/deep-learning-may-enhance-mismatch-repair-prediction-in-colorectal-cancer-W_CVbVPb</link>
      <enclosure length="1885038" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e956fa5e-638b-4669-befd-9cf2df343452/audio/f9968b11-8c5d-4132-b40d-5abc9f56d89b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Deep Learning May Enhance Mismatch Repair Prediction in Colorectal Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>A new deep learning model accelerates colorectal cancer MMR testing, using automated lesion segmentation and transformers to enable faster, cost-effective screening and treatment decisions clinically.</itunes:summary>
      <itunes:subtitle>A new deep learning model accelerates colorectal cancer MMR testing, using automated lesion segmentation and transformers to enable faster, cost-effective screening and treatment decisions clinically.</itunes:subtitle>
      <itunes:keywords>a new deep learning model accelerates colorectal cancer mmr testing, cost-effective screening and treatment decisions clinically., using automated lesion segmentation and transformers to enable faster</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>175</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7f609070-bbb2-4025-9591-d2ef03bb3752</guid>
      <title>Culturally Adapted Digital Mental Health: Insights on Retention and Engagement</title>
      <description><![CDATA[Culturally adapting digital mental health interventions can reduce dropouts and improve engagement, ensuring scalable tools effectively support diverse populations beyond Western-centric design models globally equitably. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/culturally-adapted-digital-mental-health-insights-on-retention-and-engagement-nab42mvn-HWFMC0IA</link>
      <enclosure length="1949822" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/701b0d8d-1cd5-45a2-8444-2998f45812b2/audio/434855ca-927d-4f40-b86a-f38c3cd0c541/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Culturally Adapted Digital Mental Health: Insights on Retention and Engagement</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:01</itunes:duration>
      <itunes:summary>Culturally adapting digital mental health interventions can reduce dropouts and improve engagement, ensuring scalable tools effectively support diverse populations beyond Western-centric design models globally equitably.</itunes:summary>
      <itunes:subtitle>Culturally adapting digital mental health interventions can reduce dropouts and improve engagement, ensuring scalable tools effectively support diverse populations beyond Western-centric design models globally equitably.</itunes:subtitle>
      <itunes:keywords>culturally adapting digital mental health interventions can reduce dropouts and improve engagement, ensuring scalable tools effectively support diverse populations beyond western-centric design models globally equitably.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>174</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">286a28f0-cd82-4340-bdf8-0a341e3d07a1</guid>
      <title>Maternal BMI May Influence Risk of Shoulder Dystocia</title>
      <description><![CDATA[Research links pre-pregnancy BMI to shoulder dystocia risk, highlighting maternal weight management as a factor in planning to improve delivery safety for mothers and babies. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/maternal-bmi-may-influence-risk-of-shoulder-dystocia-3lPyaDJD</link>
      <enclosure length="1431135" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/eaf07227-5870-4651-8bae-726ec6ba8e1c/audio/c366312f-576f-4e2f-b792-fba1206cdb13/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Maternal BMI May Influence Risk of Shoulder Dystocia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Research links pre-pregnancy BMI to shoulder dystocia risk, highlighting maternal weight management as a factor in planning to improve delivery safety for mothers and babies.</itunes:summary>
      <itunes:subtitle>Research links pre-pregnancy BMI to shoulder dystocia risk, highlighting maternal weight management as a factor in planning to improve delivery safety for mothers and babies.</itunes:subtitle>
      <itunes:keywords>research links pre-pregnancy bmi to shoulder dystocia risk, highlighting maternal weight management as a factor in planning to improve delivery safety for mothers and babies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>172</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c511878f-f180-4689-9bb2-19cc87e78242</guid>
      <title>Understanding Your Health Through Key Anthropometric Metrics</title>
      <description><![CDATA[Understanding BMI and waist circumference helps identify health risks early, empowering individuals and clinicians to make informed lifestyle decisions amid rising global obesity rates worldwide. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-your-health-through-key-anthropometric-metrics-SaPb4_m9</link>
      <enclosure length="1487141" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/34c9a68d-d1d7-4d9f-83de-a49fd731d63a/audio/2842a81c-3ffc-4a88-9f8c-2570466cf551/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Your Health Through Key Anthropometric Metrics</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Understanding BMI and waist circumference helps identify health risks early, empowering individuals and clinicians to make informed lifestyle decisions amid rising global obesity rates worldwide.</itunes:summary>
      <itunes:subtitle>Understanding BMI and waist circumference helps identify health risks early, empowering individuals and clinicians to make informed lifestyle decisions amid rising global obesity rates worldwide.</itunes:subtitle>
      <itunes:keywords>empowering individuals and clinicians to make informed lifestyle decisions amid rising global obesity rates worldwide., understanding bmi and waist circumference helps identify health risks early</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>171</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a3aa886c-7d30-4200-bccd-6cf241bc31f4</guid>
      <title>Uncovering Overlooked Cardiovascular Risks Throughout Women’s Lives</title>
      <description><![CDATA[Heart disease remains women’s top health threat, underscoring urgent needs for personalized risk screening, education, and awareness of female-specific factors often missed in cardiovascular care. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/uncovering-overlooked-cardiovascular-risks-throughout-womens-lives-W5D4jpKv</link>
      <enclosure length="1154864" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/20e9fbea-136a-48d7-a400-a5cecce0c93d/audio/70220772-ce7a-45de-82ce-c79dfb63ac35/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Uncovering Overlooked Cardiovascular Risks Throughout Women’s Lives</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>Heart disease remains women’s top health threat, underscoring urgent needs for personalized risk screening, education, and awareness of female-specific factors often missed in cardiovascular care.</itunes:summary>
      <itunes:subtitle>Heart disease remains women’s top health threat, underscoring urgent needs for personalized risk screening, education, and awareness of female-specific factors often missed in cardiovascular care.</itunes:subtitle>
      <itunes:keywords>and awareness of female-specific factors often missed in cardiovascular care., heart disease remains women’s top health threat, underscoring urgent needs for personalized risk screening, education</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>170</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">da9665b9-6149-467f-9392-5ccc6b1e77c9</guid>
      <title>New Guideline for Pediatric Ischemic Stroke Emergency Management</title>
      <description><![CDATA[Updated pediatric stroke guidelines stress rapid emergency response and mobile treatment units, improving recognition, access to care, and outcomes for children experiencing ischemic strokes nationwide. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-guideline-for-pediatric-ischemic-stroke-emergency-management-i4XiQoRh</link>
      <enclosure length="1575749" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5ed554ec-073e-43b8-a75a-12fa849b6123/audio/5f328c8a-286f-4328-a54c-c1af1a39689e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Guideline for Pediatric Ischemic Stroke Emergency Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:38</itunes:duration>
      <itunes:summary>Updated pediatric stroke guidelines stress rapid emergency response and mobile treatment units, improving recognition, access to care, and outcomes for children experiencing ischemic strokes nationwide.</itunes:summary>
      <itunes:subtitle>Updated pediatric stroke guidelines stress rapid emergency response and mobile treatment units, improving recognition, access to care, and outcomes for children experiencing ischemic strokes nationwide.</itunes:subtitle>
      <itunes:keywords>updated pediatric stroke guidelines stress rapid emergency response and mobile treatment units, improving recognition, and outcomes for children experiencing ischemic strokes nationwide., access to care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>169</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e6e4d052-8ec9-4f4e-9eae-0e7d87ec3abf</guid>
      <title>New Study May Provide Relief for Menopausal Hot Flashes</title>
      <description><![CDATA[Research links midlife insulin levels to menopause hot flashes and night sweats, highlighting metabolic health’s role in symptom severity, duration, and improved management strategies potentially. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-study-may-provide-relief-for-menopausal-hot-flashes-nMDxuwuQ</link>
      <enclosure length="1507621" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/24d70e3f-64de-4be0-838d-08496580f8b7/audio/43cf6b28-91ad-4340-971d-fb067fc90250/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Study May Provide Relief for Menopausal Hot Flashes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Research links midlife insulin levels to menopause hot flashes and night sweats, highlighting metabolic health’s role in symptom severity, duration, and improved management strategies potentially.</itunes:summary>
      <itunes:subtitle>Research links midlife insulin levels to menopause hot flashes and night sweats, highlighting metabolic health’s role in symptom severity, duration, and improved management strategies potentially.</itunes:subtitle>
      <itunes:keywords>research links midlife insulin levels to menopause hot flashes and night sweats, and improved management strategies potentially., duration, highlighting metabolic health’s role in symptom severity</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>168</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d63eda25-405f-4d16-8714-3af9f5b1a74a</guid>
      <title>Ectopic Inflatable Penile Prosthesis Pump Placement in Mons Fat Pad</title>
      <description><![CDATA[An erectile dysfunction surgery places the inflatable prosthesis pump in the mons fat pad, improving access, comfort, and outcomes for men with mobility challenges overall. 
]]></description>
      <pubDate>Thu, 5 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ectopic-inflatable-penile-prosthesis-pump-placement-in-mons-fat-pad-lChxTOZW</link>
      <enclosure length="1429463" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cc69239e-6fbb-43c4-979d-960aa5b9e28a/audio/d39aa7ab-7c58-4586-90bf-8a0b9ca94c25/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ectopic Inflatable Penile Prosthesis Pump Placement in Mons Fat Pad</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>An erectile dysfunction surgery places the inflatable prosthesis pump in the mons fat pad, improving access, comfort, and outcomes for men with mobility challenges overall.</itunes:summary>
      <itunes:subtitle>An erectile dysfunction surgery places the inflatable prosthesis pump in the mons fat pad, improving access, comfort, and outcomes for men with mobility challenges overall.</itunes:subtitle>
      <itunes:keywords>improving access, comfort, an erectile dysfunction surgery places the inflatable prosthesis pump in the mons fat pad, and outcomes for men with mobility challenges overall.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>167</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fb3e9b7a-d84a-41bf-b36c-0e8cd4380827</guid>
      <title>Can Bioimpedance Spectroscopy Detect Lymphedema Faster?</title>
      <description><![CDATA[VCU Massey now uses bioimpedance spectroscopy for early lymphedema detection in breast cancer patients, enabling noninvasive screening, earlier intervention, and improved long-term outcomes. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/can-bioimpedance-spectroscopy-detect-lymphedema-faster-d7HxSqVr</link>
      <enclosure length="1416924" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d369584a-9026-47e6-b681-f4cc9ae75b38/audio/57ea608e-6bd7-4b83-bf74-ffb50444cbca/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Can Bioimpedance Spectroscopy Detect Lymphedema Faster?</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>VCU Massey now uses bioimpedance spectroscopy for early lymphedema detection in breast cancer patients, enabling noninvasive screening, earlier intervention, and improved long-term outcomes.</itunes:summary>
      <itunes:subtitle>VCU Massey now uses bioimpedance spectroscopy for early lymphedema detection in breast cancer patients, enabling noninvasive screening, earlier intervention, and improved long-term outcomes.</itunes:subtitle>
      <itunes:keywords>earlier intervention, enabling noninvasive screening, and improved long-term outcomes., vcu massey now uses bioimpedance spectroscopy for early lymphedema detection in breast cancer patients</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>166</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cefca89e-dd6b-482e-a420-f6c773558b15</guid>
      <title>FDA Approves Novel Dual-Agent Eye Drops Offering a Non-Surgical Option for Presbyopia</title>
      <description><![CDATA[FDA approved a dual agent eye drop for presbyopia, offering adults over 40 improved near vision, reduced reliance on reading glasses, and expanded treatment options. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/fda-approves-novel-dual-agent-eye-drops-offering-a-non-surgical-option-for-presbyopia-4IVXi3b1</link>
      <enclosure length="1498844" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7926d133-55ee-4cc5-8044-1dc85861e2a3/audio/426c4912-c1cf-40c9-a8fa-9ab5c73dee59/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FDA Approves Novel Dual-Agent Eye Drops Offering a Non-Surgical Option for Presbyopia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>FDA approved a dual agent eye drop for presbyopia, offering adults over 40 improved near vision, reduced reliance on reading glasses, and expanded treatment options.</itunes:summary>
      <itunes:subtitle>FDA approved a dual agent eye drop for presbyopia, offering adults over 40 improved near vision, reduced reliance on reading glasses, and expanded treatment options.</itunes:subtitle>
      <itunes:keywords>and expanded treatment options., reduced reliance on reading glasses, fda approved a dual agent eye drop for presbyopia, offering adults over 40 improved near vision</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>165</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d49610f8-8000-4fc3-b180-cc3e0583af85</guid>
      <title>Insights From Global Survey on Primary Urethral Cancer Care</title>
      <description><![CDATA[An international survey reveals current practices and gaps in primary urethral cancer care, guiding earlier diagnosis, treatments, and collaborative strategies to improve outcomes for patients. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/insights-from-global-survey-on-primary-urethral-cancer-care-J_W79n_w</link>
      <enclosure length="1159043" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/82a2f8c8-cd0b-4150-8acd-936700c10c8c/audio/a499e26e-42cc-402a-a4ec-273b65d36aea/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Insights From Global Survey on Primary Urethral Cancer Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>An international survey reveals current practices and gaps in primary urethral cancer care, guiding earlier diagnosis, treatments, and collaborative strategies to improve outcomes for patients.</itunes:summary>
      <itunes:subtitle>An international survey reveals current practices and gaps in primary urethral cancer care, guiding earlier diagnosis, treatments, and collaborative strategies to improve outcomes for patients.</itunes:subtitle>
      <itunes:keywords>an international survey reveals current practices and gaps in primary urethral cancer care, and collaborative strategies to improve outcomes for patients., treatments, guiding earlier diagnosis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>164</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6b8fbe50-40e9-4b6c-abc5-8b487a1f8c06</guid>
      <title>Understanding Normal Testosterone Levels: How to Know If Yours Is High or Low</title>
      <description><![CDATA[Understanding normal testosterone ranges helps identify hormone imbalances affecting mood, energy, and health, guiding testing, diagnosis, and informed treatment decisions for men and women. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-normal-testosterone-levels-how-to-know-if-yours-is-high-or-low-dJ5gHZAc</link>
      <enclosure length="947556" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8c5711a4-7a7b-459d-92e0-fee36c671dba/audio/172575b3-79c7-4219-87b5-4c411fd37240/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Normal Testosterone Levels: How to Know If Yours Is High or Low</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:59</itunes:duration>
      <itunes:summary>Understanding normal testosterone ranges helps identify hormone imbalances affecting mood, energy, and health, guiding testing, diagnosis, and informed treatment decisions for men and women.</itunes:summary>
      <itunes:subtitle>Understanding normal testosterone ranges helps identify hormone imbalances affecting mood, energy, and health, guiding testing, diagnosis, and informed treatment decisions for men and women.</itunes:subtitle>
      <itunes:keywords>energy, and informed treatment decisions for men and women., diagnosis, understanding normal testosterone ranges helps identify hormone imbalances affecting mood, and health, guiding testing</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>163</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f09054b7-837d-4457-ad0f-8e17d57528ad</guid>
      <title>Serum IgE and Eosinophilia May Influence Seborrheic Dermatitis: Exploring Allergy Connections</title>
      <description><![CDATA[Elevated allergy-related immune markers in seborrheic dermatitis suggest a possible allergic component, prompting reconsideration of disease mechanisms and treatment approaches while causality remains under investigation. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/serum-ige-and-eosinophilia-may-influence-seborrheic-dermatitis-exploring-allergy-connections-bp2D6tOP</link>
      <enclosure length="1860379" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/dc23f935-ce91-42c7-8460-8ec40c456192/audio/a901524b-5720-4cf5-a83c-2b133f163514/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Serum IgE and Eosinophilia May Influence Seborrheic Dermatitis: Exploring Allergy Connections</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:56</itunes:duration>
      <itunes:summary>Elevated allergy-related immune markers in seborrheic dermatitis suggest a possible allergic component, prompting reconsideration of disease mechanisms and treatment approaches while causality remains under investigation.</itunes:summary>
      <itunes:subtitle>Elevated allergy-related immune markers in seborrheic dermatitis suggest a possible allergic component, prompting reconsideration of disease mechanisms and treatment approaches while causality remains under investigation.</itunes:subtitle>
      <itunes:keywords>elevated allergy-related immune markers in seborrheic dermatitis suggest a possible allergic component, prompting reconsideration of disease mechanisms and treatment approaches while causality remains under investigation.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>162</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">672bbac3-3e29-4bae-8d98-0357e922ea25</guid>
      <title>Revolutionary Lightweight Robotic Prosthesis for Lower Limbs</title>
      <description><![CDATA[Advanced robotic knee-ankle prostheses improve coordination and joint function, enabling amputees to perform demanding daily activities with more natural movement, independence, and improved quality of life. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/revolutionary-lightweight-robotic-prosthesis-for-lower-limbs-xF2rrlbh</link>
      <enclosure length="1601244" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/9fc3a86a-baf2-406d-a74c-2710e2d0d053/audio/b0f5e717-f93a-4b6d-b537-0724b97b87b6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Revolutionary Lightweight Robotic Prosthesis for Lower Limbs</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Advanced robotic knee-ankle prostheses improve coordination and joint function, enabling amputees to perform demanding daily activities with more natural movement, independence, and improved quality of life.</itunes:summary>
      <itunes:subtitle>Advanced robotic knee-ankle prostheses improve coordination and joint function, enabling amputees to perform demanding daily activities with more natural movement, independence, and improved quality of life.</itunes:subtitle>
      <itunes:keywords>and improved quality of life., advanced robotic knee-ankle prostheses improve coordination and joint function, independence, enabling amputees to perform demanding daily activities with more natural movement</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>161</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1aa1fce4-2144-46e6-85b0-fb9ef541a305</guid>
      <title>Retinal Microvascular Changes Linked to Obstructive Sleep Apnea</title>
      <description><![CDATA[Retinal imaging reveals microvascular changes in patients with obstructive sleep apnea, highlighting links between sleep disorders and eye health, and emphasizing the importance of early ophthalmic screening. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/retinal-microvascular-changes-linked-to-obstructive-sleep-apnea-fznoByYs</link>
      <enclosure length="1274400" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2ce490e8-9aa2-4284-a6c8-83ee34e828e4/audio/d7669a7e-1e6d-4a7f-891f-bf298ca15719/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Retinal Microvascular Changes Linked to Obstructive Sleep Apnea</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:19</itunes:duration>
      <itunes:summary>Retinal imaging reveals microvascular changes in patients with obstructive sleep apnea, highlighting links between sleep disorders and eye health, and emphasizing the importance of early ophthalmic screening.</itunes:summary>
      <itunes:subtitle>Retinal imaging reveals microvascular changes in patients with obstructive sleep apnea, highlighting links between sleep disorders and eye health, and emphasizing the importance of early ophthalmic screening.</itunes:subtitle>
      <itunes:keywords>highlighting links between sleep disorders and eye health, and emphasizing the importance of early ophthalmic screening., retinal imaging reveals microvascular changes in patients with obstructive sleep apnea</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>160</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a7477299-77e4-4efe-9c1f-1d91f9912240</guid>
      <title>Labor Induction Trends: Increasing Early-Term and Preterm Deliveries in the U.S.</title>
      <description><![CDATA[Rising early labor inductions before 39 weeks are prompting scrutiny of maternal and neonatal safety, challenging obstetric guidelines and decision-making for mothers and care teams. 
]]></description>
      <pubDate>Wed, 4 Feb 2026 14:16:22 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/labor-induction-trends-increasing-early-term-and-preterm-deliveries-in-the-us-eXg6Xs_V</link>
      <enclosure length="1606260" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7e1815b0-fef8-4368-9e9e-7aba17b32e11/audio/d3544397-62ed-43ce-8d85-dfb8a07429dd/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Labor Induction Trends: Increasing Early-Term and Preterm Deliveries in the U.S.</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Rising early labor inductions before 39 weeks are prompting scrutiny of maternal and neonatal safety, challenging obstetric guidelines and decision-making for mothers and care teams.</itunes:summary>
      <itunes:subtitle>Rising early labor inductions before 39 weeks are prompting scrutiny of maternal and neonatal safety, challenging obstetric guidelines and decision-making for mothers and care teams.</itunes:subtitle>
      <itunes:keywords>challenging obstetric guidelines and decision-making for mothers and care teams., rising early labor inductions before 39 weeks are prompting scrutiny of maternal and neonatal safety</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>159</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">908117a9-ee9f-4536-a9ce-c7ee273eb72f</guid>
      <title>Real-World Data on GLP-1 Receptor Agonists Highlight Benefits and Risks</title>
      <description><![CDATA[Emerging real-world data are shaping debates on GLP-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/real-world-data-on-glp-1-receptor-agonists-highlight-benefits-and-risks-T19Fg0_a</link>
      <enclosure length="1711585" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/ce61a693-f1ab-45ec-ac29-5cc8a3bb2c5e/audio/50bdb173-a055-43f6-a3ec-11aaf3120402/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Real-World Data on GLP-1 Receptor Agonists Highlight Benefits and Risks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Emerging real-world data are shaping debates on GLP-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity.</itunes:summary>
      <itunes:subtitle>Emerging real-world data are shaping debates on GLP-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity.</itunes:subtitle>
      <itunes:keywords>emerging real-world data are shaping debates on glp-1 receptor agonists’ effectiveness and safety, influencing weight and metabolic care decisions for patients and clinicians managing diabetes and obesity.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>158</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f6000d5f-7e9f-4435-9acf-0407248cf649</guid>
      <title>Etonogestrel Implant Approved for Extended Five Year Contraception</title>
      <description><![CDATA[FDA approval extends etonogestrel implant use to five years, offering sustained 99% efficacy, fewer visits, lower costs, and improved access to long-acting contraception for women. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/etonogestrel-implant-approved-for-extended-five-year-contraception-_A4nKR7U</link>
      <enclosure length="1493411" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/269da494-c5f3-4817-95b3-6e87ca26bcf9/audio/46e1cebd-6061-4cef-8552-b6f6811613e2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Etonogestrel Implant Approved for Extended Five Year Contraception</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>FDA approval extends etonogestrel implant use to five years, offering sustained 99% efficacy, fewer visits, lower costs, and improved access to long-acting contraception for women.</itunes:summary>
      <itunes:subtitle>FDA approval extends etonogestrel implant use to five years, offering sustained 99% efficacy, fewer visits, lower costs, and improved access to long-acting contraception for women.</itunes:subtitle>
      <itunes:keywords>lower costs, and improved access to long-acting contraception for women., offering sustained 99% efficacy, fda approval extends etonogestrel implant use to five years, fewer visits</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>157</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c4d9ed42-084d-497e-b977-bea56515af72</guid>
      <title>Psoriasis Burden Varies Across Age Groups and Developmental Stages</title>
      <description><![CDATA[Psoriasis prevalence is rising globally, especially among older adults, increasing long-term healthcare burden and underscoring the need for integrated management addressing skin disease, comorbidities, and psychosocial impacts. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psoriasis-burden-varies-across-age-groups-and-developmental-stages-Wdo3llDC</link>
      <enclosure length="1727468" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b793dc12-190a-4ef8-8965-129f3d6610c2/audio/8c36c40a-f2c1-43fe-a727-4e8074cf0441/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psoriasis Burden Varies Across Age Groups and Developmental Stages</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Psoriasis prevalence is rising globally, especially among older adults, increasing long-term healthcare burden and underscoring the need for integrated management addressing skin disease, comorbidities, and psychosocial impacts.</itunes:summary>
      <itunes:subtitle>Psoriasis prevalence is rising globally, especially among older adults, increasing long-term healthcare burden and underscoring the need for integrated management addressing skin disease, comorbidities, and psychosocial impacts.</itunes:subtitle>
      <itunes:keywords>especially among older adults, psoriasis prevalence is rising globally, increasing long-term healthcare burden and underscoring the need for integrated management addressing skin disease, and psychosocial impacts., comorbidities</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>156</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b90c58e0-d7f1-4123-a7ae-c87e223e65d6</guid>
      <title>Combination Hormone Therapy and Tirzepatide May Improve Weight Loss After Menopause</title>
      <description><![CDATA[Emerging evidence suggests menopausal hormone therapy may enhance weight loss with medications like tirzepatide, highlighting synergistic strategies for managing obesity and cardiometabolic risk in postmenopausal women. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/combination-hormone-therapy-and-tirzepatide-may-improve-weight-loss-after-menopause-4Zzvr3Bn</link>
      <enclosure length="1262279" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1a8ead81-2a4e-4cd5-8fb0-5786c1d04c7e/audio/3d7a172f-24d0-49ad-a726-37f27f148dfd/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Combination Hormone Therapy and Tirzepatide May Improve Weight Loss After Menopause</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Emerging evidence suggests menopausal hormone therapy may enhance weight loss with medications like tirzepatide, highlighting synergistic strategies for managing obesity and cardiometabolic risk in postmenopausal women.</itunes:summary>
      <itunes:subtitle>Emerging evidence suggests menopausal hormone therapy may enhance weight loss with medications like tirzepatide, highlighting synergistic strategies for managing obesity and cardiometabolic risk in postmenopausal women.</itunes:subtitle>
      <itunes:keywords>emerging evidence suggests menopausal hormone therapy may enhance weight loss with medications like tirzepatide, highlighting synergistic strategies for managing obesity and cardiometabolic risk in postmenopausal women.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>155</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5b3d2450-34ff-4fcb-9343-13c0c50c380e</guid>
      <title>Pregnancy Complications May Increase Autism Risk in Offspring</title>
      <description><![CDATA[Observational research links pregnancy complications to higher autism risk, underscoring maternal metabolic, cardiovascular, and inflammatory health as factors informing prenatal care, counseling, and prevention strategies. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pregnancy-complications-may-increase-autism-risk-in-offspring-ZwS5u98s</link>
      <enclosure length="1892144" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/707358e2-9d5d-4021-8ac6-5a8bc30027f9/audio/1b305580-6733-4f2b-8e24-2656e9dea291/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pregnancy Complications May Increase Autism Risk in Offspring</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:58</itunes:duration>
      <itunes:summary>Observational research links pregnancy complications to higher autism risk, underscoring maternal metabolic, cardiovascular, and inflammatory health as factors informing prenatal care, counseling, and prevention strategies.</itunes:summary>
      <itunes:subtitle>Observational research links pregnancy complications to higher autism risk, underscoring maternal metabolic, cardiovascular, and inflammatory health as factors informing prenatal care, counseling, and prevention strategies.</itunes:subtitle>
      <itunes:keywords>and inflammatory health as factors informing prenatal care, observational research links pregnancy complications to higher autism risk, and prevention strategies., counseling, underscoring maternal metabolic, cardiovascular</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>154</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4a2faf84-3c10-439e-a88d-5156e9469143</guid>
      <title>Whole Brain Radiation Therapy Shows Limited Benefit in Thyroid Cancer Brain Metastases</title>
      <description><![CDATA[Emerging evidence questions whole brain radiation benefits for thyroid cancer brain metastases, suggesting limited survival impact when combined with surgery, stereotactic radiosurgery, or targeted systemic therapies. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/whole-brain-radiation-therapy-shows-limited-benefit-in-thyroid-cancer-brain-metastases-bz5w0vJZ</link>
      <enclosure length="1905101" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/061b93e0-b8be-40da-b25b-20a17c7acbd1/audio/bef75b35-1965-48df-9691-32108e6b0138/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Whole Brain Radiation Therapy Shows Limited Benefit in Thyroid Cancer Brain Metastases</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:59</itunes:duration>
      <itunes:summary>Emerging evidence questions whole brain radiation benefits for thyroid cancer brain metastases, suggesting limited survival impact when combined with surgery, stereotactic radiosurgery, or targeted systemic therapies.</itunes:summary>
      <itunes:subtitle>Emerging evidence questions whole brain radiation benefits for thyroid cancer brain metastases, suggesting limited survival impact when combined with surgery, stereotactic radiosurgery, or targeted systemic therapies.</itunes:subtitle>
      <itunes:keywords>or targeted systemic therapies., emerging evidence questions whole brain radiation benefits for thyroid cancer brain metastases, suggesting limited survival impact when combined with surgery, stereotactic radiosurgery</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>153</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">166750ec-53c5-4a94-95eb-ff8fe5530607</guid>
      <title>Hearing Aids May Not Boost Cognitive Test Scores in Older Adults</title>
      <description><![CDATA[Evidence suggests hearing aids improve communication but do not significantly boost cognitive test performance in older adults, prompting reconsideration of strategies linking hearing loss treatment to cognitive health. 
]]></description>
      <pubDate>Tue, 3 Feb 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hearing-aids-may-not-boost-cognitive-test-scores-in-older-adults-dkmaK1Jg</link>
      <enclosure length="1263115" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cd4853ec-4c2e-47d1-8ad3-0ac47e5a5c98/audio/7dd95c1e-1277-48e2-ad1c-5f77267ac4e6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Hearing Aids May Not Boost Cognitive Test Scores in Older Adults</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Evidence suggests hearing aids improve communication but do not significantly boost cognitive test performance in older adults, prompting reconsideration of strategies linking hearing loss treatment to cognitive health.</itunes:summary>
      <itunes:subtitle>Evidence suggests hearing aids improve communication but do not significantly boost cognitive test performance in older adults, prompting reconsideration of strategies linking hearing loss treatment to cognitive health.</itunes:subtitle>
      <itunes:keywords>prompting reconsideration of strategies linking hearing loss treatment to cognitive health., evidence suggests hearing aids improve communication but do not significantly boost cognitive test performance in older adults</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>152</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">231b98f4-ba77-402c-b103-2e6d8d9caa30</guid>
      <title>Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight</title>
      <description><![CDATA[CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/novel-drug-may-help-adults-with-obesity-lose-up-to-225-weight-VlDJk9UO</link>
      <enclosure length="1483798" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f46114b7-5246-4a12-929e-e6750470648d/audio/033aa692-9076-48b1-b048-071baf7d716c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Novel Drug May Help Adults with Obesity Lose Up to 22.5% Weight</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.</itunes:summary>
      <itunes:subtitle>CT-388, a dual GLP-1/GIP agonist, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.</itunes:subtitle>
      <itunes:keywords>a dual glp-1/gip agonist, ct-388, demonstrated over 22% weight loss at 48 weeks, offering a promising new treatment option for adults with obesity.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>151</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b08c1971-e07d-4c6d-872d-9c53396ea29f</guid>
      <title>Key Insights Into Heart Issues in Chronic Kidney Disease</title>
      <description><![CDATA[New research links chronic kidney disease to heart damage via harmful kidney-derived particles, highlighting opportunities for earlier detection, targeted therapies, and improved cardiovascular risk management in CKD patients. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/key-insights-into-heart-issues-in-chronic-kidney-disease-GistGV72</link>
      <enclosure length="1192480" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7436d4e3-1829-44a9-8499-01694650b7f4/audio/467c780d-f1ec-4d0e-b0ad-9753ca4b419a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Key Insights Into Heart Issues in Chronic Kidney Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>New research links chronic kidney disease to heart damage via harmful kidney-derived particles, highlighting opportunities for earlier detection, targeted therapies, and improved cardiovascular risk management in CKD patients.</itunes:summary>
      <itunes:subtitle>New research links chronic kidney disease to heart damage via harmful kidney-derived particles, highlighting opportunities for earlier detection, targeted therapies, and improved cardiovascular risk management in CKD patients.</itunes:subtitle>
      <itunes:keywords>targeted therapies, and improved cardiovascular risk management in ckd patients., highlighting opportunities for earlier detection, new research links chronic kidney disease to heart damage via harmful kidney-derived particles</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>150</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">218498d1-9a8b-4fd7-a46a-53ec5833bda8</guid>
      <title>polyfluoroalkyl substances (PFAS) Exposure May Increase Risk of Gestational Diabetes</title>
      <description><![CDATA[PFAS exposure during pregnancy may increase gestational diabetes risk, underscoring environmental health concerns and the need for awareness, prevention strategies, and guidance during prenatal care. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/polyfluoroalkyl-substances-pfas-exposure-may-increase-risk-of-gestational-diabetes-tuvLXCzT</link>
      <enclosure length="1514309" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/61de88ae-6ba8-40d8-9f04-10c30f32a6cd/audio/9d05d57b-909a-4319-9028-f01a2d6fcaab/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>polyfluoroalkyl substances (PFAS) Exposure May Increase Risk of Gestational Diabetes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>PFAS exposure during pregnancy may increase gestational diabetes risk, underscoring environmental health concerns and the need for awareness, prevention strategies, and guidance during prenatal care.</itunes:summary>
      <itunes:subtitle>PFAS exposure during pregnancy may increase gestational diabetes risk, underscoring environmental health concerns and the need for awareness, prevention strategies, and guidance during prenatal care.</itunes:subtitle>
      <itunes:keywords>prevention strategies, pfas exposure during pregnancy may increase gestational diabetes risk, underscoring environmental health concerns and the need for awareness, and guidance during prenatal care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>149</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">311f5fce-2bff-4a14-911b-d4173faa8cea</guid>
      <title>Depression May Influence Recall of Adverse Childhood Experiences</title>
      <description><![CDATA[Depression in adolescents may alter recall of adverse childhood experiences, highlighting important links between mood, memory, and trauma that could influence mental health assessment and support strategies. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/depression-may-influence-recall-of-adverse-childhood-experiences-jB4aoixF</link>
      <enclosure length="979321" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/586efb92-1db2-41e2-b691-3a0b33bdaaa4/audio/53466e15-f2cb-4d57-9e50-b0ef99003b1e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Depression May Influence Recall of Adverse Childhood Experiences</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:01</itunes:duration>
      <itunes:summary>Depression in adolescents may alter recall of adverse childhood experiences, highlighting important links between mood, memory, and trauma that could influence mental health assessment and support strategies.</itunes:summary>
      <itunes:subtitle>Depression in adolescents may alter recall of adverse childhood experiences, highlighting important links between mood, memory, and trauma that could influence mental health assessment and support strategies.</itunes:subtitle>
      <itunes:keywords>and trauma that could influence mental health assessment and support strategies., depression in adolescents may alter recall of adverse childhood experiences, highlighting important links between mood, memory</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>147</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">40a4f430-b4ee-4b65-8df9-f598cd945095</guid>
      <title>Comparing 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer</title>
      <description><![CDATA[ANDROMEDA trial compares alpha and beta PSMA radioligand therapies with SBRT for recurrent oligometastatic prostate cancer, aiming to improve disease control and quality of life. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/comparing-225ac-psma-617-and-177lu-psma-617-in-prostate-cancer-LcnfbRyH</link>
      <enclosure length="2061417" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/76b367fc-400e-4b8c-aa82-b1c8bff18b93/audio/796f56b1-5807-40a0-9e34-10bddddb83ca/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Comparing 225Ac-PSMA-617 and 177Lu-PSMA-617 in Prostate Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:08</itunes:duration>
      <itunes:summary>ANDROMEDA trial compares alpha and beta PSMA radioligand therapies with SBRT for recurrent oligometastatic prostate cancer, aiming to improve disease control and quality of life.</itunes:summary>
      <itunes:subtitle>ANDROMEDA trial compares alpha and beta PSMA radioligand therapies with SBRT for recurrent oligometastatic prostate cancer, aiming to improve disease control and quality of life.</itunes:subtitle>
      <itunes:keywords>aiming to improve disease control and quality of life., andromeda trial compares alpha and beta psma radioligand therapies with sbrt for recurrent oligometastatic prostate cancer</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>146</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d085d77b-d792-4db9-95ce-79bf38688386</guid>
      <title>Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer</title>
      <description><![CDATA[Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/circulating-tumor-dna-monitoring-in-stage-ii-iii-breast-cancer-C2YK_90m</link>
      <enclosure length="2184715" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7321a60f-c541-4d5f-841c-4aadfd859065/audio/f804aff3-4196-4fe3-827b-4d393b6ae378/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Circulating Tumor DNA Monitoring in Stage II-III Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:16</itunes:duration>
      <itunes:summary>Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.</itunes:summary>
      <itunes:subtitle>Circulating tumor DNA testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, monitoring, and treatment adjustments that could improve survival outcomes rates.</itunes:subtitle>
      <itunes:keywords>monitoring, circulating tumor dna testing shows promise predicting relapse in high-risk breast cancer, enabling earlier intervention, and treatment adjustments that could improve survival outcomes rates.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>145</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ec3d162d-13ec-4908-9cd1-2fe8df9bd548</guid>
      <title>Selective Radioactive Iodine Linked to Improved Thyroid Cancer Survival</title>
      <description><![CDATA[Selective radioactive iodine therapy for thyroid cancer shows improved survival, reinforcing personalized treatment approaches and guiding clinicians toward more targeted, effective care strategies. 
]]></description>
      <pubDate>Mon, 2 Feb 2026 14:04:42 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/selective-radioactive-iodine-linked-to-improved-thyroid-cancer-survival-ldaQ4TKu</link>
      <enclosure length="1065421" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e98b831e-30f3-42de-90e6-9a4d94ea7a1f/audio/861f34be-5725-4ad6-a949-10fa2da02c00/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Selective Radioactive Iodine Linked to Improved Thyroid Cancer Survival</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:06</itunes:duration>
      <itunes:summary>Selective radioactive iodine therapy for thyroid cancer shows improved survival, reinforcing personalized treatment approaches and guiding clinicians toward more targeted, effective care strategies.</itunes:summary>
      <itunes:subtitle>Selective radioactive iodine therapy for thyroid cancer shows improved survival, reinforcing personalized treatment approaches and guiding clinicians toward more targeted, effective care strategies.</itunes:subtitle>
      <itunes:keywords>reinforcing personalized treatment approaches and guiding clinicians toward more targeted, effective care strategies., selective radioactive iodine therapy for thyroid cancer shows improved survival</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>144</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">12804402-2523-4d34-9b0a-142796018187</guid>
      <title>Childhood Vaccine Recommendations: Diverging From Federal Guidelines</title>
      <description><![CDATA[Diverging state vaccine guidelines for children challenge federal recommendations, risking confusion for parents and providers, inconsistent coverage, and public health impacts as school season nears. 
]]></description>
      <pubDate>Fri, 30 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/childhood-vaccine-recommendations-diverging-from-federal-guidelines-xCgL8Rkh</link>
      <enclosure length="1449107" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/430c0133-4760-43e3-9698-05ed05a24c10/audio/2720c853-4f13-4ee3-a173-461e3539ae65/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Childhood Vaccine Recommendations: Diverging From Federal Guidelines</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:30</itunes:duration>
      <itunes:summary>Diverging state vaccine guidelines for children challenge federal recommendations, risking confusion for parents and providers, inconsistent coverage, and public health impacts as school season nears.</itunes:summary>
      <itunes:subtitle>Diverging state vaccine guidelines for children challenge federal recommendations, risking confusion for parents and providers, inconsistent coverage, and public health impacts as school season nears.</itunes:subtitle>
      <itunes:keywords>risking confusion for parents and providers, inconsistent coverage, diverging state vaccine guidelines for children challenge federal recommendations, and public health impacts as school season nears.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>143</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d65ee9cb-38dd-4ccc-a366-5ebf652511b0</guid>
      <title>Mobile Support From Ex-Smokers May Boost Smoking Abstinence</title>
      <description><![CDATA[Mobile behavioral support from former smokers may improve smoking cessation rates, offering a scalable, peer-driven approach that complements existing programs and strengthens public health efforts to reduce tobacco use. 
]]></description>
      <pubDate>Fri, 30 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mobile-support-from-ex-smokers-may-boost-smoking-abstinence-jN_Suo_W</link>
      <enclosure length="1184957" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b718e469-c43b-43ad-b6f7-59c9af12fc93/audio/e031194e-eda1-418f-9d08-509a1d2fb024/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mobile Support From Ex-Smokers May Boost Smoking Abstinence</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>Mobile behavioral support from former smokers may improve smoking cessation rates, offering a scalable, peer-driven approach that complements existing programs and strengthens public health efforts to reduce tobacco use.</itunes:summary>
      <itunes:subtitle>Mobile behavioral support from former smokers may improve smoking cessation rates, offering a scalable, peer-driven approach that complements existing programs and strengthens public health efforts to reduce tobacco use.</itunes:subtitle>
      <itunes:keywords>peer-driven approach that complements existing programs and strengthens public health efforts to reduce tobacco use., offering a scalable, mobile behavioral support from former smokers may improve smoking cessation rates</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>142</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">43410659-291f-415f-b0ff-0c2d8ae016d6</guid>
      <title>Tirzepatide May Reduce Diabetic Retinopathy Risk in Patients With Diabetes</title>
      <description><![CDATA[Tirzepatide’s weight-loss benefits may also lower diabetic retinopathy risk through improved metabolic control, potentially influencing diabetes management strategies for overweight patients at risk of eye complications. 
]]></description>
      <pubDate>Fri, 30 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/tirzepatide-may-reduce-diabetic-retinopathy-risk-in-patients-with-diabetes-E6mJBsyQ</link>
      <enclosure length="1415252" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/bee83a28-c2dd-442b-a574-17b173d88682/audio/e09d15b9-f3ef-4479-b746-abff2f45f917/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Tirzepatide May Reduce Diabetic Retinopathy Risk in Patients With Diabetes</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>Tirzepatide’s weight-loss benefits may also lower diabetic retinopathy risk through improved metabolic control, potentially influencing diabetes management strategies for overweight patients at risk of eye complications.</itunes:summary>
      <itunes:subtitle>Tirzepatide’s weight-loss benefits may also lower diabetic retinopathy risk through improved metabolic control, potentially influencing diabetes management strategies for overweight patients at risk of eye complications.</itunes:subtitle>
      <itunes:keywords>tirzepatide’s weight-loss benefits may also lower diabetic retinopathy risk through improved metabolic control, potentially influencing diabetes management strategies for overweight patients at risk of eye complications.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>141</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b99c9045-654a-4f2e-ac9f-3dca8930ac63</guid>
      <title>Advancing Musculoskeletal and Joint Health (MASH): Risk Factors and Emerging Treatments</title>
      <description><![CDATA[Advances in musculoskeletal and joint health highlight key risk factors and emerging therapies, offering prevention, pain relief, mobility, and strategies for patients with joint disorders. 
]]></description>
      <pubDate>Fri, 30 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancing-musculoskeletal-and-joint-health-mash-risk-factors-and-emerging-treatments-b9o3Y4fI</link>
      <enclosure length="1451615" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a9eb73e1-7ba4-428a-a9c0-c3e6b3f7c083/audio/25a6b544-9d9b-4569-ad85-14415334d082/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancing Musculoskeletal and Joint Health (MASH): Risk Factors and Emerging Treatments</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:30</itunes:duration>
      <itunes:summary>Advances in musculoskeletal and joint health highlight key risk factors and emerging therapies, offering prevention, pain relief, mobility, and strategies for patients with joint disorders.</itunes:summary>
      <itunes:subtitle>Advances in musculoskeletal and joint health highlight key risk factors and emerging therapies, offering prevention, pain relief, mobility, and strategies for patients with joint disorders.</itunes:subtitle>
      <itunes:keywords>mobility, advances in musculoskeletal and joint health highlight key risk factors and emerging therapies, offering prevention, pain relief, and strategies for patients with joint disorders.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>140</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">89cc6963-36fc-49fa-87f9-a13b68eb0ca3</guid>
      <title>Assessing Real Advances in Hidradenitis Suppurativa Treatment: Measuring Progress Effectively</title>
      <description><![CDATA[Improved measurement tools for hidradenitis suppurativa emphasize patient-reported outcomes, helping clinicians track real-world treatment impact, personalize care, and improve quality of life and clinical decision-making. 
]]></description>
      <pubDate>Fri, 30 Jan 2026 14:15:12 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/assessing-real-advances-in-hidradenitis-suppurativa-treatment-measuring-progress-effectively-PZJgO55C</link>
      <enclosure length="1451615" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/748e3e2a-7fe1-4dea-8585-6d53e497e033/audio/973dd675-527d-440c-b2de-c8e346d2e6d5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Assessing Real Advances in Hidradenitis Suppurativa Treatment: Measuring Progress Effectively</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:30</itunes:duration>
      <itunes:summary>Improved measurement tools for hidradenitis suppurativa emphasize patient-reported outcomes, helping clinicians track real-world treatment impact, personalize care, and improve quality of life and clinical decision-making.</itunes:summary>
      <itunes:subtitle>Improved measurement tools for hidradenitis suppurativa emphasize patient-reported outcomes, helping clinicians track real-world treatment impact, personalize care, and improve quality of life and clinical decision-making.</itunes:subtitle>
      <itunes:keywords>improved measurement tools for hidradenitis suppurativa emphasize patient-reported outcomes, personalize care, helping clinicians track real-world treatment impact, and improve quality of life and clinical decision-making.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>139</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f8eda978-74d4-4393-96f1-84c31e73c169</guid>
      <title>Predicting Lung Disease in Rheumatoid Arthritis: A New Risk Model</title>
      <description><![CDATA[Emerging research improves prediction of rheumatoid arthritis–related lung disease progression, enabling earlier intervention, personalized treatment, and better outcomes for patients facing serious respiratory complications worldwide. 
]]></description>
      <pubDate>Thu, 29 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/predicting-lung-disease-in-rheumatoid-arthritis-a-new-risk-model-gM5IHw9u</link>
      <enclosure length="1179105" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d584589b-db93-4a8f-be96-9a076986062f/audio/808f4f96-f8bf-4cf9-8903-3a28721bf00a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Predicting Lung Disease in Rheumatoid Arthritis: A New Risk Model</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:13</itunes:duration>
      <itunes:summary>Emerging research improves prediction of rheumatoid arthritis–related lung disease progression, enabling earlier intervention, personalized treatment, and better outcomes for patients facing serious respiratory complications worldwide.</itunes:summary>
      <itunes:subtitle>Emerging research improves prediction of rheumatoid arthritis–related lung disease progression, enabling earlier intervention, personalized treatment, and better outcomes for patients facing serious respiratory complications worldwide.</itunes:subtitle>
      <itunes:keywords>emerging research improves prediction of rheumatoid arthritis–related lung disease progression, personalized treatment, and better outcomes for patients facing serious respiratory complications worldwide., enabling earlier intervention</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>138</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ed97a54-8c0a-43d7-8da5-61d5ea6d898e</guid>
      <title>Personalized Strategies for Managing Metabolic Dysfunction–Associated Steatohepatitis (MASH)</title>
      <description><![CDATA[Advances in understanding MASH are enabling earlier diagnosis and personalized treatment, offering new hope for patients with obesity, diabetes, and metabolic conditions at risk complications. 
]]></description>
      <pubDate>Thu, 29 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/personalized-strategies-for-managing-metabolic-dysfunctionassociated-steatohepatitis-mash-H3cj_bKJ</link>
      <enclosure length="1222155" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0deb3062-2e35-48db-b4c5-029fe7beabcd/audio/7945bd0f-84c7-4bf9-a8e2-3666cc33f1e8/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Personalized Strategies for Managing Metabolic Dysfunction–Associated Steatohepatitis (MASH)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:16</itunes:duration>
      <itunes:summary>Advances in understanding MASH are enabling earlier diagnosis and personalized treatment, offering new hope for patients with obesity, diabetes, and metabolic conditions at risk complications.</itunes:summary>
      <itunes:subtitle>Advances in understanding MASH are enabling earlier diagnosis and personalized treatment, offering new hope for patients with obesity, diabetes, and metabolic conditions at risk complications.</itunes:subtitle>
      <itunes:keywords>advances in understanding mash are enabling earlier diagnosis and personalized treatment, offering new hope for patients with obesity, diabetes, and metabolic conditions at risk complications.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>137</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">154c8323-9c41-4cc0-a7aa-3f74ffcbabf5</guid>
      <title>Long-Term Outcomes of Faricimab in Diabetic Macular Edema</title>
      <description><![CDATA[Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes. 
]]></description>
      <pubDate>Thu, 29 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/long-term-outcomes-of-faricimab-in-diabetic-macular-edema-9KZiVMXm</link>
      <enclosure length="1458720" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/65f81501-8973-41e4-9b06-b65db94260eb/audio/93705d1c-4187-4a2f-a597-79d4ade85668/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Long-Term Outcomes of Faricimab in Diabetic Macular Edema</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.</itunes:summary>
      <itunes:subtitle>Four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.</itunes:subtitle>
      <itunes:keywords>four-year data show faricimab delivers sustained vision and retinal improvements in diabetic macular edema, reducing injection frequency and easing treatment burden for patients with diabetes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>136</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e325823e-03a5-480e-a0d0-cb8ef2ea13e5</guid>
      <title>Build Your Essential Crohn’s Self-Care Routine Today</title>
      <description><![CDATA[Self-care strategies empower people with Crohn’s disease to manage symptoms, reduce flare-ups, and improve quality of life through personalized, evidence-based routines supported by healthcare providers. 
]]></description>
      <pubDate>Thu, 29 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/build-your-essential-crohns-self-care-routine-today-_e6YQP0s</link>
      <enclosure length="1184957" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/38ddc824-4bce-40c3-806e-fe74bedad557/audio/f09135c5-2580-4494-87b4-8fa25a49881c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Build Your Essential Crohn’s Self-Care Routine Today</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>Self-care strategies empower people with Crohn’s disease to manage symptoms, reduce flare-ups, and improve quality of life through personalized, evidence-based routines supported by healthcare providers.</itunes:summary>
      <itunes:subtitle>Self-care strategies empower people with Crohn’s disease to manage symptoms, reduce flare-ups, and improve quality of life through personalized, evidence-based routines supported by healthcare providers.</itunes:subtitle>
      <itunes:keywords>and improve quality of life through personalized, self-care strategies empower people with crohn’s disease to manage symptoms, reduce flare-ups, evidence-based routines supported by healthcare providers.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>135</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">850e618a-2670-419e-be84-2648d5c575df</guid>
      <title>Assessing Kidney Function in Adults with Spina Bifida: Cystatin C vs Creatinine</title>
      <description><![CDATA[Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families. 
]]></description>
      <pubDate>Thu, 29 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/assessing-kidney-function-in-adults-with-spina-bifida-cystatin-c-vs-creatinine-T_CWqIXW</link>
      <enclosure length="1439494" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/6afbf0fa-8ba2-4e00-8ce7-68c7315a55a8/audio/e4da1fb1-1017-4197-a022-9cad7e3dd767/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Assessing Kidney Function in Adults with Spina Bifida: Cystatin C vs Creatinine</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:29</itunes:duration>
      <itunes:summary>Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families.</itunes:summary>
      <itunes:subtitle>Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families.</itunes:subtitle>
      <itunes:keywords>clinicians, and families., guide follow-up care, and improve outcomes for patients, managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>134</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">eaabeec9-217d-4fdc-8f74-69e4b6ec6ee3</guid>
      <title>Managing Early-Stage Pancreatic Cancer</title>
      <description><![CDATA[Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families. 
]]></description>
      <pubDate>Wed, 28 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/managing-early-stage-pancreatic-cancer-apcoL3v4</link>
      <enclosure length="1647220" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/6b0cecdc-f3c5-4cd1-83e0-dbe3641487a4/audio/9803e421-1f5c-402c-9cd0-0cfaa6bf3d95/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Managing Early-Stage Pancreatic Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families.</itunes:summary>
      <itunes:subtitle>Managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence, guide follow-up care, and improve outcomes for patients, clinicians, and families.</itunes:subtitle>
      <itunes:keywords>clinicians, and families., guide follow-up care, and improve outcomes for patients, managing early-stage pancreatic ductal adenocarcinoma after surgery requires improved long-term surveillance to detect recurrence</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>133</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b675286d-7bb0-4089-8d1e-726a8918d5c5</guid>
      <title>Yoga as a Tool in Opioid Addiction Recovery</title>
      <description><![CDATA[Research suggests yoga can ease opioid withdrawal symptoms, supporting holistic recovery programs, improving wellbeing, and offering healthcare systems complementary strategies to strengthen addiction treatment outcomes. 
]]></description>
      <pubDate>Wed, 28 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/yoga-as-a-tool-in-opioid-addiction-recovery-Azi5XgDv</link>
      <enclosure length="1746276" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/52c3d0ea-93ab-4f44-879d-b7d28ec7988e/audio/4ad4065f-cfc2-4265-b26e-79f037abff11/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Yoga as a Tool in Opioid Addiction Recovery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:49</itunes:duration>
      <itunes:summary>Research suggests yoga can ease opioid withdrawal symptoms, supporting holistic recovery programs, improving wellbeing, and offering healthcare systems complementary strategies to strengthen addiction treatment outcomes.</itunes:summary>
      <itunes:subtitle>Research suggests yoga can ease opioid withdrawal symptoms, supporting holistic recovery programs, improving wellbeing, and offering healthcare systems complementary strategies to strengthen addiction treatment outcomes.</itunes:subtitle>
      <itunes:keywords>research suggests yoga can ease opioid withdrawal symptoms, and offering healthcare systems complementary strategies to strengthen addiction treatment outcomes., improving wellbeing, supporting holistic recovery programs</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>132</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">499b7f4c-29f8-40b5-932d-e23bd6186002</guid>
      <title>Adolescent Suicide Risk Factors</title>
      <description><![CDATA[Identifying suicide risk patterns in depressed adolescents, including psychotic features, enables intervention, tailored care, and prevention strategies for clinicians, families, and youth mental health systems. 
]]></description>
      <pubDate>Wed, 28 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/adolescent-suicide-risk-factors-7MAB_XQM</link>
      <enclosure length="1365515" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/77a95d59-b9f4-469e-a6e8-9a4aa93bd976/audio/84ecbeeb-27bd-4a54-9224-5d56018f49ce/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Adolescent Suicide Risk Factors</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Identifying suicide risk patterns in depressed adolescents, including psychotic features, enables intervention, tailored care, and prevention strategies for clinicians, families, and youth mental health systems.</itunes:summary>
      <itunes:subtitle>Identifying suicide risk patterns in depressed adolescents, including psychotic features, enables intervention, tailored care, and prevention strategies for clinicians, families, and youth mental health systems.</itunes:subtitle>
      <itunes:keywords>enables intervention, and prevention strategies for clinicians, families, tailored care, identifying suicide risk patterns in depressed adolescents, including psychotic features, and youth mental health systems.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>131</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6b91e913-60f7-49d6-919e-03bd55c6b4ce</guid>
      <title>Advances in Spinal Cord Stimulation</title>
      <description><![CDATA[ECAP-guided spinal cord stimulation enables closed-loop, personalized pain control, improving consistency and outcomes for chronic pain patients compared with traditional open-loop stimulation methods. 
]]></description>
      <pubDate>Wed, 28 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advances-in-spinal-cord-stimulation-Pjgn_0xB</link>
      <enclosure length="1317450" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c57a2ca4-1749-495a-9232-5bb4540d115a/audio/aaeeaa7e-142c-464b-912d-3d7d27c0650b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advances in Spinal Cord Stimulation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:22</itunes:duration>
      <itunes:summary>ECAP-guided spinal cord stimulation enables closed-loop, personalized pain control, improving consistency and outcomes for chronic pain patients compared with traditional open-loop stimulation methods.</itunes:summary>
      <itunes:subtitle>ECAP-guided spinal cord stimulation enables closed-loop, personalized pain control, improving consistency and outcomes for chronic pain patients compared with traditional open-loop stimulation methods.</itunes:subtitle>
      <itunes:keywords>personalized pain control, improving consistency and outcomes for chronic pain patients compared with traditional open-loop stimulation methods., ecap-guided spinal cord stimulation enables closed-loop</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>130</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1c788447-b748-46f7-933e-fe623a51c6cb</guid>
      <title>Effective Doctor-Patient Communication</title>
      <description><![CDATA[Clear, empathetic communication between clinicians and patients reduces distress, prevents delays, builds trust, and improves outcomes during uncertain or complex medical situations for everyone involved. 
]]></description>
      <pubDate>Wed, 28 Jan 2026 14:13:50 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/effective-doctor-patient-communication-9oEIFVvw</link>
      <enclosure length="1694867" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/30f19cd1-f0da-4c5b-a45d-5968674320b8/audio/b52d1c48-9801-4cde-b1e7-7cac417fd12d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Effective Doctor-Patient Communication</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>Clear, empathetic communication between clinicians and patients reduces distress, prevents delays, builds trust, and improves outcomes during uncertain or complex medical situations for everyone involved.</itunes:summary>
      <itunes:subtitle>Clear, empathetic communication between clinicians and patients reduces distress, prevents delays, builds trust, and improves outcomes during uncertain or complex medical situations for everyone involved.</itunes:subtitle>
      <itunes:keywords>clear, builds trust, prevents delays, and improves outcomes during uncertain or complex medical situations for everyone involved., empathetic communication between clinicians and patients reduces distress</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>129</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fc954b9c-bcb8-45cb-9b8d-41ecb1cbb953</guid>
      <title>Nanoparticle Breakthrough in Infertility Treatment</title>
      <description><![CDATA[Engineered lipid nanoparticles delivering mRNA to the endometrium show promise improving implantation, offering a targeted infertility therapy that could reshape reproductive medicine and gynecologic treatment. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/nanoparticle-breakthrough-in-infertility-treatment-RlEas0oZ</link>
      <enclosure length="1472095" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8d0337da-3a46-44e6-a301-cf690f5e0572/audio/a5d71455-c38a-40f7-a080-0b470ae39a4a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Nanoparticle Breakthrough in Infertility Treatment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Engineered lipid nanoparticles delivering mRNA to the endometrium show promise improving implantation, offering a targeted infertility therapy that could reshape reproductive medicine and gynecologic treatment.</itunes:summary>
      <itunes:subtitle>Engineered lipid nanoparticles delivering mRNA to the endometrium show promise improving implantation, offering a targeted infertility therapy that could reshape reproductive medicine and gynecologic treatment.</itunes:subtitle>
      <itunes:keywords>engineered lipid nanoparticles delivering mrna to the endometrium show promise improving implantation, offering a targeted infertility therapy that could reshape reproductive medicine and gynecologic treatment.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>128</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">927733fd-f4b8-486e-847b-18edafc52629</guid>
      <title>Recognizing Fiber as Essential</title>
      <description><![CDATA[Nutrition experts urge recognizing dietary fiber as an essential nutrient, reshaping guidelines, food labeling, and health strategies to address low intake and reduce disease risk. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/recognizing-fiber-as-essential-_ERUkpD7</link>
      <enclosure length="1133548" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/99fc8731-342b-4796-b8c7-268ea1d8db6b/audio/4577eca6-eb92-4b6b-ab64-b3ac9a806f90/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Recognizing Fiber as Essential</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:10</itunes:duration>
      <itunes:summary>Nutrition experts urge recognizing dietary fiber as an essential nutrient, reshaping guidelines, food labeling, and health strategies to address low intake and reduce disease risk.</itunes:summary>
      <itunes:subtitle>Nutrition experts urge recognizing dietary fiber as an essential nutrient, reshaping guidelines, food labeling, and health strategies to address low intake and reduce disease risk.</itunes:subtitle>
      <itunes:keywords>and health strategies to address low intake and reduce disease risk., food labeling, reshaping guidelines, nutrition experts urge recognizing dietary fiber as an essential nutrient</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>127</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">515b3f7a-4e32-4c3a-9624-ef7cb5c280cf</guid>
      <title>Pancreatic NETs Treatment Strategy</title>
      <description><![CDATA[New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/pancreatic-nets-treatment-strategy-j42eFEm9</link>
      <enclosure length="1281923" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e61dc43b-78aa-46c6-90a6-f334ff38437c/audio/23c0ea52-bc17-4e1b-a75a-7ac874a80f87/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Pancreatic NETs Treatment Strategy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:20</itunes:duration>
      <itunes:summary>New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:summary>
      <itunes:subtitle>New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:subtitle>
      <itunes:keywords>underscoring need for personalized, new research shows standard anxiety and depression treatments often fail autistic individuals, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>126</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6dacc3e6-c5d9-4676-b30d-6ab2f64723a4</guid>
      <title>Bridging the Mental Health Gap for Autism</title>
      <description><![CDATA[New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bridging-the-mental-health-gap-for-autism-gq92rAlq</link>
      <enclosure length="1727050" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d6776689-2a88-45e3-9abc-541c2bddc73b/audio/9c54ffc0-4c57-41e3-bf16-528a5f204ccf/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bridging the Mental Health Gap for Autism</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:summary>
      <itunes:subtitle>New research shows standard anxiety and depression treatments often fail autistic individuals, underscoring need for personalized, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:subtitle>
      <itunes:keywords>underscoring need for personalized, new research shows standard anxiety and depression treatments often fail autistic individuals, culturally responsive mental healthcare models addressing experiences and outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>125</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f6cd3298-82bf-49c7-9dc3-e33f1c65390f</guid>
      <title>The Importance of Sleep on Hormonal Health</title>
      <description><![CDATA[Emerging evidence shows sleep quality influences hormone balance, affecting mood, metabolism, and health, underscoring sleep improvement as a critical strategy for wellness and public health. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-importance-of-sleep-on-hormonal-health-Px2L3inl</link>
      <enclosure length="903252" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/326c6b7d-1b04-418b-8d67-1b8b2d32e05f/audio/828ad171-8724-49d6-8d2d-c820d43710df/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Importance of Sleep on Hormonal Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:56</itunes:duration>
      <itunes:summary>Emerging evidence shows sleep quality influences hormone balance, affecting mood, metabolism, and health, underscoring sleep improvement as a critical strategy for wellness and public health.</itunes:summary>
      <itunes:subtitle>Emerging evidence shows sleep quality influences hormone balance, affecting mood, metabolism, and health, underscoring sleep improvement as a critical strategy for wellness and public health.</itunes:subtitle>
      <itunes:keywords>metabolism, affecting mood, and health, underscoring sleep improvement as a critical strategy for wellness and public health., emerging evidence shows sleep quality influences hormone balance</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>124</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f7acf54f-3baf-4e6f-9a0e-ff638fd4fc74</guid>
      <title>Microscopic Spermatic Cord Denervation_ A Breakthrough in Pain Management</title>
      <description><![CDATA[Microscopic spermatic cord denervation offers a targeted microsurgical solution for chronic post-hernia scrotal pain, delivering high success rates and meaningful quality-of-life improvements for affected men. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/microscopic-spermatic-cord-denervation-a-breakthrough-in-pain-management-PjlYTjmj</link>
      <enclosure length="1538132" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/53a00e6c-85b5-4f65-985d-9ead7b1ba357/audio/d771d2a3-2d25-4cb1-82d6-d31d2c153bb5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Microscopic Spermatic Cord Denervation_ A Breakthrough in Pain Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Microscopic spermatic cord denervation offers a targeted microsurgical solution for chronic post-hernia scrotal pain, delivering high success rates and meaningful quality-of-life improvements for affected men.</itunes:summary>
      <itunes:subtitle>Microscopic spermatic cord denervation offers a targeted microsurgical solution for chronic post-hernia scrotal pain, delivering high success rates and meaningful quality-of-life improvements for affected men.</itunes:subtitle>
      <itunes:keywords>delivering high success rates and meaningful quality-of-life improvements for affected men., microscopic spermatic cord denervation offers a targeted microsurgical solution for chronic post-hernia scrotal pain</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>123</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d5a565a1-9c5c-400e-ac59-2939377e905c</guid>
      <title>Detecting Self-Harm Language on Instagram</title>
      <description><![CDATA[Researchers are developing ethical AI tools to detect self-harm language in youths’ private Instagram conversations, enabling earlier intervention, improved support systems, and safeguards for privacy. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/detecting-self-harm-language-on-instagram-IZAhrj5f</link>
      <enclosure length="1235112" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f2faad5b-f561-4fc6-a9fc-7cd1992c3e75/audio/57c5de8f-14a5-4c6b-ba3c-d04c62576a3b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Detecting Self-Harm Language on Instagram</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:17</itunes:duration>
      <itunes:summary>Researchers are developing ethical AI tools to detect self-harm language in youths’ private Instagram conversations, enabling earlier intervention, improved support systems, and safeguards for privacy.</itunes:summary>
      <itunes:subtitle>Researchers are developing ethical AI tools to detect self-harm language in youths’ private Instagram conversations, enabling earlier intervention, improved support systems, and safeguards for privacy.</itunes:subtitle>
      <itunes:keywords>researchers are developing ethical ai tools to detect self-harm language in youths’ private instagram conversations, and safeguards for privacy., improved support systems, enabling earlier intervention</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>122</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4ab01fae-440c-4912-9643-7c27aae8b88b</guid>
      <title>Virtual Psychedelic Therapy_ AI&apos;s Role in Mental Health</title>
      <description><![CDATA[AI-driven virtual psychedelics may accelerate mental health research, enabling safer, personalized exploration of psychedelic therapies while reshaping how clinicians study, test, and expand treatment accessibility. 
]]></description>
      <pubDate>Tue, 27 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/virtual-psychedelic-therapy-ais-role-in-mental-health-iKI1VHXy</link>
      <enclosure length="2094436" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/be99aa50-1706-4c6a-a3b5-6216f04873dc/audio/e9f1799c-c9ab-4d28-b884-f1a1e58021e8/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Virtual Psychedelic Therapy_ AI&apos;s Role in Mental Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:10</itunes:duration>
      <itunes:summary>AI-driven virtual psychedelics may accelerate mental health research, enabling safer, personalized exploration of psychedelic therapies while reshaping how clinicians study, test, and expand treatment accessibility.</itunes:summary>
      <itunes:subtitle>AI-driven virtual psychedelics may accelerate mental health research, enabling safer, personalized exploration of psychedelic therapies while reshaping how clinicians study, test, and expand treatment accessibility.</itunes:subtitle>
      <itunes:keywords>test, enabling safer, and expand treatment accessibility., ai-driven virtual psychedelics may accelerate mental health research, personalized exploration of psychedelic therapies while reshaping how clinicians study</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>121</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4ff5111a-a709-4c39-8784-7442bbb6da37</guid>
      <title>Cardiovascular Health and Environmental Advocacy</title>
      <description><![CDATA[Global cardiovascular societies urge action on pollution and climate stressors, recognizing environmental risks as critical contributors to heart disease prevention, policy reform, and improved population cardiovascular health. 
]]></description>
      <pubDate>Mon, 26 Jan 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cardiovascular-health-and-environmental-advocacy-7QbsqzEf</link>
      <enclosure length="1290701" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/be78eaea-4c1c-4471-bd52-ed689464d6e1/audio/fe619981-5ae6-45e8-9e5c-adeeed5ce45c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cardiovascular Health and Environmental Advocacy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:20</itunes:duration>
      <itunes:summary>Global cardiovascular societies urge action on pollution and climate stressors, recognizing environmental risks as critical contributors to heart disease prevention, policy reform, and improved population cardiovascular health.</itunes:summary>
      <itunes:subtitle>Global cardiovascular societies urge action on pollution and climate stressors, recognizing environmental risks as critical contributors to heart disease prevention, policy reform, and improved population cardiovascular health.</itunes:subtitle>
      <itunes:keywords>global cardiovascular societies urge action on pollution and climate stressors, and improved population cardiovascular health., recognizing environmental risks as critical contributors to heart disease prevention, policy reform</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>120</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7183294e-a603-40df-9d69-ecf2c6754e8a</guid>
      <title>Digital Mental Health Tools for Students</title>
      <description><![CDATA[University students increasingly rely on digital tools for stress management, prompting evaluation of self-directed effectiveness to improve campus mental health support, engagement strategies, and student well-being outcomes. 
]]></description>
      <pubDate>Mon, 26 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/digital-mental-health-tools-for-students-m7m0_bqC</link>
      <enclosure length="1199167" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/57a18121-1057-4eaf-9cb8-ad78f360ed9f/audio/593b3433-acae-4294-a35d-b085ce427b8a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Digital Mental Health Tools for Students</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:14</itunes:duration>
      <itunes:summary>University students increasingly rely on digital tools for stress management, prompting evaluation of self-directed effectiveness to improve campus mental health support, engagement strategies, and student well-being outcomes.</itunes:summary>
      <itunes:subtitle>University students increasingly rely on digital tools for stress management, prompting evaluation of self-directed effectiveness to improve campus mental health support, engagement strategies, and student well-being outcomes.</itunes:subtitle>
      <itunes:keywords>university students increasingly rely on digital tools for stress management, engagement strategies, prompting evaluation of self-directed effectiveness to improve campus mental health support, and student well-being outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>119</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bcd64f02-e9b6-490a-86c4-afcaa9bc5883</guid>
      <title>Alzheimer&apos;s Biomarkers in Psychiatry</title>
      <description><![CDATA[Emerging evidence links Alzheimer’s biomarkers with psychosis and neuropsychiatric symptoms, prompting integrated neurological-psychiatric diagnostics, earlier cognitive assessment, and collaborative care to improve patient outcomes globally. 
]]></description>
      <pubDate>Mon, 26 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/alzheimers-biomarkers-in-psychiatry-v8v4WWYg</link>
      <enclosure length="1342945" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7028250c-3739-4350-9116-1da73739691b/audio/2a99797b-6a9e-4b0d-ba6a-08c5ed9c7dc6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Alzheimer&apos;s Biomarkers in Psychiatry</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Emerging evidence links Alzheimer’s biomarkers with psychosis and neuropsychiatric symptoms, prompting integrated neurological-psychiatric diagnostics, earlier cognitive assessment, and collaborative care to improve patient outcomes globally.</itunes:summary>
      <itunes:subtitle>Emerging evidence links Alzheimer’s biomarkers with psychosis and neuropsychiatric symptoms, prompting integrated neurological-psychiatric diagnostics, earlier cognitive assessment, and collaborative care to improve patient outcomes globally.</itunes:subtitle>
      <itunes:keywords>and collaborative care to improve patient outcomes globally., prompting integrated neurological-psychiatric diagnostics, emerging evidence links alzheimer’s biomarkers with psychosis and neuropsychiatric symptoms, earlier cognitive assessment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>118</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">84e041ea-9df5-4540-869a-6fd0ff949651</guid>
      <title>Asthma Insights_ Bronchial Structure Differences</title>
      <description><![CDATA[Research reveals structural differences in bronchial walls of people with asthma, informing targeted therapies, earlier diagnosis, and improved management strategies for patients worldwide, globally today. 
]]></description>
      <pubDate>Mon, 26 Jan 2026 16:44:41 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/asthma-insights-bronchial-structure-differences-281w4v_o</link>
      <enclosure length="1006488" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0c32f90a-f7d7-4314-8cd7-c3ddd6ef0c18/audio/4d03b5e2-9336-4520-b28f-6d0561aa4814/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Asthma Insights_ Bronchial Structure Differences</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:02</itunes:duration>
      <itunes:summary>Research reveals structural differences in bronchial walls of people with asthma, informing targeted therapies, earlier diagnosis, and improved management strategies for patients worldwide, globally today.</itunes:summary>
      <itunes:subtitle>Research reveals structural differences in bronchial walls of people with asthma, informing targeted therapies, earlier diagnosis, and improved management strategies for patients worldwide, globally today.</itunes:subtitle>
      <itunes:keywords>earlier diagnosis, informing targeted therapies, and improved management strategies for patients worldwide, research reveals structural differences in bronchial walls of people with asthma, globally today.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>117</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c83d33b6-4442-4d08-969a-b3ebddd17318</guid>
      <title>Recognizing the Importance of Fiber</title>
      <description><![CDATA[Advocacy to recognize dietary fiber as essential could reshape nutrition policy, food labeling, and prevention strategies, addressing low intake and reducing chronic disease risk worldwide. 
]]></description>
      <pubDate>Mon, 26 Jan 2026 14:06:29 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/recognizing-the-importance-of-fiber-Cf9_JdEH</link>
      <enclosure length="1598318" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/3f407f62-5527-46fa-97bc-b522807571e8/audio/b85e18f0-06ba-41db-9dd5-cfc8e0730352/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Recognizing the Importance of Fiber</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Advocacy to recognize dietary fiber as essential could reshape nutrition policy, food labeling, and prevention strategies, addressing low intake and reducing chronic disease risk worldwide.</itunes:summary>
      <itunes:subtitle>Advocacy to recognize dietary fiber as essential could reshape nutrition policy, food labeling, and prevention strategies, addressing low intake and reducing chronic disease risk worldwide.</itunes:subtitle>
      <itunes:keywords>advocacy to recognize dietary fiber as essential could reshape nutrition policy, and prevention strategies, food labeling, addressing low intake and reducing chronic disease risk worldwide.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>116</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">3aa4f631-cd08-4d62-a182-b3e882d6234e</guid>
      <title>Cardio-Oncology Connection</title>
      <description><![CDATA[Growing recognition of cancer and cardiovascular disease links drives integrated cardio-oncology care, encouraging multidisciplinary collaboration, new monitoring protocols, and improved outcomes for patients facing overlapping risks. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cardio-oncology-connection-45HzzL2a</link>
      <enclosure length="1374710" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e2bca0af-764b-456d-8046-4a16d8a0ead5/audio/33d0fae5-5537-442d-b49b-a5ce487034ea/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cardio-Oncology Connection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Growing recognition of cancer and cardiovascular disease links drives integrated cardio-oncology care, encouraging multidisciplinary collaboration, new monitoring protocols, and improved outcomes for patients facing overlapping risks.</itunes:summary>
      <itunes:subtitle>Growing recognition of cancer and cardiovascular disease links drives integrated cardio-oncology care, encouraging multidisciplinary collaboration, new monitoring protocols, and improved outcomes for patients facing overlapping risks.</itunes:subtitle>
      <itunes:keywords>and improved outcomes for patients facing overlapping risks., growing recognition of cancer and cardiovascular disease links drives integrated cardio-oncology care, new monitoring protocols, encouraging multidisciplinary collaboration</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>115</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ab4182b2-4abf-4454-ad37-df61db0e1ff7</guid>
      <title>AI Ambient Scribes in Primary Care</title>
      <description><![CDATA[AI-powered ambient scribes in primary care transform psychiatric documentation and management, streamlining workflows while prompting evaluation of impacts on clinical decisions, mental health care quality, and patient outcomes. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-ambient-scribes-in-primary-care-WOtTpHWN</link>
      <enclosure length="1424447" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5a68adc2-b48d-417c-a5c1-f70cc151cac5/audio/aa222abd-900d-47a0-9828-30558cab1fd7/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI Ambient Scribes in Primary Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>AI-powered ambient scribes in primary care transform psychiatric documentation and management, streamlining workflows while prompting evaluation of impacts on clinical decisions, mental health care quality, and patient outcomes.</itunes:summary>
      <itunes:subtitle>AI-powered ambient scribes in primary care transform psychiatric documentation and management, streamlining workflows while prompting evaluation of impacts on clinical decisions, mental health care quality, and patient outcomes.</itunes:subtitle>
      <itunes:keywords>and patient outcomes., mental health care quality, streamlining workflows while prompting evaluation of impacts on clinical decisions, ai-powered ambient scribes in primary care transform psychiatric documentation and management</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>114</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f46e7fc2-053f-47de-8e51-2107fd72b670</guid>
      <title>Breast Cancer Breakthroughs</title>
      <description><![CDATA[Advances in breast cancer biology and diagnostics drive precision medicine, integrating liquid biopsies, AI, and targeted therapies to improve personalized treatment, outcomes, and long-term survivorship care. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/breast-cancer-breakthroughs-pl_42zfY</link>
      <enclosure length="1297388" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/904ce333-ed8d-4d66-ac7e-54a13e8d597b/audio/aa2c347c-87ab-4d99-a6e5-dad66e4782c3/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Breast Cancer Breakthroughs</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Advances in breast cancer biology and diagnostics drive precision medicine, integrating liquid biopsies, AI, and targeted therapies to improve personalized treatment, outcomes, and long-term survivorship care.</itunes:summary>
      <itunes:subtitle>Advances in breast cancer biology and diagnostics drive precision medicine, integrating liquid biopsies, AI, and targeted therapies to improve personalized treatment, outcomes, and long-term survivorship care.</itunes:subtitle>
      <itunes:keywords>outcomes, integrating liquid biopsies, and targeted therapies to improve personalized treatment, advances in breast cancer biology and diagnostics drive precision medicine, ai, and long-term survivorship care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>113</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">69f8616b-7424-4e5e-b535-6efb81666d91</guid>
      <title>Food Safety Alert_ Genova Tuna Recall</title>
      <description><![CDATA[Reinstated recall of Genova canned yellowfin tuna over botulism risk underscores food safety vigilance, urging consumers to discard products and clinicians to recognize symptoms promptly. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/food-safety-alert-genova-tuna-recall-dnv1I64X</link>
      <enclosure length="2027145" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/db3fb29c-3566-44e1-812d-2de948187dfd/audio/70856ec5-fd17-418d-bfa9-7ee7f4a669a1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Food Safety Alert_ Genova Tuna Recall</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Reinstated recall of Genova canned yellowfin tuna over botulism risk underscores food safety vigilance, urging consumers to discard products and clinicians to recognize symptoms promptly.</itunes:summary>
      <itunes:subtitle>Reinstated recall of Genova canned yellowfin tuna over botulism risk underscores food safety vigilance, urging consumers to discard products and clinicians to recognize symptoms promptly.</itunes:subtitle>
      <itunes:keywords>urging consumers to discard products and clinicians to recognize symptoms promptly., reinstated recall of genova canned yellowfin tuna over botulism risk underscores food safety vigilance</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>112</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">71c6cffa-31cf-4ae5-ad76-6a699e2ed780</guid>
      <title>Rising Colon Cancer in Young Adults_ A Call for Awareness</title>
      <description><![CDATA[Young-onset stage 3 colon cancer case underscores symptom vigilance, risk-based screening, and timely evaluation, urging clinicians to reconsider assumptions as colorectal cancer rises in patients. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rising-colon-cancer-in-young-adults-a-call-for-awareness-OLQ85hSF</link>
      <enclosure length="892803" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/da61a504-2cef-4cfe-9d5c-5045e4c8b2ed/audio/9bee327b-b796-4bbd-8dd3-9d66556f0f61/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rising Colon Cancer in Young Adults_ A Call for Awareness</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:55</itunes:duration>
      <itunes:summary>Young-onset stage 3 colon cancer case underscores symptom vigilance, risk-based screening, and timely evaluation, urging clinicians to reconsider assumptions as colorectal cancer rises in patients.</itunes:summary>
      <itunes:subtitle>Young-onset stage 3 colon cancer case underscores symptom vigilance, risk-based screening, and timely evaluation, urging clinicians to reconsider assumptions as colorectal cancer rises in patients.</itunes:subtitle>
      <itunes:keywords>and timely evaluation, young-onset stage 3 colon cancer case underscores symptom vigilance, risk-based screening, urging clinicians to reconsider assumptions as colorectal cancer rises in patients.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>111</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">051c2540-a911-4113-8c0c-cea02f3f1b06</guid>
      <title>Robotic Revolution in Cardiac Surgery</title>
      <description><![CDATA[FDA clearance of da Vinci 5 advances robotic cardiac surgery, enabling minimally invasive precision, faster recovery, and driving training, adoption, and transformation of cardiothoracic practice. 
]]></description>
      <pubDate>Fri, 23 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/robotic-revolution-in-cardiac-surgery-kHUHdcIc</link>
      <enclosure length="1668536" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/19c17e88-2645-48d0-bca7-169c0678086f/audio/a8b83d02-dc57-4680-9ae6-ed26cd3765fa/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Robotic Revolution in Cardiac Surgery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>FDA clearance of da Vinci 5 advances robotic cardiac surgery, enabling minimally invasive precision, faster recovery, and driving training, adoption, and transformation of cardiothoracic practice.</itunes:summary>
      <itunes:subtitle>FDA clearance of da Vinci 5 advances robotic cardiac surgery, enabling minimally invasive precision, faster recovery, and driving training, adoption, and transformation of cardiothoracic practice.</itunes:subtitle>
      <itunes:keywords>faster recovery, adoption, enabling minimally invasive precision, and driving training, and transformation of cardiothoracic practice., fda clearance of da vinci 5 advances robotic cardiac surgery</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>110</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">76a73de5-56de-44f3-bcb0-6f768f1c5bcb</guid>
      <title>AI Breakthrough in Early COPD Detection</title>
      <description><![CDATA[AI-enhanced ECG analysis enables earlier COPD detection, supporting preventive care, improved outcomes, reduced hospitalizations, and more efficient chronic disease management across clinical settings worldwide systems. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-breakthrough-in-early-copd-detection-zFb_enFr</link>
      <enclosure length="1398952" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/9010ea40-92e7-4192-baff-0db749d50452/audio/7f19fb9c-efbc-46c2-92be-06cc972fdf00/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI Breakthrough in Early COPD Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:27</itunes:duration>
      <itunes:summary>AI-enhanced ECG analysis enables earlier COPD detection, supporting preventive care, improved outcomes, reduced hospitalizations, and more efficient chronic disease management across clinical settings worldwide systems.</itunes:summary>
      <itunes:subtitle>AI-enhanced ECG analysis enables earlier COPD detection, supporting preventive care, improved outcomes, reduced hospitalizations, and more efficient chronic disease management across clinical settings worldwide systems.</itunes:subtitle>
      <itunes:keywords>ai-enhanced ecg analysis enables earlier copd detection, reduced hospitalizations, improved outcomes, supporting preventive care, and more efficient chronic disease management across clinical settings worldwide systems.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>109</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">390476c4-cc88-432a-ab51-83343998f4cd</guid>
      <title>Forever Chemicals and Cosmetics_ Regulatory Shifts</title>
      <description><![CDATA[FDA scrutiny of “forever chemicals” in cosmetics signals tighter regulation, driving formulation changes, transparency demands, and consumer shifts toward safer products with implications for public health and industry practices. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/forever-chemicals-and-cosmetics-regulatory-shifts-Xhkll_vP</link>
      <enclosure length="1014847" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/3a5e6a93-ad3e-40ef-b9f7-7f085b102b5c/audio/fb876a93-0a6a-4785-8986-5fb466bca06f/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Forever Chemicals and Cosmetics_ Regulatory Shifts</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:03</itunes:duration>
      <itunes:summary>FDA scrutiny of “forever chemicals” in cosmetics signals tighter regulation, driving formulation changes, transparency demands, and consumer shifts toward safer products with implications for public health and industry practices.</itunes:summary>
      <itunes:subtitle>FDA scrutiny of “forever chemicals” in cosmetics signals tighter regulation, driving formulation changes, transparency demands, and consumer shifts toward safer products with implications for public health and industry practices.</itunes:subtitle>
      <itunes:keywords>transparency demands, and consumer shifts toward safer products with implications for public health and industry practices., driving formulation changes, fda scrutiny of “forever chemicals” in cosmetics signals tighter regulation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>108</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bb5a8d47-6545-4348-9904-4a04bb2b2af3</guid>
      <title>GLP-1 Agonists_ Transforming Cardiovascular Care</title>
      <description><![CDATA[GLP-1 receptor agonists may improve survival after heart attacks and strokes, prompting efforts to increase clinician adoption, patient awareness, and integration into post-cardiovascular care pathways. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/glp-1-agonists-transforming-cardiovascular-care-cmJrMV4e</link>
      <enclosure length="1804790" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/365333e2-3053-4417-98f3-c253790195f9/audio/122962e6-e1eb-4727-8b50-5e6468f27dd9/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>GLP-1 Agonists_ Transforming Cardiovascular Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>GLP-1 receptor agonists may improve survival after heart attacks and strokes, prompting efforts to increase clinician adoption, patient awareness, and integration into post-cardiovascular care pathways.</itunes:summary>
      <itunes:subtitle>GLP-1 receptor agonists may improve survival after heart attacks and strokes, prompting efforts to increase clinician adoption, patient awareness, and integration into post-cardiovascular care pathways.</itunes:subtitle>
      <itunes:keywords>and integration into post-cardiovascular care pathways., patient awareness, glp-1 receptor agonists may improve survival after heart attacks and strokes, prompting efforts to increase clinician adoption</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>107</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c48dc89d-a8fd-4aae-be55-a9d20d090ebd</guid>
      <title>Nasal Defense Against Rhinovirus</title>
      <description><![CDATA[Nasal cellular immune responses shape rhinovirus severity, highlighting early antiviral defenses as targets for new therapies to improve outcomes in respiratory infections, especially high-risk patients. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 16:02:57 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/nasal-defense-against-rhinovirus-wwc4jWDm</link>
      <enclosure length="2074792" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/ffa4d266-1a39-4158-89ec-62fb788f8c35/audio/4fa34c83-659f-486d-84bb-7ebce3016b3a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Nasal Defense Against Rhinovirus</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:09</itunes:duration>
      <itunes:summary>Nasal cellular immune responses shape rhinovirus severity, highlighting early antiviral defenses as targets for new therapies to improve outcomes in respiratory infections, especially high-risk patients.</itunes:summary>
      <itunes:subtitle>Nasal cellular immune responses shape rhinovirus severity, highlighting early antiviral defenses as targets for new therapies to improve outcomes in respiratory infections, especially high-risk patients.</itunes:subtitle>
      <itunes:keywords>nasal cellular immune responses shape rhinovirus severity, highlighting early antiviral defenses as targets for new therapies to improve outcomes in respiratory infections, especially high-risk patients.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>106</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">939b05e1-bf73-476b-89b2-2a9a53c0ec05</guid>
      <title>Cost-Effective Iron Therapy for Anemia</title>
      <description><![CDATA[IV iron therapy offers cost-effective anemia treatment, especially for heavy menstrual bleeding, prompting clinicians to reassess protocols, improve outcomes, reduce costs, and expand patient access. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 15:00:56 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cost-effective-iron-therapy-for-anemia-zX5vdaYP</link>
      <enclosure length="1512637" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/30daa20a-4c0c-492a-ac7f-58f1c7cd5ccf/audio/07e1ee3f-397b-4cf9-9ea5-789a2520d360/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cost-Effective Iron Therapy for Anemia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>IV iron therapy offers cost-effective anemia treatment, especially for heavy menstrual bleeding, prompting clinicians to reassess protocols, improve outcomes, reduce costs, and expand patient access.</itunes:summary>
      <itunes:subtitle>IV iron therapy offers cost-effective anemia treatment, especially for heavy menstrual bleeding, prompting clinicians to reassess protocols, improve outcomes, reduce costs, and expand patient access.</itunes:subtitle>
      <itunes:keywords>prompting clinicians to reassess protocols, and expand patient access., improve outcomes, especially for heavy menstrual bleeding, reduce costs, iv iron therapy offers cost-effective anemia treatment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>105</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">78aa71b4-831f-4437-a593-b07773b47ea8</guid>
      <title>The Role of Hobbies in Stress Management</title>
      <description><![CDATA[Low-pressure hobbies support stress management and wellness, helping migraine patients improve emotional health, symptom control, and quality of life through holistic, personalized coping strategies approaches. 
]]></description>
      <pubDate>Thu, 22 Jan 2026 14:22:56 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-role-of-hobbies-in-stress-management-rgTtcv9_</link>
      <enclosure length="1499680" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/bac1b612-9da7-4b72-99b0-7cca3f87dc7d/audio/8a9ea8b6-0659-4e0c-8f63-584857984af2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Role of Hobbies in Stress Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Low-pressure hobbies support stress management and wellness, helping migraine patients improve emotional health, symptom control, and quality of life through holistic, personalized coping strategies approaches.</itunes:summary>
      <itunes:subtitle>Low-pressure hobbies support stress management and wellness, helping migraine patients improve emotional health, symptom control, and quality of life through holistic, personalized coping strategies approaches.</itunes:subtitle>
      <itunes:keywords>personalized coping strategies approaches., helping migraine patients improve emotional health, and quality of life through holistic, low-pressure hobbies support stress management and wellness, symptom control</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>104</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fcdaf688-f4dd-4557-862e-d5dc5c2959ce</guid>
      <title>Stable Social Networks in Schizophrenia Recovery</title>
      <description><![CDATA[Stable social networks persist after schizophrenia hospitalization, highlighting family engagement and social dynamics as key targets for post-discharge support, relapse prevention, and recovery-focused health care. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/stable-social-networks-in-schizophrenia-recovery-lU_8Ds1O</link>
      <enclosure length="1850348" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d729eca7-6594-4407-b00b-b77ba7a3b714/audio/009a6024-ecc7-49cd-be55-4f081f3684e2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Stable Social Networks in Schizophrenia Recovery</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>Stable social networks persist after schizophrenia hospitalization, highlighting family engagement and social dynamics as key targets for post-discharge support, relapse prevention, and recovery-focused health care.</itunes:summary>
      <itunes:subtitle>Stable social networks persist after schizophrenia hospitalization, highlighting family engagement and social dynamics as key targets for post-discharge support, relapse prevention, and recovery-focused health care.</itunes:subtitle>
      <itunes:keywords>relapse prevention, highlighting family engagement and social dynamics as key targets for post-discharge support, stable social networks persist after schizophrenia hospitalization, and recovery-focused health care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>103</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">85391962-ac6e-475d-85bd-caa0deb7db07</guid>
      <title>Cancer Care_ A Shift Towards Long-term Survivorship</title>
      <description><![CDATA[Improving cancer survival shifts care toward long-term survivorship, coordinated follow-up, and equity-focused screening, reshaping oncology and primary care roles as more patients live longer lives. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cancer-care-a-shift-towards-long-term-survivorship-vIj8phPe</link>
      <enclosure length="1559030" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a77ee202-e59a-4cef-bf31-fceeffbefdf7/audio/a225cace-ac6b-4904-9b01-66f665393d2c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cancer Care_ A Shift Towards Long-term Survivorship</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>Improving cancer survival shifts care toward long-term survivorship, coordinated follow-up, and equity-focused screening, reshaping oncology and primary care roles as more patients live longer lives.</itunes:summary>
      <itunes:subtitle>Improving cancer survival shifts care toward long-term survivorship, coordinated follow-up, and equity-focused screening, reshaping oncology and primary care roles as more patients live longer lives.</itunes:subtitle>
      <itunes:keywords>reshaping oncology and primary care roles as more patients live longer lives., coordinated follow-up, improving cancer survival shifts care toward long-term survivorship, and equity-focused screening</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>102</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2dea4eb5-0e83-4c6b-89c3-7fa2e8690e53</guid>
      <title>Gut Microbiota and Exercise_ Personalized Insights</title>
      <description><![CDATA[Gut microbiota differences shape metabolic responses to exercise, supporting personalized training, multidisciplinary care, and microbial therapies to improve outcomes for patients with obesity and diabetes. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/gut-microbiota-and-exercise-personalized-insights-SR3Lsm2u</link>
      <enclosure length="2025891" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c073eca4-a735-4049-a3f6-6b131f3cbeeb/audio/b91706f6-1449-4c7a-879a-da62126e1737/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Gut Microbiota and Exercise_ Personalized Insights</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:06</itunes:duration>
      <itunes:summary>Gut microbiota differences shape metabolic responses to exercise, supporting personalized training, multidisciplinary care, and microbial therapies to improve outcomes for patients with obesity and diabetes.</itunes:summary>
      <itunes:subtitle>Gut microbiota differences shape metabolic responses to exercise, supporting personalized training, multidisciplinary care, and microbial therapies to improve outcomes for patients with obesity and diabetes.</itunes:subtitle>
      <itunes:keywords>and microbial therapies to improve outcomes for patients with obesity and diabetes., gut microbiota differences shape metabolic responses to exercise, multidisciplinary care, supporting personalized training</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>101</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1e3d5624-d098-4740-857e-1a6a5d381309</guid>
      <title>Predictive Biomarkers for Asthma Management</title>
      <description><![CDATA[Metabolomic profiling enables a predictive model for asthma exacerbations, supporting personalized management, reduced hospitalizations, risk stratification, and potential integration of cost-effective biomarkers into routine care. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/predictive-biomarkers-for-asthma-management-FQhwBROB</link>
      <enclosure length="1494247" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f3318a93-019e-45f8-84a1-96af562322d8/audio/91421502-27b7-440e-8ad2-77ed02fe978b/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Predictive Biomarkers for Asthma Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Metabolomic profiling enables a predictive model for asthma exacerbations, supporting personalized management, reduced hospitalizations, risk stratification, and potential integration of cost-effective biomarkers into routine care.</itunes:summary>
      <itunes:subtitle>Metabolomic profiling enables a predictive model for asthma exacerbations, supporting personalized management, reduced hospitalizations, risk stratification, and potential integration of cost-effective biomarkers into routine care.</itunes:subtitle>
      <itunes:keywords>and potential integration of cost-effective biomarkers into routine care., risk stratification, reduced hospitalizations, metabolomic profiling enables a predictive model for asthma exacerbations, supporting personalized management</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>100</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b0918ab4-1d5e-4a6f-85ef-a7b6b6e26464</guid>
      <title>AI in Alzheimer&apos;s Screening</title>
      <description><![CDATA[AI-powered screening shows promise for early Alzheimer’s detection, enabling earlier intervention, better resource allocation, clinician training, and preventive care strategies for at-risk patients nationwide adoption. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-in-alzheimers-screening-nusvCvuC</link>
      <enclosure length="1724960" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/63a76bd3-ee40-4065-a85b-79ec2bc6afda/audio/5bbb87df-5961-4533-b06e-a030a0b714cb/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI in Alzheimer&apos;s Screening</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>AI-powered screening shows promise for early Alzheimer’s detection, enabling earlier intervention, better resource allocation, clinician training, and preventive care strategies for at-risk patients nationwide adoption.</itunes:summary>
      <itunes:subtitle>AI-powered screening shows promise for early Alzheimer’s detection, enabling earlier intervention, better resource allocation, clinician training, and preventive care strategies for at-risk patients nationwide adoption.</itunes:subtitle>
      <itunes:keywords>clinician training, better resource allocation, and preventive care strategies for at-risk patients nationwide adoption., enabling earlier intervention, ai-powered screening shows promise for early alzheimer’s detection</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>99</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fef13c8f-a84a-40a7-809e-582cf7e6b282</guid>
      <title>Understanding Liver Disease Risk Estimation</title>
      <description><![CDATA[Experts warn liver disease absolute risk estimates should exclude time-varying covariates, improving accuracy, guiding clinical decisions, refining guidelines, and supporting patient management and resource allocation. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-liver-disease-risk-estimation-RTqNnb3s</link>
      <enclosure length="1490067" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c12f566d-5055-4715-8fb0-b63ff6628a65/audio/4f434de6-991b-4c2a-9c5d-0177b5640104/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Liver Disease Risk Estimation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Experts warn liver disease absolute risk estimates should exclude time-varying covariates, improving accuracy, guiding clinical decisions, refining guidelines, and supporting patient management and resource allocation.</itunes:summary>
      <itunes:subtitle>Experts warn liver disease absolute risk estimates should exclude time-varying covariates, improving accuracy, guiding clinical decisions, refining guidelines, and supporting patient management and resource allocation.</itunes:subtitle>
      <itunes:keywords>refining guidelines, and supporting patient management and resource allocation., improving accuracy, guiding clinical decisions, experts warn liver disease absolute risk estimates should exclude time-varying covariates</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>98</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ea3089d8-b155-4308-aad3-c9f817c69a1b</guid>
      <title>Chromosomal Insights in Uterine Leiomyomas</title>
      <description><![CDATA[Distinct chromosomal signatures in uterine leiomyoma subtypes deepen tumor understanding, enabling improved classification, risk stratification, and future personalized diagnostics and therapies for reproductive health care. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/chromosomal-insights-in-uterine-leiomyomas-cEnCV1At</link>
      <enclosure length="1370531" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8f0fa9c4-0b9a-45b8-a66d-05f406065af9/audio/f247fd12-b428-4672-86e5-a7f52da9f5a4/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Chromosomal Insights in Uterine Leiomyomas</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Distinct chromosomal signatures in uterine leiomyoma subtypes deepen tumor understanding, enabling improved classification, risk stratification, and future personalized diagnostics and therapies for reproductive health care.</itunes:summary>
      <itunes:subtitle>Distinct chromosomal signatures in uterine leiomyoma subtypes deepen tumor understanding, enabling improved classification, risk stratification, and future personalized diagnostics and therapies for reproductive health care.</itunes:subtitle>
      <itunes:keywords>and future personalized diagnostics and therapies for reproductive health care., risk stratification, enabling improved classification, distinct chromosomal signatures in uterine leiomyoma subtypes deepen tumor understanding</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>97</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">200624f5-08c7-4dc5-afb1-3633cb31e44b</guid>
      <title>Digital Tools in Mental Health</title>
      <description><![CDATA[Smartphone mental health apps are gaining momentum, offering flexible care options while prompting clinicians to adopt training, hybrid models, and evidence-based integration strategies to meet rising demand. 
]]></description>
      <pubDate>Wed, 21 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/digital-tools-in-mental-health-xJxs8nv3</link>
      <enclosure length="1161969" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b5fd16e2-4eed-4852-bdd7-59f889a68809/audio/8ca4819b-ebcd-44b6-836b-c856a06bc873/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Digital Tools in Mental Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>Smartphone mental health apps are gaining momentum, offering flexible care options while prompting clinicians to adopt training, hybrid models, and evidence-based integration strategies to meet rising demand.</itunes:summary>
      <itunes:subtitle>Smartphone mental health apps are gaining momentum, offering flexible care options while prompting clinicians to adopt training, hybrid models, and evidence-based integration strategies to meet rising demand.</itunes:subtitle>
      <itunes:keywords>and evidence-based integration strategies to meet rising demand., smartphone mental health apps are gaining momentum, hybrid models, offering flexible care options while prompting clinicians to adopt training</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>96</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2fa5442a-d1ce-4861-b230-5032e26eeb41</guid>
      <title>Bridging the Skin Cancer Knowledge Gap</title>
      <description><![CDATA[Studies show patients misunderstand common skin cancer terms, prompting clinicians to simplify communication, strengthen education tools, and improve engagement and adherence across oncology care settings. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/bridging-the-skin-cancer-knowledge-gap-LHWWD8hx</link>
      <enclosure length="1238456" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a25d9211-f9b0-43e9-be24-b61436e4666f/audio/dd364aff-cb4e-41a1-86a5-156c98f061be/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Bridging the Skin Cancer Knowledge Gap</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:17</itunes:duration>
      <itunes:summary>Studies show patients misunderstand common skin cancer terms, prompting clinicians to simplify communication, strengthen education tools, and improve engagement and adherence across oncology care settings.</itunes:summary>
      <itunes:subtitle>Studies show patients misunderstand common skin cancer terms, prompting clinicians to simplify communication, strengthen education tools, and improve engagement and adherence across oncology care settings.</itunes:subtitle>
      <itunes:keywords>prompting clinicians to simplify communication, and improve engagement and adherence across oncology care settings., studies show patients misunderstand common skin cancer terms, strengthen education tools</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>95</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f9716433-1b12-4ed4-9315-d5c5097077c4</guid>
      <title>Advancements in Retinal Therapies</title>
      <description><![CDATA[Advances in geographic atrophy therapies emphasize slowing progression, leveraging multimodal imaging, refining patient selection, and setting realistic expectations, reshaping how clinicians diagnose, monitor, and manage GA long term. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancements-in-retinal-therapies-SOznYxeL</link>
      <enclosure length="1081721" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/91b94153-e5f5-4a57-97a7-007fecc6ed63/audio/210067ed-60cf-46ff-b037-757ddf806dc3/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancements in Retinal Therapies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:07</itunes:duration>
      <itunes:summary>Advances in geographic atrophy therapies emphasize slowing progression, leveraging multimodal imaging, refining patient selection, and setting realistic expectations, reshaping how clinicians diagnose, monitor, and manage GA long term.</itunes:summary>
      <itunes:subtitle>Advances in geographic atrophy therapies emphasize slowing progression, leveraging multimodal imaging, refining patient selection, and setting realistic expectations, reshaping how clinicians diagnose, monitor, and manage GA long term.</itunes:subtitle>
      <itunes:keywords>reshaping how clinicians diagnose, and setting realistic expectations, refining patient selection, and manage ga long term., monitor, advances in geographic atrophy therapies emphasize slowing progression, leveraging multimodal imaging</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>94</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b877fed7-46a3-45a1-98b8-83c9d8bec24b</guid>
      <title>Managing Hypertension_ A Public Health Priority</title>
      <description><![CDATA[Persistent gaps in hypertension diagnosis and treatment among adults over 40 highlight urgent needs for better screening, guideline adherence, and targeted interventions to reduce cardiovascular risk. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/managing-hypertension-a-public-health-priority-xbxwXYVQ</link>
      <enclosure length="1750038" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/84fc59ea-8ab1-4d47-8112-d9bffc5bb93b/audio/c7cc080c-bf51-4116-8caf-ddc75c68ec91/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Managing Hypertension_ A Public Health Priority</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:49</itunes:duration>
      <itunes:summary>Persistent gaps in hypertension diagnosis and treatment among adults over 40 highlight urgent needs for better screening, guideline adherence, and targeted interventions to reduce cardiovascular risk.</itunes:summary>
      <itunes:subtitle>Persistent gaps in hypertension diagnosis and treatment among adults over 40 highlight urgent needs for better screening, guideline adherence, and targeted interventions to reduce cardiovascular risk.</itunes:subtitle>
      <itunes:keywords>guideline adherence, persistent gaps in hypertension diagnosis and treatment among adults over 40 highlight urgent needs for better screening, and targeted interventions to reduce cardiovascular risk.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>93</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7b8e31dd-3b5b-4910-81df-7394f990b814</guid>
      <title>Promising Prostate Cancer Therapy</title>
      <description><![CDATA[The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/promising-prostate-cancer-therapy-u37SoeNk</link>
      <enclosure length="1217140" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8e4c11f4-156b-42d6-8618-ada27b7782e2/audio/c040d89e-59a9-4ef6-bf5f-b3f32dbc2366/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Promising Prostate Cancer Therapy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:16</itunes:duration>
      <itunes:summary>The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.</itunes:summary>
      <itunes:subtitle>The theranostic agent 67Cu-SAR-bisPSMA advances in trials, offering a promising, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.</itunes:subtitle>
      <itunes:keywords>offering a promising, the theranostic agent 67cu-sar-bispsma advances in trials, targeted treatment option for metastatic castration-resistant prostate cancer with limited existing therapies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>92</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">4094f416-d9b8-4fea-83cc-db6e93ff7665</guid>
      <title>Promising Advances in Gout Treatment</title>
      <description><![CDATA[New fast-tracked gout therapies like NASP promise improved urate control, reduced tophi, and paradigm-shifting options for patients with uncontrolled disease and limited treatment alternatives. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/promising-advances-in-gout-treatment-0FCIv27j</link>
      <enclosure length="1287775" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d84c3127-ebf1-4c60-bb2c-46616a22f0b8/audio/9ba4fe77-5bd5-4c1f-99e9-7a4a9b813a84/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Promising Advances in Gout Treatment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:20</itunes:duration>
      <itunes:summary>New fast-tracked gout therapies like NASP promise improved urate control, reduced tophi, and paradigm-shifting options for patients with uncontrolled disease and limited treatment alternatives.</itunes:summary>
      <itunes:subtitle>New fast-tracked gout therapies like NASP promise improved urate control, reduced tophi, and paradigm-shifting options for patients with uncontrolled disease and limited treatment alternatives.</itunes:subtitle>
      <itunes:keywords>new fast-tracked gout therapies like nasp promise improved urate control, reduced tophi, and paradigm-shifting options for patients with uncontrolled disease and limited treatment alternatives.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>91</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d827aef7-b7a2-487b-bb24-c159b5a72eec</guid>
      <title>Innovative Approach in Cancer Treatment</title>
      <description><![CDATA[Radionuclide-stimulated dynamic therapy uses radiopharmaceuticals to activate light-sensitive drugs, reprogram tumor immunity, overcome resistance, and offer a promising new approach for treating aggressive cancers. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/innovative-approach-in-cancer-treatment-2HYnUFii</link>
      <enclosure length="1978661" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/86af2556-7404-4296-bf4f-480c01d61f83/audio/c7e606ff-48cf-45da-9bb6-3717d29ed837/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Innovative Approach in Cancer Treatment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:03</itunes:duration>
      <itunes:summary>Radionuclide-stimulated dynamic therapy uses radiopharmaceuticals to activate light-sensitive drugs, reprogram tumor immunity, overcome resistance, and offer a promising new approach for treating aggressive cancers.</itunes:summary>
      <itunes:subtitle>Radionuclide-stimulated dynamic therapy uses radiopharmaceuticals to activate light-sensitive drugs, reprogram tumor immunity, overcome resistance, and offer a promising new approach for treating aggressive cancers.</itunes:subtitle>
      <itunes:keywords>radionuclide-stimulated dynamic therapy uses radiopharmaceuticals to activate light-sensitive drugs, overcome resistance, and offer a promising new approach for treating aggressive cancers., reprogram tumor immunity</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>90</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">46f610ab-bb36-458e-adb6-cc1e13151794</guid>
      <title>COPD and Cognitive Decline</title>
      <description><![CDATA[Emerging evidence links COPD to cognitive impairment, prompting routine screening, interdisciplinary care, and integrated treatments to address brain health, adherence challenges, and quality of life. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/copd-and-cognitive-decline-D2FQy83o</link>
      <enclosure length="1726214" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/871e4188-05b8-4b07-930f-e092183f2e5e/audio/0ba64b14-9508-4af1-9774-96001f0ff5de/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>COPD and Cognitive Decline</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Emerging evidence links COPD to cognitive impairment, prompting routine screening, interdisciplinary care, and integrated treatments to address brain health, adherence challenges, and quality of life.</itunes:summary>
      <itunes:subtitle>Emerging evidence links COPD to cognitive impairment, prompting routine screening, interdisciplinary care, and integrated treatments to address brain health, adherence challenges, and quality of life.</itunes:subtitle>
      <itunes:keywords>emerging evidence links copd to cognitive impairment, interdisciplinary care, prompting routine screening, adherence challenges, and integrated treatments to address brain health, and quality of life.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>89</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">370f4b69-fa29-463a-a1a0-5bf3b07f4093</guid>
      <title>Adolescent Cardiomyopathy Breakthrough</title>
      <description><![CDATA[Cardiac myosin inhibitors show promise for adolescents with obstructive hypertrophic cardiomyopathy, reducing LVOT obstruction and signaling disease-modifying therapy that may lessen symptoms and invasive procedures. 
]]></description>
      <pubDate>Tue, 20 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/adolescent-cardiomyopathy-breakthrough-K9riir_Z</link>
      <enclosure length="1548581" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5a5e4ad9-3fde-4088-9af4-1ca23b00081e/audio/d63d11ea-5abb-4d90-abbf-e13ae0b5e1a6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Adolescent Cardiomyopathy Breakthrough</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:36</itunes:duration>
      <itunes:summary>Cardiac myosin inhibitors show promise for adolescents with obstructive hypertrophic cardiomyopathy, reducing LVOT obstruction and signaling disease-modifying therapy that may lessen symptoms and invasive procedures.</itunes:summary>
      <itunes:subtitle>Cardiac myosin inhibitors show promise for adolescents with obstructive hypertrophic cardiomyopathy, reducing LVOT obstruction and signaling disease-modifying therapy that may lessen symptoms and invasive procedures.</itunes:subtitle>
      <itunes:keywords>cardiac myosin inhibitors show promise for adolescents with obstructive hypertrophic cardiomyopathy, reducing lvot obstruction and signaling disease-modifying therapy that may lessen symptoms and invasive procedures.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>88</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1ecb9819-8d9b-4404-84e0-29d39dc1cd61</guid>
      <title>Physician Mental Health Crisis</title>
      <description><![CDATA[Physician mental health remains strained as emotional stress rises, burnout persists, stigma limits care, and systemic workplace reforms are prioritized to protect clinicians and patients. 
]]></description>
      <pubDate>Mon, 19 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/physician-mental-health-crisis-0HHKu4UJ</link>
      <enclosure length="1134802" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e1f57e76-da89-459c-962f-f3b1cc1b68e1/audio/42c0539f-f1b7-4d35-a35e-4845844d0d39/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Physician Mental Health Crisis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:10</itunes:duration>
      <itunes:summary>Physician mental health remains strained as emotional stress rises, burnout persists, stigma limits care, and systemic workplace reforms are prioritized to protect clinicians and patients.</itunes:summary>
      <itunes:subtitle>Physician mental health remains strained as emotional stress rises, burnout persists, stigma limits care, and systemic workplace reforms are prioritized to protect clinicians and patients.</itunes:subtitle>
      <itunes:keywords>physician mental health remains strained as emotional stress rises, stigma limits care, burnout persists, and systemic workplace reforms are prioritized to protect clinicians and patients.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>87</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e1280e8f-fdd4-4c56-9bbf-8c2804833d9c</guid>
      <title>Coffee and Health_ New Discoveries</title>
      <description><![CDATA[2025 studies suggest moderate coffee intake lowers atrial fibrillation recurrence, cardiovascular mortality, and type 2 diabetes risk, challenging concerns while emphasizing moderation and individual tolerance. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/coffee-and-health-new-discoveries-yrkwwv_J</link>
      <enclosure length="1374292" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/078904c3-115f-490e-9f6d-81c3d41a52f0/audio/dbe1bdb7-3259-4599-92d8-006fea230b1e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Coffee and Health_ New Discoveries</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>2025 studies suggest moderate coffee intake lowers atrial fibrillation recurrence, cardiovascular mortality, and type 2 diabetes risk, challenging concerns while emphasizing moderation and individual tolerance.</itunes:summary>
      <itunes:subtitle>2025 studies suggest moderate coffee intake lowers atrial fibrillation recurrence, cardiovascular mortality, and type 2 diabetes risk, challenging concerns while emphasizing moderation and individual tolerance.</itunes:subtitle>
      <itunes:keywords>2025 studies suggest moderate coffee intake lowers atrial fibrillation recurrence, challenging concerns while emphasizing moderation and individual tolerance., and type 2 diabetes risk, cardiovascular mortality</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>86</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">193474c9-70b4-433b-9db9-9fc5ea24cc92</guid>
      <title>Choosing the Right Gym</title>
      <description><![CDATA[Selecting the right gym involves balancing cost, location, hours, facilities, and coaching options to support consistency, motivation, and effective progress toward personal fitness goals success. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/choosing-the-right-gym-TWwMElc9</link>
      <enclosure length="983083" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/9fa6d36c-0a5f-4a68-aaf8-3447e5c8120b/audio/18395bde-b606-4431-bb92-049348c042e5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Choosing the Right Gym</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:01</itunes:duration>
      <itunes:summary>Selecting the right gym involves balancing cost, location, hours, facilities, and coaching options to support consistency, motivation, and effective progress toward personal fitness goals success.</itunes:summary>
      <itunes:subtitle>Selecting the right gym involves balancing cost, location, hours, facilities, and coaching options to support consistency, motivation, and effective progress toward personal fitness goals success.</itunes:subtitle>
      <itunes:keywords>motivation, and coaching options to support consistency, selecting the right gym involves balancing cost, facilities, and effective progress toward personal fitness goals success., hours, location</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>85</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2f097e21-2dbd-4056-bebc-97f223784c4c</guid>
      <title>Peptide Potential in Pain Management</title>
      <description><![CDATA[Emerging research shows peptides can target pain pathways, offering more precise, potentially better-tolerated treatments for chronic pain conditions that respond poorly to conventional analgesics. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/peptide-potential-in-pain-management-N4yu9_SD</link>
      <enclosure length="1423194" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1c7df997-199d-46a8-83d8-1392d6d72ac8/audio/47dad7f0-c1cf-480e-8d47-ac38346aa1f3/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Peptide Potential in Pain Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>Emerging research shows peptides can target pain pathways, offering more precise, potentially better-tolerated treatments for chronic pain conditions that respond poorly to conventional analgesics.</itunes:summary>
      <itunes:subtitle>Emerging research shows peptides can target pain pathways, offering more precise, potentially better-tolerated treatments for chronic pain conditions that respond poorly to conventional analgesics.</itunes:subtitle>
      <itunes:keywords>potentially better-tolerated treatments for chronic pain conditions that respond poorly to conventional analgesics., offering more precise, emerging research shows peptides can target pain pathways</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>84</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">58f9e694-b775-4479-a761-d5d663036dec</guid>
      <title>Thyroid Storm_ Understanding the Crisis</title>
      <description><![CDATA[Thyroid storm is a rare, life-threatening hyperthyroid emergency causing severe cardiovascular and neurological symptoms, requiring rapid recognition and aggressive treatment to reduce morbidity and mortality. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/thyroid-storm-understanding-the-crisis-GzfxNW5w</link>
      <enclosure length="1569479" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/bbf91862-4985-4cc8-9efd-36b3e0fbaa5a/audio/4dc0f53d-b670-4ee2-94ef-9876cfb6d5f5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Thyroid Storm_ Understanding the Crisis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:38</itunes:duration>
      <itunes:summary>Thyroid storm is a rare, life-threatening hyperthyroid emergency causing severe cardiovascular and neurological symptoms, requiring rapid recognition and aggressive treatment to reduce morbidity and mortality.</itunes:summary>
      <itunes:subtitle>Thyroid storm is a rare, life-threatening hyperthyroid emergency causing severe cardiovascular and neurological symptoms, requiring rapid recognition and aggressive treatment to reduce morbidity and mortality.</itunes:subtitle>
      <itunes:keywords>requiring rapid recognition and aggressive treatment to reduce morbidity and mortality., thyroid storm is a rare, life-threatening hyperthyroid emergency causing severe cardiovascular and neurological symptoms</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>83</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">84a975ce-0594-4e9c-b72e-af006d4db511</guid>
      <title>Gut Microbiota and Breast Cancer</title>
      <description><![CDATA[Emerging research links gut microbiota and the estrobolome to breast cancer development, exploring how oral endocrine therapy alters microbial composition and may influence recurrence risk. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/gut-microbiota-and-breast-cancer-47i5rlBS</link>
      <enclosure length="1496754" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/db6985bf-b96f-435d-8bf9-e39d43b43b78/audio/daf4f58b-f534-4858-b121-06feb97a58d0/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Gut Microbiota and Breast Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Emerging research links gut microbiota and the estrobolome to breast cancer development, exploring how oral endocrine therapy alters microbial composition and may influence recurrence risk.</itunes:summary>
      <itunes:subtitle>Emerging research links gut microbiota and the estrobolome to breast cancer development, exploring how oral endocrine therapy alters microbial composition and may influence recurrence risk.</itunes:subtitle>
      <itunes:keywords>emerging research links gut microbiota and the estrobolome to breast cancer development, exploring how oral endocrine therapy alters microbial composition and may influence recurrence risk.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>82</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">37699078-5706-46bd-9c02-97e617f607a0</guid>
      <title>Impact of Gut Bacteria on Immune Response to Influenza</title>
      <description><![CDATA[New research shows gut bacteria shape immune responses to influenza, with greater microbiome diversity enhancing viral defense, reducing disease severity, and highlighting probiotics’ potential in infection management. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-gut-bacteria-on-immune-response-to-influenza-VPg1gUQ9</link>
      <enclosure length="1116412" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/eae63323-6b63-488f-89d8-02d7b15fc4cd/audio/82e814c2-66fd-4b16-b275-73fd39e783e2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Gut Bacteria on Immune Response to Influenza</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:09</itunes:duration>
      <itunes:summary>New research shows gut bacteria shape immune responses to influenza, with greater microbiome diversity enhancing viral defense, reducing disease severity, and highlighting probiotics’ potential in infection management.</itunes:summary>
      <itunes:subtitle>New research shows gut bacteria shape immune responses to influenza, with greater microbiome diversity enhancing viral defense, reducing disease severity, and highlighting probiotics’ potential in infection management.</itunes:subtitle>
      <itunes:keywords>new research shows gut bacteria shape immune responses to influenza, reducing disease severity, with greater microbiome diversity enhancing viral defense, and highlighting probiotics’ potential in infection management.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>81</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b0d8fe41-a5ea-4161-859f-9c47ad322c28</guid>
      <title>Elevated Monocyte Levels_ Health Implications</title>
      <description><![CDATA[Elevated monocyte levels signal immune activation, often linked to chronic infection, inflammation, autoimmune disease, or cancer, guiding clinicians toward further evaluation, diagnosis, and patient management. 
]]></description>
      <pubDate>Fri, 16 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/elevated-monocyte-levels-health-implications-vM5gdAdG</link>
      <enclosure length="1385995" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c848dc93-3269-49c8-b460-8f92a937f80b/audio/7c0911e8-057c-449c-905d-b6b46bfec210/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Elevated Monocyte Levels_ Health Implications</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>Elevated monocyte levels signal immune activation, often linked to chronic infection, inflammation, autoimmune disease, or cancer, guiding clinicians toward further evaluation, diagnosis, and patient management.</itunes:summary>
      <itunes:subtitle>Elevated monocyte levels signal immune activation, often linked to chronic infection, inflammation, autoimmune disease, or cancer, guiding clinicians toward further evaluation, diagnosis, and patient management.</itunes:subtitle>
      <itunes:keywords>autoimmune disease, diagnosis, elevated monocyte levels signal immune activation, or cancer, inflammation, guiding clinicians toward further evaluation, often linked to chronic infection, and patient management.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>80</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">17cf5fd0-184d-4115-8c34-4f96db616c8b</guid>
      <title>Navigating Family Expectations with Myasthenia Gravis</title>
      <description><![CDATA[Living with myasthenia gravis requires setting boundaries, communicating needs, challenging family expectations, rejecting societal timelines, and prioritizing self-advocacy, well-being, and autonomy amid invisible limitations daily. 
]]></description>
      <pubDate>Thu, 15 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/navigating-family-expectations-with-myasthenia-gravis-rOHX5V7T</link>
      <enclosure length="1639278" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/4501261c-9627-4173-b6bf-8fe0e51d9ef1/audio/1d01ced8-a7f4-487c-b8ec-45e8aa5c08a2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Navigating Family Expectations with Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Living with myasthenia gravis requires setting boundaries, communicating needs, challenging family expectations, rejecting societal timelines, and prioritizing self-advocacy, well-being, and autonomy amid invisible limitations daily.</itunes:summary>
      <itunes:subtitle>Living with myasthenia gravis requires setting boundaries, communicating needs, challenging family expectations, rejecting societal timelines, and prioritizing self-advocacy, well-being, and autonomy amid invisible limitations daily.</itunes:subtitle>
      <itunes:keywords>rejecting societal timelines, well-being, living with myasthenia gravis requires setting boundaries, challenging family expectations, and prioritizing self-advocacy, communicating needs, and autonomy amid invisible limitations daily.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>79</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b3025b0c-ceb3-4518-ac60-030e15892691</guid>
      <title>Rest as Resistance_ Embracing Rest for Resilience</title>
      <description><![CDATA[A Black woman living with HIV reframes rest as resistance, prioritizing self-advocacy, healing, and structural change over productivity, challenging stigma while advancing holistic, policy-informed wellness. 
]]></description>
      <pubDate>Thu, 15 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rest-as-resistance-embracing-rest-for-resilience-5iDHJSs8</link>
      <enclosure length="1238038" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cac0ecea-7fc5-4b1e-a123-420efd2d4caa/audio/9c054a12-b178-4305-a32b-f80829913cd2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rest as Resistance_ Embracing Rest for Resilience</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:17</itunes:duration>
      <itunes:summary>A Black woman living with HIV reframes rest as resistance, prioritizing self-advocacy, healing, and structural change over productivity, challenging stigma while advancing holistic, policy-informed wellness.</itunes:summary>
      <itunes:subtitle>A Black woman living with HIV reframes rest as resistance, prioritizing self-advocacy, healing, and structural change over productivity, challenging stigma while advancing holistic, policy-informed wellness.</itunes:subtitle>
      <itunes:keywords>healing, prioritizing self-advocacy, a black woman living with hiv reframes rest as resistance, policy-informed wellness., and structural change over productivity, challenging stigma while advancing holistic</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>78</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">26b65146-464e-4347-bf3e-b2980c14efb0</guid>
      <title>Advancing Brain Health Through Data Competitions</title>
      <description><![CDATA[Data science competitions accelerate brain health research, uniting diverse experts to apply machine learning, uncover neurological disease patterns, improve analyses, and inspire innovative therapies worldwide. 
]]></description>
      <pubDate>Thu, 15 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancing-brain-health-through-data-competitions-6CVscOjx</link>
      <enclosure length="1490067" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/540ee25f-40d5-41b2-9229-25fbd2f2159f/audio/a32456f7-14e0-4038-884e-d97512c46c6e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancing Brain Health Through Data Competitions</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Data science competitions accelerate brain health research, uniting diverse experts to apply machine learning, uncover neurological disease patterns, improve analyses, and inspire innovative therapies worldwide.</itunes:summary>
      <itunes:subtitle>Data science competitions accelerate brain health research, uniting diverse experts to apply machine learning, uncover neurological disease patterns, improve analyses, and inspire innovative therapies worldwide.</itunes:subtitle>
      <itunes:keywords>and inspire innovative therapies worldwide., improve analyses, uniting diverse experts to apply machine learning, data science competitions accelerate brain health research, uncover neurological disease patterns</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>77</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">a3ee29a0-b4ca-4c48-82e5-43c2186e276f</guid>
      <title>Maternal Hypertension Disparities</title>
      <description><![CDATA[Study reveals major disparities in pregnancy-related hypertension among Asian American, Native Hawaiian, and Pacific Islander subgroups, urging targeted prevention to reduce maternal morbidity and mortality. 
]]></description>
      <pubDate>Thu, 15 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/maternal-hypertension-disparities-2Mjl4Azh</link>
      <enclosure length="1762576" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8cf20629-d174-4e74-9dec-c8994e443f42/audio/bc6249a8-c49d-4a16-b3b4-915ed55c0eda/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Maternal Hypertension Disparities</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Study reveals major disparities in pregnancy-related hypertension among Asian American, Native Hawaiian, and Pacific Islander subgroups, urging targeted prevention to reduce maternal morbidity and mortality.</itunes:summary>
      <itunes:subtitle>Study reveals major disparities in pregnancy-related hypertension among Asian American, Native Hawaiian, and Pacific Islander subgroups, urging targeted prevention to reduce maternal morbidity and mortality.</itunes:subtitle>
      <itunes:keywords>and pacific islander subgroups, urging targeted prevention to reduce maternal morbidity and mortality., study reveals major disparities in pregnancy-related hypertension among asian american, native hawaiian</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>76</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5b772cb3-3043-4e3a-850c-f3a9c41707cd</guid>
      <title>Metabolomic Breakthrough in Diabetes Prediction</title>
      <description><![CDATA[A large, diverse cohort study identifies a metabolomic signature improving long-term type 2 diabetes risk prediction, revealing lifestyle-sensitive metabolites that may enable earlier, personalized prevention strategies. 
]]></description>
      <pubDate>Thu, 15 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/metabolomic-breakthrough-in-diabetes-prediction-x0CZTkH5</link>
      <enclosure length="1739589" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d193c389-023e-4009-b14e-616eff9629e8/audio/c0657f7e-77c6-426c-b475-ca0d5bb5d391/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Metabolomic Breakthrough in Diabetes Prediction</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:48</itunes:duration>
      <itunes:summary>A large, diverse cohort study identifies a metabolomic signature improving long-term type 2 diabetes risk prediction, revealing lifestyle-sensitive metabolites that may enable earlier, personalized prevention strategies.</itunes:summary>
      <itunes:subtitle>A large, diverse cohort study identifies a metabolomic signature improving long-term type 2 diabetes risk prediction, revealing lifestyle-sensitive metabolites that may enable earlier, personalized prevention strategies.</itunes:subtitle>
      <itunes:keywords>personalized prevention strategies., revealing lifestyle-sensitive metabolites that may enable earlier, a large, diverse cohort study identifies a metabolomic signature improving long-term type 2 diabetes risk prediction</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>75</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fe40ceab-439b-4c5f-901e-5618262e3a76</guid>
      <title>Enhancing Stroke Care Through Public Reporting</title>
      <description><![CDATA[Public reporting through the Get With The Guidelines–Stroke Registry improves hospital stroke care processes, boosts outcomes, reduces readmissions, and promotes transparency, accountability, and continuous quality improvement. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/enhancing-stroke-care-through-public-reporting-JYFemUcs</link>
      <enclosure length="1723706" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/fb0865d4-099d-40be-b9e9-89c5ac302491/audio/109d9c2b-f1eb-4937-bb0a-363fbde076fe/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Enhancing Stroke Care Through Public Reporting</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Public reporting through the Get With The Guidelines–Stroke Registry improves hospital stroke care processes, boosts outcomes, reduces readmissions, and promotes transparency, accountability, and continuous quality improvement.</itunes:summary>
      <itunes:subtitle>Public reporting through the Get With The Guidelines–Stroke Registry improves hospital stroke care processes, boosts outcomes, reduces readmissions, and promotes transparency, accountability, and continuous quality improvement.</itunes:subtitle>
      <itunes:keywords>public reporting through the get with the guidelines–stroke registry improves hospital stroke care processes, reduces readmissions, and continuous quality improvement., and promotes transparency, boosts outcomes, accountability</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>74</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fcdc13e7-5b2c-4a82-8565-171fb1c30fec</guid>
      <title>Improving Law Enforcement Interaction in Emergency Departments</title>
      <description><![CDATA[Research outlines strategies for managing law enforcement in emergency departments, emphasizing trauma-informed training, survivor advocates, legal support, and balancing patient autonomy with investigative needs. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/improving-law-enforcement-interaction-in-emergency-departments-dAfv31vI</link>
      <enclosure length="1276072" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/201f5085-f28c-4f5d-84c1-c715fe1be6ad/audio/a83f237e-74dc-49b0-903d-5c67bec561a1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Improving Law Enforcement Interaction in Emergency Departments</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:19</itunes:duration>
      <itunes:summary>Research outlines strategies for managing law enforcement in emergency departments, emphasizing trauma-informed training, survivor advocates, legal support, and balancing patient autonomy with investigative needs.</itunes:summary>
      <itunes:subtitle>Research outlines strategies for managing law enforcement in emergency departments, emphasizing trauma-informed training, survivor advocates, legal support, and balancing patient autonomy with investigative needs.</itunes:subtitle>
      <itunes:keywords>survivor advocates, emphasizing trauma-informed training, and balancing patient autonomy with investigative needs., legal support, research outlines strategies for managing law enforcement in emergency departments</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>73</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">85e9cd4c-2d1c-4b79-b706-514092268869</guid>
      <title>Psychosocial Challenges of Myasthenia Gravis</title>
      <description><![CDATA[Living with myasthenia gravis challenges family expectations, requiring clear communication, boundary-setting, and self-advocacy to honor fluctuating health, redefine milestones, and affirm self-worth beyond societal timelines. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psychosocial-challenges-of-myasthenia-gravis-79zovuxY</link>
      <enclosure length="1146505" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e1ab4165-9b59-4dfc-ac9b-5f9ccf8a5da9/audio/4d0d19f5-3fe7-4cff-bdc6-6277311ece24/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psychosocial Challenges of Myasthenia Gravis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:11</itunes:duration>
      <itunes:summary>Living with myasthenia gravis challenges family expectations, requiring clear communication, boundary-setting, and self-advocacy to honor fluctuating health, redefine milestones, and affirm self-worth beyond societal timelines.</itunes:summary>
      <itunes:subtitle>Living with myasthenia gravis challenges family expectations, requiring clear communication, boundary-setting, and self-advocacy to honor fluctuating health, redefine milestones, and affirm self-worth beyond societal timelines.</itunes:subtitle>
      <itunes:keywords>living with myasthenia gravis challenges family expectations, and affirm self-worth beyond societal timelines., boundary-setting, requiring clear communication, and self-advocacy to honor fluctuating health, redefine milestones</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>72</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b6bffb2d-b3a0-4462-a8dc-a5da7cccedcd</guid>
      <title>Maternal Blood Pressure and Pregnancy Risks</title>
      <description><![CDATA[Study of 700,000 pregnancies links higher maternal blood pressure to increased induction, preterm birth, diabetes, and neonatal care, underscoring need for better monitoring and intervention. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/maternal-blood-pressure-and-pregnancy-risks-1NFesW_k</link>
      <enclosure length="1260607" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/be06605c-a545-4461-9517-538948a831cf/audio/97642b19-20c1-41f5-ad37-2008fe39926d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Maternal Blood Pressure and Pregnancy Risks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Study of 700,000 pregnancies links higher maternal blood pressure to increased induction, preterm birth, diabetes, and neonatal care, underscoring need for better monitoring and intervention.</itunes:summary>
      <itunes:subtitle>Study of 700,000 pregnancies links higher maternal blood pressure to increased induction, preterm birth, diabetes, and neonatal care, underscoring need for better monitoring and intervention.</itunes:subtitle>
      <itunes:keywords>underscoring need for better monitoring and intervention., diabetes, 000 pregnancies links higher maternal blood pressure to increased induction, preterm birth, study of 700, and neonatal care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>71</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d023a427-570f-47c5-8e8f-8a1194221d21</guid>
      <title>New Hope for Liver Fibrosis Treatment</title>
      <description><![CDATA[McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027. 
]]></description>
      <pubDate>Wed, 14 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/new-hope-for-liver-fibrosis-treatment-2vxE41bI</link>
      <enclosure length="1552761" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/58418377-bca9-41d6-8484-cee90da9a2b8/audio/86a27ad7-9a4c-4a2a-bbaa-6bdfab94f4ac/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>New Hope for Liver Fibrosis Treatment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027.</itunes:summary>
      <itunes:subtitle>McMaster researchers report EVT0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for MASH with clinical trials expected by 2027.</itunes:subtitle>
      <itunes:keywords>mcmaster researchers report evt0185 may prevent and reverse liver fibrosis by targeting metabolism, offering a promising therapy for mash with clinical trials expected by 2027.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>70</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d34a39e9-e53c-4b21-986b-7f69a523198a</guid>
      <title>From Layoff to Advocacy_ A Journey with Eczema</title>
      <description><![CDATA[After an unexpected layoff, one individual transformed eczema struggles into advocacy, building community, amplifying patient voices, and contributing to research, education, and awareness despite setbacks. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/from-layoff-to-advocacy-a-journey-with-eczema-L7T6VTKT</link>
      <enclosure length="1210452" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1d8e02ee-79c0-4cf0-a763-fdad551d63a5/audio/4bed18bd-b02d-4a2e-ab3f-adabbd8af01a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>From Layoff to Advocacy_ A Journey with Eczema</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:15</itunes:duration>
      <itunes:summary>After an unexpected layoff, one individual transformed eczema struggles into advocacy, building community, amplifying patient voices, and contributing to research, education, and awareness despite setbacks.</itunes:summary>
      <itunes:subtitle>After an unexpected layoff, one individual transformed eczema struggles into advocacy, building community, amplifying patient voices, and contributing to research, education, and awareness despite setbacks.</itunes:subtitle>
      <itunes:keywords>and awareness despite setbacks., and contributing to research, one individual transformed eczema struggles into advocacy, building community, amplifying patient voices, education, after an unexpected layoff</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>69</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">26756d77-17d2-49d8-bb77-863feaa99b71</guid>
      <title>Understanding Exocrine Pancreatic Insufficiency</title>
      <description><![CDATA[ 
]]></description>
      <pubDate>Tue, 13 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-exocrine-pancreatic-insufficiency-yYTpRfOg</link>
      <enclosure length="1758815" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0c7c286e-80ff-4a17-828c-dc6cf31b2d1d/audio/3d3c6085-24de-411c-8d27-573db27ce8f0/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Exocrine Pancreatic Insufficiency</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:49</itunes:duration>
      <itunes:summary></itunes:summary>
      <itunes:subtitle></itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>68</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f7825ec5-8f83-4048-932e-4baa469939a0</guid>
      <title>Inflammaging and Skin Aging Insights</title>
      <description><![CDATA[Inflammaging drives skin aging through chronic inflammation, degrading collagen and elastin; lifestyle factors, stress, sleep, diet, and exercise play key roles in prevention and healthier skin. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/inflammaging-and-skin-aging-insights-C5JLzZnt</link>
      <enclosure length="1647638" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/eab1787f-69c9-4b3e-9ab8-33e6fcfda255/audio/c3333bb8-175e-4a88-a0bc-e62cac6c94c4/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Inflammaging and Skin Aging Insights</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:42</itunes:duration>
      <itunes:summary>Inflammaging drives skin aging through chronic inflammation, degrading collagen and elastin; lifestyle factors, stress, sleep, diet, and exercise play key roles in prevention and healthier skin.</itunes:summary>
      <itunes:subtitle>Inflammaging drives skin aging through chronic inflammation, degrading collagen and elastin; lifestyle factors, stress, sleep, diet, and exercise play key roles in prevention and healthier skin.</itunes:subtitle>
      <itunes:keywords>and exercise play key roles in prevention and healthier skin., degrading collagen and elastin; lifestyle factors, diet, stress, inflammaging drives skin aging through chronic inflammation, sleep</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>67</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">37f18d0f-bea6-4e24-b554-3bbf4c9403e5</guid>
      <title>Weight Loss and Fat Tissue Normalization</title>
      <description><![CDATA[Study finds weight loss reverses obesity-related fat tissue changes, normalizing immune and vascular cells, challenging notions of permanent adipose damage and highlighting benefits of moderate, sustained weight reduction. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/weight-loss-and-fat-tissue-normalization-TzBIe2lC</link>
      <enclosure length="1307419" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/824984e2-2407-4d40-8b94-52325bf95726/audio/b24e61af-f0ae-43b3-93ed-70ba8d50585a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Weight Loss and Fat Tissue Normalization</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Study finds weight loss reverses obesity-related fat tissue changes, normalizing immune and vascular cells, challenging notions of permanent adipose damage and highlighting benefits of moderate, sustained weight reduction.</itunes:summary>
      <itunes:subtitle>Study finds weight loss reverses obesity-related fat tissue changes, normalizing immune and vascular cells, challenging notions of permanent adipose damage and highlighting benefits of moderate, sustained weight reduction.</itunes:subtitle>
      <itunes:keywords>study finds weight loss reverses obesity-related fat tissue changes, sustained weight reduction., normalizing immune and vascular cells, challenging notions of permanent adipose damage and highlighting benefits of moderate</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>66</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">233a18ef-ceb3-4472-b4ef-b18a33615527</guid>
      <title>Enhancing Breast Cancer Screening with Polygenic Risk</title>
      <description><![CDATA[Study shows genome-wide polygenic risk scores outperform older models in predicting breast cancer risk, improving screening accuracy, especially among European and South Asian ancestry groups. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/enhancing-breast-cancer-screening-with-polygenic-risk-f_uDFeqH</link>
      <enclosure length="1967376" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7f69dd3d-5cbd-42e9-90cc-e6fa9e021753/audio/80bc9ce6-9615-4514-bd51-aa6efd1d05f5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Enhancing Breast Cancer Screening with Polygenic Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Study shows genome-wide polygenic risk scores outperform older models in predicting breast cancer risk, improving screening accuracy, especially among European and South Asian ancestry groups.</itunes:summary>
      <itunes:subtitle>Study shows genome-wide polygenic risk scores outperform older models in predicting breast cancer risk, improving screening accuracy, especially among European and South Asian ancestry groups.</itunes:subtitle>
      <itunes:keywords>especially among european and south asian ancestry groups., study shows genome-wide polygenic risk scores outperform older models in predicting breast cancer risk, improving screening accuracy</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>65</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cb0b1c54-95d9-4da6-9341-2bd95a2c4c84</guid>
      <title>Winter Indoor Health Strategies</title>
      <description><![CDATA[Winter cleaning tips emphasize disinfecting high-touch surfaces, improving ventilation, reducing allergens, promoting hand hygiene, and using HEPA air purifiers to prevent indoor germ spread. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/winter-indoor-health-strategies-XjQARuru</link>
      <enclosure length="1018191" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/60e8c967-639d-450b-b1ca-ecc502539e79/audio/7841272b-1186-4967-b33e-0bd068fd9dfc/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Winter Indoor Health Strategies</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:03</itunes:duration>
      <itunes:summary>Winter cleaning tips emphasize disinfecting high-touch surfaces, improving ventilation, reducing allergens, promoting hand hygiene, and using HEPA air purifiers to prevent indoor germ spread.</itunes:summary>
      <itunes:subtitle>Winter cleaning tips emphasize disinfecting high-touch surfaces, improving ventilation, reducing allergens, promoting hand hygiene, and using HEPA air purifiers to prevent indoor germ spread.</itunes:subtitle>
      <itunes:keywords>reducing allergens, winter cleaning tips emphasize disinfecting high-touch surfaces, improving ventilation, and using hepa air purifiers to prevent indoor germ spread., promoting hand hygiene</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>64</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">27007197-3974-421e-8f15-f7d5fa010d3b</guid>
      <title>The Role of Cuproptosis in Asthma</title>
      <description><![CDATA[Research identifies copper-dependent cell death, cuproptosis, as a driver of airway remodeling in chronic asthma, with blockade reducing inflammation and EMT, highlighting therapeutic potential. 
]]></description>
      <pubDate>Tue, 13 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/the-role-of-cuproptosis-in-asthma-YjBtib3I</link>
      <enclosure length="1710332" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2d790dbb-7848-446a-9271-1b44a967d3c6/audio/8393251d-8adb-44cf-92ea-105c720c867d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>The Role of Cuproptosis in Asthma</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:46</itunes:duration>
      <itunes:summary>Research identifies copper-dependent cell death, cuproptosis, as a driver of airway remodeling in chronic asthma, with blockade reducing inflammation and EMT, highlighting therapeutic potential.</itunes:summary>
      <itunes:subtitle>Research identifies copper-dependent cell death, cuproptosis, as a driver of airway remodeling in chronic asthma, with blockade reducing inflammation and EMT, highlighting therapeutic potential.</itunes:subtitle>
      <itunes:keywords>highlighting therapeutic potential., as a driver of airway remodeling in chronic asthma, cuproptosis, research identifies copper-dependent cell death, with blockade reducing inflammation and emt</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>63</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9392ad9b-0f27-46ca-8672-415039d58ddb</guid>
      <title>Concussion Recovery_ Sleep Disorders</title>
      <description><![CDATA[Sleep disorders commonly follow sports-related concussion, affecting recovery regardless of injury severity, requiring assessment and individualized management to restore sleep, circadian regulation, and optimize outcomes. 
]]></description>
      <pubDate>Mon, 12 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/concussion-recovery-sleep-disorders-mo4uNq76</link>
      <enclosure length="1594975" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/ea9e294e-6c98-43f0-9b0f-bb663318653a/audio/191e9ec6-aeff-4add-a4df-f4de4486d081/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Concussion Recovery_ Sleep Disorders</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>Sleep disorders commonly follow sports-related concussion, affecting recovery regardless of injury severity, requiring assessment and individualized management to restore sleep, circadian regulation, and optimize outcomes.</itunes:summary>
      <itunes:subtitle>Sleep disorders commonly follow sports-related concussion, affecting recovery regardless of injury severity, requiring assessment and individualized management to restore sleep, circadian regulation, and optimize outcomes.</itunes:subtitle>
      <itunes:keywords>circadian regulation, affecting recovery regardless of injury severity, requiring assessment and individualized management to restore sleep, and optimize outcomes., sleep disorders commonly follow sports-related concussion</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>61</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">512b5964-f5f1-478f-88c1-2b19dde6c665</guid>
      <title>AI-Powered Ambient Scribes in Healthcare</title>
      <description><![CDATA[AI ambient scribes reduce clinician documentation time and burnout, but high costs and billing integration raise concerns about upcoding, spending, autonomy, and need for oversight. 
]]></description>
      <pubDate>Mon, 12 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-powered-ambient-scribes-in-healthcare-R7_mnMLK</link>
      <enclosure length="1414416" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/17c1efde-4e77-420d-b212-85de5cbfcee9/audio/6e18be26-33fc-4873-9f28-ed5effe5b1fe/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI-Powered Ambient Scribes in Healthcare</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>AI ambient scribes reduce clinician documentation time and burnout, but high costs and billing integration raise concerns about upcoding, spending, autonomy, and need for oversight.</itunes:summary>
      <itunes:subtitle>AI ambient scribes reduce clinician documentation time and burnout, but high costs and billing integration raise concerns about upcoding, spending, autonomy, and need for oversight.</itunes:subtitle>
      <itunes:keywords>autonomy, and need for oversight., but high costs and billing integration raise concerns about upcoding, spending, ai ambient scribes reduce clinician documentation time and burnout</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>62</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bce78048-6b13-4a15-9a1f-e864b0c4bbc0</guid>
      <title>Understanding IBS-D_ Symptoms, Diagnosis, and Management</title>
      <description><![CDATA[IBS-D management requires careful diagnosis, dietary strategies like low-FODMAP, targeted medications, and patient education addressing psychosocial factors to improve symptoms, quality of life, and care. 
]]></description>
      <pubDate>Mon, 12 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-ibs-d-symptoms-diagnosis-and-management-Q33nhIxb</link>
      <enclosure length="1803536" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/0aa5e888-a477-44be-97aa-02cc475142a2/audio/3074993b-4cb5-4cba-bea1-4674799e1d51/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding IBS-D_ Symptoms, Diagnosis, and Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:52</itunes:duration>
      <itunes:summary>IBS-D management requires careful diagnosis, dietary strategies like low-FODMAP, targeted medications, and patient education addressing psychosocial factors to improve symptoms, quality of life, and care.</itunes:summary>
      <itunes:subtitle>IBS-D management requires careful diagnosis, dietary strategies like low-FODMAP, targeted medications, and patient education addressing psychosocial factors to improve symptoms, quality of life, and care.</itunes:subtitle>
      <itunes:keywords>and patient education addressing psychosocial factors to improve symptoms, targeted medications, ibs-d management requires careful diagnosis, and care., quality of life, dietary strategies like low-fodmap</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>60</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">195917e8-26ae-440d-9714-f7e6ebf0e945</guid>
      <title>Healthcare Challenges in 2026</title>
      <description><![CDATA[ACA subsidy expiration may leave 4.8 million uninsured by 2026, forcing reliance on safety-net clinics, highlighting affordability gaps, Medicaid expansion issues, and urgent healthcare access challenges. 
]]></description>
      <pubDate>Mon, 12 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/healthcare-challenges-in-2026-8kfNMMph</link>
      <enclosure length="1463318" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/71d8d6dd-e6cd-463d-9049-e7985eb86f08/audio/f3bdb583-783c-43fd-b336-28e18c8ac3c1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Healthcare Challenges in 2026</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>ACA subsidy expiration may leave 4.8 million uninsured by 2026, forcing reliance on safety-net clinics, highlighting affordability gaps, Medicaid expansion issues, and urgent healthcare access challenges.</itunes:summary>
      <itunes:subtitle>ACA subsidy expiration may leave 4.8 million uninsured by 2026, forcing reliance on safety-net clinics, highlighting affordability gaps, Medicaid expansion issues, and urgent healthcare access challenges.</itunes:subtitle>
      <itunes:keywords>and urgent healthcare access challenges., medicaid expansion issues, highlighting affordability gaps, aca subsidy expiration may leave 4.8 million uninsured by 2026, forcing reliance on safety-net clinics</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>59</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f42fb3da-e498-406e-bdda-2ab669fc5dc1</guid>
      <title>Preventive Care Cost Disparities</title>
      <description><![CDATA[Study shows patients with chronic conditions face higher out-of-pocket costs for preventive care despite ACA protections, highlighting billing issues and need for standardized cost-sharing practices. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 22:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/preventive-care-cost-disparities-j75ZpNR2</link>
      <enclosure length="1656833" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8a713a15-299a-4b66-88c1-00b1596f1de7/audio/0ebe5790-54bd-487d-868c-f4e654940b27/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Preventive Care Cost Disparities</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Study shows patients with chronic conditions face higher out-of-pocket costs for preventive care despite ACA protections, highlighting billing issues and need for standardized cost-sharing practices.</itunes:summary>
      <itunes:subtitle>Study shows patients with chronic conditions face higher out-of-pocket costs for preventive care despite ACA protections, highlighting billing issues and need for standardized cost-sharing practices.</itunes:subtitle>
      <itunes:keywords>highlighting billing issues and need for standardized cost-sharing practices., study shows patients with chronic conditions face higher out-of-pocket costs for preventive care despite aca protections</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>58</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ec388213-1e4b-4c13-b018-7eb041dd01af</guid>
      <title>Disparities in Young Adult Colorectal Cancer Survival Rates</title>
      <description><![CDATA[Study shows adults with metastatic colorectal cancer have worse survival in low socioeconomic neighborhoods and among Black patients, highlighting structural inequities and need for interventions. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 21:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/disparities-in-young-adult-colorectal-cancer-survival-rates-jFOxZPoy</link>
      <enclosure length="2308013" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f57377ed-f4af-4d7a-bb58-3661c10537bf/audio/b54573b2-6771-4d2b-9da9-e8b34810e97c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Disparities in Young Adult Colorectal Cancer Survival Rates</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:24</itunes:duration>
      <itunes:summary>Study shows adults with metastatic colorectal cancer have worse survival in low socioeconomic neighborhoods and among Black patients, highlighting structural inequities and need for interventions.</itunes:summary>
      <itunes:subtitle>Study shows adults with metastatic colorectal cancer have worse survival in low socioeconomic neighborhoods and among Black patients, highlighting structural inequities and need for interventions.</itunes:subtitle>
      <itunes:keywords>study shows adults with metastatic colorectal cancer have worse survival in low socioeconomic neighborhoods and among black patients, highlighting structural inequities and need for interventions.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>57</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cd2b79dc-8c4c-47a8-aa8e-22460c351934</guid>
      <title>California Cuts Medicaid Coverage for Weight Loss Drugs</title>
      <description><![CDATA[California will end Medicaid coverage for GLP-1 weight loss drugs in 2026, limiting obesity treatment access for low-income residents despite effectiveness and affordability concerns. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/california-cuts-medicaid-coverage-for-weight-loss-drugs-xNe8ekJI</link>
      <enclosure length="895729" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/babbdda2-904d-4f91-93bb-5e974dbbbac2/audio/7168fbd1-2226-47a5-9d49-5723196bc287/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>California Cuts Medicaid Coverage for Weight Loss Drugs</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:55</itunes:duration>
      <itunes:summary>California will end Medicaid coverage for GLP-1 weight loss drugs in 2026, limiting obesity treatment access for low-income residents despite effectiveness and affordability concerns.</itunes:summary>
      <itunes:subtitle>California will end Medicaid coverage for GLP-1 weight loss drugs in 2026, limiting obesity treatment access for low-income residents despite effectiveness and affordability concerns.</itunes:subtitle>
      <itunes:keywords>limiting obesity treatment access for low-income residents despite effectiveness and affordability concerns., california will end medicaid coverage for glp-1 weight loss drugs in 2026</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>56</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">9a6af254-71c2-4375-9814-0e471e720008</guid>
      <title>Understanding Pathological Demand Avoidance (PDA)</title>
      <description><![CDATA[Pathological Demand Avoidance involves extreme demand avoidance, often overlapping autism, frequently underrecognized, requiring early identification, assessment, and individualized supports to improve functioning and life outcomes. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-pathological-demand-avoidance-pda-zBjxxlBM</link>
      <enclosure length="1575749" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/92568762-95d9-4790-a462-3bcfb2cffed0/audio/74fd4b15-eed1-40b4-8524-48a9cc7fd3d6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Pathological Demand Avoidance (PDA)</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:38</itunes:duration>
      <itunes:summary>Pathological Demand Avoidance involves extreme demand avoidance, often overlapping autism, frequently underrecognized, requiring early identification, assessment, and individualized supports to improve functioning and life outcomes.</itunes:summary>
      <itunes:subtitle>Pathological Demand Avoidance involves extreme demand avoidance, often overlapping autism, frequently underrecognized, requiring early identification, assessment, and individualized supports to improve functioning and life outcomes.</itunes:subtitle>
      <itunes:keywords>and individualized supports to improve functioning and life outcomes., often overlapping autism, requiring early identification, pathological demand avoidance involves extreme demand avoidance, frequently underrecognized, assessment</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>55</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7e302701-f4ac-4e8e-bdfd-3db849a8bb03</guid>
      <title>Flu Surge Strains Kansas City Hospitals</title>
      <description><![CDATA[Kansas City hospitals report sharp influenza surge, increasing admissions and illness severity, stressing resources, prompting vaccination campaigns, preparedness efforts, and monitoring to protect vulnerable populations. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 17:07:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/flu-surge-strains-kansas-city-hospitals-ft8uGGhj</link>
      <enclosure length="869398" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f3ce3730-1ccc-4f1e-a9fc-c6230e2ea6b2/audio/c019361c-2c14-40fe-a881-8ed12425c1c1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Flu Surge Strains Kansas City Hospitals</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:54</itunes:duration>
      <itunes:summary>Kansas City hospitals report sharp influenza surge, increasing admissions and illness severity, stressing resources, prompting vaccination campaigns, preparedness efforts, and monitoring to protect vulnerable populations.</itunes:summary>
      <itunes:subtitle>Kansas City hospitals report sharp influenza surge, increasing admissions and illness severity, stressing resources, prompting vaccination campaigns, preparedness efforts, and monitoring to protect vulnerable populations.</itunes:subtitle>
      <itunes:keywords>preparedness efforts, prompting vaccination campaigns, kansas city hospitals report sharp influenza surge, and monitoring to protect vulnerable populations., increasing admissions and illness severity, stressing resources</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>54</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f8b62d39-297d-4271-94f9-1c329abb1dca</guid>
      <title>GLP-1 Therapy for Global Obesity Management</title>
      <description><![CDATA[Global analysis shows over 27% of adults eligible for GLP-1 obesity therapy, mostly in low-income regions, highlighting access inequities and need for equitable deployment strategies. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 16:14:59 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/glp-1-therapy-for-global-obesity-management-bLQd2lW8</link>
      <enclosure length="1617963" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1ea0789d-a20c-451c-8567-aa48280f1088/audio/cb1bb9ef-d7a9-4f43-a466-17181a085e8d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>GLP-1 Therapy for Global Obesity Management</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Global analysis shows over 27% of adults eligible for GLP-1 obesity therapy, mostly in low-income regions, highlighting access inequities and need for equitable deployment strategies.</itunes:summary>
      <itunes:subtitle>Global analysis shows over 27% of adults eligible for GLP-1 obesity therapy, mostly in low-income regions, highlighting access inequities and need for equitable deployment strategies.</itunes:subtitle>
      <itunes:keywords>global analysis shows over 27% of adults eligible for glp-1 obesity therapy, mostly in low-income regions, highlighting access inequities and need for equitable deployment strategies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>53</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8c4161ad-cd89-48da-8291-19217e15ca12</guid>
      <title>Challenges in Xenotransplantation_ Overcoming Innate Immune Responses</title>
      <description><![CDATA[Study of pig kidney xenotransplant reveals innate immune activation threatens graft survival, highlights macrophage role, dd-cfDNA monitoring, and need for advanced genetic engineering and immune modulation strategies. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 16:00:29 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/challenges-in-xenotransplantation-overcoming-innate-immune-responses-2gZpNIqt</link>
      <enclosure length="1102201" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b383435e-f2af-4107-bbdc-324c9626c38c/audio/136185eb-c168-45b6-93db-94b7a231f11e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Challenges in Xenotransplantation_ Overcoming Innate Immune Responses</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:08</itunes:duration>
      <itunes:summary>Study of pig kidney xenotransplant reveals innate immune activation threatens graft survival, highlights macrophage role, dd-cfDNA monitoring, and need for advanced genetic engineering and immune modulation strategies.</itunes:summary>
      <itunes:subtitle>Study of pig kidney xenotransplant reveals innate immune activation threatens graft survival, highlights macrophage role, dd-cfDNA monitoring, and need for advanced genetic engineering and immune modulation strategies.</itunes:subtitle>
      <itunes:keywords>and need for advanced genetic engineering and immune modulation strategies., dd-cfdna monitoring, study of pig kidney xenotransplant reveals innate immune activation threatens graft survival, highlights macrophage role</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>52</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c38ff287-3c8d-45be-839e-b9bed2ac7943</guid>
      <title>Advancements in Thyroid Care</title>
      <description><![CDATA[Review highlights advances in thyroid care, supporting laser ablation for benign nodules, exploring metformin benefits, and reassuring safety of radioactive iodine therapy for Graves’ disease. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 15:44:15 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancements-in-thyroid-care-Br_ZgIfn</link>
      <enclosure length="1151938" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2acdcd7b-8258-44f1-89fa-64fc696cf215/audio/a508757e-6530-4f8d-b0e7-dac5d1908dec/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancements in Thyroid Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:11</itunes:duration>
      <itunes:summary>Review highlights advances in thyroid care, supporting laser ablation for benign nodules, exploring metformin benefits, and reassuring safety of radioactive iodine therapy for Graves’ disease.</itunes:summary>
      <itunes:subtitle>Review highlights advances in thyroid care, supporting laser ablation for benign nodules, exploring metformin benefits, and reassuring safety of radioactive iodine therapy for Graves’ disease.</itunes:subtitle>
      <itunes:keywords>review highlights advances in thyroid care, supporting laser ablation for benign nodules, exploring metformin benefits, and reassuring safety of radioactive iodine therapy for graves’ disease.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>51</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">08d7d194-c387-47b0-89fa-ccf26b1890cc</guid>
      <title>Addressing Workplace Burnout</title>
      <description><![CDATA[ICD-11 defines burnout as an occupational phenomenon, supporting workplace screening and organizational interventions alongside clinical care to prevent burnout and promote employee mental health and productivity. 
]]></description>
      <pubDate>Fri, 9 Jan 2026 15:22:14 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/addressing-workplace-burnout-6_RobJ5p</link>
      <enclosure length="1683582" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/8c00013e-7990-4e47-bfc7-1729a7e1dc7e/audio/a800c01b-4f96-4bed-a209-97e868740ac5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Addressing Workplace Burnout</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:45</itunes:duration>
      <itunes:summary>ICD-11 defines burnout as an occupational phenomenon, supporting workplace screening and organizational interventions alongside clinical care to prevent burnout and promote employee mental health and productivity.</itunes:summary>
      <itunes:subtitle>ICD-11 defines burnout as an occupational phenomenon, supporting workplace screening and organizational interventions alongside clinical care to prevent burnout and promote employee mental health and productivity.</itunes:subtitle>
      <itunes:keywords>icd-11 defines burnout as an occupational phenomenon, supporting workplace screening and organizational interventions alongside clinical care to prevent burnout and promote employee mental health and productivity.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>50</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5139592a-1c1c-404f-ac8e-e5566cd66646</guid>
      <title>Ballot Impact on LGBTQ+ Health in 2024 Election</title>
      <description><![CDATA[Analysis of 2024 U.S. ballot measures shows mostly protective outcomes for LGBTQ+ health, impacting reproductive, gender-affirming, HIV, and mental health access amid evolving state policies. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 23:34:44 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ballot-impact-on-lgbtq-health-in-2024-election-yEZz0l8_</link>
      <enclosure length="1626322" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a377922d-dfd1-4b57-8bed-98b2571d9c6c/audio/bf5bff90-dc33-4904-b700-40f337ce7bd7/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Ballot Impact on LGBTQ+ Health in 2024 Election</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Analysis of 2024 U.S. ballot measures shows mostly protective outcomes for LGBTQ+ health, impacting reproductive, gender-affirming, HIV, and mental health access amid evolving state policies.</itunes:summary>
      <itunes:subtitle>Analysis of 2024 U.S. ballot measures shows mostly protective outcomes for LGBTQ+ health, impacting reproductive, gender-affirming, HIV, and mental health access amid evolving state policies.</itunes:subtitle>
      <itunes:keywords>impacting reproductive, hiv, analysis of 2024 u.s. ballot measures shows mostly protective outcomes for lgbtq+ health, and mental health access amid evolving state policies., gender-affirming</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>49</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">91608194-191d-48b2-a9a9-81f5a94c3e98</guid>
      <title>Prescription Weight Loss Medications and Nutritional Risks</title>
      <description><![CDATA[Study warns users of GLP-1 weight loss drugs may lack nutritional guidance, risking deficiencies and muscle loss, urging structured dietary support alongside semaglutide and tirzepatide therapy. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 23:31:03 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/prescription-weight-loss-medications-and-nutritional-risks-4KLhJAvz</link>
      <enclosure length="1468333" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2913db98-d774-40d6-b60a-34b3868aeecf/audio/d9adffc0-4138-44a3-b8a1-2cb6d0667277/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Prescription Weight Loss Medications and Nutritional Risks</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Study warns users of GLP-1 weight loss drugs may lack nutritional guidance, risking deficiencies and muscle loss, urging structured dietary support alongside semaglutide and tirzepatide therapy.</itunes:summary>
      <itunes:subtitle>Study warns users of GLP-1 weight loss drugs may lack nutritional guidance, risking deficiencies and muscle loss, urging structured dietary support alongside semaglutide and tirzepatide therapy.</itunes:subtitle>
      <itunes:keywords>study warns users of glp-1 weight loss drugs may lack nutritional guidance, urging structured dietary support alongside semaglutide and tirzepatide therapy., risking deficiencies and muscle loss</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>45</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">11084924-6ad6-4813-9270-9145ee5b4486</guid>
      <title>Drug Shortages in Primary Care</title>
      <description><![CDATA[Survey shows widespread drug shortages affecting U.S. primary care, harming patient outcomes, altering treatment decisions, increasing administrative burden, and contributing to physician burnout and care disruption. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 23:29:09 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/drug-shortages-in-primary-care-0SmRNI8Y</link>
      <enclosure length="1241799" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/15ce400c-8800-484f-952c-32fc7aec5d5c/audio/9cdd3abc-4c7c-46f7-a435-0b3dd9440f1d/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Drug Shortages in Primary Care</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:17</itunes:duration>
      <itunes:summary>Survey shows widespread drug shortages affecting U.S. primary care, harming patient outcomes, altering treatment decisions, increasing administrative burden, and contributing to physician burnout and care disruption.</itunes:summary>
      <itunes:subtitle>Survey shows widespread drug shortages affecting U.S. primary care, harming patient outcomes, altering treatment decisions, increasing administrative burden, and contributing to physician burnout and care disruption.</itunes:subtitle>
      <itunes:keywords>altering treatment decisions, increasing administrative burden, harming patient outcomes, survey shows widespread drug shortages affecting u.s. primary care, and contributing to physician burnout and care disruption.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>48</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">77db0b92-c3f9-447c-8302-8354dbfd9136</guid>
      <title>Surgeons&apos; Confusion Under Maryland&apos;s All-Payer Model</title>
      <description><![CDATA[Qualitative study finds surgeons poorly informed about Maryland’s All-Payer Model, reporting communication gaps, increased care centralization, and limited referral improvements, highlighting need for better clinician engagement. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 20:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/surgeons-confusion-under-marylands-all-payer-model-TcD574In</link>
      <enclosure length="1343363" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/bb0b860f-c2d0-436c-9672-201d46eefa20/audio/5ff0f13a-d45b-4f9a-81ab-c385d1fd46a1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Surgeons&apos; Confusion Under Maryland&apos;s All-Payer Model</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Qualitative study finds surgeons poorly informed about Maryland’s All-Payer Model, reporting communication gaps, increased care centralization, and limited referral improvements, highlighting need for better clinician engagement.</itunes:summary>
      <itunes:subtitle>Qualitative study finds surgeons poorly informed about Maryland’s All-Payer Model, reporting communication gaps, increased care centralization, and limited referral improvements, highlighting need for better clinician engagement.</itunes:subtitle>
      <itunes:keywords>qualitative study finds surgeons poorly informed about maryland’s all-payer model, increased care centralization, highlighting need for better clinician engagement., and limited referral improvements, reporting communication gaps</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>47</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">83908de0-35e6-42b2-890e-d6fa3805db91</guid>
      <title>Understanding Cancer Progression Through Biophysical Properties</title>
      <description><![CDATA[LesM microfluidic device captures circulating tumor cells by mechanical properties, linking cancer cell biomechanics and intratumoral bacteria to metastasis prediction and personalized antimicrobial treatment strategies. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/understanding-cancer-progression-through-biophysical-properties-ySh4_eWC</link>
      <enclosure length="1842407" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/86c0d92a-927a-4a26-b207-07d1d285ddda/audio/aa070cce-91d8-4daa-bef7-5eb6810edc21/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Understanding Cancer Progression Through Biophysical Properties</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:55</itunes:duration>
      <itunes:summary>LesM microfluidic device captures circulating tumor cells by mechanical properties, linking cancer cell biomechanics and intratumoral bacteria to metastasis prediction and personalized antimicrobial treatment strategies.</itunes:summary>
      <itunes:subtitle>LesM microfluidic device captures circulating tumor cells by mechanical properties, linking cancer cell biomechanics and intratumoral bacteria to metastasis prediction and personalized antimicrobial treatment strategies.</itunes:subtitle>
      <itunes:keywords>linking cancer cell biomechanics and intratumoral bacteria to metastasis prediction and personalized antimicrobial treatment strategies., lesm microfluidic device captures circulating tumor cells by mechanical properties</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>46</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">cc1b6e99-b7b3-49d2-bd2c-0c7d4f8829e2</guid>
      <title>Advancements in Elbow Pain Relief</title>
      <description><![CDATA[Anatomical study maps elbow articular nerve branches, revealing musculocutaneous, median, and radial contributions, enabling targeted minimally invasive nerve blockade for improved chronic elbow arthritis pain relief. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancements-in-elbow-pain-relief-GxS8AmiI</link>
      <enclosure length="1876261" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/1de2378a-faef-433b-9126-c672886e7106/audio/30c1082e-e2f7-4157-8449-53f7cf58041e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancements in Elbow Pain Relief</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Anatomical study maps elbow articular nerve branches, revealing musculocutaneous, median, and radial contributions, enabling targeted minimally invasive nerve blockade for improved chronic elbow arthritis pain relief.</itunes:summary>
      <itunes:subtitle>Anatomical study maps elbow articular nerve branches, revealing musculocutaneous, median, and radial contributions, enabling targeted minimally invasive nerve blockade for improved chronic elbow arthritis pain relief.</itunes:subtitle>
      <itunes:keywords>revealing musculocutaneous, and radial contributions, anatomical study maps elbow articular nerve branches, enabling targeted minimally invasive nerve blockade for improved chronic elbow arthritis pain relief., median</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>44</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">baf3473e-c156-45ca-86bc-f13bcd06a21b</guid>
      <title>UK Weight Management Medication Trends 2024-2025</title>
      <description><![CDATA[UCL study estimates 1.6 million Britons used weight loss drugs, with millions more interested, highlighting rising demand, access inequalities, and concerns about supervision and long-term impacts. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/uk-weight-management-medication-trends-2024-2025-XQd6cObo</link>
      <enclosure length="1943971" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/34550b71-c1c7-480a-8caa-3ff961cc03f9/audio/6679667b-2663-4b96-b92a-0a66f88a9d69/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>UK Weight Management Medication Trends 2024-2025</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:01</itunes:duration>
      <itunes:summary>UCL study estimates 1.6 million Britons used weight loss drugs, with millions more interested, highlighting rising demand, access inequalities, and concerns about supervision and long-term impacts.</itunes:summary>
      <itunes:subtitle>UCL study estimates 1.6 million Britons used weight loss drugs, with millions more interested, highlighting rising demand, access inequalities, and concerns about supervision and long-term impacts.</itunes:subtitle>
      <itunes:keywords>and concerns about supervision and long-term impacts., ucl study estimates 1.6 million britons used weight loss drugs, with millions more interested, highlighting rising demand, access inequalities</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>43</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f02196c4-0dd8-4373-b7af-f3603956a5d1</guid>
      <title>Weight Regain After Stopping GLP-1 Treatment</title>
      <description><![CDATA[BMJ analysis shows stopping GLP-1 weight loss drugs leads to rapid weight regain and loss of metabolic benefits, underscoring need for long-term lifestyle strategies alongside medication. 
]]></description>
      <pubDate>Thu, 8 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/weight-regain-after-stopping-glp-1-treatment-WxJgG627</link>
      <enclosure length="1269803" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2d258a3c-4e8f-45be-ab47-de162fce92d6/audio/c6addf5b-729d-4ff6-9563-7ed15a3df8db/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Weight Regain After Stopping GLP-1 Treatment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:19</itunes:duration>
      <itunes:summary>BMJ analysis shows stopping GLP-1 weight loss drugs leads to rapid weight regain and loss of metabolic benefits, underscoring need for long-term lifestyle strategies alongside medication.</itunes:summary>
      <itunes:subtitle>BMJ analysis shows stopping GLP-1 weight loss drugs leads to rapid weight regain and loss of metabolic benefits, underscoring need for long-term lifestyle strategies alongside medication.</itunes:subtitle>
      <itunes:keywords>underscoring need for long-term lifestyle strategies alongside medication., bmj analysis shows stopping glp-1 weight loss drugs leads to rapid weight regain and loss of metabolic benefits</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>42</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fdd2468d-4f7c-4758-bfb3-2f6189562fa2</guid>
      <title>Impact of Migrant Protection Protocols on Asylum Seekers&apos; Trauma</title>
      <description><![CDATA[Study finds Migrant Protection Protocols exposure increases asylum seeker trauma, violence, and PTSD risk dramatically, challenging policy effectiveness and urging humanitarian, evidence-based immigration reforms globally. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/impact-of-migrant-protection-protocols-on-asylum-seekers-trauma-cazpCxKd</link>
      <enclosure length="1378472" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c991f493-2753-4f5f-9877-8d349af5968b/audio/feef0f1a-ce5c-425c-be25-d77259c57dcb/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Impact of Migrant Protection Protocols on Asylum Seekers&apos; Trauma</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:26</itunes:duration>
      <itunes:summary>Study finds Migrant Protection Protocols exposure increases asylum seeker trauma, violence, and PTSD risk dramatically, challenging policy effectiveness and urging humanitarian, evidence-based immigration reforms globally.</itunes:summary>
      <itunes:subtitle>Study finds Migrant Protection Protocols exposure increases asylum seeker trauma, violence, and PTSD risk dramatically, challenging policy effectiveness and urging humanitarian, evidence-based immigration reforms globally.</itunes:subtitle>
      <itunes:keywords>study finds migrant protection protocols exposure increases asylum seeker trauma, violence, and ptsd risk dramatically, challenging policy effectiveness and urging humanitarian, evidence-based immigration reforms globally.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>41</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fff1e2aa-4c76-483f-b7f9-af8c5398465d</guid>
      <title>Mayo Clinic&apos;s JAX Shock Consortium</title>
      <description><![CDATA[Mayo Clinic’s JAX Shock consortium improves cardiogenic shock outcomes through early identification, coordinated multidisciplinary care, raising survival to 85% and reducing mortality across regional hospitals. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mayo-clinics-jax-shock-consortium-Eg27QPVz</link>
      <enclosure length="1966541" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/60719302-dd46-4e1f-b7eb-f1f50eb91f11/audio/c59fc2eb-dd86-4b31-b90f-381b298f03ba/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mayo Clinic&apos;s JAX Shock Consortium</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:02</itunes:duration>
      <itunes:summary>Mayo Clinic’s JAX Shock consortium improves cardiogenic shock outcomes through early identification, coordinated multidisciplinary care, raising survival to 85% and reducing mortality across regional hospitals.</itunes:summary>
      <itunes:subtitle>Mayo Clinic’s JAX Shock consortium improves cardiogenic shock outcomes through early identification, coordinated multidisciplinary care, raising survival to 85% and reducing mortality across regional hospitals.</itunes:subtitle>
      <itunes:keywords>mayo clinic’s jax shock consortium improves cardiogenic shock outcomes through early identification, coordinated multidisciplinary care, raising survival to 85% and reducing mortality across regional hospitals.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>40</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5846313a-3ba4-4859-aad8-7f5f3c33fb8c</guid>
      <title>Mitral Valve Surgery for Octogenarians</title>
      <description><![CDATA[Mayo Clinic study suggests mitral valve surgery offers better durability and survival than TEER in octogenarians with regurgitation, emphasizing individualized decisions based on physiologic age. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mitral-valve-surgery-for-octogenarians-oI2u4IZL</link>
      <enclosure length="1515145" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/d70088c3-ff42-40de-9701-40d236079b4a/audio/4a815529-e364-4ff1-a3e7-57796d473d04/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mitral Valve Surgery for Octogenarians</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:34</itunes:duration>
      <itunes:summary>Mayo Clinic study suggests mitral valve surgery offers better durability and survival than TEER in octogenarians with regurgitation, emphasizing individualized decisions based on physiologic age.</itunes:summary>
      <itunes:subtitle>Mayo Clinic study suggests mitral valve surgery offers better durability and survival than TEER in octogenarians with regurgitation, emphasizing individualized decisions based on physiologic age.</itunes:subtitle>
      <itunes:keywords>emphasizing individualized decisions based on physiologic age., mayo clinic study suggests mitral valve surgery offers better durability and survival than teer in octogenarians with regurgitation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>39</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">b7ce3b2c-95b3-4f20-b3aa-edfea0463568</guid>
      <title>Rethinking Heart Attacks in Younger Women</title>
      <description><![CDATA[Mayo Clinic study shows younger women’s myocardial infarctions often stem from nonatherosclerotic causes like SCAD and embolism, underscoring need for precise diagnosis and tailored treatment. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rethinking-heart-attacks-in-younger-women-KCBU9pxB</link>
      <enclosure length="1930596" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b75623d1-b1a9-41f3-9b97-546257ea21ed/audio/edaa246d-9b1d-488d-adbb-6ffa4f469dab/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rethinking Heart Attacks in Younger Women</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:00</itunes:duration>
      <itunes:summary>Mayo Clinic study shows younger women’s myocardial infarctions often stem from nonatherosclerotic causes like SCAD and embolism, underscoring need for precise diagnosis and tailored treatment.</itunes:summary>
      <itunes:subtitle>Mayo Clinic study shows younger women’s myocardial infarctions often stem from nonatherosclerotic causes like SCAD and embolism, underscoring need for precise diagnosis and tailored treatment.</itunes:subtitle>
      <itunes:keywords>mayo clinic study shows younger women’s myocardial infarctions often stem from nonatherosclerotic causes like scad and embolism, underscoring need for precise diagnosis and tailored treatment.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>38</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">fe6b87f2-3fdd-4fa9-b95e-8cc1a039ea56</guid>
      <title>Differentiating Inflammatory Pathways in EGPA and SEA</title>
      <description><![CDATA[Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/differentiating-inflammatory-pathways-in-egpa-and-sea-OF4_pjkj</link>
      <enclosure length="2005829" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/ac7f5de2-4364-4ec2-896a-8b70a2f5f7e1/audio/dc84333d-9149-43d6-9716-899be4323121/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Differentiating Inflammatory Pathways in EGPA and SEA</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:05</itunes:duration>
      <itunes:summary>Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.</itunes:summary>
      <itunes:subtitle>Study reveals EGPA driven by interferon-mediated inflammation distinct from severe eosinophilic asthma, identifying immune cell signatures and IGF1 pathways as potential therapeutic targets for patients.</itunes:subtitle>
      <itunes:keywords>identifying immune cell signatures and igf1 pathways as potential therapeutic targets for patients., study reveals egpa driven by interferon-mediated inflammation distinct from severe eosinophilic asthma</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>37</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6e2aed3e-173c-4848-ada3-0255f3399486</guid>
      <title>Machine Learning in Schizophrenia Assessment</title>
      <description><![CDATA[Machine learning improves neurocognitive profiling in schizophrenia, enabling precise detection of cognitive deficits, personalized interventions, enhanced diagnostic accuracy, and better patient outcomes in psychiatric care. 
]]></description>
      <pubDate>Wed, 7 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/machine-learning-in-schizophrenia-assessment-9oZZYZmv</link>
      <enclosure length="894893" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f4f49400-995e-49ef-922a-a8c059c73bef/audio/fa7859b5-4ab9-4c9a-bf74-1fcda91eb916/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Machine Learning in Schizophrenia Assessment</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:55</itunes:duration>
      <itunes:summary>Machine learning improves neurocognitive profiling in schizophrenia, enabling precise detection of cognitive deficits, personalized interventions, enhanced diagnostic accuracy, and better patient outcomes in psychiatric care.</itunes:summary>
      <itunes:subtitle>Machine learning improves neurocognitive profiling in schizophrenia, enabling precise detection of cognitive deficits, personalized interventions, enhanced diagnostic accuracy, and better patient outcomes in psychiatric care.</itunes:subtitle>
      <itunes:keywords>enhanced diagnostic accuracy, and better patient outcomes in psychiatric care., personalized interventions, machine learning improves neurocognitive profiling in schizophrenia, enabling precise detection of cognitive deficits</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>36</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6309bd25-3468-4c3d-9783-e3ef5eff94fb</guid>
      <title>E-Cigarette Flavor Bans Reduce Youth Initiation</title>
      <description><![CDATA[Study shows state e-cigarette flavor bans significantly reduce initiation among young adults, but not adolescents, revealing socioeconomic disparities and need for broader, more equitable vaping prevention strategies. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 19:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/e-cigarette-flavor-bans-reduce-youth-initiation-K4Yb4SaL</link>
      <enclosure length="1458302" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/97518d56-3198-4b93-8f47-9d31b99d792c/audio/d56a20ee-d0ed-4a8c-9546-b4b78216dc36/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>E-Cigarette Flavor Bans Reduce Youth Initiation</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:31</itunes:duration>
      <itunes:summary>Study shows state e-cigarette flavor bans significantly reduce initiation among young adults, but not adolescents, revealing socioeconomic disparities and need for broader, more equitable vaping prevention strategies.</itunes:summary>
      <itunes:subtitle>Study shows state e-cigarette flavor bans significantly reduce initiation among young adults, but not adolescents, revealing socioeconomic disparities and need for broader, more equitable vaping prevention strategies.</itunes:subtitle>
      <itunes:keywords>revealing socioeconomic disparities and need for broader, study shows state e-cigarette flavor bans significantly reduce initiation among young adults, but not adolescents, more equitable vaping prevention strategies.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>35</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e17b0c67-8b4a-413b-8f2f-fd9d75e9b059</guid>
      <title>Home-Based Self-Sampling for Anal Precancer</title>
      <description><![CDATA[Study finds home-based self-sampling for anal precancer screening cost-effective, boosting access and compliance, especially in high-risk groups, while reducing healthcare costs and improving early detection. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/home-based-self-sampling-for-anal-precancer-f_QRyolX</link>
      <enclosure length="1615455" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f6dd4ed8-3538-4e2f-8e27-fd1d9baf0fdb/audio/eb70ec8e-2b94-4202-8653-63c30ca582c8/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Home-Based Self-Sampling for Anal Precancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Study finds home-based self-sampling for anal precancer screening cost-effective, boosting access and compliance, especially in high-risk groups, while reducing healthcare costs and improving early detection.</itunes:summary>
      <itunes:subtitle>Study finds home-based self-sampling for anal precancer screening cost-effective, boosting access and compliance, especially in high-risk groups, while reducing healthcare costs and improving early detection.</itunes:subtitle>
      <itunes:keywords>while reducing healthcare costs and improving early detection., study finds home-based self-sampling for anal precancer screening cost-effective, especially in high-risk groups, boosting access and compliance</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>34</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">91c2a6b6-ed22-4f8c-b403-45ee72704f8c</guid>
      <title>Racial Disparities in Chemotherapy-Induced Alopecia</title>
      <description><![CDATA[Study reveals racial disparities in persistent chemotherapy-induced alopecia, with Black and Latina breast cancer patients disproportionately affected, highlighting need for counseling and culturally sensitive care. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/racial-disparities-in-chemotherapy-induced-alopecia-JlIeMH1B</link>
      <enclosure length="1606260" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/4bdc6bf9-d4f1-4084-8271-3b2bd10bb83b/audio/1f3b0ea2-5c43-4c39-aca6-97bfbd93bddd/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Racial Disparities in Chemotherapy-Induced Alopecia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:40</itunes:duration>
      <itunes:summary>Study reveals racial disparities in persistent chemotherapy-induced alopecia, with Black and Latina breast cancer patients disproportionately affected, highlighting need for counseling and culturally sensitive care.</itunes:summary>
      <itunes:subtitle>Study reveals racial disparities in persistent chemotherapy-induced alopecia, with Black and Latina breast cancer patients disproportionately affected, highlighting need for counseling and culturally sensitive care.</itunes:subtitle>
      <itunes:keywords>highlighting need for counseling and culturally sensitive care., study reveals racial disparities in persistent chemotherapy-induced alopecia, with black and latina breast cancer patients disproportionately affected</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>33</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6d57a523-7e4a-4afb-8117-725db9dfeee4</guid>
      <title>Nature Exposure and Pain Relief</title>
      <description><![CDATA[Meta-analysis shows nature exposure modestly reduces self-reported pain, supporting nonpharmacologic pain management, though heterogeneity and bias highlight need for more rigorous, controlled future studies. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/nature-exposure-and-pain-relief-mRCVOhq2</link>
      <enclosure length="1495083" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/7999588b-a2c5-4c78-84a7-867e45e1aa43/audio/43b238d7-d644-4fbc-85f1-d26007abe474/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Nature Exposure and Pain Relief</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Meta-analysis shows nature exposure modestly reduces self-reported pain, supporting nonpharmacologic pain management, though heterogeneity and bias highlight need for more rigorous, controlled future studies.</itunes:summary>
      <itunes:subtitle>Meta-analysis shows nature exposure modestly reduces self-reported pain, supporting nonpharmacologic pain management, though heterogeneity and bias highlight need for more rigorous, controlled future studies.</itunes:subtitle>
      <itunes:keywords>meta-analysis shows nature exposure modestly reduces self-reported pain, supporting nonpharmacologic pain management, controlled future studies., though heterogeneity and bias highlight need for more rigorous</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>32</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f875a191-cf89-47e4-a213-cbc9495653ee</guid>
      <title>AI-Enhanced Echocardiography for Cardiac Amyloidosis Detection</title>
      <description><![CDATA[AI-enhanced echocardiography, FDA-approved, detects cardiac amyloidosis with high accuracy, outperforming prior tools and enabling earlier diagnosis and treatment in heart failure patients. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-enhanced-echocardiography-for-cardiac-amyloidosis-detection-rg08mKnI</link>
      <enclosure length="1589541" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/442fa961-9362-4687-b937-51474a9f0fee/audio/fb6cf4f8-fb3d-434d-9613-07d7be4aca40/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI-Enhanced Echocardiography for Cardiac Amyloidosis Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:39</itunes:duration>
      <itunes:summary>AI-enhanced echocardiography, FDA-approved, detects cardiac amyloidosis with high accuracy, outperforming prior tools and enabling earlier diagnosis and treatment in heart failure patients.</itunes:summary>
      <itunes:subtitle>AI-enhanced echocardiography, FDA-approved, detects cardiac amyloidosis with high accuracy, outperforming prior tools and enabling earlier diagnosis and treatment in heart failure patients.</itunes:subtitle>
      <itunes:keywords>fda-approved, detects cardiac amyloidosis with high accuracy, outperforming prior tools and enabling earlier diagnosis and treatment in heart failure patients., ai-enhanced echocardiography</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>31</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f42b1d71-e239-49d8-831a-13f7e93b3c8d</guid>
      <title>Mitral Valve Repair in Hypertrophic Cardiomyopathy</title>
      <description><![CDATA[Mayo Clinic study shows mitral valve repair during septal myectomy is safe, durable, and effective for obstructive HCM patients with degenerative mitral regurgitation. 
]]></description>
      <pubDate>Tue, 6 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/mitral-valve-repair-in-hypertrophic-cardiomyopathy-UiGW_8PT</link>
      <enclosure length="1344199" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/01a23e88-aae6-4b0d-a966-9b3906d027db/audio/8dcf6826-b902-4356-b7fb-fcd35a63175c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Mitral Valve Repair in Hypertrophic Cardiomyopathy</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:23</itunes:duration>
      <itunes:summary>Mayo Clinic study shows mitral valve repair during septal myectomy is safe, durable, and effective for obstructive HCM patients with degenerative mitral regurgitation.</itunes:summary>
      <itunes:subtitle>Mayo Clinic study shows mitral valve repair during septal myectomy is safe, durable, and effective for obstructive HCM patients with degenerative mitral regurgitation.</itunes:subtitle>
      <itunes:keywords>durable, mayo clinic study shows mitral valve repair during septal myectomy is safe, and effective for obstructive hcm patients with degenerative mitral regurgitation.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>30</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c2421b5c-f428-4135-9e95-870ff26ae62b</guid>
      <title>Advancing Opioid Misuse Detection with Deep Learning</title>
      <description><![CDATA[Entropy-informed personalized deep learning improves opioid misuse detection, outperforming traditional models, enabling targeted interventions in pain and addiction care, and addressing the opioid crisis globally. 
]]></description>
      <pubDate>Mon, 5 Jan 2026 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advancing-opioid-misuse-detection-with-deep-learning-62bRvXAq</link>
      <enclosure length="1919729" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a4a76b4f-eedd-4f8d-a51d-0e39fec18caa/audio/85011cbd-9382-4a08-acf6-5135feee8d31/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advancing Opioid Misuse Detection with Deep Learning</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:59</itunes:duration>
      <itunes:summary>Entropy-informed personalized deep learning improves opioid misuse detection, outperforming traditional models, enabling targeted interventions in pain and addiction care, and addressing the opioid crisis globally.</itunes:summary>
      <itunes:subtitle>Entropy-informed personalized deep learning improves opioid misuse detection, outperforming traditional models, enabling targeted interventions in pain and addiction care, and addressing the opioid crisis globally.</itunes:subtitle>
      <itunes:keywords>enabling targeted interventions in pain and addiction care, and addressing the opioid crisis globally., outperforming traditional models, entropy-informed personalized deep learning improves opioid misuse detection</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>29</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0a36c030-05ea-40f9-b95b-0aafa268942a</guid>
      <title>Vital Vitamin D_ Health Benefits and Sources</title>
      <description><![CDATA[Vitamin D-rich foods like fatty fish, fortified products, eggs, and tofu support bone and immune health, especially for individuals with limited sun exposure or deficiency risk. 
]]></description>
      <pubDate>Mon, 5 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/vital-vitamin-d-health-benefits-and-sources-fshqz4hl</link>
      <enclosure length="1833212" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/aa447ebb-3cc6-4bfb-9c68-7da499c4ec39/audio/b73006f3-961e-4bed-ac2b-168407a5e06c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Vital Vitamin D_ Health Benefits and Sources</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Vitamin D-rich foods like fatty fish, fortified products, eggs, and tofu support bone and immune health, especially for individuals with limited sun exposure or deficiency risk.</itunes:summary>
      <itunes:subtitle>Vitamin D-rich foods like fatty fish, fortified products, eggs, and tofu support bone and immune health, especially for individuals with limited sun exposure or deficiency risk.</itunes:subtitle>
      <itunes:keywords>especially for individuals with limited sun exposure or deficiency risk., and tofu support bone and immune health, eggs, vitamin d-rich foods like fatty fish, fortified products</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>28</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">5c6cfd3a-ec3d-4f40-8b13-c794ded30c9e</guid>
      <title>Prenatal Care and Its Impact</title>
      <description><![CDATA[Nearly 25% miss first-trimester prenatal care, increasing risks like preterm birth and low birth weight, highlighting need for improved access, education, and early pregnancy monitoring. 
]]></description>
      <pubDate>Mon, 5 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/prenatal-care-and-its-impact-VL3u9U2g</link>
      <enclosure length="1656833" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cb059f47-b101-45ba-8255-241bbbf79064/audio/3822378b-bdfb-4d33-b9de-33b28822e1c1/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Prenatal Care and Its Impact</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:43</itunes:duration>
      <itunes:summary>Nearly 25% miss first-trimester prenatal care, increasing risks like preterm birth and low birth weight, highlighting need for improved access, education, and early pregnancy monitoring.</itunes:summary>
      <itunes:subtitle>Nearly 25% miss first-trimester prenatal care, increasing risks like preterm birth and low birth weight, highlighting need for improved access, education, and early pregnancy monitoring.</itunes:subtitle>
      <itunes:keywords>highlighting need for improved access, nearly 25% miss first-trimester prenatal care, education, increasing risks like preterm birth and low birth weight, and early pregnancy monitoring.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>27</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">d054ad8a-e531-4708-82b4-214edeba4283</guid>
      <title>FOXQ1_ A New Link in Breast Cancer Pathogenesis</title>
      <description><![CDATA[Study identifies FOXQ1-WNT2-β-catenin axis driving triple-negative breast cancer aggressiveness, linking poor prognosis, EMT, invasion, and highlighting miR-96-5p as a promising therapeutic target for future treatment. 
]]></description>
      <pubDate>Mon, 5 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/foxq1-a-new-link-in-breast-cancer-pathogenesis-x7lnanjg</link>
      <enclosure length="1723288" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/eb60b659-71dd-4cdd-8d3f-04b735a1254d/audio/c43e5a2e-dbf1-4146-ab00-d2c0692ba139/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>FOXQ1_ A New Link in Breast Cancer Pathogenesis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>Study identifies FOXQ1-WNT2-β-catenin axis driving triple-negative breast cancer aggressiveness, linking poor prognosis, EMT, invasion, and highlighting miR-96-5p as a promising therapeutic target for future treatment.</itunes:summary>
      <itunes:subtitle>Study identifies FOXQ1-WNT2-β-catenin axis driving triple-negative breast cancer aggressiveness, linking poor prognosis, EMT, invasion, and highlighting miR-96-5p as a promising therapeutic target for future treatment.</itunes:subtitle>
      <itunes:keywords>invasion, emt, study identifies foxq1-wnt2-β-catenin axis driving triple-negative breast cancer aggressiveness, linking poor prognosis, and highlighting mir-96-5p as a promising therapeutic target for future treatment.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>26</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1134da90-f0a4-4613-9f5b-aa03af35b102</guid>
      <title>TAVR_ A Minimally Invasive Heart Valve Solution</title>
      <description><![CDATA[TAVR provides minimally invasive aortic stenosis treatment, expanding to patients, guided by multidisciplinary assessment of anatomy, comorbidities, and longevity, while surgery remains appropriate for cases. 
]]></description>
      <pubDate>Mon, 5 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/tavr-a-minimally-invasive-heart-valve-solution-MNYyBq79</link>
      <enclosure length="1562792" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/35d144f3-4b50-4931-8c25-179a09e9c475/audio/efcdc958-b614-42b5-b300-6c033150f1d6/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>TAVR_ A Minimally Invasive Heart Valve Solution</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:37</itunes:duration>
      <itunes:summary>TAVR provides minimally invasive aortic stenosis treatment, expanding to patients, guided by multidisciplinary assessment of anatomy, comorbidities, and longevity, while surgery remains appropriate for cases.</itunes:summary>
      <itunes:subtitle>TAVR provides minimally invasive aortic stenosis treatment, expanding to patients, guided by multidisciplinary assessment of anatomy, comorbidities, and longevity, while surgery remains appropriate for cases.</itunes:subtitle>
      <itunes:keywords>and longevity, guided by multidisciplinary assessment of anatomy, while surgery remains appropriate for cases., comorbidities, tavr provides minimally invasive aortic stenosis treatment, expanding to patients</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>25</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">1c2c2ef6-a534-48bc-9af1-3924a1506a1b</guid>
      <title>Neighborhood Environment and Genetic Risk in Children&apos;s Mental Health</title>
      <description><![CDATA[Study links neighborhood pollution and socioeconomic disadvantage with genetic risk, increasing psychotic-like experiences in children, underscoring gene–environment interaction and prevention through environmental interventions strategies early. 
]]></description>
      <pubDate>Fri, 2 Jan 2026 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/neighborhood-environment-and-genetic-risk-in-childrens-mental-health-ZF5pCMSd</link>
      <enclosure length="1109306" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e333aa88-8d94-4685-880c-dee8cbfe7de6/audio/7558cf79-8796-4b68-ae9b-7ec99b8c7ee8/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Neighborhood Environment and Genetic Risk in Children&apos;s Mental Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:09</itunes:duration>
      <itunes:summary>Study links neighborhood pollution and socioeconomic disadvantage with genetic risk, increasing psychotic-like experiences in children, underscoring gene–environment interaction and prevention through environmental interventions strategies early.</itunes:summary>
      <itunes:subtitle>Study links neighborhood pollution and socioeconomic disadvantage with genetic risk, increasing psychotic-like experiences in children, underscoring gene–environment interaction and prevention through environmental interventions strategies early.</itunes:subtitle>
      <itunes:keywords>study links neighborhood pollution and socioeconomic disadvantage with genetic risk, underscoring gene–environment interaction and prevention through environmental interventions strategies early., increasing psychotic-like experiences in children</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>24</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">19ac5e26-3d11-4343-a2ba-96cdae2fac20</guid>
      <title>Winter Wellness Routines</title>
      <description><![CDATA[Winter morning routines boost wellbeing by supporting circadian rhythms, mood, and energy through light exposure, exercise, mindfulness, and nutrition, helping reduce seasonal symptoms and resilience. 
]]></description>
      <pubDate>Fri, 2 Jan 2026 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/winter-wellness-routines-ePwNOJuE</link>
      <enclosure length="1626322" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/daa4ae69-cc8d-4548-a3ac-72e58dc281d8/audio/e00bf91b-b22e-4211-af13-f0eb961a8850/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Winter Wellness Routines</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:41</itunes:duration>
      <itunes:summary>Winter morning routines boost wellbeing by supporting circadian rhythms, mood, and energy through light exposure, exercise, mindfulness, and nutrition, helping reduce seasonal symptoms and resilience.</itunes:summary>
      <itunes:subtitle>Winter morning routines boost wellbeing by supporting circadian rhythms, mood, and energy through light exposure, exercise, mindfulness, and nutrition, helping reduce seasonal symptoms and resilience.</itunes:subtitle>
      <itunes:keywords>mindfulness, winter morning routines boost wellbeing by supporting circadian rhythms, and energy through light exposure, mood, and nutrition, exercise, helping reduce seasonal symptoms and resilience.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>23</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">6ede6492-af1f-4d91-a8b7-145196cf72eb</guid>
      <title>CAR-T Therapy for Cardiac Patients</title>
      <description><![CDATA[Mayo Clinic case series shows CAR-T therapy can be safely used in lymphoma patients with cardiomyopathy or cardiac metastases through careful selection and multidisciplinary cardio-oncology management. 
]]></description>
      <pubDate>Fri, 2 Jan 2026 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/car-t-therapy-for-cardiac-patients-Q_01yEgo</link>
      <enclosure length="1412745" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/421de4d1-94d9-4bbc-a572-26d3a4b47635/audio/2a25f506-446f-42f0-9fa9-8e72cded1bc5/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>CAR-T Therapy for Cardiac Patients</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:28</itunes:duration>
      <itunes:summary>Mayo Clinic case series shows CAR-T therapy can be safely used in lymphoma patients with cardiomyopathy or cardiac metastases through careful selection and multidisciplinary cardio-oncology management.</itunes:summary>
      <itunes:subtitle>Mayo Clinic case series shows CAR-T therapy can be safely used in lymphoma patients with cardiomyopathy or cardiac metastases through careful selection and multidisciplinary cardio-oncology management.</itunes:subtitle>
      <itunes:keywords>mayo clinic case series shows car-t therapy can be safely used in lymphoma patients with cardiomyopathy or cardiac metastases through careful selection and multidisciplinary cardio-oncology management.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>22</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">e7e90bbb-3c40-4c15-9577-668a02f88b76</guid>
      <title>Rheumatoid Arthritis and Heart Failure Risk</title>
      <description><![CDATA[Analysis shows rheumatoid arthritis increases risk of systolic and diastolic heart failure over time, urging integrated cardiology–rheumatology care and proactive cardiovascular monitoring for improved outcomes. 
]]></description>
      <pubDate>Fri, 2 Jan 2026 14:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/rheumatoid-arthritis-and-heart-failure-risk-5iqwlwFB</link>
      <enclosure length="1324137" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a7aaed6d-3997-4c6d-891c-d0d88bbf04fd/audio/a34244d0-8cac-4459-986b-ada0d9160d04/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Rheumatoid Arthritis and Heart Failure Risk</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:22</itunes:duration>
      <itunes:summary>Analysis shows rheumatoid arthritis increases risk of systolic and diastolic heart failure over time, urging integrated cardiology–rheumatology care and proactive cardiovascular monitoring for improved outcomes.</itunes:summary>
      <itunes:subtitle>Analysis shows rheumatoid arthritis increases risk of systolic and diastolic heart failure over time, urging integrated cardiology–rheumatology care and proactive cardiovascular monitoring for improved outcomes.</itunes:subtitle>
      <itunes:keywords>analysis shows rheumatoid arthritis increases risk of systolic and diastolic heart failure over time, urging integrated cardiology–rheumatology care and proactive cardiovascular monitoring for improved outcomes.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>21</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">7ac4d0fe-0022-4347-95cf-192ce3baa386</guid>
      <title>Peripheral Artery Disease Overview</title>
      <description><![CDATA[PAD affects millions worldwide, causes limb ischemia, requires multidisciplinary care, early referral, lifestyle changes, and revascularization to prevent amputations, stroke, and heart attack risk reduction. 
]]></description>
      <pubDate>Fri, 2 Jan 2026 13:12:54 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/peripheral-artery-disease-overview-_ctCs9by</link>
      <enclosure length="1719945" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c89539da-458a-439f-8a14-a22fa2a61cec/audio/5c2bb6af-8bbe-4804-bcfc-51d5bb8f299e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Peripheral Artery Disease Overview</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:47</itunes:duration>
      <itunes:summary>PAD affects millions worldwide, causes limb ischemia, requires multidisciplinary care, early referral, lifestyle changes, and revascularization to prevent amputations, stroke, and heart attack risk reduction.</itunes:summary>
      <itunes:subtitle>PAD affects millions worldwide, causes limb ischemia, requires multidisciplinary care, early referral, lifestyle changes, and revascularization to prevent amputations, stroke, and heart attack risk reduction.</itunes:subtitle>
      <itunes:keywords>causes limb ischemia, stroke, pad affects millions worldwide, early referral, lifestyle changes, and revascularization to prevent amputations, and heart attack risk reduction., requires multidisciplinary care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>20</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0628f8bd-1b3a-416e-9c8c-7c9cc43cdf72</guid>
      <title>Catheter Ablation&apos;s Impact on AFib Readmissions in Young Adults</title>
      <description><![CDATA[Catheter ablation in younger AFib patients reduces one-year readmissions without increasing mortality, highlighting benefits but revealing disparities in access by income and race. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 18:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/catheter-ablations-impact-on-afib-readmissions-in-young-adults-21Dqtk_P</link>
      <enclosure length="1534789" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5ed40909-6ad3-404b-8248-6fe8cf57005f/audio/02894ea3-a6c3-4ab4-9d5d-ec8815c91d40/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Catheter Ablation&apos;s Impact on AFib Readmissions in Young Adults</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:35</itunes:duration>
      <itunes:summary>Catheter ablation in younger AFib patients reduces one-year readmissions without increasing mortality, highlighting benefits but revealing disparities in access by income and race.</itunes:summary>
      <itunes:subtitle>Catheter ablation in younger AFib patients reduces one-year readmissions without increasing mortality, highlighting benefits but revealing disparities in access by income and race.</itunes:subtitle>
      <itunes:keywords>highlighting benefits but revealing disparities in access by income and race., catheter ablation in younger afib patients reduces one-year readmissions without increasing mortality</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>19</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">f47eae1a-d42e-4bfa-bbec-41917c3266a4</guid>
      <title>Cardiovascular Health and Vision_ A New Connection</title>
      <description><![CDATA[Higher PCE cardiovascular risk strongly predicts future AMD, glaucoma, DR, RVO, and HTR, supporting PCE use in primary care for early ocular disease detection. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 17:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/cardiovascular-health-and-vision-a-new-connection-jxtIFyYo</link>
      <enclosure length="2136650" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2efa408d-0099-451a-9b4e-6bd54a4aceaa/audio/9a242636-0a7f-4307-8942-cdb2e53f8310/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cardiovascular Health and Vision_ A New Connection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:13</itunes:duration>
      <itunes:summary>Higher PCE cardiovascular risk strongly predicts future AMD, glaucoma, DR, RVO, and HTR, supporting PCE use in primary care for early ocular disease detection.</itunes:summary>
      <itunes:subtitle>Higher PCE cardiovascular risk strongly predicts future AMD, glaucoma, DR, RVO, and HTR, supporting PCE use in primary care for early ocular disease detection.</itunes:subtitle>
      <itunes:keywords>higher pce cardiovascular risk strongly predicts future amd, supporting pce use in primary care for early ocular disease detection., glaucoma, and htr, dr, rvo</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>18</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ce822e85-e2e4-48e0-a43c-5c9b0d04a1f3</guid>
      <title>Patient Perception in Axial Spondylarthritis Study</title>
      <description><![CDATA[Study shows many axSpA patients report acceptable symptoms despite high disease activity, highlighting PASS usefulness and need to integrate patient perspectives with clinical measures for better care. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 16:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/patient-perception-in-axial-spondylarthritis-study-xuLCJBDO</link>
      <enclosure length="1836555" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/65eee610-242c-4d48-94aa-2512c354667c/audio/d7d4b609-be06-4e31-9259-4dcf9c56704c/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Patient Perception in Axial Spondylarthritis Study</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:54</itunes:duration>
      <itunes:summary>Study shows many axSpA patients report acceptable symptoms despite high disease activity, highlighting PASS usefulness and need to integrate patient perspectives with clinical measures for better care.</itunes:summary>
      <itunes:subtitle>Study shows many axSpA patients report acceptable symptoms despite high disease activity, highlighting PASS usefulness and need to integrate patient perspectives with clinical measures for better care.</itunes:subtitle>
      <itunes:keywords>study shows many axspa patients report acceptable symptoms despite high disease activity, highlighting pass usefulness and need to integrate patient perspectives with clinical measures for better care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>17</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2066fff4-8aa0-4813-b648-22d2ff71fe58</guid>
      <title>Long-Term Guselkumab Persistence in Plaque Psoriasis</title>
      <description><![CDATA[Study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by BMI or severity, while prior biologic—especially IL-17—use increases discontinuation risk. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 15:00:00 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/long-term-guselkumab-persistence-in-plaque-psoriasis-qqFHouG5</link>
      <enclosure length="1479618" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/3b0c02a1-a2da-49aa-98fb-913cfd0e3030/audio/30fd2c86-99da-41d6-8821-85680f9484b4/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Long-Term Guselkumab Persistence in Plaque Psoriasis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:32</itunes:duration>
      <itunes:summary>Study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by BMI or severity, while prior biologic—especially IL-17—use increases discontinuation risk.</itunes:summary>
      <itunes:subtitle>Study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by BMI or severity, while prior biologic—especially IL-17—use increases discontinuation risk.</itunes:subtitle>
      <itunes:keywords>study shows strong long-term guselkumab persistence in plaque psoriasis, unaffected by bmi or severity, while prior biologic—especially il-17—use increases discontinuation risk.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>16</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">926ec3b6-fc5b-41b0-b9fe-754bd6d19d0f</guid>
      <title>Depression and Anxiety in Gender-Diverse Youths in Australia</title>
      <description><![CDATA[Research shows gender- and sexuality-diverse adolescents face much higher depression and anxiety odds, needing targeted mental health support, safer environments, and identity-affirming interventions in Australia. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 14:16:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/depression-and-anxiety-in-gender-diverse-youths-in-australia-2XvKZvIW</link>
      <enclosure length="1502188" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cb777ac9-5972-4a13-b078-537f065f7706/audio/67abea06-e23b-4327-9317-80a638556290/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Depression and Anxiety in Gender-Diverse Youths in Australia</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:33</itunes:duration>
      <itunes:summary>Research shows gender- and sexuality-diverse adolescents face much higher depression and anxiety odds, needing targeted mental health support, safer environments, and identity-affirming interventions in Australia.</itunes:summary>
      <itunes:subtitle>Research shows gender- and sexuality-diverse adolescents face much higher depression and anxiety odds, needing targeted mental health support, safer environments, and identity-affirming interventions in Australia.</itunes:subtitle>
      <itunes:keywords>and identity-affirming interventions in australia., research shows gender- and sexuality-diverse adolescents face much higher depression and anxiety odds, safer environments, needing targeted mental health support</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>15</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">000c9368-d89f-47fc-99db-5754c039dc27</guid>
      <title>Psoriasis and Eczema Triggers Study</title>
      <description><![CDATA[Study identifies stress and poor sleep worsen psoriasis, while humidity and dust aggravate eczema, guiding tailored management to improve outcomes for patients with inflammatory skin disease. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 03:16:40 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/psoriasis-and-eczema-triggers-study-b_esXUah</link>
      <enclosure length="1667700" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5d146c3e-0d09-4571-82c5-b6b1408c7a6a/audio/9921a612-1200-4dbd-945a-f9ff6b0d7dda/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Psoriasis and Eczema Triggers Study</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:44</itunes:duration>
      <itunes:summary>Study identifies stress and poor sleep worsen psoriasis, while humidity and dust aggravate eczema, guiding tailored management to improve outcomes for patients with inflammatory skin disease.</itunes:summary>
      <itunes:subtitle>Study identifies stress and poor sleep worsen psoriasis, while humidity and dust aggravate eczema, guiding tailored management to improve outcomes for patients with inflammatory skin disease.</itunes:subtitle>
      <itunes:keywords>study identifies stress and poor sleep worsen psoriasis, guiding tailored management to improve outcomes for patients with inflammatory skin disease., while humidity and dust aggravate eczema</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>14</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">032d77f5-76f6-471b-967f-eb6648a50982</guid>
      <title>HRV&apos;s Impact on Adult Respiratory Health</title>
      <description><![CDATA[Study confirms HRV causes adult LRTIs, shows seasonal peaks, co-infections, pneumonia risk in males with fever or cough, emphasizing diagnostic consideration in adult pneumonia cases. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 03:05:48 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/hrvs-impact-on-adult-respiratory-health-1kMKcZ_s</link>
      <enclosure length="1208781" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/37483df6-da42-497b-a4e6-4c81d2af7b43/audio/46724e98-0817-456c-ae04-7824d144a5ba/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>HRV&apos;s Impact on Adult Respiratory Health</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:15</itunes:duration>
      <itunes:summary>Study confirms HRV causes adult LRTIs, shows seasonal peaks, co-infections, pneumonia risk in males with fever or cough, emphasizing diagnostic consideration in adult pneumonia cases.</itunes:summary>
      <itunes:subtitle>Study confirms HRV causes adult LRTIs, shows seasonal peaks, co-infections, pneumonia risk in males with fever or cough, emphasizing diagnostic consideration in adult pneumonia cases.</itunes:subtitle>
      <itunes:keywords>co-infections, pneumonia risk in males with fever or cough, shows seasonal peaks, emphasizing diagnostic consideration in adult pneumonia cases., study confirms hrv causes adult lrtis</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>13</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2fa16dc6-401f-4f32-bd1a-20bb2b413324</guid>
      <title>ADHD Overdiagnosis in Younger Schoolchildren</title>
      <description><![CDATA[Research shows inattention often misdiagnosed as ADHD, stressing careful evaluation, modest environmental impact, and neurodevelopmental roots to improve diagnostic accuracy and treatment in pediatric practice. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 02:58:26 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/adhd-overdiagnosis-in-younger-schoolchildren-2F0WtPfh</link>
      <enclosure length="2156294" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/f5ac0b29-9b82-4cac-afc6-e28263697250/audio/0e4b9771-c201-4b39-9c11-12cd664dfb18/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>ADHD Overdiagnosis in Younger Schoolchildren</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:14</itunes:duration>
      <itunes:summary>Research shows inattention often misdiagnosed as ADHD, stressing careful evaluation, modest environmental impact, and neurodevelopmental roots to improve diagnostic accuracy and treatment in pediatric practice.</itunes:summary>
      <itunes:subtitle>Research shows inattention often misdiagnosed as ADHD, stressing careful evaluation, modest environmental impact, and neurodevelopmental roots to improve diagnostic accuracy and treatment in pediatric practice.</itunes:subtitle>
      <itunes:keywords>and neurodevelopmental roots to improve diagnostic accuracy and treatment in pediatric practice., modest environmental impact, research shows inattention often misdiagnosed as adhd, stressing careful evaluation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>12</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">c0354899-d0b2-4b31-b52a-51cdec5803e8</guid>
      <title>Addressing Bacterial Vaginosis Recurrence</title>
      <description><![CDATA[To improve Bacterial Vaginosis outcomes, new research suggests treating male partners. This approach can significantly reduce recurrence rates and enhance the overall standard of care. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 02:51:42 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/addressing-bacterial-vaginosis-recurrence-OwKjPWQ7</link>
      <enclosure length="715171" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e09905dd-95f1-40c2-a6dc-948fd0703636/audio/cdb0a60e-e458-44ac-9715-aad29cfb78a2/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Addressing Bacterial Vaginosis Recurrence</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:00:44</itunes:duration>
      <itunes:summary>To improve Bacterial Vaginosis outcomes, new research suggests treating male partners. This approach can significantly reduce recurrence rates and enhance the overall standard of care.</itunes:summary>
      <itunes:subtitle>To improve Bacterial Vaginosis outcomes, new research suggests treating male partners. This approach can significantly reduce recurrence rates and enhance the overall standard of care.</itunes:subtitle>
      <itunes:keywords>to improve bacterial vaginosis outcomes, new research suggests treating male partners. this approach can significantly reduce recurrence rates and enhance the overall standard of care.</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>11</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">580e269c-8621-4bc7-9be0-8df4fbd5ec00</guid>
      <title>Cardiac and Respiratory Case Study Analysis</title>
      <description><![CDATA[Case study reviews management of a 53-year-old with cardiovascular disease and progressive dyspnea, emphasizing thorough evaluation, multidisciplinary care, and critical heart-lung interplay in treatment decisions. 
]]></description>
      <pubDate>Tue, 30 Dec 2025 02:31:58 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/case-study-managing-progressive-dyspnea-in-a-53-year-old-man-L65GpMIg</link>
      <enclosure length="1296970" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/c13d2e04-1011-449b-8da3-f7527af20f91/audio/9802cf2e-c3b1-4caa-b193-1edbddab11a3/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Cardiac and Respiratory Case Study Analysis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:21</itunes:duration>
      <itunes:summary>Case study reviews management of a 53-year-old with cardiovascular disease and progressive dyspnea, emphasizing thorough evaluation, multidisciplinary care, and critical heart-lung interplay in treatment decisions.</itunes:summary>
      <itunes:subtitle>Case study reviews management of a 53-year-old with cardiovascular disease and progressive dyspnea, emphasizing thorough evaluation, multidisciplinary care, and critical heart-lung interplay in treatment decisions.</itunes:subtitle>
      <itunes:keywords>case study reviews management of a 53-year-old with cardiovascular disease and progressive dyspnea, emphasizing thorough evaluation, and critical heart-lung interplay in treatment decisions., multidisciplinary care</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>10</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">8fd3745b-6d02-4873-a6ee-51763d0eb17d</guid>
      <title>Transcatheter Heart Valve Market Growth</title>
      <description><![CDATA[Transcatheter heart valve therapies are rapidly expanding, driven by innovation, broader patient eligibility, rising disease prevalence, competitive dynamics, and need for intervention to improve outcomes. 
]]></description>
      <pubDate>Tue, 23 Dec 2025 14:27:39 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/transcatheter-heart-valve-market-growth-gfBVm72a</link>
      <enclosure length="2070194" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/e3e7f0f4-5a67-42be-886e-55e37f4c2ee3/audio/537bed44-f12c-4ba1-a53a-3767abbe906e/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Transcatheter Heart Valve Market Growth</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:02:09</itunes:duration>
      <itunes:summary>Transcatheter heart valve therapies are rapidly expanding, driven by innovation, broader patient eligibility, rising disease prevalence, competitive dynamics, and need for intervention to improve outcomes.</itunes:summary>
      <itunes:subtitle>Transcatheter heart valve therapies are rapidly expanding, driven by innovation, broader patient eligibility, rising disease prevalence, competitive dynamics, and need for intervention to improve outcomes.</itunes:subtitle>
      <itunes:keywords>competitive dynamics, rising disease prevalence, and need for intervention to improve outcomes., broader patient eligibility, transcatheter heart valve therapies are rapidly expanding, driven by innovation</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>9</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">68787406-3acf-475b-b7d3-06422340d713</guid>
      <title>Choroidal Metastasis_ A Critical Marker for Systemic Cancer</title>
      <description><![CDATA[Choroidal metastasis is the most common intraocular malignancy, often revealing systemic cancer; early ocular detection and modern systemic therapies can improve vision, survival, and outcomes. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 17:54:04 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/choroidal-metastasis-a-critical-marker-for-systemic-cancer-5SbHpBYN</link>
      <enclosure length="1887964" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/534190a9-58a4-4182-b29c-ec112419f7ef/audio/378fb670-5285-4574-ac03-3b3a85cee307/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Choroidal Metastasis_ A Critical Marker for Systemic Cancer</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:57</itunes:duration>
      <itunes:summary>Choroidal metastasis is the most common intraocular malignancy, often revealing systemic cancer; early ocular detection and modern systemic therapies can improve vision, survival, and outcomes.</itunes:summary>
      <itunes:subtitle>Choroidal metastasis is the most common intraocular malignancy, often revealing systemic cancer; early ocular detection and modern systemic therapies can improve vision, survival, and outcomes.</itunes:subtitle>
      <itunes:keywords>and outcomes., survival, choroidal metastasis is the most common intraocular malignancy, often revealing systemic cancer; early ocular detection and modern systemic therapies can improve vision</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>8</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">2ab2b456-9e93-4d4a-a18d-c474f43d9e07</guid>
      <title>Urologist Burnout Crisis</title>
      <description><![CDATA[Survey finds 45% of U.S. urologists report burnout, limited help-seeking, and licensure mental health questions as key barriers, highlighting urgent need for policy reform. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:51:04 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/urologist-burnout-crisis-1yBKZsIm</link>
      <enclosure length="1368023" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/b298d5a0-608e-40c9-9cf4-0a1fbf2079c1/audio/0d317140-e5e7-45fc-8393-516caa33a907/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Urologist Burnout Crisis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:25</itunes:duration>
      <itunes:summary>Survey finds 45% of U.S. urologists report burnout, limited help-seeking, and licensure mental health questions as key barriers, highlighting urgent need for policy reform.</itunes:summary>
      <itunes:subtitle>Survey finds 45% of U.S. urologists report burnout, limited help-seeking, and licensure mental health questions as key barriers, highlighting urgent need for policy reform.</itunes:subtitle>
      <itunes:keywords>and licensure mental health questions as key barriers, highlighting urgent need for policy reform., survey finds 45% of u.s. urologists report burnout, limited help-seeking</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>7</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">ead184ec-d461-4d0c-9899-b2522d1948cc</guid>
      <title>Reevaluating Postoperative Antibiotics</title>
      <description><![CDATA[Study shows 30-day postoperative UTI rates are low at 2.5%, unaffected by antibiotics, with higher risk in younger and female patients, supporting reassessment of postoperative antibiotic use. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:45:41 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/reevaluating-postoperative-antibiotics-DwQkDaxg</link>
      <enclosure length="1766756" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cfe84557-a783-4b37-a54d-3257f4f2c64b/audio/9ab661cd-b5ce-4614-8ad2-b0a31eb40aa3/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Reevaluating Postoperative Antibiotics</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:50</itunes:duration>
      <itunes:summary>Study shows 30-day postoperative UTI rates are low at 2.5%, unaffected by antibiotics, with higher risk in younger and female patients, supporting reassessment of postoperative antibiotic use.</itunes:summary>
      <itunes:subtitle>Study shows 30-day postoperative UTI rates are low at 2.5%, unaffected by antibiotics, with higher risk in younger and female patients, supporting reassessment of postoperative antibiotic use.</itunes:subtitle>
      <itunes:keywords>supporting reassessment of postoperative antibiotic use., unaffected by antibiotics, with higher risk in younger and female patients, study shows 30-day postoperative uti rates are low at 2.5%</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>6</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">bb12033f-4db7-40c3-a864-3df36185bcf9</guid>
      <title>Food Insecurity Among Medical Trainees</title>
      <description><![CDATA[Study finds 14% of medical trainees face food insecurity, disproportionately affecting Black and early-year residents, and associated with higher burnout, social isolation, and reduced well-being. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:42:32 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/food-insecurity-among-medical-trainees-Zo80gX0B</link>
      <enclosure length="1059151" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/a59fa168-396d-473d-83ce-5100fb1df0b6/audio/3b0e07bf-064c-4a90-8c15-132c83ae09db/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Food Insecurity Among Medical Trainees</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:06</itunes:duration>
      <itunes:summary>Study finds 14% of medical trainees face food insecurity, disproportionately affecting Black and early-year residents, and associated with higher burnout, social isolation, and reduced well-being.</itunes:summary>
      <itunes:subtitle>Study finds 14% of medical trainees face food insecurity, disproportionately affecting Black and early-year residents, and associated with higher burnout, social isolation, and reduced well-being.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>5</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">61aa7e4e-8e4e-4465-9c85-35d04582628a</guid>
      <title>EHR Time and Physician Burnout</title>
      <description><![CDATA[Dedicating appointment time for EHR tasks reduced after-hours work and physician burnout, with minimal productivity impact, suggesting structured EHR time may improve clinician efficiency and well-being. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:41:07 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ehr-time-and-physician-burnout-CsnEQjdD</link>
      <enclosure length="1239292" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/64a70ec1-3fe9-431d-bdfe-6b09cab353a7/audio/d0074c4f-6389-4d9b-80ac-a19c8fdd0831/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>EHR Time and Physician Burnout</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:17</itunes:duration>
      <itunes:summary>Dedicating appointment time for EHR tasks reduced after-hours work and physician burnout, with minimal productivity impact, suggesting structured EHR time may improve clinician efficiency and well-being.</itunes:summary>
      <itunes:subtitle>Dedicating appointment time for EHR tasks reduced after-hours work and physician burnout, with minimal productivity impact, suggesting structured EHR time may improve clinician efficiency and well-being.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>4</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">47c9c5ab-6667-4da5-be0f-92d3f9e6d38f</guid>
      <title>Gender Differences in Youth Psychosis</title>
      <description><![CDATA[Gender differences in youth first-episode psychosis affect symptom onset, diagnosis, treatment response, and relapse risk, underscoring the need for gender-sensitive evaluation, earlier detection, and tailored clinical care. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:37:53 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/gender-differences-in-youth-psychosis-ZWNv593V</link>
      <enclosure length="1400206" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/2878c63f-aec2-45df-bbc8-ae1b03d90107/audio/2cca803c-f28a-46a1-8048-c2bdfa317a27/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Gender Differences in Youth Psychosis</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:27</itunes:duration>
      <itunes:summary>Gender differences in youth first-episode psychosis affect symptom onset, diagnosis, treatment response, and relapse risk, underscoring the need for gender-sensitive evaluation, earlier detection, and tailored clinical care.</itunes:summary>
      <itunes:subtitle>Gender differences in youth first-episode psychosis affect symptom onset, diagnosis, treatment response, and relapse risk, underscoring the need for gender-sensitive evaluation, earlier detection, and tailored clinical care.</itunes:subtitle>
      <itunes:keywords>underscoring the need for gender-sensitive evaluation, diagnosis, doctor, and relapse risk, and tailored clinical care., earlier detection, hcp, treatment response, physician, gender differences in youth first-episode psychosis affect symptom onset</itunes:keywords>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>3</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">95382665-e1f9-4ec9-a232-604ab9224423</guid>
      <title>Advances in Multimodal Imaging for Adult Congenital Heart Disease</title>
      <description><![CDATA[Mayo Clinic highlights imaging, including echocardiography, CT, MRI, and 3D printing, to improve diagnosis, surgical planning, education, and outcomes in adults with congenital heart disease. 
]]></description>
      <pubDate>Mon, 22 Dec 2025 03:35:55 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/advances-in-multimodal-imaging-for-adult-congenital-heart-disease-pUBzbb60</link>
      <enclosure length="1262279" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/5e3439e5-a35f-4e76-9246-ef157aefb84d/audio/b2860d15-3912-46fb-94bc-788b41aff0fd/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>Advances in Multimodal Imaging for Adult Congenital Heart Disease</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:18</itunes:duration>
      <itunes:summary>Mayo Clinic highlights imaging, including echocardiography, CT, MRI, and 3D printing, to improve diagnosis, surgical planning, education, and outcomes in adults with congenital heart disease.</itunes:summary>
      <itunes:subtitle>Mayo Clinic highlights imaging, including echocardiography, CT, MRI, and 3D printing, to improve diagnosis, surgical planning, education, and outcomes in adults with congenital heart disease.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>2</itunes:episode>
    </item>
    <item>
      <guid isPermaLink="false">0ba0301d-b3a5-4a62-b8c7-34fc22cc3a50</guid>
      <title>AI Tool May Enhance Accuracy of Skin Cancer Detection</title>
      <description><![CDATA[Researchers developed MST-AI, an AI model using the Monk Skin Tone scale to significantly improve skin cancer detection accuracy and equity for patients with darker skin. 
]]></description>
      <pubDate>Tue, 16 Dec 2025 21:57:32 +0000</pubDate>
      <author>info@thebrief.health (TheBrief.Health)</author>
      <link>https://thebrief-health.simplecast.com/episodes/ai-tool-may-enhance-accuracy-of-skin-cancer-detection-ziSgJbRT</link>
      <enclosure length="1164477" type="audio/mpeg" url="https://cdn.simplecast.com/audio/cae8faab-f5c7-48f1-9d92-5a800080fa1f/episodes/cb240cef-3f75-42b6-91af-8edaf4c74dd8/audio/fcca9eb3-7193-4894-8c28-42bcd6406a3a/default_tc.mp3?aid=rss_feed&amp;feed=3xFUWysr"/>
      <itunes:title>AI Tool May Enhance Accuracy of Skin Cancer Detection</itunes:title>
      <itunes:author>TheBrief.Health</itunes:author>
      <itunes:duration>00:01:12</itunes:duration>
      <itunes:summary>Researchers developed MST-AI, an AI model using the Monk Skin Tone scale to significantly improve skin cancer detection accuracy and equity for patients with darker skin.</itunes:summary>
      <itunes:subtitle>Researchers developed MST-AI, an AI model using the Monk Skin Tone scale to significantly improve skin cancer detection accuracy and equity for patients with darker skin.</itunes:subtitle>
      <itunes:explicit>false</itunes:explicit>
      <itunes:episodeType>full</itunes:episodeType>
      <itunes:episode>1</itunes:episode>
    </item>
  </channel>
</rss>